Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADGRA1	"GPR123, KIAA1828"	ENSG00000197177	"Adhesion G protein-coupled receptor A1"	Q86SQ6	10	133070929-133131675	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 38.4"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 25.2;Hepatic stellate cells: 11.7;Inhibitory neurons: 24.6;Oligodendrocyte precursor cells: 29.1"	"Cancer enriched"	"Detected in single"	13	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"RH-30: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042773	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042773: AB_10794764"		"unprognostic (8.31e-2)"			"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"		"unprognostic (2.29e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.66e-1)"			0.0	3.8	16.3	0.0	14.2	0.0	0.0	3.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	18.8	15.2	0.4	0.2	0.1	0.0	9.8	18.5	0.0	0.1	0.0	2.8	0.0	10.9	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.7	38.4	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	14.2	3.3	27.5	18.8	15.2	9.8	18.5	10.9	4.2	38.4	15.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.5	0.0	2.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	29.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	72.3	36.1	53.6	39.1	63.8	21.9	40.2	57.1	66.5	47.8	47.1	50.0	25.3	36.1	56.1	45.2	31.3	40.8	45.8	51.7	62.0	39.3	49.0	46.2	51.2	63.0	58.4	40.6	32.5	32.5	21.4	47.8	62.8	35.1	36.1	19.4	28.0	42.1	28.4	26.6	28.9	54.2	58.9	37.4	28.2	44.3	58.5	33.8	37.5	49.7	52.9	47.2	31.2	69.6	74.3	56.2	65.5	70.4	181.2	169.9	71.4	135.7	145.0	95.1	87.0	64.3	62.0	39.5	67.2	161.7	73.4	44.8	81.4	89.9	115.4	59.6	30.0	50.4	64.2	61.9	95.2	62.5	28.4	104.0	78.9	113.4	108.9	102.4	117.8	49.6	77.1	54.3	180.8	27.6	40.9	38.4	163.6	83.9	118.8	43.8	183.9	57.9	110.9	49.7	43.1	72.1	91.0	53.4	83.8	100.3	43.5	38.5	94.1	127.4	62.9	124.9	162.7	40.3	80.4	35.2	118.1	38.7	128.0	5.7	2.8	2.9	5.7	4.4	4.8	14.2	7.2	6.2	2.5	13.8	7.4	5.8	1.6	3.5	5.0	7.2	10.2	4.1	53.6	63.8	57.1	66.5	51.7	62.0	63.0	58.4	62.8	58.9	58.5	69.6	80.2	22.4	49.9	6.5	57.9	32.5	36.2	19.8	20.5	18.8	20.8	18.0	8.6	27.1	18.7	33.1	33.3	20.6	46.5	19.0	29.4	38.6	20.4	27.1	48.9	52.4	36.1	46.7	8.9	37.9	55.0	52.6	12.8	46.6	3.8	32.4	43.9	36.9	31.5	23.5	11.1	22.4	22.4	37.8	40.2	23.8	60.3	42.5	37.4	30.9	58.9	32.1	38.1	10.6	10.0	51.1	19.8	50.8	32.1	61.2	24.4	54.4	32.8	13.8	32.9	66.1	43.9	35.3	17.9	26.6	30.3	9.0	28.0	32.0	17.8	33.7
AMZ1	KIAA1950	ENSG00000174945	"Archaelysin family metallopeptidase 1"	Q400G9	7	2679522-2775500	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 7.5"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;MCF7: 7.5;SK-BR-3: 5.2;T-47d: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020233	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA020233: AB_1844818"	"unprognostic (9.08e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-9)"	"unprognostic (1.60e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	0.0	0.0	7.4	0.2	7.5	0.4	0.1	3.4	5.1	0.9	0.0	0.1	0.1	0.8	0.0	0.0	0.3	0.1	0.1	3.6	1.9	0.0	0.8	0.5	0.2	3.6	3.7	0.2	0.1	0.0	0.6	0.8	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.6	0.4	0.0	0.6	6.1	0.0	0.0	0.0	0.3	0.1	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.0	2.3	3.4	1.6	2.2	0.0	1.0	0.6	0.2	2.2	0.2	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	7.5	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	5.2	0.0	0.1	27.7	0.0	0.0	0.1	0.1	0.1	0.1	1.0	0.2	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.4	7.5	3.4	5.1	3.6	1.9	3.6	3.7	2.1	0.6	6.1	1.7	0.1	0.0	0.5	14.4	0.9	0.0	0.1	0.0	0.0	0.8	0.3	0.3	3.3	0.0	0.0	0.0	4.2	0.3	1.6	0.0	0.0	0.0	18.8	0.5	1.6	0.4	0.0	0.0	6.1	0.0	9.8	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	10.6	0.2	0.0	0.0	1.9	9.9	0.0	1.7	1.8	5.6	0.0	0.0	0.0	104.5	20.7	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
APBA1	"D9S411E, MINT1, X11"	ENSG00000107282	"Amyloid beta precursor protein binding family A member 1"	Q02410	9	69427532-69672371	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5"	"Group enriched"	"Detected in many"	7	"Astrocytes: 53.5;Excitatory neurons: 130.3;Horizontal cells: 69.0;Inhibitory neurons: 181.6;Microglial cells: 78.7;Oligodendrocyte precursor cells: 141.3;Oligodendrocytes: 106.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 7.2;BJ hTERT+: 6.0;HAP1: 17.2;SCLC-21H: 6.5;TIME: 7.8;U-138 MG: 6.9;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061287			Supported	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA061287: AB_2684467"	"unprognostic (4.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.21e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.66e-3)"	2.9	1.2	14.1	0.7	13.1	0.0	2.5	0.0	16.5	3.6	0.0	2.9	0.6	4.1	0.1	1.8	2.5	1.3	3.0	16.0	9.5	2.2	11.9	1.4	0.6	15.1	13.8	5.3	1.9	6.8	6.3	1.4	16.1	1.9	1.9	3.2	2.9	1.1	2.0	3.9	1.8	0.8	0.0	3.8	2.0	2.8	7.9	0.2	2.0	0.6	0.3	2.8	3.6	0.9	0.0	0.0	0.6	0.0	3.1	2.2	0.1	7.2	6.0	0.1	0.1	0.0	0.0	0.0	3.2	3.0	0.0	0.1	17.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	2.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	2.5	6.5	4.2	0.4	0.9	0.1	0.2	0.0	0.0	7.8	6.9	0.8	0.0	0.5	7.1	3.3	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.1	0.0	16.5	16.0	9.5	15.1	13.8	16.1	0.0	7.9	0.9	1.0	0.0	0.0	53.5	0.0	1.8	1.2	0.2	0.0	15.4	2.0	2.2	4.9	0.0	0.2	0.0	4.2	0.8	0.0	3.7	0.0	0.1	0.3	0.9	1.7	1.4	4.2	0.0	130.3	0.0	0.6	1.7	0.0	1.0	0.0	1.3	3.3	5.8	3.1	69.0	181.6	1.6	0.0	3.7	1.4	0.6	2.5	1.4	0.0	78.7	1.0	3.2	0.0	141.3	106.2	0.2	0.4	10.9	0.0	0.6	0.0	0.4	0.1	9.1	0.0	1.6	2.3	1.1	1.3	0.5	2.4	0.4	0.5	6.0	1.2	0.4
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC regulator of WNT signaling pathway"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	6.9	4.6	28.4	6.2	26.0	9.1	5.7	23.1	31.0	5.7	0.1	6.7	6.2	5.6	3.3	7.7	4.3	4.9	7.2	52.8	27.4	6.2	5.7	6.2	5.6	32.1	30.7	6.6	4.1	8.5	3.9	5.1	39.0	5.2	6.2	20.0	3.8	4.1	8.5	5.7	8.5	7.5	16.0	6.1	5.0	5.1	37.9	8.5	5.9	11.8	5.9	5.4	3.6	20.9	11.3	10.1	16.8	12.2	13.4	11.3	6.7	17.9	8.5	9.7	11.5	8.2	8.9	22.0	17.0	23.1	15.5	9.0	17.4	14.6	15.9	13.2	12.2	16.8	14.9	6.2	6.6	8.4	8.6	9.3	9.8	16.6	10.8	6.8	13.6	10.2	20.9	7.2	14.3	7.8	9.6	4.2	6.0	6.1	3.6	8.1	20.8	10.7	8.9	14.1	17.0	10.1	16.9	6.5	7.1	6.8	9.1	6.7	22.8	19.6	9.5	19.5	13.6	5.6	9.5	8.2	10.8	15.3	11.2	11.8	2.5	4.9	2.9	1.3	2.4	2.8	1.5	1.9	2.1	3.1	2.4	2.4	11.4	2.9	2.4	2.7	1.5	1.0	28.4	26.0	23.1	31.0	52.8	27.4	32.1	30.7	39.0	16.0	37.9	20.9	40.6	51.3	23.6	536.4	21.9	11.2	8.9	10.1	19.9	196.9	13.1	14.9	56.6	18.6	20.1	0.0	66.7	5.4	28.9	28.6	0.0	18.7	10.5	20.1	27.6	31.2	27.5	17.4	165.8	19.5	6.5	25.9	19.4	29.7	19.0	28.7	26.7	13.9	16.3	79.1	236.4	17.2	2.0	18.9	12.4	5.5	17.7	27.8	17.8	85.3	30.7	23.4	23.7	196.6	150.8	20.3	34.7	19.5	22.9	10.4	37.2	5.1	18.0	41.5	39.5	44.1	34.0	19.2	30.4	26.5	11.6	2.9	22.4	27.1	16.0	8.9
APLF	"C2orf13, MGC47799, Xip1, ZCCHH1"	ENSG00000169621	"Aprataxin and PNKP like factor"	Q8IW19	2	68467572-68655862	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 103.7;Late spermatids: 164.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029396, HPA034642, HPA034643"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431"	"unprognostic (9.37e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.39e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.85e-3)"	1.2	1.1	2.0	0.8	3.2	0.7	1.4	0.1	2.2	1.1	0.0	1.1	0.6	1.3	1.0	1.5	0.5	1.0	0.9	2.7	1.9	0.9	1.5	0.9	1.2	0.7	2.2	0.9	0.6	0.9	0.4	1.8	1.0	1.1	0.8	0.4	1.1	1.3	1.1	2.3	0.5	1.1	0.9	0.8	0.7	1.0	1.5	0.8	1.1	1.3	1.2	1.0	1.4	3.2	1.8	0.3	1.7	1.8	3.4	4.4	1.0	1.7	3.6	1.1	1.4	0.7	1.1	3.4	1.1	1.7	2.2	0.5	0.3	2.7	2.7	2.9	0.4	2.5	0.1	0.4	1.5	0.8	2.4	2.4	2.2	1.7	2.5	2.2	0.8	1.7	0.2	2.8	1.2	0.2	1.3	3.1	1.1	1.8	0.9	1.5	0.6	1.6	2.4	1.0	0.4	1.1	1.8	0.0	1.7	2.6	0.0	0.6	1.2	3.4	0.6	1.5	1.3	2.0	0.9	2.4	1.5	0.8	2.0	7.0	0.5	1.9	0.4	0.7	0.6	0.6	0.8	0.7	0.8	0.5	0.8	0.4	0.0	1.0	0.6	0.7	1.4	0.5	2.0	3.2	0.1	2.2	2.7	1.9	0.7	2.2	1.0	0.9	1.5	3.2	3.6	3.2	2.6	14.0	3.1	2.4	2.4	4.4	8.0	0.5	2.4	3.6	3.5	0.0	2.9	0.0	2.1	6.3	2.6	0.3	0.0	3.5	103.7	1.4	4.0	3.1	3.5	3.4	21.8	1.9	2.2	3.2	4.6	1.7	0.0	3.9	2.2	1.2	2.2	3.3	3.2	0.7	2.0	1.9	2.6	164.1	4.4	2.3	0.0	9.4	4.2	0.5	3.1	22.6	29.0	1.4	0.5	1.9	6.4	2.8	0.2	2.2	1.3	0.2	0.0	4.8	4.7	7.7	4.8	5.0	3.3	4.9	1.8	2.2	0.7	1.5
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	280450-283010	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 249.4;pancreas: 112.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 12.1;Excitatory neurons: 27.8;Inhibitory neurons: 32.1;Proximal enterocytes: 64.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.6;HEK 293: 26.6;MCF7: 34.9;SCLC-21H: 10.9;SH-SY5Y: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	4.5	2.8	116.5	1.1	138.7	0.2	1.3	118.2	249.4	0.5	49.9	5.9	16.7	0.1	0.9	0.5	0.5	0.1	10.2	130.1	121.2	0.3	0.2	0.5	0.0	110.3	106.1	0.3	112.7	0.6	10.1	2.2	109.8	0.9	0.4	4.0	0.4	0.3	1.9	0.2	6.9	0.6	84.9	0.1	26.8	3.6	112.6	0.0	0.3	1.4	0.4	0.4	1.1	134.9	0.0	0.8	0.2	2.9	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	26.6	0.0	0.4	0.2	0.7	0.0	0.1	0.2	0.0	0.0	0.0	1.3	0.3	0.0	1.8	0.1	0.0	34.9	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.3	0.0	0.0	10.9	13.9	0.2	0.1	0.0	0.4	2.6	0.0	0.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.5	138.7	118.2	249.4	130.1	121.2	110.3	106.1	109.8	84.9	112.6	134.9	0.1	0.0	0.0	12.1	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.3	1.4	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.4	0.1	1.2	2.7	27.8	11.7	0.2	2.5	6.1	0.0	0.0	0.2	1.4	0.0	0.4	0.0	32.1	3.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	8.4	0.0	2.2	0.0	6.6	10.9	3.9	3.9	0.0	0.0	0.1	64.0	0.1	0.0	3.7	0.0	0.0	0.4	0.2	3.9	0.0	0.0	0.4	0.0	0.0	7.0	0.1
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597933	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 128.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 209.6;Excitatory neurons: 204.7;Inhibitory neurons: 301.5;Microglial cells: 98.4;Oligodendrocyte precursor cells: 232.7;Oligodendrocytes: 136.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.2;hTERT-RPE1: 29.7;LHCN-M2: 26.0;SK-MEL-30: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favorable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	2.2	2.1	94.4	2.1	100.6	0.4	1.4	47.8	111.7	5.6	29.8	5.8	1.7	5.9	8.2	2.0	5.3	2.5	4.1	128.0	64.2	21.7	0.4	5.0	2.3	61.8	70.5	10.7	3.4	6.4	11.5	1.1	53.6	5.5	2.1	8.1	1.2	5.0	9.7	2.1	2.7	3.9	60.2	3.5	4.1	9.9	84.0	2.2	7.0	6.0	3.0	4.3	2.0	66.7	0.4	16.1	28.4	0.0	0.1	3.6	0.1	12.2	17.3	13.9	28.2	0.0	0.0	0.0	3.0	14.7	7.2	0.4	10.5	0.6	17.7	0.0	2.9	0.5	0.0	1.0	0.9	0.0	7.2	13.2	0.5	6.1	0.3	29.7	0.0	0.0	0.0	0.1	26.0	14.0	0.0	0.0	5.7	0.0	0.2	0.0	0.3	0.0	6.0	20.5	14.9	20.6	1.5	0.2	30.8	1.8	0.6	0.0	0.0	22.2	4.4	0.6	14.7	0.0	0.0	0.0	8.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.4	100.6	47.8	111.7	128.0	64.2	61.8	70.5	53.6	60.2	84.0	66.7	0.1	0.0	2.3	209.6	0.0	1.3	1.2	1.5	4.0	17.0	3.2	3.4	7.6	2.8	4.7	3.7	8.4	0.2	0.1	0.2	13.7	6.0	36.7	8.5	2.7	1.8	22.9	0.0	204.7	0.2	3.6	2.7	3.1	4.4	2.5	5.7	0.4	0.0	0.2	1.7	301.5	2.6	8.2	0.0	1.6	39.8	0.6	0.4	7.2	98.4	0.1	5.9	2.1	232.7	136.9	2.4	2.3	3.0	0.0	2.2	0.3	1.0	1.6	9.3	6.6	2.6	2.5	2.1	3.0	0.5	0.3	2.7	0.6	1.9	1.3	1.4
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.9;brain: 29.8;retina: 14.0"	"Group enriched"	"Detected in some"	6	"Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	0.8	14.9	22.9	0.4	27.1	0.0	0.7	3.0	29.8	0.4	0.0	0.5	0.3	0.9	3.3	0.0	1.6	0.6	0.5	28.5	23.3	0.1	0.2	0.2	0.1	6.1	10.7	5.7	0.5	0.1	9.0	0.3	7.5	1.0	0.3	14.0	0.9	1.6	0.1	0.1	0.3	0.9	11.5	2.2	0.3	0.7	22.7	0.0	0.0	0.3	0.3	0.0	0.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	27.1	3.0	29.8	28.5	23.3	6.1	10.7	7.5	11.5	22.7	11.5	0.0	0.0	0.0	191.3	0.0	0.1	0.0	0.0	0.0	7.9	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.3	0.2	0.0	0.0	218.7	0.0	0.1	0.7	0.0	0.2	0.0	4.0	5.0	0.0	0.5	23.5	275.6	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	25.3	0.0	0.8	0.0	280.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.7	4.4	1.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0
ATP6V1G2	"ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10"	ENSG00000213760	"ATPase H+ transporting V1 subunit G2"	O95670	6	31544444-31548427	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 97.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 83.7;Cone photoreceptor cells: 14.6;Enteroendocrine cells: 14.3;Horizontal cells: 30.3;Muller glia cells: 25.1;Rod photoreceptor cells: 14.1"	"Cancer enriched"	"Detected in many"	11	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HSkMC: 3.2;Karpas-707: 6.7;RPMI-8226: 4.9;SCLC-21H: 9.5"									"CAB004616, HPA068667"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB004616: AB_667829, HPA068667: "	"unprognostic (9.95e-2)"	"unprognostic (8.75e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.11e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.41e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.02e-1)"	1.0	2.3	53.0	0.7	61.0	0.1	0.9	77.1	97.0	1.7	21.3	4.6	0.3	1.6	0.2	0.7	1.6	1.0	2.8	60.0	52.0	2.7	0.8	1.3	0.5	51.3	43.7	3.0	0.8	0.0	9.2	0.0	51.1	2.0	0.3	13.7	0.8	0.0	1.8	0.7	2.8	0.4	43.3	2.8	1.7	1.9	52.4	0.0	3.0	0.0	0.5	1.1	2.1	75.1	0.0	0.5	2.6	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.0	0.0	3.2	0.3	0.1	0.0	0.8	0.0	0.0	0.5	3.2	0.5	0.7	0.1	1.4	0.0	0.9	0.7	6.7	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.2	0.0	4.9	0.0	0.0	9.5	2.3	0.0	0.2	0.0	0.0	0.8	1.4	0.8	0.5	0.1	0.0	0.0	0.3	0.4	0.3	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	53.0	61.0	77.1	97.0	60.0	52.0	51.3	43.7	51.1	43.3	52.4	75.1	0.9	0.0	0.5	0.0	1.2	0.4	0.3	0.4	0.0	83.7	0.7	0.8	2.3	0.0	0.1	1.8	14.6	0.2	0.1	0.3	9.8	0.3	0.0	0.1	2.6	1.2	14.3	0.4	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.2	0.0	0.2	0.6	30.3	0.0	0.5	2.0	0.0	1.1	0.2	0.9	0.4	1.8	0.0	0.1	25.1	1.0	0.0	0.0	0.1	0.0	2.2	0.5	0.1	0.7	7.8	0.0	14.1	0.0	1.7	3.2	0.1	2.0	0.4	0.1	0.1	1.5	0.4	0.1	0.1
ATP9A	"ATPIIA, KIAA0611"	ENSG00000054793	"ATPase phospholipid transporting 9A (putative)"	O75110	20	51596514-51768390	"Enzymes, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 112.2;Inhibitory neurons: 87.1;Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 74.0;SK-BR-3: 69.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020699, HPA035630"	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB020699: , HPA035630: AB_10669526"	"unprognostic (5.19e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.67e-5)"	"unprognostic (5.82e-2)"	"unprognostic (5.81e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	30.6	11.5	55.9	5.8	63.2	2.7	14.1	26.0	63.7	8.5	0.0	18.5	13.6	12.4	18.5	12.9	24.8	12.0	11.6	67.1	52.2	9.2	7.5	9.7	3.7	41.8	50.0	18.8	15.1	29.5	16.2	4.9	46.8	20.5	16.4	20.5	25.7	15.5	16.3	6.8	17.8	12.7	33.2	2.9	20.4	18.8	53.4	7.4	28.1	17.6	3.1	11.9	9.8	48.7	25.8	21.7	17.2	38.8	49.0	36.8	0.4	9.1	17.1	5.8	1.7	50.4	51.9	0.0	74.0	37.2	29.1	20.1	22.9	12.9	5.7	20.2	7.1	0.0	23.2	19.8	6.7	0.0	0.1	12.1	25.6	1.3	3.5	13.3	31.4	4.7	0.1	0.2	6.6	35.9	2.0	0.2	3.1	25.4	27.0	4.1	0.0	0.1	11.6	35.7	32.7	23.2	36.3	69.9	13.2	6.0	13.5	0.6	20.7	48.1	12.7	19.1	3.9	0.0	0.3	0.8	12.7	0.1	4.4	4.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.7	55.9	63.2	26.0	63.7	67.1	52.2	41.8	50.0	46.8	33.2	53.4	48.7	4.8	16.0	13.6	43.4	0.5	2.9	14.6	13.8	4.0	35.9	16.0	11.3	12.7	31.5	19.1	18.4	4.2	0.4	2.5	64.3	1.9	21.4	0.8	20.4	4.7	9.8	55.2	0.8	112.2	17.2	0.5	9.9	26.5	28.8	1.3	14.3	11.0	12.8	5.4	43.7	87.1	34.9	18.3	2.2	2.1	3.4	13.4	12.1	3.6	40.3	0.2	5.0	2.1	60.8	90.3	24.6	28.8	23.3	2.1	33.7	36.3	1.4	34.9	7.4	6.6	10.1	8.0	1.2	8.2	9.9	4.1	0.3	2.3	0.7	24.8	27.3
ATXN7L3	DKFZp761G2113	ENSG00000087152	"Ataxin 7 like 3"	Q14CW9	17	44191805-44200113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064316	Supported		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Plasma membrane"	"HPA064316: AB_2685243"	"unprognostic (2.37e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.86e-3)"	"unprognostic (6.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.40e-1)"	23.3	24.6	51.0	32.6	58.1	45.0	21.3	28.0	76.6	28.4	12.0	26.8	31.2	28.3	25.9	40.1	26.5	24.1	24.9	58.5	35.9	29.2	28.0	25.2	37.2	58.3	42.4	25.5	24.2	24.5	35.1	30.7	60.6	26.9	24.3	21.5	27.9	27.7	25.3	31.2	29.6	25.8	33.0	36.3	28.3	36.9	48.3	42.1	29.1	22.6	35.5	28.7	28.1	54.1	40.9	67.7	73.3	47.8	50.1	49.5	39.8	49.1	54.3	61.4	57.7	52.0	45.1	71.3	38.6	55.5	56.6	43.9	57.7	46.1	51.2	83.6	57.2	48.5	58.9	58.5	49.3	76.3	94.3	56.1	69.0	51.7	54.1	65.0	60.3	54.2	66.1	43.5	40.8	30.7	92.3	58.0	55.1	36.7	52.5	62.8	70.9	54.1	49.8	57.9	46.5	59.0	29.0	25.4	50.5	101.4	62.0	67.1	52.2	61.5	63.8	32.3	46.5	52.1	73.8	86.4	40.6	32.6	36.8	0.4	1.2	1.5	1.7	0.7	1.0	1.4	1.4	1.1	1.0	2.4	1.0	1.3	2.5	0.5	0.9	1.6	0.8	1.1	51.0	58.1	28.0	76.6	58.5	35.9	58.3	42.4	60.6	33.0	48.3	54.1	14.3	3.2	3.7	5.5	9.4	7.1	5.6	8.0	8.6	17.4	13.7	9.1	6.2	5.7	6.6	18.4	16.7	6.3	11.3	22.2	3.9	7.1	14.7	14.0	16.9	10.5	14.4	4.0	9.1	13.1	6.7	7.2	8.6	20.7	2.5	9.9	10.4	8.1	8.4	28.6	8.6	11.0	4.1	11.1	10.9	40.0	9.0	10.0	5.4	8.4	12.7	8.6	5.2	3.0	5.3	15.0	13.6	5.7	5.5	8.6	14.1	4.6	7.6	13.9	6.6	6.7	9.3	6.3	8.5	11.0	10.5	13.7	10.0	10.4	11.2	9.1
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134412242	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 195.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 27.4;Bipolar cells: 37.0;Excitatory neurons: 37.2;Inhibitory neurons: 30.4;Muller glia cells: 116.2;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 77.8"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.1;HMC-1: 25.3;NTERA-2: 22.1;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	0.2	4.2	146.6	0.4	135.6	1.0	3.9	114.3	195.2	0.4	32.5	0.9	0.5	1.4	0.2	0.2	0.4	0.3	0.3	191.8	85.5	1.8	5.8	0.6	2.1	133.6	145.2	0.2	0.4	0.0	4.5	0.1	118.9	2.8	0.1	23.8	1.2	0.4	0.1	0.5	0.6	0.1	115.0	1.4	34.9	0.9	133.6	0.4	6.2	0.2	0.4	0.7	0.3	176.0	0.0	0.0	23.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.9	0.0	0.9	1.2	1.6	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.1	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.1	22.1	1.1	0.0	0.4	0.0	1.7	0.0	0.1	3.1	8.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	2.3	0.1	0.0	0.1	0.0	0.1	0.2	0.1	5.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	146.6	135.6	114.3	195.2	191.8	85.5	133.6	145.2	118.9	115.0	133.6	176.0	0.1	0.0	0.0	27.4	0.1	0.0	0.0	0.0	0.0	37.0	1.2	0.8	1.1	2.8	0.0	0.0	4.2	0.0	14.4	0.1	0.0	0.0	1.8	0.1	0.1	0.4	1.8	0.4	37.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	4.7	0.1	23.5	30.4	0.0	0.0	0.3	0.0	3.9	0.0	0.2	0.0	3.7	0.0	116.2	15.5	33.2	77.8	0.0	0.0	0.4	7.5	0.9	0.0	1.9	0.0	8.6	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.1	3.8	0.0	0.0	0.3
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 164.7"	"Group enriched"	"Detected in some"	8	"Astrocytes: 136.1;Horizontal cells: 109.4;Melanocytes: 186.7;Oligodendrocyte precursor cells: 288.0"	"Cancer enriched"	"Detected in many"	5	"glioma: 348.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.7;K-562: 108.3;U-266/70: 63.3;U-266/84: 133.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"	NA	NA		120000	"Cluster 34: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	0.2	8.4	155.0	0.6	119.5	0.0	0.2	108.3	164.7	2.7	38.3	2.2	7.0	5.9	15.4	0.6	4.0	3.4	0.5	133.1	104.8	0.2	0.1	0.4	0.3	107.5	100.0	0.2	0.1	1.7	2.8	0.7	103.4	0.2	0.0	4.1	1.6	1.8	0.6	15.6	7.8	2.0	94.3	0.5	2.2	1.2	113.7	0.1	0.2	0.0	0.0	0.9	0.9	116.3	44.2	28.4	0.2	8.1	0.0	0.0	11.9	0.4	0.0	0.0	0.0	1.1	21.0	0.1	45.8	0.0	1.0	30.9	0.3	0.0	0.0	76.7	2.9	8.0	20.9	25.6	0.0	3.0	7.3	0.0	0.0	0.0	0.0	1.0	0.0	3.8	108.3	21.0	0.0	12.6	0.1	0.1	2.2	22.2	4.2	0.1	46.7	0.1	0.0	5.4	0.2	0.8	0.1	0.0	43.8	2.2	0.2	2.8	8.8	0.1	24.7	8.7	11.8	63.3	133.2	0.2	8.5	20.4	3.4	7.8	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.0	119.5	108.3	164.7	133.1	104.8	107.5	100.0	103.4	94.3	113.7	116.3	0.2	0.0	0.0	136.1	0.0	6.9	0.0	0.0	0.0	6.0	0.2	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	2.9	0.1	1.8	0.7	1.8	0.0	16.8	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.5	109.4	20.2	0.1	0.0	0.0	1.9	6.9	0.3	0.1	186.7	9.4	0.0	2.1	1.0	288.0	3.5	0.8	0.1	0.0	0.0	0.3	0.1	0.4	0.0	3.2	0.0	0.2	1.7	5.4	6.5	0.0	1.7	0.0	0.2	0.0	0.0	0.0
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR activator of RhoGEF and GTPase"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	19.4	11.1	34.3	11.0	65.7	34.6	17.4	15.9	30.7	14.3	10.6	11.7	10.0	12.3	16.1	24.5	12.1	9.3	12.2	45.0	22.2	21.1	13.8	18.6	13.7	27.1	26.5	9.4	14.6	20.6	25.0	10.3	24.1	11.8	7.6	7.4	18.3	10.1	5.8	23.5	10.2	8.8	20.9	11.4	16.1	11.0	35.0	14.7	19.7	5.7	10.8	15.3	14.3	14.1	47.6	20.1	30.3	31.2	17.7	12.1	45.6	16.8	15.7	15.2	12.2	35.6	18.7	32.9	30.5	14.4	14.7	47.6	3.6	46.8	4.3	63.3	32.3	28.8	27.7	28.6	22.9	26.9	14.6	10.2	31.1	22.8	19.8	27.0	53.6	23.3	112.5	15.1	7.0	31.3	25.4	21.4	25.8	37.4	19.5	32.9	12.4	21.7	23.7	29.6	27.7	26.3	30.7	26.1	12.6	19.3	16.6	21.7	61.4	9.1	1.0	14.9	14.0	3.4	14.8	11.7	23.4	20.1	14.3	0.0	0.5	0.0	3.1	0.2	1.1	0.6	1.5	1.6	0.4	0.6	1.3	1.7	0.5	1.5	0.5	0.4	0.8	1.4	34.3	65.7	15.9	30.7	45.0	22.2	27.1	26.5	24.1	20.9	35.0	14.1	19.3	9.6	11.5	51.2	4.5	15.4	11.9	18.2	6.2	22.9	17.1	9.9	7.5	17.2	20.9	18.4	22.9	14.0	23.9	17.7	9.8	14.4	5.6	22.1	8.0	27.8	19.9	5.5	24.6	16.6	6.8	7.1	11.7	31.4	10.8	9.9	70.6	22.1	7.2	23.5	20.7	13.9	12.2	9.3	11.1	13.5	8.7	9.2	5.4	18.7	6.6	13.2	15.5	32.2	7.0	27.7	8.1	5.7	10.7	11.8	10.7	18.2	12.5	9.4	0.0	4.0	6.8	2.7	7.3	9.3	15.8	10.8	10.3	10.0	13.7	13.3
BHLHA9	BHLHF42	ENSG00000205899	"Basic helix-loop-helix family member a9"	Q7RTU4	17	1270444-1271815	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 1.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"						"unprognostic (9.27e-2)"							"unprognostic (2.63e-1)"				"unprognostic (2.99e-1)"	"unprognostic (7.74e-2)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.6	0.4	0.2	1.0	0.0	1.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177170958-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.6;brain: 19.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 121.1;Excitatory neurons: 116.8;Inhibitory neurons: 148.3;Oligodendrocyte precursor cells: 96.5"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.7;PC-3: 1.3;REH: 2.1;SCLC-21H: 5.6;SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.6	9.6	17.2	0.0	16.5	0.0	0.9	1.3	19.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	17.9	10.7	0.0	0.1	0.0	0.0	4.5	9.6	0.0	0.0	0.0	4.2	0.5	4.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	2.1	16.2	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	2.1	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	16.5	1.3	19.9	17.9	10.7	4.5	9.6	4.9	4.9	16.2	13.4	0.0	0.0	0.0	121.1	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.2	0.3	0.0	0.0	0.0	116.8	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.1	15.2	148.3	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	25.3	0.0	0.5	0.0	96.5	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312562	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 141.8;pituitary gland: 53.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.8;Excitatory neurons: 30.1;Horizontal cells: 38.7;Inhibitory neurons: 27.6;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 29.4;Proximal enterocytes: 23.6"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 56.4;SH-SY5Y: 51.8;WM-115: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.5	12.0	75.0	3.7	90.1	0.5	2.6	47.5	141.8	5.9	0.0	11.8	3.8	8.3	4.0	3.2	5.4	4.4	12.8	103.2	66.1	2.4	0.7	1.9	2.7	70.4	54.8	5.5	2.8	16.9	53.0	1.1	66.8	8.3	1.6	20.4	2.3	5.0	0.7	1.5	4.7	5.6	32.9	1.8	4.9	11.4	74.1	2.3	3.1	1.4	1.4	6.3	4.6	105.5	0.8	2.8	33.2	17.6	0.1	1.4	0.3	5.9	7.7	7.1	10.3	13.1	5.9	7.0	3.7	6.2	6.6	0.3	7.0	0.3	6.6	33.3	28.0	4.6	4.0	1.4	7.0	1.5	12.8	4.6	0.6	7.3	0.0	27.4	0.3	17.9	6.6	40.8	6.5	1.9	9.0	1.7	24.9	0.7	2.3	20.4	8.5	1.1	0.5	0.0	56.4	51.8	0.1	1.0	12.8	9.2	2.9	3.8	0.0	13.7	15.2	7.7	10.8	37.9	28.0	16.6	13.8	3.1	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	90.1	47.5	141.8	103.2	66.1	70.4	54.8	66.8	32.9	74.1	105.5	0.3	0.0	1.3	9.4	5.2	0.1	1.0	0.1	1.2	34.8	0.9	2.2	1.2	0.0	0.6	1.8	2.1	0.0	1.2	10.4	0.0	0.4	1.2	0.3	3.8	0.9	3.5	0.0	30.1	0.0	0.0	1.2	0.5	0.3	0.0	2.3	0.0	0.0	1.6	38.7	27.6	1.6	0.0	6.6	0.4	0.3	0.6	1.0	0.0	1.0	2.3	4.1	3.1	17.1	29.4	0.5	0.1	4.9	9.8	1.0	23.6	0.9	0.2	10.1	0.0	0.6	2.1	3.9	7.0	0.0	0.0	0.0	1.1	2.8	1.9	0.2
C12orf43	"Custos, FLJ12448"	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	9.8	8.1	11.7	6.9	11.9	7.4	9.3	8.8	13.6	7.8	7.2	11.2	5.0	9.5	4.4	7.2	9.0	5.1	7.4	12.3	9.5	8.2	10.5	6.7	8.7	10.9	9.6	11.2	7.5	9.0	7.4	7.2	10.8	7.7	5.3	6.0	8.7	6.2	7.2	6.7	6.7	8.4	8.6	7.8	8.2	6.1	9.4	7.2	6.4	5.9	7.4	9.6	7.0	10.4	14.2	31.4	16.2	12.8	14.0	11.0	17.8	17.2	17.5	28.3	17.9	22.8	13.0	26.2	17.2	16.8	15.0	15.7	19.2	26.3	16.8	31.6	21.4	21.1	12.4	17.1	16.7	28.1	16.2	12.9	13.6	26.0	16.4	17.9	16.4	27.0	25.5	6.7	15.1	23.3	30.9	22.0	28.8	11.1	23.2	27.4	19.0	19.8	17.5	20.8	22.0	14.0	23.0	9.9	18.6	13.4	27.0	13.1	15.9	15.6	18.7	12.8	18.4	12.3	19.1	20.5	20.5	16.5	23.6	5.7	15.6	9.0	23.8	21.3	21.8	23.8	23.5	23.2	16.1	19.0	27.5	23.6	2.2	18.4	18.5	13.3	23.8	20.6	11.7	11.9	8.8	13.6	12.3	9.5	10.9	9.6	10.8	8.6	9.4	10.4	16.1	25.6	18.1	3.3	17.3	8.8	16.4	12.2	6.8	19.6	12.4	12.4	7.0	11.5	9.6	18.4	20.9	24.3	13.9	8.6	23.5	16.5	5.9	9.8	17.1	16.0	2.4	10.7	6.8	18.5	22.3	16.3	8.2	10.1	14.5	22.3	12.5	11.7	16.7	16.8	6.4	9.5	10.2	10.4	7.3	13.8	13.7	13.2	14.2	3.7	21.7	18.8	24.7	4.0	4.8	15.6	12.3	12.8	11.3	13.8	5.3	16.7	16.3	15.7	19.7	19.6	16.9	16.3	16.4	12.7	7.7	13.7	17.6	16.0	10.9	14.0
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158751	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 26.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 28.3;Cone photoreceptor cells: 8.4;Oligodendrocyte precursor cells: 37.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.6"	"Region enhanced"	"Detected in many"		"hippocampal formation: 22.7"	"Low region specificity"	"Detected in many"			HPA057934	Uncertain				"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA057934: AB_2683558"	"unprognostic (6.95e-2)"				"unprognostic (9.74e-2)"			"unprognostic (4.48e-3)"		"unprognostic (1.08e-1)"	"unprognostic (9.91e-4)"			"unprognostic (2.60e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"		0.0	0.0	17.6	0.0	9.4	0.0	0.2	3.9	17.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.5	16.3	0.0	0.0	0.0	0.1	7.3	7.0	0.1	0.0	0.0	0.5	0.0	6.1	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	4.5	0.0	0.0	0.2	20.3	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	9.4	3.9	17.0	26.5	16.3	7.3	7.0	6.1	4.5	20.3	8.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	28.3	1.3	0.8	0.5	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	37.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0
C2CD4C	"FAM148C, KIAA1957, NLF3"	ENSG00000183186	"C2 calcium dependent domain containing 4C"	Q8TF44	19	405445-409147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.2;Excitatory neurons: 3.6;Granulosa cells: 3.7;Hepatic stellate cells: 3.6;Rod photoreceptor cells: 7.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;MCF7: 4.4;NTERA-2: 6.2;SCLC-21H: 11.1;U-2 OS: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055915	Uncertain		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA055915: AB_2682968"	"unprognostic (1.29e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.39e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.74e-1)"	3.8	1.0	9.8	0.3	11.4	0.0	3.0	3.7	17.4	3.0	2.5	1.3	0.4	2.3	0.0	0.7	2.0	2.8	4.8	10.8	17.1	2.5	0.7	1.8	0.1	7.5	7.6	0.3	1.0	0.1	2.6	0.4	8.8	1.0	0.0	0.8	0.3	0.0	0.9	0.8	1.4	0.1	8.7	1.0	0.8	2.0	13.0	0.1	3.9	0.5	0.0	0.6	1.0	7.1	0.0	0.5	1.5	1.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	2.0	0.0	0.5	0.0	0.7	2.4	2.4	0.2	0.1	6.4	1.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.0	4.4	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.1	3.2	1.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	6.5	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	11.4	3.7	17.4	10.8	17.1	7.5	7.6	8.8	8.7	13.0	7.1	13.2	0.0	0.0	0.3	0.1	0.3	0.3	0.3	0.0	0.5	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	1.9	3.0	0.0	3.6	0.4	0.0	0.1	0.0	0.2	0.0	3.7	3.6	0.1	0.0	0.0	3.1	0.0	2.0	0.0	0.4	0.3	0.0	0.0	0.0	1.9	0.0	2.0	0.0	3.0	0.6	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.6	0.0	0.4	0.4	0.7	2.2	0.0	0.3	0.0	0.1	0.0	0.0	0.1
C2orf80	"GONDA1, LOC389073"	ENSG00000188674	"Chromosome 2 open reading frame 80"	Q0P641	2	208165343-208190030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"brain: 31.8"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 25.8;Inhibitory neurons: 11.7;Oligodendrocyte precursor cells: 31.7"	"Cancer enriched"	"Detected in single"	41	"glioma: 11.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042639			Approved	"Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA042639: AB_10794915"					"unprognostic (6.36e-2)"					"unprognostic (2.12e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.05e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.98e-2)"			0.0	0.1	21.0	0.4	26.5	1.1	0.0	6.3	31.8	0.0	7.4	0.2	0.2	0.1	0.0	0.9	0.1	0.2	0.1	27.2	20.5	0.1	0.3	0.0	0.2	11.6	13.3	0.2	0.0	0.1	1.0	0.1	13.9	0.2	0.2	1.4	0.3	0.4	0.3	0.4	0.3	0.1	11.0	0.1	0.2	0.6	17.0	0.0	0.1	0.0	0.0	0.0	0.0	15.1	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.5	1.7	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.3	3.2	0.6	0.5	0.3	0.4	0.2	0.5	0.3	0.3	0.2	0.7	0.3	0.3	4.6	0.5	0.3	0.8	0.1	0.1	21.0	26.5	6.3	31.8	27.2	20.5	11.6	13.3	13.9	11.0	17.0	15.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	1.0	0.0	31.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CA11	"CARP2, CARPX1"	ENSG00000063180	"Carbonic anhydrase 11"	O75493	19	48637946-48646187	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 330.0;choroid plexus: 146.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 46.1;hTERT-RPE1: 47.1;SCLC-21H: 32.6;U-266/84: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041778			Approved	Vesicles,Microtubules	"Secreted in brain"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Microtubules"		"HPA041778: AB_10794525"	"unprognostic (1.39e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (2.59e-3)"	"unprognostic (5.72e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.80e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (2.11e-5)"	"unprognostic (3.79e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.75e-1)"	13.1	17.3	240.8	3.2	256.9	1.6	8.5	215.4	330.0	15.9	146.2	19.4	8.4	33.0	28.2	8.0	21.4	5.5	10.7	266.6	167.0	14.7	1.7	5.8	5.0	170.3	169.2	48.8	5.9	58.0	37.2	1.1	172.2	14.0	2.5	30.0	8.9	13.5	9.2	14.3	9.3	18.2	163.8	6.1	13.0	6.4	180.5	6.6	12.1	7.4	5.3	9.2	12.2	231.9	2.0	12.7	22.9	46.1	3.1	1.2	0.6	1.5	14.9	1.5	3.3	3.1	15.7	7.5	1.7	1.7	4.2	4.9	9.4	4.6	1.3	1.6	13.5	3.3	7.2	0.2	3.0	0.3	9.8	5.4	9.2	1.4	2.0	47.1	1.8	19.8	6.1	20.5	0.7	5.0	4.1	1.4	9.9	7.5	4.7	2.6	0.9	16.1	10.1	0.4	32.6	18.2	1.7	1.6	2.7	6.1	6.3	0.8	0.2	3.9	14.2	0.1	0.4	18.9	33.9	1.3	5.7	4.3	2.0	0.0	0.4	0.0	1.5	0.5	1.5	1.0	1.2	1.2	0.7	1.3	1.5	1.3	0.0	1.3	0.0	1.9	1.5	0.7	240.8	256.9	215.4	330.0	266.6	167.0	170.3	169.2	172.2	163.8	180.5	231.9	5.1	3.2	8.1	11.1	9.3	7.1	9.1	13.2	12.5	81.0	15.5	12.1	5.4	21.5	9.6	31.3	16.7	0.7	9.8	3.9	25.4	11.5	15.0	6.7	6.3	6.7	13.1	3.6	47.0	10.0	0.4	11.6	5.6	7.9	6.3	3.1	8.9	47.5	6.0	28.6	18.1	6.4	16.2	20.4	26.4	7.9	22.1	6.8	8.8	5.6	5.6	50.4	12.3	7.1	6.8	3.4	2.9	26.7	4.3	4.3	20.7	38.7	7.5	30.8	6.6	4.2	8.9	1.3	4.9	5.9	10.9	0.4	6.9	8.7	5.2	6.4
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720003-29731833	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 28.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1"	"Group enriched"	"Detected in all"	4	"cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 51.0"	HPA016439	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.1	5.6	3.1	0.0	3.0	0.2	0.1	19.8	35.0	0.1	0.6	0.8	0.4	0.1	0.0	0.1	0.1	0.0	0.2	38.2	4.2	0.2	0.3	0.1	0.1	27.7	14.8	0.1	3.1	0.0	0.4	0.0	30.0	0.4	0.0	1.0	0.2	0.0	0.1	0.2	1.5	0.0	22.2	0.4	0.3	0.6	3.9	0.0	0.3	0.0	0.0	0.1	0.1	16.5	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	10.3	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	9.7	3.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	3.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	3.1	3.0	19.8	35.0	38.2	4.2	27.7	14.8	30.0	22.2	3.9	16.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	28.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.1;prostate: 11.7"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocyte precursor cells: 145.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 387.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 118.1"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.5	0.8	26.5	0.1	35.1	0.0	5.3	6.9	26.8	0.4	4.2	0.8	0.2	0.5	0.1	0.2	4.2	0.4	0.2	14.5	17.9	0.2	0.0	5.7	0.0	11.7	16.7	0.1	0.4	1.2	0.3	0.7	15.0	11.7	0.1	0.7	1.7	1.3	0.1	0.5	0.1	1.1	14.3	0.0	1.5	0.2	29.6	0.0	0.1	0.0	0.0	0.4	0.7	9.5	6.4	4.1	15.6	0.0	0.0	0.0	4.4	0.0	0.0	1.4	0.0	4.6	0.2	0.0	0.2	0.0	41.2	64.1	0.1	0.0	0.0	0.0	0.3	0.0	1.8	3.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	34.5	0.1	0.3	15.7	7.3	0.0	0.0	0.4	8.7	0.0	11.1	15.8	387.4	3.6	10.4	0.0	38.1	38.5	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	35.1	6.9	26.8	14.5	17.9	11.7	16.7	15.0	14.3	29.6	9.5	0.0	3.2	1.3	0.0	0.0	0.0	1.1	0.3	0.0	0.2	6.4	3.4	1.3	0.0	1.4	0.0	0.0	0.3	0.1	0.6	0.0	0.1	2.6	1.0	0.2	0.1	7.7	0.0	1.8	0.2	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.0	3.4	0.0	145.3	0.3	0.7	0.2	0.0	0.0	2.6	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909278-53943950	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 56.6;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 32.0;Horizontal cells: 134.6;Inhibitory neurons: 43.3;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.3"	"Cancer enriched"	"Detected in some"	16	"glioma: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 52.8;GAMG: 14.6;HMC-1: 40.8;hTERT-RPE1: 51.4;SH-SY5Y: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"							"unprognostic (3.11e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.24e-2)"				"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.01e-5)"	"unprognostic (1.51e-1)"	"unprognostic (7.36e-2)"			0.0	0.4	44.2	0.0	38.8	0.0	0.0	37.5	56.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	38.9	0.0	0.0	0.0	0.0	39.9	41.2	0.0	0.1	0.1	6.6	0.0	38.9	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	0.0	31.9	0.0	0.1	0.5	50.5	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	7.0	52.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	40.8	0.4	0.0	0.1	0.0	51.4	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.9	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	38.8	37.5	56.6	43.9	38.9	39.9	41.2	38.9	31.9	50.5	45.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	32.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	134.6	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.2	0.0	23.1	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CAMK2N1	CaMKIINalpha	ENSG00000162545	"Calcium/calmodulin dependent protein kinase II inhibitor 1"	Q7Z7J9	1	20482391-20486210	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 461.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 640.5;Intestinal goblet cells: 431.4;Paneth cells: 367.7;Proximal tubular cells: 519.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;MAIT T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 212.1;CAPAN-2: 199.1;Hep G2: 165.6;SK-BR-3: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075200	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA075200: "	"unprognostic (1.67e-1)"	"unprognostic (2.70e-3)"	"unprognostic (9.71e-3)"	"unprognostic (3.13e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (1.37e-7)"	"prognostic unfavorable (5.49e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-2)"	20.1	61.6	340.5	9.3	322.3	0.5	19.8	172.0	461.3	32.5	115.4	85.0	80.4	27.8	38.1	27.8	22.3	27.4	22.3	354.6	206.5	86.2	53.8	67.9	1.9	224.8	222.4	30.2	8.8	42.4	37.7	11.6	215.9	35.8	77.0	32.6	30.4	40.8	7.1	12.0	86.9	22.7	226.7	12.2	19.5	4.7	265.4	2.0	10.8	9.9	7.0	27.3	24.3	348.6	63.1	17.5	15.0	212.1	28.4	52.6	2.2	52.6	119.0	9.5	4.8	20.1	199.1	6.3	14.7	21.7	7.7	103.2	4.6	90.0	5.9	11.7	3.8	1.3	0.9	165.6	31.4	0.1	6.2	8.4	41.2	5.6	21.2	19.6	16.4	4.3	6.3	0.5	105.8	17.4	0.2	0.5	2.8	109.7	3.9	5.6	9.4	0.4	59.3	93.5	57.6	16.2	28.5	159.6	16.3	10.2	30.6	0.6	5.0	34.9	46.1	48.5	21.1	0.1	0.1	2.5	119.5	13.5	22.0	0.0	0.0	0.0	1.6	0.0	1.1	0.5	0.5	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	340.5	322.3	172.0	461.3	354.6	206.5	224.8	222.4	215.9	226.7	265.4	348.6	28.3	3.2	1.1	35.6	7.6	9.3	11.7	2.3	0.6	248.6	96.5	104.5	20.8	178.7	2.5	248.3	6.2	0.5	10.1	640.5	229.0	20.1	0.8	6.2	45.6	20.0	299.2	8.0	132.5	40.8	2.9	65.1	9.2	12.0	1.3	4.6	9.3	201.6	0.3	85.8	108.7	431.4	14.2	1.9	12.1	3.9	62.7	5.6	39.2	26.2	0.6	81.1	0.0	27.6	249.1	141.5	367.7	94.0	3.5	37.7	183.2	519.2	1.2	35.6	131.5	86.2	96.4	0.8	2.8	1.0	7.5	2.1	14.7	0.8	223.5	50.3
CCDC34	"L15, NY-REN-41, RAMA3"	ENSG00000109881	"Coiled-coil domain containing 34"	Q96HJ3	11	27330827-27363234	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 383.4;Endometrial ciliated cells: 156.1;Spermatocytes: 336.8;Spermatogonia: 218.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 159.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037574	Uncertain		Approved	"Nuclear membrane,Nucleoli fibrillar center"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane, Nucleoli fibrillar center"		"HPA037574: AB_10795136"	"unprognostic (8.23e-3)"	"unprognostic (1.09e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.32e-7)"	"unprognostic (9.09e-2)"	"unprognostic (1.34e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.11e-2)"	3.8	5.3	16.1	5.6	15.9	13.7	11.2	13.8	32.8	4.4	16.7	8.8	10.7	4.9	11.3	5.5	12.5	3.4	3.4	15.9	15.4	5.0	4.6	2.3	6.5	15.2	14.9	9.7	4.3	8.1	5.5	5.1	15.4	5.4	10.1	6.2	4.1	4.3	3.1	6.5	8.9	3.5	14.3	4.4	9.3	48.8	15.9	15.8	5.6	3.4	8.8	3.3	3.5	14.8	46.1	50.4	41.6	44.7	7.5	17.6	30.8	29.5	11.1	29.8	28.8	28.2	8.3	49.4	20.2	15.8	42.7	40.2	41.9	18.2	54.3	19.5	58.2	39.4	62.6	74.1	3.8	40.6	15.4	5.7	13.4	26.0	12.5	13.2	23.3	70.1	39.0	15.9	32.1	32.6	79.3	63.1	42.9	31.4	44.1	74.8	152.8	7.4	12.8	15.2	32.2	42.2	44.0	19.5	20.8	23.4	52.8	21.4	11.1	47.8	45.2	91.3	69.4	153.2	159.4	34.8	44.5	2.0	42.7	0.0	0.2	0.4	3.1	1.0	3.7	3.4	3.9	4.2	1.0	4.0	4.5	2.8	0.0	3.7	3.8	2.3	6.7	1.1	16.1	15.9	13.8	32.8	15.9	15.4	15.2	14.9	15.4	14.3	15.9	14.8	5.1	0.0	1.7	4.9	10.1	22.8	22.9	33.2	13.1	10.3	71.4	73.3	9.2	27.1	20.6	23.9	12.5	45.5	3.4	41.0	19.6	14.1	383.4	156.1	12.5	11.1	21.6	91.3	11.5	12.3	25.1	17.2	31.1	15.3	7.0	30.9	10.0	16.0	22.0	3.3	7.5	40.5	18.3	8.9	8.4	82.4	21.5	5.7	14.2	0.0	4.7	26.6	7.2	1.0	1.2	5.5	12.1	20.7	13.9	10.3	6.2	17.6	101.5	20.6	6.6	11.6	18.3	336.8	218.8	33.2	20.6	16.1	9.1	10.3	71.2	15.5
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252261-61940617	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.0;lymphoid tissue: 3.7;ovary: 6.3;skeletal muscle: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 157.0;Excitatory neurons: 54.4;Inhibitory neurons: 70.0;Oligodendrocyte precursor cells: 108.0;Skeletal myocytes: 28.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.8;hTERT-HME1: 14.1;U-2 OS: 19.4;U-251 MG: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"		NA	NA		19000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA015613: AB_2732414"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	0.1	1.3	7.3	0.0	4.3	0.1	0.2	0.0	3.4	0.6	0.0	0.3	0.0	0.2	0.0	0.2	0.6	0.1	0.2	3.0	5.0	0.3	0.2	0.3	0.0	1.3	3.0	6.3	0.5	0.1	0.5	0.0	0.4	0.3	0.0	0.7	0.3	0.8	3.8	0.7	0.2	0.0	0.0	3.7	0.2	0.9	11.0	0.2	0.3	0.0	0.0	0.2	0.2	1.1	0.1	1.2	10.8	0.0	0.2	0.7	0.2	3.1	0.0	5.6	0.6	0.3	0.0	0.0	0.3	3.7	3.6	4.1	0.0	6.2	2.2	0.3	0.0	0.0	0.1	0.1	7.1	0.0	0.1	1.1	1.4	1.1	14.1	3.0	1.2	0.4	0.0	0.1	2.1	0.4	0.1	0.1	1.3	0.0	0.1	0.0	0.0	1.6	3.2	0.0	1.0	2.7	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	19.4	0.1	35.2	6.3	0.1	0.1	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	4.3	0.0	3.4	3.0	5.0	1.3	3.0	0.4	0.0	11.0	1.1	0.0	3.2	0.0	157.0	0.0	0.3	0.4	0.0	0.0	1.8	0.4	0.9	1.6	0.0	0.7	0.0	2.1	0.0	0.1	0.1	0.0	1.3	0.9	0.1	0.3	0.2	0.0	0.0	54.4	0.0	0.0	1.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	16.8	70.0	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.0	10.3	0.0	19.9	0.0	108.0	24.9	0.2	0.0	0.4	0.0	0.6	0.0	0.1	0.0	1.6	0.0	28.7	0.4	0.1	2.2	0.0	0.3	0.0	0.1	0.4	0.0	0.3
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 22.4"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 220.8;Inhibitory neurons: 236.4;Oligodendrocytes: 145.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.0;fHDF/TERT166: 6.3;HaCaT: 14.4;LHCN-M2: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"		NA	NA		870000		"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.1	0.1	7.2	0.0	9.9	0.0	0.3	0.0	22.4	0.4	0.0	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.2	16.3	5.7	0.0	0.0	0.1	0.0	6.4	9.8	1.7	0.0	0.1	0.7	0.3	18.4	0.4	0.1	2.2	0.4	5.0	0.4	0.1	0.2	0.4	7.6	0.0	0.1	0.3	9.1	0.5	0.1	0.9	0.0	0.4	0.1	2.5	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.3	0.0	14.4	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	17.3	0.0	0.0	0.0	1.3	0.0	1.3	0.0	0.0	1.1	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.9	0.0	22.4	16.3	5.7	6.4	9.8	18.4	7.6	9.1	2.5	0.4	0.0	0.5	3.9	0.0	0.1	0.8	1.3	1.2	15.1	0.1	0.9	1.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.1	0.1	0.5	0.0	0.0	220.8	0.0	0.2	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	236.4	0.0	2.0	0.0	0.0	1.3	0.0	0.1	0.0	8.4	0.0	0.7	0.0	7.5	145.7	0.0	0.0	0.4	0.0	0.3	0.0	0.2	2.7	0.7	0.0	0.7	4.7	1.3	2.5	0.5	0.1	0.3	0.1	0.1	0.0	0.8
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787115-790113	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 234.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 94.2;Excitatory neurons: 42.9;Horizontal cells: 75.7;Inhibitory neurons: 45.6;Rod photoreceptor cells: 25.5"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.6;Karpas-707: 31.0;SCLC-21H: 54.1;SH-SY5Y: 20.4;U-266/70: 21.1;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced	Supported	Approved	Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	0.1	5.5	55.0	1.0	78.8	0.0	0.1	56.9	234.7	0.2	20.0	4.0	0.6	0.9	0.2	0.4	0.1	0.0	1.1	67.4	79.3	1.2	0.3	0.2	0.3	103.8	57.9	0.2	0.2	0.3	26.0	0.0	93.4	3.2	0.1	7.6	0.2	1.5	0.2	0.2	1.4	0.5	21.6	0.3	0.9	0.3	106.3	0.0	0.2	0.0	0.1	0.8	1.1	116.6	0.0	0.7	0.7	1.4	0.2	0.3	0.2	1.3	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.5	13.6	0.5	0.0	0.0	0.0	8.5	0.3	0.0	0.1	0.0	0.1	0.0	5.3	0.6	0.0	0.8	0.0	0.0	0.2	0.0	0.0	31.0	0.5	0.1	0.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	54.1	20.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	1.2	0.9	21.1	6.2	1.3	28.6	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	55.0	78.8	56.9	234.7	67.4	79.3	103.8	57.9	93.4	21.6	106.3	116.6	0.1	0.0	0.0	17.6	0.5	0.1	0.1	0.0	0.0	94.2	0.0	0.0	0.5	0.0	0.0	0.0	10.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.4	0.6	0.0	0.0	42.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	75.7	45.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.5	0.0	6.7	0.0	15.1	10.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	25.5	0.0	0.1	1.7	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0
CENPVL1	"CENPVP1, PRR6L1"	ENSG00000223591	"Centromere protein V like 1"	A0A0U1RR11	X	51710512-51712131	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 2.7;testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 65: Brain - Ion transport"																							0.0	0.0	1.2	0.0	2.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.7	0.0	1.4	0.3	2.7	0.9	1.2	0.9	0.4	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CENPVL2	CENPVP2	ENSG00000283093	"Centromere protein V like 2"	P0DPI3	X	51681212-51682831	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 2.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 65: Brain - Ion transport"																							0.0	0.0	1.2	0.0	2.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.7	0.0	1.4	0.3	2.7	0.9	1.2	0.9	0.4	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CENPVL3	CENPVP3	ENSG00000224109	"Centromere protein V like 3"	A0A0U1RRI6	X	51617020-51618912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 3.8;testis: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 4.3;PC-3: 14.0;U-2 OS: 9.5"															NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"																"unprognostic (3.07e-2)"			"unprognostic (1.48e-1)"			0.0	0.5	1.5	0.0	2.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.7	0.0	0.0	0.0	0.0	1.0	2.1	0.0	0.0	0.5	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	3.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.1	0.0	1.3	1.0	3.7	1.0	2.1	1.5	0.7	3.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CGREF1	CGR11	ENSG00000138028	"Cell growth regulator with EF-hand domain 1"	Q99674	2	27098889-27119128	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3;salivary gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 40.1;SK-BR-3: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008241, HPA071103"	Uncertain		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA		700000		"Cluster 65: Brain - Ion transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA008241: AB_1846605, HPA071103: "	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (8.45e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.24e-4)"	"unprognostic (1.20e-2)"	4.2	2.3	20.4	1.0	21.7	1.9	6.3	17.1	28.3	3.5	2.1	2.6	3.9	11.6	1.4	3.5	12.4	3.9	4.9	27.0	18.1	3.8	14.9	1.1	0.5	12.8	12.1	13.9	2.1	0.2	3.3	0.3	12.8	4.2	3.8	3.7	25.3	0.9	6.5	2.3	5.6	5.4	10.2	0.6	11.4	3.8	17.2	0.2	1.8	6.9	0.4	3.7	1.5	16.4	7.6	6.3	0.3	8.1	18.3	6.8	0.7	9.1	0.0	0.8	0.4	1.7	6.2	0.1	2.4	18.2	2.2	0.4	1.4	2.1	0.5	0.7	3.7	0.1	10.4	16.4	16.9	5.3	0.6	4.7	18.1	2.6	2.1	11.6	0.7	1.3	0.2	0.4	1.2	24.0	4.0	6.8	2.1	40.1	16.8	0.3	0.0	0.6	0.1	0.3	17.8	26.6	17.7	78.7	9.4	0.2	25.3	13.3	0.0	0.0	6.9	0.0	0.7	2.3	0.8	0.7	0.0	0.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	21.7	17.1	28.3	27.0	18.1	12.8	12.1	12.8	10.2	17.2	16.4	0.1	0.0	0.0	2.6	0.4	0.6	0.2	0.0	1.8	9.2	9.2	12.6	1.4	0.0	0.0	0.0	4.2	0.0	0.1	0.2	0.0	0.1	1.1	0.3	3.0	0.4	0.0	5.5	16.6	1.5	0.2	3.8	4.6	0.1	0.0	0.4	3.6	5.0	0.4	0.0	15.9	6.8	0.0	0.6	0.7	3.1	4.4	0.2	0.0	1.9	0.0	0.5	0.0	12.5	0.8	2.1	0.0	8.6	1.1	1.8	3.4	4.4	0.0	2.2	0.0	1.7	0.7	3.2	16.2	2.2	0.4	0.1	0.1	3.2	0.9	0.1
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49667942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 13.0;placenta: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"NB-4: 20.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 20.6"	"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0"	"CAB002313, HPA048547, CAB079053"	Supported	Supported				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437"					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.0	0.0	0.6	0.2	2.8	0.0	0.0	0.3	13.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	7.9	5.1	0.0	0.3	0.0	0.0	5.5	9.4	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.8	20.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.8	0.3	13.0	0.1	3.1	7.9	5.1	9.4	1.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174798809-175005381	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 772.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 195.2;Excitatory neurons: 596.4;Inhibitory neurons: 111.7;Microglial cells: 97.4;Oligodendrocyte precursor cells: 149.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 6.5;memory CD8 T-cell: 2.1;T-reg: 8.0"	"Lineage enriched"	"Detected in single"	18	"T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 186.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036111			Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	11.8	13.3	368.6	7.3	445.9	0.8	10.5	194.0	772.6	9.2	170.6	10.2	3.3	7.9	38.3	6.9	6.5	11.1	15.1	492.6	241.5	4.7	2.1	19.6	21.5	210.2	225.4	5.8	4.2	43.4	36.3	38.6	210.5	17.0	5.1	39.5	3.2	9.6	2.7	3.8	7.5	13.1	192.4	5.5	7.1	21.3	239.1	3.1	10.2	3.7	18.7	8.7	6.7	422.8	0.4	17.4	57.6	16.3	14.7	67.4	0.4	45.6	186.7	65.1	97.0	0.3	5.4	0.5	1.6	71.8	39.9	2.0	68.0	1.9	30.3	1.3	32.9	11.1	20.1	3.8	34.4	6.4	1.7	53.6	1.9	31.6	11.1	16.1	33.6	30.0	0.7	1.9	57.2	11.8	29.3	2.5	71.7	2.6	23.7	8.2	70.3	0.8	0.9	0.6	71.3	76.3	41.3	0.5	7.3	36.0	3.2	2.2	10.1	26.8	3.9	9.8	20.6	6.4	33.7	0.7	6.7	0.4	6.6	0.4	0.1	0.1	0.3	0.1	0.8	0.2	6.5	2.1	0.0	0.1	1.3	0.4	0.4	0.2	0.2	0.3	8.0	1.0	368.6	445.9	194.0	772.6	492.6	241.5	210.2	225.4	210.5	192.4	239.1	422.8	15.4	3.2	1.9	195.2	1.6	4.5	0.3	0.0	0.0	85.1	7.3	1.4	6.2	1.5	2.6	3.7	27.1	1.2	0.5	0.1	0.0	0.3	24.1	5.3	5.6	17.9	2.4	0.0	596.4	0.6	1.1	28.4	2.0	3.6	0.0	5.1	10.4	0.5	2.7	77.4	111.7	0.0	0.0	0.0	4.0	23.2	3.1	0.9	7.2	97.4	0.0	59.1	0.0	149.8	88.1	0.6	0.0	5.3	1.3	0.6	0.0	0.3	1.0	14.1	13.1	23.8	27.3	17.8	23.6	0.1	3.7	2.1	12.5	5.1	0.2	0.3
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81444808-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 180.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.59e-1)"	27.9	22.1	45.2	32.1	46.2	26.1	23.2	12.6	50.1	30.7	0.0	26.5	40.4	18.8	6.1	35.8	23.0	25.6	13.0	48.8	51.1	20.7	13.5	26.3	22.2	29.9	34.8	22.8	19.3	7.8	55.6	28.4	46.1	17.7	23.1	10.8	20.1	15.0	4.7	34.3	49.9	22.5	19.9	22.5	33.3	17.2	52.7	20.1	15.6	5.3	18.2	31.2	32.8	34.4	40.9	133.5	25.9	13.3	13.4	10.7	52.7	28.9	19.5	17.9	7.9	45.5	81.5	18.2	24.2	24.1	23.9	40.6	16.9	96.2	17.0	11.6	12.3	87.4	24.4	80.0	13.3	27.2	180.8	10.5	39.9	33.1	42.5	27.1	50.0	31.7	77.6	15.3	11.1	40.9	47.7	33.8	20.6	39.5	28.1	84.9	8.5	17.8	22.6	39.7	135.0	27.1	67.4	24.7	8.6	25.9	19.1	35.7	34.6	28.5	30.6	27.7	26.8	19.2	15.9	78.0	33.6	31.5	11.7	3.0	0.7	1.0	0.4	0.5	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.2	2.4	0.2	0.1	0.2	0.1	0.4	45.2	46.2	12.6	50.1	48.8	51.1	29.9	34.8	46.1	19.9	52.7	34.4	81.5	12.8	16.6	59.4	31.7	107.3	66.6	43.8	48.9	15.6	21.5	21.1	7.8	47.1	27.7	14.7	0.0	46.5	71.2	58.0	7.9	22.3	70.0	51.1	9.2	77.3	72.1	17.9	119.1	23.8	106.6	25.7	35.7	45.4	45.1	29.8	70.6	31.6	32.0	25.2	95.2	128.0	40.7	69.4	115.9	100.8	47.5	95.5	12.4	100.2	68.2	8.0	37.0	69.9	52.9	65.5	30.9	143.3	35.2	69.6	47.3	49.6	57.6	3.4	13.1	8.0	24.1	5.0	15.4	51.8	143.5	88.7	42.8	6.4	39.1	111.7
CNIH3	"CNIH-3, FLJ38993"	ENSG00000143786	"Cornichon family AMPA receptor auxiliary protein 3"	Q8TBE1	1	224434660-224740554	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;pancreas: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 65.3;Distal tubular cells: 31.3;Excitatory neurons: 61.1;Inhibitory neurons: 47.5;Late spermatids: 38.0;Oligodendrocyte precursor cells: 68.3"	"Group enriched"	"Detected in many"	4	"glioma: 6.0;melanoma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.7;hTEC/SVTERT24-B: 47.0;hTERT-RPE1: 26.4;NTERA-2: 17.3;U-266/70: 25.1;U-87 MG: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.03e-1)"	"unprognostic (3.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.63e-1)"	0.9	0.3	6.9	0.2	7.2	0.0	0.9	1.8	11.0	1.1	1.8	0.5	0.3	0.7	0.4	0.2	0.9	0.6	0.3	11.9	13.5	0.7	0.3	0.4	0.4	6.7	6.7	1.9	8.0	0.1	1.0	0.1	2.7	0.5	0.2	1.2	0.6	0.5	0.4	0.4	0.2	0.4	3.2	0.2	1.0	2.2	5.0	0.2	0.5	0.4	0.4	0.8	0.9	5.4	0.5	0.3	0.6	0.6	0.5	0.9	0.2	3.5	18.7	0.5	1.0	0.1	4.3	0.1	1.8	8.2	1.4	0.0	0.0	0.0	3.1	0.1	1.0	0.0	0.0	0.0	0.3	1.7	1.4	0.6	0.0	47.0	0.5	26.4	0.0	0.2	0.0	0.1	2.8	0.1	0.1	6.0	17.3	0.2	2.2	0.1	0.9	0.0	3.0	1.7	0.6	0.4	0.0	0.0	12.1	1.8	0.1	0.4	0.1	0.1	4.2	0.1	0.5	25.1	1.1	0.0	55.3	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.9	7.2	1.8	11.0	11.9	13.5	6.7	6.7	2.7	3.2	5.0	5.4	2.7	0.0	2.0	65.3	1.8	2.8	2.1	3.6	2.8	2.8	5.3	7.7	2.4	1.5	2.9	1.8	0.0	2.3	1.0	1.4	31.3	0.9	16.0	3.0	3.3	2.9	1.2	4.0	61.1	3.0	0.6	3.9	0.5	1.9	2.5	6.9	3.3	2.6	6.2	0.0	47.5	2.7	0.0	0.6	2.5	38.0	2.8	1.9	0.0	19.7	1.1	15.1	2.1	68.3	25.3	0.6	0.8	1.2	0.8	1.9	0.4	17.3	28.8	0.7	0.0	5.0	2.5	2.3	8.6	3.2	2.3	5.1	2.5	5.3	1.5	2.7
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020949-100358885	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 968.9;Inhibitory neurons: 2295.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039492, HPA041223"	Approved				"Intracellular and membrane"	NA	NA		480000		"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	4.7	1.1	0.3	0.0	0.1	0.0	0.0	1.3	0.0	0.2	0.2	0.5	2.6	0.5	0.0	0.0	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	4.1	4.7	1.1	0.0	1.3	0.5	0.0	2.9	0.1	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	3.5	0.1	0.0	0.0	0.0	968.9	0.0	0.2	1.1	0.0	0.4	0.0	0.0	1.1	0.0	0.2	0.0	2295.2	0.0	2.0	0.0	0.0	0.4	0.9	0.0	0.0	42.2	0.0	0.1	0.0	112.1	23.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	12.5	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein family member 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 7.9"	"Group enriched"	"Detected in some"	49	"Excitatory neurons: 554.6;Inhibitory neurons: 906.4;Oligodendrocyte precursor cells: 760.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;SH-SY5Y: 2.6"					"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: AB_2686083, HPA069356: AB_2686127"				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.0	0.5	2.4	0.0	0.6	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	5.1	0.1	0.0	0.0	0.0	6.8	6.3	0.0	0.1	0.0	0.0	0.0	7.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	7.9	4.3	5.1	6.8	6.3	7.3	0.0	7.2	0.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.1	0.0	0.0	554.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	906.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.4	0.0	1.0	0.0	760.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
COL20A1	KIAA1510	ENSG00000101203	"Collagen type XX alpha 1 chain"	Q9P218	20	63293186-63334851	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 8.3;choroid plexus: 2.8;testis: 2.5"	"Group enriched"	"Detected in some"	11	"Oligodendrocyte precursor cells: 72.9;Spermatocytes: 21.8"	"Cancer enriched"	"Detected in single"	19	"glioma: 8.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA072382			Uncertain	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 68: Oligodendrocytes - Mixed function"	"Endoplasmic reticulum"		"HPA072382: "	"unprognostic (6.34e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.41e-7)"	"unprognostic (7.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.16e-1)"	0.0	0.2	3.9	0.0	4.0	0.0	0.0	3.0	8.3	0.5	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.9	2.8	0.1	0.0	0.0	0.0	3.7	3.3	0.2	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	3.3	0.7	0.0	2.5	3.4	0.0	0.0	0.3	0.0	0.0	0.1	5.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	3.0	8.3	3.9	2.8	3.7	3.3	3.6	3.3	3.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	72.9	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.2	0.1	21.8	4.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826129	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 273.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.5;Bipolar cells: 33.4;Endothelial cells: 29.6;Excitatory neurons: 44.2;Inhibitory neurons: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 84.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	17.2	13.4	26.1	1.2	43.0	0.1	18.2	59.7	273.5	16.9	0.0	5.0	1.0	10.8	0.1	5.7	16.4	0.4	11.5	18.5	72.8	10.9	8.3	9.4	0.8	135.5	25.1	9.4	3.2	1.4	12.8	0.3	128.2	13.8	0.2	5.7	9.6	0.7	4.1	3.4	5.1	0.4	13.9	27.2	4.9	8.6	124.2	3.6	7.5	0.2	0.2	8.3	12.9	89.9	5.7	0.5	0.1	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	16.3	1.7	4.2	1.9	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.4	0.0	1.8	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.0	0.3	0.0	2.5	2.3	0.0	2.6	4.4	2.6	0.1	0.0	1.6	0.0	0.4	84.3	11.8	0.4	5.5	0.0	0.2	8.5	0.3	0.1	0.0	0.5	0.1	0.1	0.2	4.7	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	26.1	43.0	59.7	273.5	18.5	72.8	135.5	25.1	128.2	13.9	124.2	89.9	45.5	0.0	0.0	5.9	0.4	1.0	3.2	0.4	1.8	33.4	7.8	8.1	3.6	0.0	1.9	0.0	4.2	0.1	2.8	2.5	1.9	1.2	1.4	1.1	5.4	29.6	21.5	0.0	44.2	0.8	3.2	1.8	2.6	1.4	0.0	0.3	14.3	4.8	0.2	18.5	90.7	2.1	0.0	0.3	1.9	2.3	1.8	0.5	1.8	8.4	0.0	16.8	0.0	8.0	4.7	0.8	5.2	0.0	0.6	2.6	0.3	1.2	0.0	21.7	0.0	0.4	2.3	4.3	9.8	0.2	1.1	1.0	1.6	0.8	2.7	1.3
CPNE6		ENSG00000100884	"Copine 6"	O95741	14	24070837-24078100	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 54.3;retina: 16.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Bipolar cells: 26.3;Horizontal cells: 32.0;Inhibitory neurons: 11.4;Late spermatids: 18.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031636, HPA076665"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"			"HPA031636: AB_10601203, HPA076665: "	"unprognostic (1.02e-2)"	"unprognostic (3.26e-4)"	"unprognostic (1.64e-1)"	"unprognostic (5.66e-5)"	"unprognostic (3.51e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.71e-1)"	0.2	0.2	42.1	0.2	37.7	0.2	0.0	20.0	41.1	0.2	12.2	1.5	2.5	0.2	0.3	1.7	0.3	0.0	0.2	54.3	24.9	7.0	2.1	0.1	0.0	31.4	23.2	0.1	0.0	0.0	8.0	0.0	32.7	2.8	0.5	16.4	0.0	12.3	0.1	0.4	3.4	0.3	20.8	0.0	0.4	0.5	31.3	0.1	0.2	0.1	0.0	0.7	0.4	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	37.7	20.0	41.1	54.3	24.9	31.4	23.2	32.7	20.8	31.3	26.0	0.0	0.0	0.0	15.3	0.0	0.1	0.0	0.0	0.0	26.3	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	6.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	11.4	0.2	0.0	0.0	0.0	18.1	0.6	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.3	6.5	2.4	0.0	3.8	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CRYBB2	"CCA2, CRYB2, CRYB2A"	ENSG00000244752	"Crystallin beta B2"	P43320	22	25212564-25231870	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.6;Breast myoepithelial cells: 12.8;Distal tubular cells: 27.4;Melanocytes: 12.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.1"	"Region enhanced"	"Detected in some"		"hippocampal formation: 1.7"	"Low region specificity"	"Detected in many"			HPA043749	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA043749: AB_2678652"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.57e-3)"	"unprognostic (9.51e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-3)"	0.2	0.4	2.7	0.0	2.6	0.0	0.3	2.0	4.5	0.3	2.0	0.4	0.2	0.1	0.3	0.4	0.1	0.1	0.2	2.7	2.3	0.5	0.3	0.3	0.0	2.1	2.2	0.1	0.2	0.0	1.4	0.0	2.5	0.6	0.3	0.4	0.3	0.1	0.5	0.4	0.3	0.2	2.0	0.1	0.2	1.7	2.9	0.0	1.0	0.0	0.0	0.2	0.4	2.5	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.9	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	2.7	2.6	2.0	4.5	2.7	2.3	2.1	2.2	2.5	2.0	2.9	2.5	0.9	0.0	0.0	2.0	1.0	5.4	0.6	6.7	0.6	0.3	10.6	12.8	1.4	1.5	1.5	1.8	0.0	0.1	0.9	1.7	27.4	0.1	3.0	1.7	1.2	2.9	0.0	8.0	2.4	0.2	0.1	3.4	0.0	2.5	0.0	3.1	4.6	3.2	0.2	0.0	0.4	0.3	0.0	1.2	3.1	9.6	2.5	0.8	12.4	1.9	0.0	0.4	0.0	0.5	0.3	0.5	0.1	8.2	0.0	0.4	0.0	9.7	0.6	0.1	0.0	6.2	2.1	2.6	3.3	0.4	3.8	0.1	1.3	7.6	0.2	0.6
CSAG1	"CSAGE, CT24.1"	ENSG00000198930	"Chondrosarcoma associated gene 1"	Q6PB30	X	152727484-152733735	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;choroid plexus: 2.6"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 5.4;Spermatogonia: 12.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 16.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 120.2;HMC-1: 64.4;K-562: 44.4;OE19: 140.6;PC-3: 58.8;U-266/70: 103.4"															NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.83e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.68e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.70e-3)"	0.0	0.0	3.1	0.1	2.9	0.0	0.0	2.9	7.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	2.8	0.0	0.0	0.0	0.4	3.0	2.9	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.2	0.0	0.0	3.0	0.1	0.0	0.0	8.4	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	0.0	0.0	0.0	0.0	0.4	0.0	2.2	2.0	0.0	0.0	0.0	64.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	44.4	0.6	0.0	0.0	0.2	0.0	0.0	140.6	58.8	0.0	0.0	0.3	0.0	0.1	6.4	36.1	0.0	21.6	19.1	0.0	1.0	0.0	0.0	0.1	0.8	21.8	7.3	103.4	1.7	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	2.9	7.1	2.9	2.8	3.0	2.9	3.1	2.7	2.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.4	12.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7
CSMD2	KIAA1884	ENSG00000121904	"CUB and Sushi multiple domains 2"	Q7Z408	1	33513999-34165842	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 9.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.0;Inhibitory neurons: 148.9;Oligodendrocyte precursor cells: 314.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 6.8;HEL: 10.5;NTERA-2: 8.1;PC-3: 8.4;U-87 MG: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.33e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.25e-5)"	"unprognostic (1.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-2)"	0.2	0.5	5.3	0.2	3.2	0.0	0.1	0.7	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.2	7.1	5.5	0.1	0.0	0.1	0.2	2.3	2.7	0.0	0.2	0.0	0.1	0.0	1.8	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.1	0.3	1.0	0.2	0.1	0.5	9.3	0.0	0.1	0.1	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.0	2.4	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.2	0.7	4.8	7.1	5.5	2.3	2.7	1.8	1.0	9.3	2.5	1.4	6.4	3.0	2.6	0.0	0.3	0.6	0.0	0.0	11.2	0.1	0.0	5.5	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	4.3	3.2	0.2	2.3	1.2	0.0	0.0	159.0	2.9	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.7	148.9	0.0	0.0	0.0	0.3	6.0	1.5	0.4	0.0	12.2	0.3	0.1	0.0	314.7	52.5	1.4	0.0	3.8	0.0	0.9	0.0	0.1	0.0	1.9	0.0	1.4	0.7	0.3	2.1	0.0	0.4	0.0	0.2	0.2	0.0	0.3
CSMD3		ENSG00000164796	"CUB and Sushi multiple domains 3"	Q7Z407	8	112222928-113436939	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 6.8"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 915.9;Inhibitory neurons: 867.9;Oligodendrocyte precursor cells: 1761.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029007, HPA029008"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA029007: AB_10601802, HPA029008: "	"unprognostic (2.26e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.26e-2)"		"unprognostic (3.54e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.03e-10)"	"unprognostic (1.95e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-3)"	0.0	0.0	6.8	0.0	4.3	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	4.8	0.0	0.0	0.0	0.0	1.9	2.7	0.0	0.2	0.0	0.1	0.0	1.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	4.3	0.0	6.0	5.7	4.8	1.9	2.7	1.6	0.8	5.0	0.7	0.0	0.0	3.0	21.5	0.2	0.3	0.1	0.0	0.0	7.3	0.0	0.0	1.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.5	0.1	0.4	0.0	0.0	915.9	0.0	0.0	0.9	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	867.9	0.0	0.0	0.0	0.8	6.3	0.0	0.3	0.0	19.7	0.0	0.5	0.0	1761.3	92.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.2	17.1	8.2	0.0	0.6	0.0	0.0	0.0	0.0	0.3
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562238-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 83.2;choroid plexus: 65.2;retina: 28.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 67.6;Muller glia cells: 94.7;Oligodendrocyte precursor cells: 233.7"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.6;HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	0.9	0.8	58.3	0.2	62.4	0.1	0.6	33.6	83.2	0.3	65.2	1.1	0.0	0.3	0.1	0.3	0.3	0.1	0.5	62.5	49.7	0.2	0.2	3.2	0.2	41.2	45.6	0.2	0.3	0.3	1.7	0.8	45.8	0.4	0.2	28.3	0.3	0.0	0.5	1.1	0.3	0.4	37.0	0.0	0.4	1.9	48.0	0.1	0.4	0.0	0.1	0.1	0.2	46.1	0.3	1.7	32.6	5.7	0.6	0.0	0.9	0.6	0.1	1.2	0.3	0.3	2.0	0.1	2.5	0.1	2.4	0.5	2.7	0.3	0.3	0.0	8.8	0.5	1.4	0.0	0.0	0.4	1.4	0.0	1.1	0.1	0.0	0.9	0.1	1.1	6.6	0.3	0.1	1.5	0.2	0.4	3.1	2.4	3.3	0.5	0.2	0.7	1.4	1.1	3.4	1.5	2.1	4.1	0.1	0.9	1.6	3.1	0.3	0.1	6.5	0.1	1.9	0.8	0.8	0.0	0.5	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	62.4	33.6	83.2	62.5	49.7	41.2	45.6	45.8	37.0	48.0	46.1	0.7	3.2	2.0	67.6	0.1	0.8	0.1	0.0	0.0	28.6	2.2	1.8	1.3	0.0	0.0	0.0	6.2	0.2	0.0	0.5	0.0	0.2	2.0	0.6	0.6	0.3	1.8	0.0	18.6	0.0	0.2	0.5	0.0	2.0	0.0	6.1	0.0	0.5	0.2	6.7	25.0	0.3	0.0	0.0	0.2	0.6	0.3	0.2	0.0	7.5	0.0	94.7	0.0	233.7	9.9	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	22.7	0.0	0.8	0.8	13.5	3.3	0.0	0.6	0.1	0.2	0.2	0.4	0.1
CTXND1	LINC01314	ENSG00000259417	"Cortexin domain containing 1"	A0A1B0GTU2	15	80195481-80252213	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9;liver: 9.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 6.3;Proximal tubular cells: 14.0"	"Group enriched"	"Detected in many"	7	"glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.6;WM-115: 4.7"	"Region enriched"	"Detected in all"	4	"hippocampal formation: 35.0"											NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.15e-5)"	"unprognostic (8.42e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.59e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.34e-1)"	0.3	3.7	11.4	0.2	9.4	0.0	0.2	4.9	14.0	0.3	3.0	0.9	0.4	0.1	5.4	0.1	0.3	0.1	2.7	30.9	9.8	2.2	9.4	1.5	0.2	7.2	11.1	0.4	0.5	0.0	1.4	0.0	8.4	0.3	0.2	1.4	0.1	0.1	0.5	0.8	0.5	0.0	6.4	1.4	2.6	0.4	14.4	0.0	0.4	0.1	0.2	0.5	0.3	6.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.4	4.9	14.0	30.9	9.8	7.2	11.1	8.4	6.4	14.4	6.0	0.0	0.0	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.9	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CYP46A1	CYP46	ENSG00000036530	"Cytochrome P450 family 46 subfamily A member 1"	Q9Y6A2	14	99684298-99727301	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.1;Cone photoreceptor cells: 66.7;Excitatory neurons: 53.0;Inhibitory neurons: 41.6;Rod photoreceptor cells: 28.4"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"plasmacytoid DC: 3.4"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 3.4"	"Group enriched"	"Detected in some"	4	"AF22: 2.4;U-937: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (2.16e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.50e-5)"	"unprognostic (9.48e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.32e-5)"	"unprognostic (5.21e-2)"	"unprognostic (2.44e-4)"	"unprognostic (5.97e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.88e-3)"	1.9	2.0	45.7	0.3	96.2	0.0	0.8	20.1	66.7	1.4	17.5	0.7	0.2	1.5	0.9	0.2	1.0	0.4	4.7	52.7	34.0	1.4	1.3	0.6	0.6	25.3	32.0	1.6	2.1	1.9	16.6	0.0	26.2	1.4	0.2	5.1	1.4	0.6	1.1	0.4	0.5	0.8	23.5	0.2	0.7	2.5	38.2	0.4	1.7	0.5	0.1	0.9	0.7	39.0	0.0	0.0	2.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	45.7	96.2	20.1	66.7	52.7	34.0	25.3	32.0	26.2	23.5	38.2	39.0	3.5	3.2	6.0	58.1	0.7	1.7	6.4	0.0	1.2	11.5	1.8	3.3	7.0	2.8	1.8	1.8	66.7	0.2	8.7	0.0	1.9	0.2	0.7	0.9	5.0	7.6	0.0	0.0	53.0	1.1	0.3	4.0	0.5	0.6	1.3	2.1	2.9	3.4	0.6	8.4	41.6	0.0	0.0	2.1	3.0	1.3	4.7	0.9	3.6	6.5	1.1	20.8	0.0	23.6	11.8	0.1	0.1	4.1	2.2	4.1	0.0	7.4	0.9	28.4	0.0	8.1	3.9	9.4	5.3	0.0	1.4	0.1	1.5	2.7	0.1	3.5
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148451-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;epididymis: 3.6;fallopian tube: 3.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 27.0;Granulosa cells: 14.3;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 71.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HAP1: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.2	0.1	4.4	0.0	5.0	0.0	0.1	1.3	5.8	0.3	1.4	0.1	0.2	0.3	3.6	0.0	3.7	0.0	0.0	5.7	7.0	1.0	0.0	0.1	0.0	3.7	3.6	0.5	0.2	0.0	0.5	0.0	3.9	0.4	0.0	2.0	0.5	0.1	0.0	0.0	0.3	0.0	2.0	0.0	0.4	0.0	8.1	0.0	0.1	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	1.3	5.8	5.7	7.0	3.7	3.6	3.9	2.0	8.1	3.0	0.4	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	2.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.1	3.3	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	4.2	0.0	71.4	4.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078445-150257438	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0"	"Group enriched"	"Detected in many"	6	"Astrocytes: 501.1;Excitatory neurons: 189.8;Inhibitory neurons: 173.2;Oligodendrocyte precursor cells: 172.4"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.6;BJ: 11.8;BJ hTERT+: 24.9;fHDF/TERT166: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	1.7	2.8	45.8	0.9	42.0	0.5	1.4	34.6	43.6	2.0	7.7	5.6	1.4	2.7	2.0	1.5	1.9	2.5	12.2	59.0	41.2	2.3	0.6	2.1	0.4	41.2	46.6	2.9	2.2	0.6	8.3	1.5	38.4	2.7	2.0	18.4	0.8	2.0	1.2	1.0	2.2	4.7	46.6	1.2	2.3	2.8	42.7	0.2	2.6	1.4	0.3	2.6	1.3	46.8	1.2	4.2	23.6	3.7	0.0	1.1	0.4	11.8	24.9	3.5	0.9	0.1	0.0	0.0	0.4	11.0	3.6	0.1	3.5	0.0	4.4	5.1	2.1	0.0	7.0	0.0	5.0	0.7	0.7	0.6	0.0	2.2	0.2	2.2	1.2	0.6	0.0	0.1	2.5	0.2	0.4	0.0	0.5	0.3	1.6	0.0	2.8	1.0	0.1	1.0	9.2	9.1	4.7	3.4	1.0	2.0	0.0	0.1	2.1	3.3	1.3	2.2	1.3	1.1	0.0	0.1	3.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	45.8	42.0	34.6	43.6	59.0	41.2	41.2	46.6	38.4	46.6	42.7	46.8	10.7	0.0	0.0	501.1	0.6	0.5	0.1	0.0	0.6	26.2	2.8	2.2	10.5	1.5	0.7	3.7	16.7	0.0	0.0	0.8	0.0	0.4	0.1	0.4	4.6	7.6	3.0	0.0	189.8	0.7	0.0	3.4	1.1	0.5	4.5	5.7	7.5	0.0	1.6	35.3	173.2	0.3	0.0	0.6	3.4	0.3	1.8	0.7	5.4	43.1	0.2	31.2	0.0	172.4	37.6	0.1	0.4	3.8	0.3	0.6	0.0	0.4	0.1	9.6	13.1	5.6	9.2	0.1	2.0	0.1	0.6	0.3	0.9	6.6	1.4	0.2
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	0.3	0.4	46.9	0.5	41.2	1.1	0.2	0.0	48.2	0.2	0.0	0.3	0.2	0.3	0.0	0.1	0.3	0.1	0.1	36.0	19.1	1.3	0.1	0.2	0.3	0.0	17.8	0.1	1.1	0.2	4.8	0.0	0.0	0.2	0.0	1.8	0.2	0.2	0.1	0.2	0.5	0.0	0.0	1.9	0.3	7.5	51.6	0.3	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	8.0	0.1	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.3	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	12.5	2.4	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	46.9	41.2	0.0	48.2	36.0	19.1	0.0	17.8	0.0	0.0	51.6	0.0	0.2	0.0	0.0	1.0	1.8	0.3	0.9	0.8	1.8	4.1	0.7	0.8	1.0	0.0	0.1	1.8	4.2	0.1	0.9	0.8	3.9	0.4	18.9	0.2	0.1	0.4	1.2	0.0	39.1	0.6	0.2	0.4	0.0	0.1	0.0	0.3	0.4	0.1	10.1	21.9	27.9	0.4	0.0	7.1	0.6	19.3	0.9	4.1	0.0	1.9	0.7	1.5	1.0	8.0	0.7	0.2	0.0	0.0	0.8	0.2	1.3	0.8	0.0	2.2	0.0	0.7	0.4	3.4	4.9	1.1	0.3	0.0	1.3	0.1	0.9	0.6
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.7;choroid plexus: 2.3;pituitary gland: 3.4;testis: 1.4"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.6;naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	13	"B-cells: 2.6;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 83.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024559, HPA056533"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA024559: , HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.0	0.0	5.1	0.1	5.7	0.0	0.0	3.1	5.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.7	0.0	0.0	0.0	0.1	4.9	4.7	0.2	0.0	0.5	3.4	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.1	0.0	1.4	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.1	3.9	0.9	2.0	0.0	0.0	0.6	1.1	0.0	0.7	0.2	0.5	0.9	0.1	3.7	0.0	1.5	0.1	2.3	1.0	0.2	1.2	6.0	0.2	0.1	0.3	0.3	1.0	4.6	0.0	0.0	0.1	0.1	0.1	0.1	4.3	1.1	0.1	0.3	0.0	0.2	0.0	0.7	0.0	6.2	0.6	0.2	0.2	0.2	0.2	13.6	14.1	2.9	0.1	83.7	0.3	0.0	0.2	0.0	0.0	2.6	0.1	1.0	1.4	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.5	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	5.1	5.7	3.1	5.6	4.7	4.7	4.9	4.7	4.2	4.4	4.6	5.4	0.3	0.0	0.0	0.3	1.1	0.3	0.3	0.4	0.0	0.5	1.3	4.7	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.6	0.1	0.7	0.2	3.0	0.0	1.7	0.6	0.6	1.0	0.5	0.3	0.0	1.7	0.0	0.0	0.3	0.0	3.4	0.3	0.0	0.0	0.0	2.2	1.2	0.1	1.8	0.0	0.0	0.9	0.0	24.6	0.5	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.7	6.6	0.0	0.6	6.5	39.5	0.2	0.1	0.3	0.5	1.7	0.0	0.1
DLX1		ENSG00000144355	"Distal-less homeobox 1"	P56177	2	172084740-172089677	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 18.8"	"Cell type enriched"	"Detected in some"	23	"Inhibitory neurons: 30.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 18.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 28.6;olfactory bulb: 82.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 48.8"	"HPA007175, HPA045884"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA007175: , HPA045884: AB_10960361"	"unprognostic (2.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.92e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.40e-9)"	"unprognostic (2.22e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.91e-3)"	0.1	1.3	5.9	0.2	4.8	0.0	0.1	0.0	4.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.5	18.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0	3.5	0.0	1.0	0.1	0.3	0.1	0.2	2.7	2.4	0.6	0.6	134.5	2.0	4.5	0.3	3.2	6.5	7.7	4.1	1.0	0.2	0.0	7.8	7.2	7.5	9.4	7.4	1.2	5.2	0.3	33.3	21.1	14.4	5.7	0.1	7.9	15.9	0.0	2.2	1.9	3.2	5.4	0.0	6.7	12.4	0.0	6.3	8.1	0.1	1.9	0.1	0.0	22.9	0.4	15.8	0.0	0.9	4.5	11.3	0.0	6.1	0.8	17.5	0.4	5.2	9.5	7.1	36.9	0.2	16.4	16.4	0.2	0.0	0.1	15.2	21.4	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	4.8	0.0	4.4	3.5	18.8	0.0	0.2	0.0	0.0	3.5	2.7	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025273-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001306, CAB033665"	Approved		Supported	Microtubules,Cytosol		NA	Yes		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Microtubules	"CAB033665: AB_2094242, HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	102.6	134.7	143.9	83.9	154.7	148.8	65.8	147.4	438.9	83.7	142.7	61.9	44.5	81.0	80.4	51.7	102.7	83.6	72.9	154.1	159.8	114.6	216.9	94.4	80.6	147.7	152.8	83.5	59.7	105.2	80.7	108.3	160.9	85.8	63.5	78.2	61.0	64.7	47.3	43.8	50.1	87.2	155.3	72.0	67.7	135.0	164.6	95.7	66.0	61.5	89.1	130.7	57.3	174.0	255.6	447.5	353.7	123.6	240.2	155.1	202.4	256.5	205.9	451.2	348.2	299.2	115.0	259.5	191.6	175.4	254.9	113.1	515.7	154.7	386.1	368.2	150.2	208.3	537.3	382.7	115.1	242.5	234.2	96.1	156.1	170.4	53.9	218.4	273.6	110.9	330.5	109.7	262.0	208.6	407.7	530.3	345.3	254.2	308.2	294.7	126.6	132.9	254.1	148.8	223.8	243.5	345.4	220.6	120.0	262.5	103.5	231.5	236.1	160.0	273.1	184.6	346.2	69.9	233.3	271.7	209.9	208.3	140.9	154.1	140.8	160.9	93.3	202.0	111.1	127.5	116.8	105.7	127.8	119.7	119.6	113.4	176.2	117.8	268.3	213.4	110.4	209.9	143.9	154.7	147.4	438.9	154.1	159.8	147.7	152.8	160.9	155.3	164.6	174.0	1110.8	214.7	154.9	7.8	368.7	264.6	942.8	245.3	327.8	209.3	307.8	513.5	187.7	95.8	257.7	82.8	208.5	274.0	619.1	287.9	172.1	247.7	536.4	549.2	348.2	427.8	391.1	198.9	16.2	181.1	341.6	392.8	188.6	526.1	424.7	127.6	133.2	129.6	231.1	121.1	16.7	327.3	213.6	156.0	497.4	222.2	99.1	402.3	284.6	22.5	243.7	150.5	91.6	8.0	22.5	189.8	334.7	94.8	195.8	393.8	134.7	178.1	417.8	161.7	105.2	391.1	476.0	492.7	209.4	238.5	265.4	464.9	678.9	179.2	273.3	636.8
DNAJB1	"Hsp40, HSPF1, RSPH16B, Sis1"	ENSG00000132002	"DnaJ heat shock protein family (Hsp40) member B1"	P25685	19	14514769-14560391	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1705.1"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1392.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 1705.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017450, HPA063247"	Enhanced		Supported	Nucleoplasm		NA	Yes		23000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB017450: AB_10631418, HPA063247: AB_2684971"	"unprognostic (3.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (2.20e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.77e-2)"	206.0	216.1	228.5	40.9	241.7	133.8	62.0	320.9	1705.1	188.1	259.4	86.7	35.2	54.0	40.8	439.9	75.3	183.7	182.8	243.8	240.2	245.0	230.3	286.0	42.0	250.4	251.8	231.9	89.8	66.4	148.4	123.4	285.4	73.9	48.4	81.2	109.7	127.1	51.2	128.5	62.7	54.5	240.6	104.5	149.1	149.4	241.8	107.3	97.2	208.0	76.5	133.6	257.7	323.4	192.5	212.5	80.8	81.7	146.8	114.1	45.6	125.9	99.9	210.4	158.8	126.3	106.7	54.8	135.4	121.0	135.5	144.9	169.1	96.7	150.3	55.0	76.1	86.7	115.0	275.6	94.6	57.9	78.5	61.0	237.5	85.3	73.4	114.7	71.6	35.7	131.2	471.6	123.6	130.5	102.2	60.1	80.4	285.9	228.3	73.7	106.3	121.7	101.8	62.4	67.0	51.1	121.1	233.7	127.1	90.8	60.3	60.6	64.7	156.4	98.0	184.1	264.8	193.5	141.7	65.7	114.4	109.2	151.1	68.8	92.4	116.2	171.6	159.0	184.8	93.7	244.5	214.9	76.0	92.0	281.6	219.9	137.6	125.1	172.2	45.1	270.9	322.6	228.5	241.7	320.9	1705.1	243.8	240.2	250.4	251.8	285.4	240.6	241.8	323.4	750.2	157.0	95.4	32.3	248.7	425.8	1142.1	148.0	719.3	60.9	468.8	476.4	367.1	72.9	118.6	23.9	118.9	135.6	214.2	459.6	41.1	132.8	491.8	374.8	339.3	397.3	407.3	60.0	10.2	162.6	199.3	661.2	408.7	552.8	339.4	100.2	86.7	59.9	158.1	52.2	8.9	420.1	81.4	85.1	1392.1	475.3	63.3	559.3	503.4	23.4	31.3	160.7	25.7	3.0	16.5	123.8	380.7	36.9	697.0	461.1	117.3	59.1	138.0	164.7	26.3	398.9	673.3	290.2	53.4	1186.0	478.9	274.9	948.4	104.8	393.7	606.2
DOC2A		ENSG00000149927	"Double C2 domain alpha"	Q14183	16	30005514-30023270	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.2;choroid plexus: 26.5;testis: 37.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 284.7;Late spermatids: 200.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;MCF7: 10.8;REH: 11.0;SCLC-21H: 35.9;U-937: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA065676			Uncertain	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"	"Nucleoplasm, Nucleoli"	"HPA065676: AB_2685528"	"unprognostic (1.46e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-1)"	2.7	4.5	47.5	0.2	57.6	1.0	1.9	34.7	72.2	2.8	26.5	6.8	0.7	1.4	0.3	1.8	8.7	0.7	1.4	60.3	28.3	5.3	0.9	5.6	0.3	34.0	38.5	15.4	1.6	0.8	9.4	0.1	35.4	8.2	1.3	1.1	1.4	0.5	0.2	0.6	2.6	0.7	27.5	6.0	0.8	37.8	38.2	0.1	1.0	0.0	0.1	1.1	2.2	42.5	0.9	1.8	1.2	0.7	0.4	0.0	13.1	0.4	0.9	0.5	0.4	5.6	3.3	0.0	1.1	0.1	1.6	0.3	7.1	2.7	0.3	0.0	0.7	1.1	0.3	0.2	0.5	1.0	3.5	1.6	0.8	0.2	0.8	6.5	0.0	3.9	0.3	0.0	0.0	10.8	2.2	4.0	1.7	4.0	5.1	11.0	0.0	0.5	0.4	0.8	35.9	2.3	0.3	3.0	0.3	2.6	3.4	2.0	0.0	0.0	1.5	0.1	0.2	0.2	0.0	0.0	0.2	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.5	57.6	34.7	72.2	60.3	28.3	34.0	38.5	35.4	27.5	38.2	42.5	1.5	0.0	4.6	8.8	0.4	0.6	3.5	2.5	6.8	3.7	4.0	3.4	0.7	1.5	7.8	1.8	22.9	0.3	0.2	3.0	1.9	0.1	284.7	12.2	0.2	1.7	1.2	0.0	28.2	0.0	1.0	2.1	1.5	0.3	0.0	3.5	2.5	0.0	0.5	0.0	10.7	3.6	10.2	1.9	1.0	200.4	0.6	2.2	1.8	4.7	0.1	2.3	0.0	3.5	2.6	0.0	1.0	1.9	0.1	2.3	0.3	0.3	57.5	2.0	0.0	0.5	0.9	3.2	6.1	0.6	0.9	0.1	0.3	2.5	4.3	1.1
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206407	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	7.8	4.4	17.1	6.6	41.6	1.4	4.8	11.4	21.9	5.0	0.0	3.2	1.5	4.6	2.8	2.5	5.2	5.0	4.9	40.6	17.8	4.5	10.0	17.3	2.7	16.5	18.1	8.4	3.2	3.3	3.2	6.9	15.6	4.0	2.8	10.5	3.3	2.5	6.2	2.5	2.4	7.3	14.9	1.8	2.2	2.1	19.2	1.7	3.5	7.3	2.2	3.7	3.5	26.0	0.1	3.5	8.8	7.8	7.2	10.4	5.3	1.0	9.6	1.7	2.8	0.0	0.2	0.8	7.6	2.3	2.0	0.5	1.5	8.8	6.5	2.9	12.9	0.4	5.8	14.3	5.1	1.1	0.4	4.9	1.0	43.3	20.8	3.0	75.5	3.4	0.1	22.6	3.8	1.0	2.0	0.7	5.1	1.5	15.8	0.8	7.0	3.6	6.0	0.5	1.9	7.5	6.2	4.3	5.8	8.2	0.8	0.4	69.0	6.6	3.4	13.7	3.0	1.2	0.5	0.9	0.7	1.8	16.5	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.1	0.0	0.1	17.1	41.6	11.4	21.9	40.6	17.8	16.5	18.1	15.6	14.9	19.2	26.0	56.4	48.1	6.8	791.0	1.1	5.2	3.3	7.5	8.6	27.4	3.7	6.3	13.1	2.8	16.7	3.7	22.9	0.3	0.1	2.3	0.0	2.1	3.8	1.3	5.5	47.1	10.9	5.3	422.8	0.4	0.2	21.4	0.5	2.2	2.5	5.0	43.9	17.0	14.6	94.2	177.1	0.7	14.2	16.7	21.0	1.5	5.6	27.4	8.8	1568.3	6.1	5.4	0.0	434.3	815.3	1.2	8.0	8.2	0.2	8.2	0.0	1.8	12.2	11.4	13.1	4.2	5.8	0.6	1.9	2.3	2.7	0.0	0.6	26.2	1.5	1.8
DRD3		ENSG00000151577	"Dopamine receptor D3"	P35462	3	114127580-114199407	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 5.6"	"Group enriched"	"Detected in some"	12	"Early spermatids: 6.2;Late spermatids: 19.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basal ganglia: 5.6;cerebral cortex: 2.8;hypothalamus: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 7.4"	"Region enriched"	"Detected in many"	10	"basal ganglia: 17.9"							NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"		"Cluster 25: Spermatids - Spermatogenesis"								"unprognostic (2.32e-1)"													0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	5.6	0.0	2.8	0.1	4.1	0.0	0.2	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD5	"DRD1B, DRD1L2"	ENSG00000169676	"Dopamine receptor D5"	P21918	4	9781634-9784009	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Dystonia, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6;stomach 1: 4.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Horizontal cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 7.0"	HPA048930	Supported					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048930: AB_2680562"		"unprognostic (2.03e-2)"			"unprognostic (2.63e-1)"	"unprognostic (9.73e-2)"		"unprognostic (4.27e-2)"		"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-4)"	"unprognostic (5.09e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.36e-3)"	0.0	0.0	3.2	1.4	6.6	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	0.0	0.4	0.0	2.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.4	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.6	0.0	3.3	1.6	1.6	2.0	1.1	2.2	1.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847158	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.6;pituitary gland: 4.2;retina: 1.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 4376.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019324, HPA057493"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA019324: AB_2670118, HPA057493: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.0	0.0	5.4	0.0	5.8	0.0	0.1	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.6	4.2	0.0	0.1	0.0	0.0	2.3	2.8	0.0	0.1	0.0	4.2	0.7	3.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.8	0.1	6.6	5.6	4.2	2.3	2.8	3.5	2.9	4.1	4.1	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	19.6	0.0	0.4	1.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.4	0.0	0.0	1083.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	16.8	649.1	0.0	0.0	2.4	0.0	4.2	0.0	0.0	0.0	200.5	0.0	0.7	0.0	4376.6	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.0	0.1	1.7	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0
EFNB3	"EPLG8, LERK-8"	ENSG00000108947	"Ephrin B3"	Q15768	17	7705202-7711372	"Cancer-related genes, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 11.6;Early spermatids: 9.2;Excitatory neurons: 9.1"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.9;AN3-CA: 32.3;hTERT-RPE1: 32.6;SH-SY5Y: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001623	Approved					NA	NA		11000		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA001623: AB_1848026"	"unprognostic (5.17e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.20e-2)"	3.5	2.0	23.1	0.7	25.8	0.0	3.5	0.1	25.3	7.4	5.6	0.7	0.3	10.3	0.5	2.0	5.5	1.2	1.1	23.0	37.3	1.2	1.7	1.0	0.3	9.2	10.7	4.7	1.2	12.0	5.7	1.2	8.7	2.1	0.6	3.6	1.4	0.5	0.3	5.9	0.9	3.7	5.8	0.1	0.8	3.6	38.2	0.4	0.7	0.1	0.9	1.0	2.4	10.7	0.0	1.0	53.9	32.3	1.0	0.7	0.4	0.6	7.2	4.8	3.1	2.0	3.4	0.0	1.1	2.1	0.3	0.4	13.9	6.9	2.8	0.0	6.8	0.2	0.0	0.1	1.5	0.0	0.0	3.1	1.4	1.5	1.1	32.6	0.3	0.5	0.0	0.0	0.9	5.4	0.0	0.0	4.8	0.0	1.0	0.2	0.1	0.0	7.4	0.7	3.4	28.1	0.0	0.0	1.1	9.4	2.9	0.0	0.1	3.2	10.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	25.8	0.1	25.3	23.0	37.3	9.2	10.7	8.7	5.8	38.2	10.7	2.1	0.0	0.0	1.0	0.2	4.1	3.8	4.6	6.8	2.2	5.9	11.6	1.7	1.5	0.9	0.0	0.0	0.3	0.0	0.1	0.0	1.1	9.2	2.5	5.9	1.3	6.7	2.7	9.1	0.2	1.0	4.6	0.0	0.7	1.3	3.3	2.2	0.0	0.4	5.0	6.8	0.3	4.1	0.0	0.4	5.6	4.7	0.2	0.0	1.0	0.0	1.4	0.0	0.5	1.3	0.2	0.0	3.4	0.0	1.6	0.0	0.0	6.0	0.7	0.0	0.0	2.2	0.7	0.7	1.8	2.8	0.3	0.1	1.2	0.0	1.6
ELAVL4	"HUD, PNEM"	ENSG00000162374	"ELAV like RNA binding protein 4"	P26378	1	50024029-50203772	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 52.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 155.5;Excitatory neurons: 158.7;Inhibitory neurons: 109.7;Late spermatids: 159.4;Oligodendrocyte precursor cells: 75.4"	"Cancer enriched"	"Detected in some"	4	"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Cell line enriched"	"Detected in some"	17	"SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004442, HPA043047"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB004442: AB_627765, HPA043047: AB_2732502"	"unprognostic (1.25e-1)"	"unprognostic (6.63e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.83e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.43e-2)"	0.1	11.2	13.9	2.4	18.0	0.0	0.2	7.4	52.8	0.0	0.0	2.2	1.4	0.0	0.0	0.2	0.1	0.1	0.2	20.0	18.5	0.1	0.1	0.3	0.2	36.5	14.0	0.0	2.3	0.0	3.4	0.2	31.7	0.1	2.8	3.9	0.2	0.1	0.0	0.4	2.2	1.1	2.0	0.2	1.0	8.5	11.4	0.9	0.0	0.0	0.2	0.1	0.2	17.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.2	157.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	13.9	18.0	7.4	52.8	20.0	18.5	36.5	14.0	31.7	2.0	11.4	17.4	0.1	0.0	0.0	7.2	0.1	0.8	0.0	0.0	0.0	3.9	0.1	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	155.5	0.0	0.0	0.3	32.9	0.0	158.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	109.7	0.1	4.1	4.0	5.0	159.4	1.5	3.1	1.8	22.5	0.0	1.5	0.0	75.4	5.9	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.1	8.9	11.8	0.0	0.9	0.1	0.2	0.0	0.1	0.1
EPHX4	"ABHD7, EH4, EPHXRP, FLJ90341"	ENSG00000172031	"Epoxide hydrolase 4"	Q8IUS5	1	92029985-92063538	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9;choroid plexus: 5.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 55.3;Inhibitory neurons: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 12.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.4;CAPAN-2: 13.0;EFO-21: 25.9;RPTEC TERT1: 36.1;U-251 MG: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035067	Uncertain		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA035067: AB_10601465"	"unprognostic (1.27e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (6.10e-8)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (5.36e-3)"	"unprognostic (2.72e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.44e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.36e-6)"	"unprognostic (6.93e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	0.5	0.5	4.0	0.5	9.2	0.0	1.4	1.9	10.9	0.9	5.7	0.6	0.6	0.6	0.5	0.8	0.4	0.4	0.5	6.9	2.3	0.4	0.0	0.6	0.2	3.1	2.3	0.1	0.0	0.4	1.1	0.8	3.1	0.9	0.5	2.1	0.2	1.8	0.1	0.5	0.4	1.1	1.8	0.0	0.3	1.2	2.8	0.0	1.8	0.1	0.2	0.7	0.2	5.5	15.4	0.5	2.9	0.0	0.0	0.0	0.7	0.3	5.5	0.5	0.3	0.0	13.0	0.0	25.9	0.0	3.9	0.2	0.5	1.2	0.5	0.0	8.0	0.0	0.1	0.0	0.2	1.1	0.0	0.9	0.7	0.0	0.0	9.4	4.5	0.0	0.1	0.0	0.4	0.9	2.2	0.6	2.8	0.0	5.2	0.5	0.3	0.0	36.1	3.0	1.8	2.2	9.1	0.0	2.9	0.2	0.0	2.2	0.2	0.0	0.1	0.0	10.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	2.0	0.1	1.4	3.0	0.0	0.0	0.3	2.8	0.0	0.5	0.0	0.0	0.0	1.5	4.0	9.2	1.9	10.9	6.9	2.3	3.1	2.3	3.1	1.8	2.8	5.5	2.0	0.0	0.0	4.9	0.0	0.1	0.1	2.0	0.0	2.0	6.7	4.6	1.0	0.0	1.5	0.0	2.1	0.4	3.2	0.1	0.0	0.4	1.7	1.0	0.1	6.2	0.0	0.0	55.3	0.9	0.7	0.3	0.0	1.3	0.0	0.3	0.4	0.0	0.2	1.7	32.5	0.0	0.0	0.0	0.4	0.1	0.0	0.2	3.6	4.7	0.1	8.6	0.0	5.5	2.7	5.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.6	0.0	0.1	0.8	6.0	0.7	0.1	0.4	0.0	1.1	0.2	0.3	0.3
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 359.4;parathyroid gland: 98.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	4.7	41.6	180.7	4.9	189.0	0.0	1.8	107.7	359.4	6.7	0.0	8.5	2.2	9.9	8.0	4.2	14.2	10.2	41.9	205.6	161.0	2.1	0.4	2.2	3.7	223.0	129.4	3.9	2.4	98.1	42.0	0.2	206.5	14.2	3.5	72.3	2.6	9.0	1.2	0.9	6.3	12.2	106.8	1.9	4.2	30.5	175.3	1.9	1.8	1.2	2.8	9.5	10.5	223.0	0.0	0.5	0.5	0.7	2.7	1.7	0.1	0.7	3.6	0.7	0.4	0.4	0.0	0.0	0.1	5.1	0.2	0.3	1.5	0.0	0.4	0.0	0.0	2.9	0.0	0.0	12.2	0.1	0.1	1.1	0.2	2.7	0.0	0.0	0.0	0.3	1.6	0.4	0.7	0.0	0.1	0.0	0.1	16.7	0.0	0.0	0.2	0.0	0.0	0.0	4.4	6.7	0.0	0.2	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.1	0.1	0.4	0.0	0.0	38.5	0.0	0.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.1	180.7	189.0	107.7	359.4	205.6	161.0	223.0	129.4	206.5	106.8	175.3	223.0	0.2	0.0	0.0	31.0	0.0	0.3	0.3	0.7	0.6	141.9	2.3	2.3	1.1	0.0	0.4	0.0	2.1	0.0	0.3	0.1	0.0	0.1	202.2	0.1	0.5	0.7	0.0	0.0	77.6	0.2	0.1	16.7	1.1	0.0	26.1	0.0	0.0	0.0	0.4	232.2	105.1	2.2	12.2	0.0	0.4	52.0	5.0	0.5	0.0	13.1	0.0	35.6	0.0	45.2	55.5	0.1	0.0	5.3	0.3	0.5	0.0	0.4	0.0	20.2	0.0	0.9	0.7	4.8	5.8	0.5	0.3	0.1	0.5	0.4	0.7	0.3
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;choroid plexus: 3.3;testis: 7.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.6;Early spermatids: 18.8;Excitatory neurons: 13.1;Horizontal cells: 20.2;Inhibitory neurons: 24.0;Late spermatids: 28.6;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 15.6;Spermatocytes: 26.4;Spermatogonia: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 14.5;Karpas-707: 46.0;U-2197: 23.9;U-266/70: 35.7;U-266/84: 82.6"					"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.0	1.2	5.2	0.0	5.2	0.0	0.2	4.3	9.5	0.5	3.3	0.1	0.0	0.3	0.2	0.0	0.3	0.1	0.9	4.7	6.3	0.0	0.0	0.0	0.0	4.6	5.6	0.4	0.0	0.0	2.2	0.0	5.8	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	4.5	0.0	0.0	7.6	5.8	0.0	0.2	0.0	0.0	0.0	0.1	4.7	0.3	2.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	46.0	0.0	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.3	0.0	0.0	0.0	0.9	1.1	23.9	1.0	35.7	82.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.2	4.3	9.5	4.7	6.3	4.6	5.6	5.8	4.5	5.8	4.7	0.1	0.0	0.0	3.6	0.0	0.6	0.0	0.0	0.0	13.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.1	0.0	0.0	13.1	0.0	0.1	0.5	0.0	0.0	0.0	3.0	0.7	0.0	0.0	20.2	24.0	0.0	0.0	0.0	0.3	28.6	1.2	0.1	0.0	1.0	0.0	2.9	0.0	22.6	15.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.2	26.4	39.0	0.0	0.1	0.0	0.1	3.7	0.0	0.0
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107867496	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.7;pituitary gland: 5.4"	"Group enriched"	"Detected in many"	6	"Astrocytes: 918.7;Excitatory neurons: 3051.8;Inhibitory neurons: 2146.4;Oligodendrocyte precursor cells: 2307.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.3;RPTEC TERT1: 11.4;SCLC-21H: 7.2;SH-SY5Y: 16.6;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039453	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039453: AB_10795290"	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.4	1.1	7.5	0.1	8.6	0.0	0.2	5.9	10.7	0.5	1.0	0.2	0.1	0.6	1.7	0.2	0.2	0.4	0.2	9.3	10.5	0.1	0.0	0.4	0.1	6.0	7.1	0.2	0.1	0.0	5.4	0.4	7.1	1.1	0.2	2.0	0.0	1.6	0.0	0.0	0.2	0.4	4.9	0.1	0.2	1.0	8.4	0.0	0.4	0.0	0.3	0.5	0.3	8.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.6	0.0	2.4	0.0	5.3	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	4.5	0.0	0.0	0.2	0.0	11.4	1.9	7.2	16.6	0.0	0.0	0.0	0.2	4.2	0.0	0.2	5.0	2.1	1.7	0.2	0.0	0.0	0.0	10.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	8.6	5.9	10.7	9.3	10.5	6.0	7.1	7.1	4.9	8.4	8.3	2.8	3.2	24.6	918.7	0.0	0.1	0.3	0.0	0.0	19.7	0.9	0.3	0.8	0.0	1.9	3.7	0.0	0.0	0.0	0.0	0.0	1.3	62.3	8.9	39.5	4.4	0.0	0.0	3051.8	0.0	0.1	3.7	0.0	20.7	0.0	0.5	8.2	0.0	0.2	37.0	2146.4	0.0	0.0	0.0	0.4	22.7	1.8	0.2	0.0	306.3	0.0	6.8	0.0	2307.6	37.2	0.5	0.0	1.2	0.0	0.9	0.0	0.1	0.0	1.6	6.6	0.3	1.5	1.1	2.0	0.1	0.0	0.0	0.4	1.0	0.0	0.3
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630247-69633596	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 19.4;Collecting duct cells: 16.5;Distal tubular cells: 11.7;Ductal cells: 24.3;Exocrine glandular cells: 18.4;Pancreatic endocrine cells: 20.7;Proximal tubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"gdT-cell: 4.3;MAIT T-cell: 10.9;memory CD4 T-cell: 10.5;memory CD8 T-cell: 7.0;naive CD4 T-cell: 17.2;naive CD8 T-cell: 5.7;T-reg: 7.8"	"Lineage enriched"	"Detected in single"	25	"T-cells: 17.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 57.5"					"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavorable (8.64e-4)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (9.72e-4)"	1.6	3.0	26.3	1.9	27.3	1.1	4.7	30.4	40.3	2.2	19.2	6.6	2.7	3.2	11.1	4.8	4.3	2.0	6.6	35.5	31.7	10.7	3.7	4.0	2.9	21.7	24.2	2.1	8.2	8.2	12.7	1.2	28.2	7.8	2.3	11.3	5.5	4.7	4.7	3.4	3.5	3.8	21.5	1.4	5.8	22.2	26.4	2.8	5.8	1.2	2.3	5.8	3.0	22.2	29.4	31.9	3.9	31.8	0.0	0.0	13.6	2.9	0.8	5.1	5.6	23.4	23.6	0.0	42.8	0.6	18.6	11.8	16.6	9.6	7.1	29.4	22.8	0.0	6.7	8.8	8.1	0.0	10.0	0.0	9.4	0.2	4.8	3.8	0.0	43.8	11.1	0.1	0.5	39.9	0.3	0.0	19.1	11.8	57.5	0.0	0.0	0.4	10.9	16.6	16.0	22.2	12.1	29.6	19.0	7.8	20.5	5.1	1.4	0.8	19.4	0.1	8.5	5.1	15.2	0.1	0.4	0.0	0.8	0.0	0.0	0.0	4.3	0.0	10.9	0.1	10.5	7.0	0.1	0.4	17.2	5.7	0.6	0.2	0.0	0.1	7.8	3.1	26.3	27.3	30.4	40.3	35.5	31.7	21.7	24.2	28.2	21.5	26.4	22.2	1.4	0.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.3	19.4	0.0	0.0	3.1	16.5	0.0	7.5	0.6	0.0	11.7	24.3	0.0	5.7	0.4	0.7	0.0	0.0	0.0	18.4	5.6	0.6	0.0	5.0	0.0	8.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.3	0.0	0.0	13.5	4.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	2.8	3.7	0.0	0.0
FAT3	"CDHF15, CDHR10, KIAA1989"	ENSG00000165323	"FAT atypical cadherin 3"	Q8TDW7	11	92224818-92896473	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 19.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 265.8;Excitatory neurons: 512.9;Inhibitory neurons: 149.2;Oligodendrocyte precursor cells: 88.4"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.3;fHDF/TERT166: 2.2;NTERA-2: 2.5;SuSa: 2.2;U-2 OS: 2.1;U-251 MG: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026878, HPA074824"	Uncertain		Approved	"Cell Junctions"		NA	NA		4700		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"HPA026878: AB_1848430, HPA074824: "	"unprognostic (5.00e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.76e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.66e-4)"	"unprognostic (8.83e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.25e-1)"	0.5	0.0	5.5	0.0	19.3	0.0	0.1	1.3	9.0	0.6	0.0	0.2	0.0	0.6	0.6	0.1	0.6	0.0	0.2	4.0	15.5	0.2	0.0	1.2	0.0	0.5	4.7	0.5	0.0	0.0	2.9	0.1	1.9	2.0	0.1	1.3	0.0	3.8	0.1	0.2	0.0	0.1	0.8	0.1	2.2	0.7	7.5	0.1	0.0	0.2	0.2	2.3	1.0	1.0	0.0	0.3	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	1.4	2.2	0.0	1.2	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	2.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	19.3	1.3	9.0	4.0	15.5	0.5	4.7	1.9	0.8	7.5	1.0	0.0	0.0	0.0	265.8	0.0	0.1	0.3	0.9	0.0	20.8	0.1	0.5	1.8	0.0	0.1	14.7	0.0	0.1	0.0	0.1	0.0	0.7	4.8	0.1	0.2	0.2	0.0	0.0	512.9	0.0	0.1	1.9	0.0	0.0	0.0	3.7	1.4	0.0	0.1	0.0	149.2	0.0	24.4	0.0	0.0	3.8	1.2	0.3	0.0	13.1	0.0	0.8	0.0	88.4	7.0	0.2	0.0	7.5	0.0	0.6	0.0	0.0	0.0	1.7	0.0	2.5	4.4	1.0	6.5	0.1	0.0	0.0	0.0	44.8	0.0	0.1
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529305-168530634	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.4;pituitary gland: 15.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cone photoreceptor cells: 6.2;Enteroendocrine cells: 6.7;Horizontal cells: 6.7;Inhibitory neurons: 6.6;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 24.2;SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049546, HPA077724"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: AB_2680811, HPA077724: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.2	3.0	22.0	0.1	21.0	0.0	0.6	12.8	35.4	0.5	4.6	0.9	0.4	0.2	0.0	0.2	0.4	0.2	0.3	20.4	32.2	0.6	0.7	0.1	0.0	22.7	21.0	0.7	0.9	0.4	15.5	0.2	26.1	1.0	0.1	1.4	0.9	0.3	0.1	0.5	0.5	0.2	11.4	0.2	0.5	5.9	23.1	0.0	0.2	0.0	0.0	0.3	0.3	20.1	0.0	0.5	1.8	0.3	0.1	0.0	0.9	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	20.2	2.1	0.0	1.2	0.0	0.0	1.5	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	21.0	12.8	35.4	20.4	32.2	22.7	21.0	26.1	11.4	23.1	20.1	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.6	8.5	1.4	1.8	1.2	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	1.7	0.9	1.4	0.2	6.7	0.0	4.3	0.2	0.1	0.8	0.0	2.4	0.0	1.6	0.0	0.0	0.1	6.7	6.6	0.4	0.0	0.0	0.0	2.3	0.0	0.1	3.6	1.0	0.0	0.7	0.0	3.0	1.1	0.2	0.0	0.0	0.0	0.3	1.0	0.4	0.0	2.8	6.6	0.2	0.4	3.1	0.4	0.2	0.1	0.0	0.1	1.2	0.3	0.0
FBXL15	"Fbl15, FBXO37, MGC11279"	ENSG00000107872	"F-box and leucine rich repeat protein 15"	Q9H469	10	102419189-102423136	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 211.3;Proximal enterocytes: 176.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (1.08e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (3.99e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.92e-4)"	6.3	7.0	12.9	2.7	13.6	4.6	3.2	11.8	21.8	3.6	8.3	8.6	9.1	5.9	0.3	4.1	4.1	0.7	4.3	13.6	13.4	5.7	4.2	3.8	2.1	17.2	13.0	3.8	4.6	3.8	16.3	1.4	15.1	3.7	1.1	4.7	5.2	2.3	9.1	3.4	8.0	1.4	10.0	6.6	8.5	8.0	13.7	1.0	3.1	1.4	1.1	5.5	3.6	13.8	19.9	3.5	3.8	3.6	2.2	2.5	13.4	6.4	4.3	2.4	2.0	5.0	4.9	7.4	16.4	1.9	2.1	9.7	1.8	2.3	0.3	13.0	24.4	10.7	6.8	8.2	3.2	7.8	11.2	1.9	5.2	1.7	3.0	4.5	2.8	3.7	15.1	4.5	0.4	7.2	5.2	44.7	5.2	4.3	14.3	13.8	4.6	8.6	2.4	3.5	15.1	18.6	4.7	4.1	20.5	0.8	8.6	6.2	8.3	1.9	6.9	7.4	5.4	15.4	8.8	8.2	4.7	7.5	0.7	43.9	51.6	60.2	39.0	40.2	31.3	33.2	37.0	32.7	50.1	37.5	36.5	31.3	23.8	33.0	47.7	44.5	43.1	39.7	12.9	13.6	11.8	21.8	13.6	13.4	17.2	13.0	15.1	10.0	13.7	13.8	34.7	16.0	16.0	4.9	29.6	25.0	28.8	47.5	21.1	60.2	31.6	35.9	21.5	51.5	34.3	31.3	20.9	24.6	38.3	75.3	211.3	52.7	44.3	21.5	13.3	30.7	84.9	12.0	16.7	77.2	20.7	23.8	30.1	22.0	32.4	20.4	43.5	48.5	66.7	26.9	17.2	59.3	57.0	44.0	49.7	21.0	29.8	36.8	39.2	6.5	84.1	54.1	61.8	4.5	6.6	47.4	76.7	30.5	19.6	34.3	176.2	139.0	22.3	53.3	13.1	18.2	40.3	20.6	23.2	24.3	31.4	30.0	31.1	37.2	59.9	24.8
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7;choroid plexus: 10.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 9.3;Cone photoreceptor cells: 14.6;Excitatory neurons: 10.6;Inhibitory neurons: 13.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6;testis cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;RPMI-8226: 1.8"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	HPA052600	Uncertain				"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA052600: AB_2681881"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.5	3.9	15.1	0.0	14.9	0.1	0.4	22.0	25.7	3.0	10.6	0.4	0.0	1.1	0.1	0.2	1.5	0.2	0.5	14.3	14.2	1.4	0.4	0.7	0.0	11.9	12.2	1.5	1.2	0.8	5.1	0.1	12.2	2.7	0.0	1.1	0.7	0.1	0.0	0.5	0.4	0.3	10.9	3.6	0.5	0.7	14.2	0.4	4.8	0.0	0.0	0.6	1.3	14.4	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	14.9	22.0	25.7	14.3	14.2	11.9	12.2	12.2	10.9	14.2	14.4	0.2	0.0	0.0	2.3	0.0	0.0	0.3	0.1	0.0	9.3	0.2	0.4	1.1	0.0	0.2	0.0	14.6	0.1	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.1	0.0	0.0	10.6	0.2	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	1.7	13.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.8	1.0	0.0	0.6	0.0	2.0	2.4	0.1	0.0	1.2	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.3	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.4	0.0	0.1
FKBP1B	"FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase"	ENSG00000119782	"FKBP prolyl isomerase 1B"	P68106	2	24049701-24063681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.9"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.2;T-reg: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 47.9;NTERA-2: 42.9;SH-SY5Y: 30.7;SuSa: 46.1;TIME: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045572, HPA051798"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"HPA045572: AB_2732521, HPA051798: AB_2681615"	"unprognostic (3.01e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	5.6	4.4	32.5	2.2	36.1	1.6	5.5	26.5	47.9	6.7	23.0	7.1	19.6	4.8	2.7	8.3	3.9	5.4	5.1	39.2	30.9	8.7	6.6	10.5	1.5	27.7	27.6	5.5	7.5	7.0	6.4	4.0	30.3	7.2	3.3	7.7	6.6	6.3	1.4	6.5	6.8	2.7	25.9	2.8	15.0	1.6	32.7	1.6	6.7	1.2	2.3	5.6	8.1	30.5	0.2	2.0	17.2	0.0	10.9	4.7	6.2	5.8	6.0	2.5	3.6	1.2	2.0	0.0	4.3	10.3	15.4	6.8	25.7	20.2	1.6	3.0	16.1	6.0	0.2	47.9	4.5	0.0	14.1	3.9	4.6	5.9	1.1	14.7	16.5	6.8	1.5	0.1	5.9	0.2	2.0	0.0	42.9	1.7	3.0	3.1	1.5	0.2	2.0	1.3	4.1	30.7	0.3	0.1	5.8	46.1	1.2	2.2	38.0	0.0	5.2	0.2	1.4	1.1	0.5	0.0	6.4	0.0	1.3	0.4	0.4	2.2	0.1	0.4	0.0	0.1	0.2	0.2	1.0	1.2	0.0	0.1	0.0	0.1	0.0	0.2	2.8	0.5	32.5	36.1	26.5	47.9	39.2	30.9	27.7	27.6	30.3	25.9	32.7	30.5	9.3	0.0	6.8	2.9	1.8	9.2	14.0	13.7	11.4	2.1	6.5	13.7	0.9	22.8	4.7	7.3	0.0	4.9	2.7	15.8	13.7	27.6	0.6	3.5	5.0	10.9	9.5	7.0	16.9	38.2	31.9	6.9	16.3	7.1	1.3	3.4	15.7	10.2	7.5	1.7	7.8	8.9	2.0	4.0	17.4	2.9	2.8	9.1	28.4	4.7	13.0	31.4	1.0	2.5	1.3	49.8	25.4	4.1	2.4	15.5	10.6	6.8	2.0	3.6	26.3	2.9	10.6	1.6	5.4	9.1	7.4	5.2	4.9	1.4	4.5	19.3
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FKBP prolyl isomerase 4"	Q02790	12	2794970-2805423	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 372.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		480000	"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	35.4	38.1	92.1	22.3	95.9	24.2	53.1	127.7	372.1	41.7	89.6	35.7	20.3	32.2	44.6	69.3	38.2	24.8	42.7	96.6	104.4	68.1	57.5	38.0	19.8	101.0	101.4	50.4	52.0	47.8	36.1	50.6	106.2	44.4	37.8	52.2	48.1	44.9	69.4	49.8	25.6	40.0	97.8	24.3	58.0	58.4	103.0	25.1	44.4	48.5	29.9	44.6	46.0	141.7	91.6	198.6	56.2	94.9	68.5	40.1	268.3	87.5	31.2	141.2	95.0	199.1	108.3	120.9	24.5	56.6	98.2	121.9	353.3	118.5	168.2	222.6	226.1	133.2	141.8	71.4	52.6	105.5	35.0	36.5	106.6	167.2	165.9	84.0	83.5	119.8	124.9	166.4	57.6	261.5	186.2	94.9	480.0	266.5	141.2	110.0	98.7	72.4	119.5	114.2	80.7	116.0	101.6	272.7	45.3	348.8	368.0	70.3	44.9	69.1	216.4	78.6	224.1	40.9	67.9	177.0	61.4	154.7	72.2	17.0	11.5	6.7	12.5	10.5	13.9	14.0	11.0	11.9	6.4	14.3	11.3	13.5	1.5	9.2	15.5	5.6	11.0	11.1	92.1	95.9	127.7	372.1	96.6	104.4	101.0	101.4	106.2	97.8	103.0	141.7	31.9	6.4	11.5	10.1	39.1	143.9	261.5	38.5	80.8	60.3	133.9	96.3	13.1	54.3	26.8	53.3	75.0	186.1	27.2	111.0	154.6	82.0	125.4	49.7	47.4	43.5	106.1	77.8	12.9	25.9	117.3	42.6	41.8	74.5	38.2	45.3	20.7	49.3	62.0	97.6	15.5	124.9	63.1	17.5	102.1	40.9	34.8	67.7	92.5	4.7	40.2	48.3	25.7	10.1	17.6	60.3	100.1	38.7	47.3	272.4	77.3	141.7	21.1	63.4	85.5	28.3	117.2	149.4	74.4	111.5	132.8	223.3	74.0	38.6	148.7	147.3
FSD1	"MGC3213, MIR1"	ENSG00000105255	"Fibronectin type III and SPRY domain containing 1"	Q9BTV5	19	4304598-4323843	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 16.0;testis: 7.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.6;Distal tubular cells: 15.6;Excitatory neurons: 26.6;Horizontal cells: 16.8;Inhibitory neurons: 19.7;NK-cells: 16.5;Spermatogonia: 30.4"	"Group enriched"	"Detected in many"	6	"glioma: 9.2;testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.6;NK-cell: 5.4;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 1.4;NK-cells: 5.4;T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 55.3;SH-SY5Y: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043141	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA043141: AB_10797137"	"unprognostic (8.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.29e-2)"	"unprognostic (9.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	0.3	0.7	11.9	0.7	12.7	0.7	0.0	9.3	15.6	0.6	2.5	0.6	1.0	0.5	0.1	0.2	0.1	0.3	0.1	13.9	12.1	0.3	0.4	0.2	1.1	14.7	10.4	0.2	0.1	0.0	2.0	0.8	16.0	0.3	0.1	1.8	0.1	0.1	0.0	0.2	0.9	0.4	7.7	0.9	0.3	7.6	15.5	0.9	0.1	0.0	0.4	0.1	0.3	11.7	0.1	6.7	18.6	9.7	0.1	1.8	7.9	7.9	3.2	25.0	19.3	15.6	0.5	24.3	6.7	5.5	13.1	1.6	17.0	12.8	8.0	15.6	24.9	6.8	5.6	0.5	9.9	0.0	1.6	4.2	0.1	14.6	0.9	10.1	13.5	21.5	1.1	0.0	1.2	18.4	11.2	0.0	23.9	0.1	12.7	0.0	8.8	0.0	0.1	0.6	55.3	57.6	2.1	0.9	1.7	3.0	0.2	0.2	15.3	3.9	17.6	7.3	7.3	13.7	18.4	6.1	9.4	0.0	9.7	0.0	0.0	0.0	0.5	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	5.4	0.0	1.4	0.4	0.7	11.9	12.7	9.3	15.6	13.9	12.1	14.7	10.4	16.0	7.7	15.5	11.7	0.2	0.0	1.1	2.0	0.4	0.1	0.7	0.0	0.0	12.6	0.1	0.0	0.5	0.0	0.6	3.7	2.1	3.2	6.1	0.3	15.6	0.1	4.0	0.1	1.1	0.5	2.4	2.7	26.6	0.0	1.3	1.4	0.5	0.2	2.5	3.5	0.7	0.4	0.8	16.8	19.7	0.4	0.0	0.0	0.0	5.3	0.9	0.3	0.0	3.7	0.1	1.7	16.5	8.5	9.5	0.0	0.1	0.4	0.5	0.3	0.0	0.3	0.0	7.1	0.0	0.9	1.6	3.7	30.4	0.0	0.0	2.7	5.6	0.1	0.3	0.4
FXYD7		ENSG00000221946	"FXYD domain containing ion transport regulator 7"	P58549	19	35143250-35154302	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 273.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2;ovarian cancer: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 52.1"	"Group enriched"	"Detected in many"	23	"B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1"									HPA026916	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026916: AB_1849217"	"unprognostic (1.25e-3)"	"unprognostic (8.73e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.95e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	2.1	0.4	119.1	1.7	140.3	0.6	1.1	45.1	273.1	5.8	37.8	2.7	0.6	1.9	0.0	0.4	0.9	0.4	0.7	153.8	75.1	0.4	1.1	1.1	2.8	124.3	83.1	1.0	0.2	0.0	2.1	0.1	129.5	1.0	0.2	1.6	0.5	0.3	2.7	1.3	2.0	0.2	70.1	2.8	1.0	1.3	101.6	0.2	0.5	0.1	1.5	0.8	3.1	185.5	0.6	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	1.8	0.0	0.2	0.3	0.1	0.2	0.6	0.0	0.1	0.0	5.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	2.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	15.0	0.0	9.5	19.0	23.7	17.2	0.1	14.6	7.5	13.8	0.6	52.1	0.1	1.3	7.5	4.9	119.1	140.3	45.1	273.1	153.8	75.1	124.3	83.1	129.5	70.1	101.6	185.5	1.1	0.0	1.3	7.2	8.0	2.0	0.1	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	1.8	0.0	0.0	14.0	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.4	42.0	0.2	0.1	1.1	0.0	0.0	1.3	0.1	0.7	0.2	0.1	1.7	12.9	0.0	0.0	0.0	4.4	0.2	1.2	0.7	3.6	9.4	0.2	1.5	0.0	3.5	6.2	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	6.6	0.7	1.1	3.1	5.0	0.1	1.1	0.3	19.2	0.0	0.0	0.0
GABRB1		ENSG00000163288	"Gamma-aminobutyric acid type A receptor subunit beta1"	P18505	4	46993723-47426447	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 26.3"	"Group enriched"	"Detected in some"	15	"Astrocytes: 926.2;Excitatory neurons: 440.3;Inhibitory neurons: 507.4;Oligodendrocyte precursor cells: 266.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.1;U-87 MG: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (3.11e-2)"		"unprognostic (7.56e-3)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"			"unprognostic (1.11e-1)"		"unprognostic (4.98e-3)"		"unprognostic (8.16e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.34e-1)"		0.0	0.2	19.1	0.0	24.8	0.0	0.0	0.3	26.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	3.6	26.2	24.6	0.3	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.3	1.5	0.1	0.6	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	26.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	24.8	0.3	26.3	26.2	24.6	0.5	7.4	0.6	1.1	26.1	2.3	0.0	0.0	0.0	926.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.1	1.2	0.0	440.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	507.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.1	32.9	0.0	266.9	16.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.3	1.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0
GABRQ		ENSG00000268089	"Gamma-aminobutyric acid type A receptor subunit theta"	Q9UN88	X	152637895-152657542	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 72.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.0;Glandular and luminal cells: 2.8;Spermatogonia: 1.4;Squamous epithelial cells: 2.5;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.4;SiHa: 11.6;SuSa: 5.0;U-87 MG: 37.2"	"Region enriched"	"Detected in many"	5	"hypothalamus: 52.6"	"Group enriched"	"Detected in some"	4	"hypothalamus: 7.7;midbrain: 20.8;pons: 6.3"							NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (3.68e-3)"	"unprognostic (7.78e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.10e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.70e-2)"	0.0	2.2	22.3	0.0	25.3	0.0	0.0	0.1	27.1	7.7	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	17.6	72.4	0.0	0.0	0.0	0.0	9.6	27.9	0.0	0.0	0.0	0.1	0.1	22.2	0.4	0.0	0.2	0.0	0.5	0.0	0.3	0.2	0.8	3.0	0.0	0.0	1.2	41.4	0.0	0.0	0.0	0.1	0.0	0.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.2	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	1.6	11.6	2.1	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	25.3	0.1	27.1	17.6	72.4	9.6	27.9	22.2	3.0	41.4	1.7	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.6	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.0	1.4	2.5	1.8	0.8	0.0	0.0	0.0	0.5
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216665-26304558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 37.6;retina: 9.5"	"Cell type enriched"	"Detected in some"	13	"Inhibitory neurons: 293.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			0.0	0.0	13.1	0.0	37.3	0.0	0.0	6.9	16.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.0	37.6	0.0	0.0	0.0	0.0	6.6	14.8	0.0	3.6	0.0	0.4	0.0	7.7	0.0	0.0	9.5	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.1	0.4	11.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	37.3	6.9	16.2	6.0	37.6	6.6	14.8	7.7	3.1	11.9	3.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.6	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	293.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.6	0.0	0.3	0.0	2.0	6.1	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;lymphoid tissue: 2.5"	"Group enriched"	"Detected in some"	17	"Excitatory neurons: 424.4;Inhibitory neurons: 1567.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031019	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.0	0.2	3.6	0.4	2.8	0.4	0.2	0.5	4.0	1.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.1	6.0	7.8	0.0	0.1	0.1	0.3	0.2	5.3	0.0	0.1	0.0	0.0	0.0	2.3	0.7	0.2	1.3	0.3	0.0	0.3	0.1	0.5	0.0	1.1	2.5	1.0	2.4	4.0	0.0	0.1	1.4	0.1	0.1	0.4	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.8	0.5	4.0	6.0	7.8	0.2	5.3	2.3	1.1	4.0	0.6	0.0	0.0	1.5	10.4	2.4	0.3	0.1	0.0	0.0	1.6	0.3	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	424.4	4.1	0.0	0.3	2.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1567.9	2.6	0.0	1.6	0.0	21.1	0.3	0.9	5.4	13.1	0.0	0.1	0.0	57.3	9.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	1.2	0.2	1.6	1.6	0.0	0.3	0.0	0.0	0.1	0.4	0.1
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 277.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	131.6	7.5	149.2	0.0	0.9	36.3	277.0	0.6	0.0	10.5	2.5	0.2	0.1	1.1	0.2	4.7	4.3	149.9	187.2	0.2	0.2	0.3	0.2	55.6	156.5	0.2	0.8	0.0	10.0	1.7	113.3	0.9	4.8	8.0	2.1	0.3	0.3	0.5	5.5	4.3	28.5	0.0	2.9	0.4	150.7	0.1	0.2	0.6	0.4	1.3	1.9	121.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	131.6	149.2	36.3	277.0	149.9	187.2	55.6	156.5	113.3	28.5	150.7	121.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636920-174829247	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 10.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 25.3;Early spermatids: 24.7;Excitatory neurons: 52.4;Inhibitory neurons: 11.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.0	0.8	4.2	0.0	3.4	0.0	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.2	0.8	3.6	0.0	0.4	0.0	0.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.5	10.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	3.4	0.0	3.0	2.6	4.5	0.8	3.6	0.6	0.9	10.5	0.0	0.0	0.0	0.6	1.3	1.6	0.0	1.3	0.0	0.0	5.0	25.3	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.1	0.4	0.0	0.0	52.4	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	2.8	0.0	0.2	0.0	1.0	1.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.6	0.0	1.0	0.3	0.7	1.6	0.1	0.1	0.0	0.3	0.0	0.0	0.4
GNAO1	G-ALPHA-o	ENSG00000087258	"G protein subunit alpha o1"	P09471	16	56191390-56357444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 171.2;retina: 52.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.8;Bipolar cells: 189.2;Excitatory neurons: 138.7;Inhibitory neurons: 132.2;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 368.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.7;BJ hTERT+ SV40 Large T+: 20.0;SCLC-21H: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008387, HPA040878"	Enhanced					NA	NA		510000		"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB008387: AB_591430, HPA040878: AB_2677184"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.00e-1)"	"unprognostic (9.70e-5)"	3.0	7.9	100.8	3.4	171.2	0.1	1.1	55.1	121.9	2.1	0.0	34.0	3.1	7.7	3.0	2.9	2.9	2.5	34.1	101.9	87.6	1.1	10.2	0.9	1.1	74.6	89.6	1.7	3.9	1.5	28.5	0.5	77.9	5.1	5.1	52.4	2.3	16.5	2.0	1.4	7.3	10.2	44.6	1.3	11.0	13.8	107.3	1.1	1.9	0.6	1.1	7.9	2.5	110.3	7.3	0.0	0.6	0.1	0.0	0.1	0.9	7.6	30.7	20.0	9.5	0.4	0.0	0.0	0.2	0.0	7.3	0.6	4.9	0.0	13.7	0.2	0.9	0.0	2.0	0.0	0.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0	0.0	6.1	0.0	0.2	0.0	0.8	0.0	0.1	11.1	0.3	0.1	0.1	7.1	0.1	0.0	0.0	61.2	12.2	12.5	0.2	0.7	3.1	0.2	0.0	0.0	0.2	6.8	0.0	3.6	0.8	0.0	0.1	0.3	0.5	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	100.8	171.2	55.1	121.9	101.9	87.6	74.6	89.6	77.9	44.6	107.3	110.3	0.6	0.0	0.5	135.8	0.8	0.8	0.3	0.2	0.0	189.2	1.4	0.6	43.3	1.5	0.1	0.0	6.2	0.4	4.9	0.1	0.0	0.0	26.8	0.7	4.4	1.5	23.3	0.8	138.7	0.0	0.2	6.8	1.5	1.2	0.0	0.2	0.7	10.4	0.1	79.1	132.2	1.0	0.0	0.8	2.1	53.6	34.8	1.7	3.6	13.1	0.0	20.5	1.0	87.9	368.3	0.3	0.0	44.4	2.1	0.4	0.1	0.3	0.1	13.1	0.0	8.2	5.6	15.4	8.8	0.3	0.4	0.1	7.2	0.1	0.3	0.2
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716097-78031811	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 556.6;Excitatory neurons: 405.6;Microglial cells: 394.4;Oligodendrocyte precursor cells: 338.3;Oligodendrocytes: 495.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 27.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		800000	"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: AB_2680544"	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	23.5	21.3	37.2	18.8	42.2	43.8	20.1	35.8	51.3	21.1	19.3	30.3	14.5	23.7	18.7	23.2	16.9	20.1	8.6	51.0	38.5	20.9	22.0	31.1	9.9	40.5	42.7	22.4	14.6	16.3	12.5	21.7	39.9	21.2	27.2	10.4	16.8	25.7	10.5	8.9	16.8	27.4	42.4	11.3	27.9	11.5	45.5	19.7	23.1	11.8	9.1	23.5	13.8	48.5	30.6	34.1	29.8	32.0	34.9	35.5	42.8	40.7	29.7	16.6	20.6	10.5	24.1	0.1	32.0	35.5	24.5	48.5	22.5	23.4	20.6	1.1	12.5	83.0	29.0	21.4	31.4	51.8	30.0	24.3	28.0	33.9	32.5	34.3	42.7	70.3	14.8	0.2	29.5	38.5	58.8	31.0	24.0	46.5	4.7	22.0	36.5	0.3	37.8	64.5	33.1	49.6	29.3	23.3	30.5	27.5	22.2	18.3	55.0	29.2	1.9	41.9	24.0	0.2	0.1	0.3	20.3	28.9	32.0	27.0	2.5	5.7	0.8	2.2	1.7	0.9	2.0	1.1	2.8	0.9	2.1	1.7	8.9	3.6	4.5	3.2	2.2	1.5	37.2	42.2	35.8	51.3	51.0	38.5	40.5	42.7	39.9	42.4	45.5	48.5	117.7	176.3	97.5	556.6	4.8	47.3	38.4	42.7	39.3	34.0	75.6	54.5	6.0	58.6	48.3	77.3	16.7	47.4	33.4	137.0	7.9	36.2	18.9	57.5	64.2	107.3	92.3	58.0	405.6	39.7	53.2	51.7	70.8	76.0	50.7	40.2	98.6	64.0	53.7	82.4	242.0	92.5	30.5	139.5	173.9	11.1	39.4	128.8	48.0	394.4	114.6	40.5	8.2	338.3	495.2	54.2	60.7	52.3	6.2	70.5	52.9	45.4	67.0	5.0	26.3	62.3	40.8	5.6	13.2	46.3	21.6	29.0	25.0	45.2	75.4	70.1
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 113.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	51.3	22.0	38.5	41.1	44.8	64.0	21.0	0.8	55.4	11.9	10.9	24.1	15.2	12.2	5.1	14.1	5.8	17.3	13.5	54.1	75.2	7.5	12.7	19.0	47.7	10.6	20.5	14.4	7.3	3.5	14.9	19.5	27.2	10.6	19.6	15.0	8.1	9.0	5.6	7.8	21.2	19.8	13.6	61.7	15.9	113.4	46.4	62.0	5.7	13.1	45.4	22.2	5.3	22.2	0.0	3.1	77.2	48.6	11.6	15.0	1.2	12.9	15.9	6.1	4.9	6.4	0.2	0.2	1.8	140.2	8.9	0.3	10.4	0.0	4.2	36.4	1.2	0.0	0.7	0.0	6.0	7.4	0.3	25.1	0.0	6.2	0.5	32.2	0.0	67.9	0.0	6.5	39.7	0.0	112.5	12.0	41.1	0.0	9.5	39.4	6.1	2.0	6.4	0.0	11.5	89.2	0.3	0.1	34.5	2.7	0.0	0.3	0.0	18.7	3.1	0.3	9.9	0.2	0.0	5.5	15.5	39.2	249.0	379.4	64.0	177.1	162.8	111.9	110.5	38.1	88.9	134.2	65.8	36.2	55.5	98.5	185.2	25.2	177.3	28.0	143.2	158.6	38.5	44.8	0.8	55.4	54.1	75.2	10.6	20.5	27.2	13.6	46.4	22.2	11.6	6.4	7.2	3.3	101.3	11.5	0.4	0.0	2.2	18.7	1.5	1.9	1.0	1.5	0.0	3.7	2.1	0.6	251.8	0.8	1.9	0.2	714.4	0.5	2.7	11.7	175.8	20.4	66.2	0.0	0.6	23.9	11.7	0.8	32.3	0.2	11.0	0.9	51.1	0.0	59.6	2.4	0.0	94.1	60.0	1146.4	9.9	84.0	55.2	24.4	33.3	0.7	246.1	96.0	3.2	0.5	0.1	6.0	62.7	0.2	0.1	0.9	0.0	2.2	39.5	10.2	12.2	11.2	4.6	1.3	6.7	0.7	191.5	2.2	0.5	0.2
GNG3		ENSG00000162188	"G protein subunit gamma 3"	P63215	11	62707676-62709201	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 295.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.8;Early spermatids: 27.6;Excitatory neurons: 23.3;Inhibitory neurons: 20.7;Late spermatids: 123.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 12.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 16.9;naive B-cell: 17.1"	"Lineage enriched"	"Detected in single"	31	"B-cells: 17.1"	"Group enriched"	"Detected in many"	7	"Karpas-707: 149.4;SCLC-21H: 292.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.43e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.68e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.37e-5)"	"unprognostic (3.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.00e-1)"	0.3	14.8	168.3	1.9	183.3	1.1	0.3	132.0	295.7	0.3	62.2	8.3	1.3	0.2	1.0	0.4	0.2	0.3	0.6	203.9	207.0	0.6	0.8	0.4	0.4	146.2	148.2	0.6	0.7	0.9	48.4	0.1	179.5	0.7	2.6	35.3	0.6	0.7	0.6	0.6	3.2	1.2	106.6	0.3	1.5	11.3	152.4	0.0	0.4	0.1	0.2	0.3	1.2	201.3	0.5	1.0	7.3	0.5	0.0	0.0	3.2	0.6	0.0	0.5	0.0	2.4	1.4	0.4	0.8	0.0	0.3	1.0	0.0	0.0	0.0	2.2	0.5	0.8	0.9	2.1	0.2	1.3	0.6	0.3	0.0	0.1	0.0	1.3	0.0	1.1	1.7	149.4	0.0	1.3	0.3	3.9	33.2	0.7	0.1	2.0	1.3	0.8	0.5	2.4	292.9	2.5	0.8	1.0	0.2	1.5	1.7	0.7	0.4	1.7	2.9	0.9	0.5	0.9	2.4	0.8	1.5	1.1	0.4	0.0	0.1	0.5	0.0	0.0	0.0	16.9	0.1	0.1	0.1	17.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	168.3	183.3	132.0	295.7	203.9	207.0	146.2	148.2	179.5	106.6	152.4	201.3	0.1	0.0	0.0	5.9	1.2	0.0	0.4	0.0	0.0	39.8	0.4	0.9	0.1	0.0	0.0	0.0	4.2	0.2	0.0	0.2	0.0	0.1	27.6	0.5	0.0	0.1	0.0	0.0	23.3	0.4	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.3	5.0	20.7	0.2	0.0	0.0	0.4	123.0	0.9	0.1	0.0	2.8	0.6	5.3	0.0	8.0	7.4	0.0	1.2	0.0	0.0	0.0	0.1	0.3	0.0	14.1	0.0	0.0	0.1	4.4	3.0	0.0	0.3	0.0	0.1	0.4	0.1	0.2
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702694	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"brain: 360.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 145.4;Distal tubular cells: 123.3;Horizontal cells: 169.9;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 206.1;Plasma cells: 169.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9;melanoma: 20.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 57.2;naive B-cell: 50.1;plasmacytoid DC: 48.0"	"Group enriched"	"Detected in many"	4	"B-cells: 57.2;dendritic cells: 48.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 22.3;REH: 66.5;SK-MEL-30: 31.2;U-266/70: 61.0;U-266/84: 30.0"	"Region enriched"	"Detected in all"	6	"basal ganglia: 1277.2"					HPA057790	Supported	Supported				NA	NA		72000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA057790: AB_2683527"	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favorable (3.05e-4)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"	3.5	5.7	70.8	5.3	360.9	6.6	4.4	83.9	127.9	5.5	14.0	6.7	5.2	7.2	5.1	12.0	8.2	3.5	26.4	70.1	66.0	10.5	4.2	4.0	9.9	97.2	87.9	12.2	8.0	6.2	17.4	1.4	76.8	9.5	3.1	15.1	26.0	5.7	3.4	2.6	14.2	3.5	76.0	19.4	6.8	8.9	154.1	2.7	5.8	8.1	9.4	7.9	3.3	81.4	0.2	0.0	3.2	7.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.7	22.3	1.0	0.3	0.3	0.2	3.5	0.0	0.1	0.0	3.1	0.6	0.1	2.7	1.6	0.0	12.9	0.4	0.5	0.0	0.2	0.2	0.0	2.7	0.3	14.2	0.0	2.2	0.6	1.4	2.6	0.4	1.4	66.5	0.0	6.2	0.3	0.0	0.1	9.2	0.1	0.1	31.2	2.1	0.4	5.6	0.1	0.1	3.0	0.2	0.2	61.0	30.0	4.7	0.2	7.0	16.5	3.5	1.5	8.0	0.4	0.5	1.1	57.2	0.5	0.4	6.0	50.1	1.2	0.7	11.8	0.2	0.1	48.0	0.0	3.0	70.8	360.9	83.9	127.9	70.1	66.0	97.2	87.9	76.8	76.0	154.1	81.4	14.5	6.4	4.2	40.8	145.4	2.5	13.0	0.3	5.2	10.5	22.9	30.1	55.1	15.7	3.3	9.2	8.4	0.6	56.1	0.9	123.3	17.0	5.4	2.1	2.3	11.7	6.1	8.6	26.5	4.8	1.1	6.6	5.6	3.5	12.7	8.6	19.2	11.4	63.2	169.9	38.8	2.0	0.0	8.5	15.0	11.4	2.5	12.3	51.6	45.9	11.2	84.7	3.1	102.5	206.1	2.7	1.8	2.6	169.7	7.5	0.7	22.6	2.9	11.1	6.6	7.1	5.4	2.7	2.6	1.5	2.0	3.4	6.9	2.1	2.2	7.2
GOLGA7	"GCP16, GOLGA3AP1, GOLGA7A, HSPC041"	ENSG00000147533	"Golgin A7"	Q7Z5G4	8	41490396-41510980	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046878: AB_2679854"	"unprognostic (2.93e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.88e-1)"	41.3	31.5	73.8	28.7	91.2	42.6	34.1	78.5	112.3	30.5	56.6	29.9	31.6	33.6	27.9	34.5	23.2	33.3	28.1	73.6	78.2	42.8	46.9	30.3	36.9	84.1	83.6	31.2	32.4	33.7	15.8	48.6	82.3	30.6	26.0	31.7	38.8	26.5	25.5	47.8	32.1	32.0	75.4	36.3	28.5	40.8	76.6	36.5	28.5	29.8	32.0	33.1	24.8	110.0	58.2	64.9	48.2	56.1	59.8	51.7	36.8	49.6	48.5	57.2	63.0	115.8	53.3	27.9	64.4	46.7	54.6	39.6	48.0	38.6	63.5	39.3	42.7	56.5	36.7	48.0	65.3	26.2	45.3	45.6	71.1	36.6	54.1	46.3	56.5	49.4	68.1	53.9	46.7	42.6	83.6	70.7	54.1	53.1	31.2	50.4	86.8	30.6	66.9	53.3	86.1	55.5	44.6	34.4	90.7	40.3	70.5	49.9	58.9	48.2	46.4	61.7	44.0	40.7	67.7	40.7	51.3	44.5	68.3	204.9	78.1	78.8	83.9	68.5	82.2	34.8	79.4	76.9	59.2	32.9	65.8	65.9	136.7	78.0	68.1	40.5	94.9	139.7	73.8	91.2	78.5	112.3	73.6	78.2	84.1	83.6	82.3	75.4	76.6	110.0	74.6	6.4	22.9	11.8	31.4	110.4	53.9	63.1	44.3	28.3	48.3	42.9	25.5	28.6	38.4	29.5	4.2	61.2	69.6	29.5	95.9	62.7	22.2	28.1	43.1	57.4	42.5	33.9	15.8	48.0	68.4	55.0	29.6	36.5	17.7	35.4	52.5	46.6	64.3	18.5	17.8	30.3	59.0	69.7	95.2	21.7	45.1	53.7	60.5	13.1	65.5	77.9	87.6	14.6	90.5	55.1	21.0	62.1	31.2	77.0	53.2	120.5	28.4	30.7	59.2	49.2	60.4	152.3	135.0	43.5	108.5	85.9	69.5	38.1	30.5	55.4
GPR101		ENSG00000165370	"G protein-coupled receptor 101"	Q96P66	X	137023929-137033995	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	143	"brain: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 12.4;cerebral cortex: 4.4;hypothalamus: 14.3;thalamus: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 38.3"	"Low region specificity"	"Detected in many"			HPA001084	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA001084: AB_1078920"																		0.0	0.0	2.1	0.0	12.4	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	12.4	0.3	4.4	0.1	14.3	1.3	0.6	1.5	1.2	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR162	"A-2, GRCA"	ENSG00000250510	"G protein-coupled receptor 162"	Q16538	12	6821624-6829972	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 180.3;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 86.3;Excitatory neurons: 36.8;Horizontal cells: 40.4;Inhibitory neurons: 32.9;Muller glia cells: 55.9;Respiratory ciliated cells: 56.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.9;intermediate monocyte: 4.3;neutrophil: 17.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 17.4;monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.7;AN3-CA: 21.1;hTERT-RPE1: 18.1;NTERA-2: 19.8;SH-SY5Y: 13.5;U-2 OS: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055135	Enhanced		Approved	"Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"		"HPA055135: AB_2682710"	"unprognostic (4.76e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.29e-5)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (3.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.64e-2)"	5.1	6.8	116.5	4.4	122.2	1.3	2.7	111.7	180.3	5.8	108.2	15.2	3.1	7.6	2.5	2.3	18.3	5.9	10.9	138.2	106.4	5.6	6.2	17.6	1.5	100.8	100.5	5.8	2.5	10.6	31.7	4.4	101.0	5.8	2.7	20.6	1.4	1.7	1.5	1.4	8.0	5.9	93.3	6.6	5.0	1.5	106.2	1.4	2.8	1.1	0.7	7.2	2.8	117.4	0.0	3.9	17.7	21.1	1.9	1.3	0.1	1.3	4.6	3.9	2.3	0.4	0.0	0.0	0.1	2.6	0.1	0.1	2.8	0.0	1.9	0.0	1.3	2.1	0.2	0.0	3.0	0.4	0.0	3.2	0.0	6.0	0.3	18.1	10.9	1.6	1.0	0.1	1.5	0.0	0.5	1.5	19.8	0.0	0.1	0.0	2.2	3.9	1.3	0.0	1.5	13.5	0.0	0.0	0.6	12.0	0.1	5.3	7.4	2.7	16.1	1.4	2.5	0.0	1.3	0.1	2.9	3.8	0.3	0.0	6.9	0.0	0.0	4.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	17.4	0.0	1.5	1.7	0.0	1.9	116.5	122.2	111.7	180.3	138.2	106.4	100.8	100.5	101.0	93.3	106.2	117.4	0.5	0.0	0.0	11.8	0.3	0.8	0.2	2.3	0.0	86.3	3.6	1.3	3.8	1.5	2.6	1.8	4.2	0.1	0.0	0.0	1.9	0.0	0.1	9.3	5.6	3.5	0.0	0.4	36.8	0.0	0.1	2.9	0.0	0.3	0.0	0.6	6.1	1.5	2.6	40.4	32.9	0.0	2.0	3.7	3.4	0.6	7.5	5.2	0.0	6.5	4.2	55.9	0.0	23.1	3.7	0.1	0.0	14.7	0.1	0.5	0.0	1.9	56.2	9.0	0.0	0.5	8.1	0.0	0.2	0.2	0.1	0.3	0.2	1.3	0.1	0.1
GPR19		ENSG00000183150	"G protein-coupled receptor 19"	Q15760	12	12660890-12696207	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3;pituitary gland: 7.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.8;Excitatory neurons: 15.2;Inhibitory neurons: 15.6;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.9;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.9;NTERA-2: 39.7;SuSa: 28.5;WM-115: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013955	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013955: AB_1849287"	"unprognostic (1.92e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.62e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-1)"	"unprognostic (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.67e-12)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-1)"	0.3	0.8	7.2	2.0	7.3	0.9	0.3	9.1	10.3	0.1	3.6	0.5	0.3	0.1	0.1	0.5	0.2	0.3	0.1	7.0	9.1	0.1	0.2	0.2	1.8	6.3	6.8	0.0	0.3	0.1	7.8	0.3	6.9	0.1	0.6	2.0	0.1	0.1	0.0	0.8	0.5	0.3	7.0	0.7	0.4	4.3	7.6	2.8	0.1	0.0	2.4	0.3	0.1	6.9	1.6	0.6	16.6	0.4	0.0	0.0	7.0	1.6	1.7	2.9	2.5	6.6	10.1	6.8	2.5	1.2	2.3	1.3	2.7	0.3	4.8	39.9	0.3	1.6	0.7	1.1	0.0	1.7	0.6	0.1	0.0	3.1	1.9	1.2	0.5	0.7	0.3	13.8	0.6	2.4	0.6	1.0	39.7	1.7	3.0	4.4	2.5	0.2	0.2	1.4	5.4	5.0	0.7	1.4	13.4	28.5	0.9	1.7	0.0	0.8	7.2	1.3	3.9	7.6	7.2	13.3	3.1	4.7	20.4	0.0	0.0	0.0	1.2	0.0	0.8	0.2	2.4	1.4	0.0	0.1	0.4	0.9	2.9	0.3	0.0	0.0	6.5	0.3	7.2	7.3	9.1	10.3	7.0	9.1	6.3	6.8	6.9	7.0	7.6	6.9	0.2	0.0	0.0	7.8	0.4	0.1	0.1	0.0	0.0	1.8	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.7	0.1	0.2	0.1	0.0	2.7	15.2	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	15.6	0.1	0.0	0.3	0.3	1.6	0.3	0.2	0.0	2.8	0.0	1.7	0.0	15.6	5.9	0.2	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.8	3.6	0.6	0.0	0.0	0.1	1.2	0.0	0.3	0.1
GPR26		ENSG00000154478	"G protein-coupled receptor 26"	Q8NDV2	10	123666355-123697399	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"brain: 7.7"	"Cell type enriched"	"Detected in some"	6	"Excitatory neurons: 11.4"	"Cancer enriched"	"Detected in single"	13	"breast cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 62.7"	HPA062736	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA062736: AB_2684855"	"unprognostic (4.15e-2)"				"unprognostic (5.75e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.12e-1)"			"unprognostic (9.09e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.12e-1)"			0.0	0.0	1.2	0.0	1.5	0.0	0.0	0.0	3.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	2.0	0.0	0.0	0.0	0.0	2.6	7.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	3.5	6.4	2.0	2.6	7.7	1.6	1.7	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GPR45	"PSP24, PSP24A"	ENSG00000135973	"G protein-coupled receptor 45"	Q9Y5Y3	2	105241743-105243467	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Group enriched"	"Detected in some"	51	"Early spermatids: 4.2;Late spermatids: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 1.3;U-2 OS: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055940	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA055940: AB_2682977"	"unprognostic (3.80e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.99e-2)"	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.1	0.1	0.0	0.0	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.7	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.8	0.6	1.5	0.6	0.9	0.9	0.5	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR6		ENSG00000146360	"G protein-coupled receptor 6"	P46095	6	109978256-109980718	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	11	"basal ganglia: 91.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 29.7"							NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"								"unprognostic (1.14e-2)"						"unprognostic (1.59e-2)"				"unprognostic (7.10e-3)"			0.0	0.0	3.6	0.0	24.5	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	24.5	0.0	5.1	3.2	4.5	0.1	0.3	0.2	0.2	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794125-96837477	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.4;Excitatory neurons: 46.2;Granulosa cells: 31.2;Inhibitory neurons: 20.3;Late spermatids: 35.2;Spermatocytes: 24.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.8;HHSteC: 13.5;Karpas-707: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	0.5	0.9	1.4	0.7	3.5	0.1	0.4	0.7	2.7	1.5	2.7	1.2	1.5	0.5	0.3	0.5	0.7	0.7	0.5	1.5	0.1	0.3	0.0	0.3	0.1	1.6	0.6	1.0	1.4	1.0	0.9	0.7	2.0	0.9	1.8	0.2	0.4	0.5	0.2	0.4	1.1	0.6	0.0	0.3	1.1	2.4	0.9	0.6	0.6	0.1	0.2	0.8	1.4	1.8	0.0	0.1	1.6	0.4	2.3	0.8	0.4	1.0	0.0	0.0	0.2	0.2	1.2	0.1	0.0	0.1	1.3	1.2	5.4	2.5	0.0	8.8	4.1	5.2	0.4	0.0	13.5	3.3	0.6	2.5	0.4	0.0	3.7	0.3	0.0	7.6	3.8	20.8	0.5	0.4	2.5	0.0	5.4	0.0	0.7	0.0	1.9	4.3	0.3	0.2	2.4	1.5	0.3	3.3	0.6	1.7	1.3	0.7	0.0	1.4	2.1	0.2	2.0	1.6	0.9	0.1	0.8	2.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	1.4	3.5	0.7	2.7	1.5	0.1	1.6	0.6	2.0	0.0	0.9	1.8	0.6	0.0	0.0	2.3	0.2	1.9	0.7	0.3	4.0	1.5	0.6	0.9	0.7	2.8	0.1	1.8	0.0	0.2	0.3	0.1	0.0	0.4	31.4	0.1	0.5	0.7	3.0	0.4	46.2	0.9	0.7	2.5	1.1	0.1	0.0	31.2	1.1	0.0	0.2	0.0	20.3	0.5	0.0	0.0	8.9	35.2	3.4	0.4	1.8	9.4	0.1	0.2	0.0	11.6	4.8	0.4	0.1	4.9	1.0	1.1	0.1	0.2	0.0	0.2	0.0	0.4	2.2	24.6	10.5	1.9	0.3	0.1	0.4	2.1	0.5	0.3
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538139-100542021	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 93.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.1;Excitatory neurons: 1.8;Hepatocytes: 2.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Region enriched"	"Detected in many"	7	"basal ganglia: 93.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HSkMC: 1.6;SCLC-21H: 2.0"	"Region enriched"	"Detected in many"	10	"basal ganglia: 718.8"	"Region enriched"	"Detected in many"	42	"basal ganglia: 273.1"	HPA007488		Approved				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA007488: AB_2667844"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.4	0.3	4.8	0.3	93.9	0.0	7.2	0.1	14.4	0.1	0.1	0.9	0.3	0.1	0.0	0.1	0.1	0.0	0.2	3.1	2.6	0.1	8.9	0.1	0.1	10.1	1.4	2.6	0.0	1.0	1.1	0.0	1.0	0.3	0.3	0.3	0.4	0.0	0.2	0.0	0.4	0.1	0.9	10.5	0.2	0.1	7.5	0.2	0.1	0.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	93.9	0.1	14.4	3.1	2.6	10.1	1.4	1.0	0.9	7.5	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511746-120988906	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 82.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 115.6;Inhibitory neurons: 43.7;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 108.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.1;HEL: 18.9;T-47d: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074453: AB_2732255"	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	0.0	1.7	6.8	0.0	6.5	0.0	0.4	5.6	6.4	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.3	10.3	6.0	0.2	0.0	1.5	0.1	7.2	6.2	2.8	0.0	0.0	1.6	0.2	7.3	0.3	0.1	1.0	0.1	0.0	0.0	0.2	0.1	0.1	4.9	0.4	0.0	0.8	9.6	0.1	2.0	0.1	0.1	0.1	0.2	5.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.6	18.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.6	4.7	0.0	0.2	0.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.5	5.6	6.4	10.3	6.0	7.2	6.2	7.3	4.9	9.6	5.5	0.0	0.0	0.6	82.9	0.1	0.0	0.1	0.0	1.2	0.8	0.5	0.5	1.6	0.0	0.0	0.0	35.5	0.0	0.7	0.0	0.0	0.0	4.4	0.3	0.0	0.2	0.0	0.0	115.6	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	43.7	0.0	0.0	0.8	0.0	7.5	0.3	1.0	0.0	4.7	0.2	0.0	8.2	196.1	108.3	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	7.8	0.2	0.8	3.3	0.1	0.0	0.1	0.4	0.1	0.0	0.5
GRIN3A	GluN3A	ENSG00000198785	"Glutamate ionotropic receptor NMDA type subunit 3A"	Q8TCU5	9	101569352-101738647	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 220.7"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.29e-1)"	"unprognostic (7.10e-3)"	"unprognostic (3.01e-5)"	"unprognostic (3.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.06e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.87e-1)"	"unprognostic (9.41e-2)"	0.1	0.1	3.9	0.2	4.0	0.1	0.2	0.0	3.8	1.5	0.0	0.3	0.1	0.3	0.3	0.1	0.1	0.0	0.6	3.0	1.7	0.1	0.2	0.2	0.4	1.3	1.7	0.8	0.1	0.0	0.1	0.0	1.4	0.6	0.2	0.8	0.2	0.9	0.1	0.3	0.2	0.1	1.1	0.7	0.1	0.3	5.8	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	3.9	4.0	0.0	3.8	3.0	1.7	1.3	1.7	1.4	1.1	5.8	0.4	0.2	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.1	0.6	0.0	0.0	37.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	220.7	0.0	0.0	2.4	1.1	0.8	0.9	0.2	0.0	0.0	0.1	0.1	0.0	1.5	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	6.6	0.0	0.8	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0
GSX2	Gsh2	ENSG00000180613	"GS homeobox 2"	Q9BZM3	4	54099523-54102498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"glioma: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"									NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"								"unprognostic (4.48e-2)"						"unprognostic (1.05e-1)"				"unprognostic (7.01e-2)"	"unprognostic (1.89e-1)"		0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.6	0.2	0.2	0.2	0.2	0.4	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H1-1	"H1.1, H1a, H1F1, HIST1H1A"	ENSG00000124610	"H1.1 linker histone, cluster member"	Q02539	6	26017032-26017787	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 1.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.3;Cytotrophoblasts: 1.2;Extravillous trophoblasts: 4.2;Hofbauer cells: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Not detected"	"Not detected"							"HPA043753, HPA056830"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA043753: AB_2678654, HPA056830: "		"unprognostic (3.80e-1)"					"unprognostic (1.82e-1)"			"unprognostic (1.15e-1)"				"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.4	0.2	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19254756-19262804	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 107.1"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 16.0;Hepatocytes: 6.7;Inhibitory neurons: 19.9;Proximal enterocytes: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;NTERA-2: 8.3;SCLC-21H: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055856: AB_2682946"					"unprognostic (3.36e-4)"													0.1	1.0	5.8	0.1	3.7	0.2	0.2	18.3	107.1	2.0	0.0	0.2	12.4	0.8	0.1	0.0	0.2	0.2	0.1	10.7	20.0	0.5	14.1	0.1	0.1	46.6	9.7	0.6	0.9	0.0	0.7	0.2	43.2	0.6	0.1	2.3	0.1	0.3	0.0	0.2	15.4	0.2	10.9	0.1	0.3	0.1	33.6	0.0	0.0	0.0	0.0	0.1	0.5	35.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	3.5	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.0	0.1	0.0	0.4	0.1	0.7	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.7	18.3	107.1	10.7	20.0	46.6	9.7	43.2	10.9	33.6	35.6	0.1	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	16.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.4	6.7	0.1	0.0	19.9	0.6	0.0	0.0	0.0	0.2	0.3	0.1	0.0	1.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	15.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646156-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;lung: 16.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 175.6;Leydig cells: 136.1;Oligodendrocytes: 413.3;Theca cells: 162.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 322.6;TIME: 376.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	2.3	2.3	10.4	0.4	25.4	0.8	0.3	10.7	19.6	1.3	0.0	3.2	2.6	1.6	3.8	0.0	0.1	1.1	0.2	17.1	11.0	0.8	6.8	16.2	0.0	20.0	20.2	0.6	2.6	0.0	0.3	0.0	13.6	4.7	3.2	0.9	0.3	2.6	0.4	0.2	3.7	0.1	9.4	0.0	5.9	1.5	18.1	2.7	0.6	1.3	0.0	5.0	0.3	37.3	0.0	0.1	4.9	0.1	0.3	1.9	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.0	0.2	0.3	0.0	2.2	0.0	2.0	0.1	0.0	0.1	0.1	0.0	0.0	10.4	7.8	17.2	322.6	29.1	0.1	0.0	4.8	0.0	47.7	0.0	4.4	0.0	2.8	0.4	65.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	376.7	0.4	3.9	0.3	2.5	2.2	0.0	10.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	25.4	10.7	19.6	17.1	11.0	20.0	20.2	13.6	9.4	18.1	37.3	0.3	12.8	175.6	3.9	0.4	0.0	0.0	0.5	0.0	42.7	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.5	6.0	0.6	0.0	0.0	17.6	0.4	0.0	38.9	0.0	0.4	16.5	0.1	9.3	0.1	0.1	0.0	13.9	0.0	2.0	0.0	0.4	4.5	136.1	1.3	1.8	1.0	0.0	0.3	0.0	8.5	413.3	0.1	0.0	44.0	0.0	0.0	0.0	0.0	4.4	3.3	0.0	1.7	0.9	0.3	0.5	0.0	0.6	0.0	1.0	162.7	0.0	0.0
HRH3	GPCR97	ENSG00000101180	"Histamine receptor H3"	Q9Y5N1	20	62214960-62220278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"brain: 59.6"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 23.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.56e-1)"	"unprognostic (3.22e-1)"		"unprognostic (4.15e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.77e-2)"			"unprognostic (1.62e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.17e-4)"	"unprognostic (2.40e-1)"		"unprognostic (3.66e-3)"	"unprognostic (3.30e-1)"		"unprognostic (3.59e-2)"	0.0	0.4	21.4	0.0	51.1	0.0	0.0	10.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	31.6	0.0	0.0	0.0	0.0	3.5	26.3	0.0	0.0	0.0	2.0	0.0	3.9	0.1	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.1	0.8	59.6	0.0	0.0	0.0	0.0	0.2	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	15.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	51.1	10.1	22.2	16.1	31.6	3.5	26.3	3.9	3.6	59.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.3	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HRK	DP5	ENSG00000135116	"Harakiri, BCL2 interacting protein"	O00198	12	116856144-116881441	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;choroid plexus: 4.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.3;Endometrial ciliated cells: 10.3;Enteroendocrine cells: 11.3;Excitatory neurons: 9.5;Paneth cells: 10.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	30	"eosinophil: 1.3;memory B-cell: 3.6;naive B-cell: 3.9"	"Group enriched"	"Detected in many"	27	"B-cells: 3.9;granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 11.1;SCLC-21H: 9.1;SH-SY5Y: 7.8;SK-MEL-30: 22.0;U-698: 37.0"	"Low region specificity"	"Detected in all"							CAB025973	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025973: "	"unprognostic (9.38e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.42e-2)"	0.2	0.7	4.5	0.4	6.1	0.7	0.1	0.6	7.4	0.0	4.5	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	14.4	3.4	0.1	0.0	0.1	0.8	1.5	2.1	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.1	0.3	0.2	0.0	0.5	0.2	0.1	0.0	1.3	0.2	0.0	0.5	3.9	3.5	3.8	0.0	0.7	0.0	0.0	2.8	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.4	0.0	0.2	4.5	2.4	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.2	0.0	2.1	0.1	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.1	1.0	0.0	1.5	0.1	0.0	9.1	7.8	0.5	0.0	22.0	0.4	0.6	0.2	0.0	0.0	1.8	0.2	0.0	1.0	0.5	37.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	6.1	0.6	7.4	14.4	3.4	1.5	2.1	1.1	1.3	3.9	2.8	1.1	0.0	0.0	0.0	7.0	0.1	0.1	0.1	0.0	4.5	3.2	3.0	2.4	0.0	0.8	0.0	14.6	0.1	0.1	2.2	0.0	0.1	11.3	10.3	0.1	1.4	11.3	0.0	9.5	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.4	4.5	0.0	0.2	3.6	5.6	0.6	0.2	0.0	6.6	0.3	0.0	10.1	0.0	1.1	0.3	0.0	0.2	6.6	0.6	0.0	0.1	0.7	0.4	3.0	0.7	0.0	0.1	0.3	0.0	1.0	0.1
HS3ST4	3OST4	ENSG00000182601	"Heparan sulfate-glucosamine 3-sulfotransferase 4"	Q9Y661	16	25691959-26137685	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 38.1"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 431.4;Microglial cells: 536.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.95e-1)"		"unprognostic (2.24e-1)"	"unprognostic (1.43e-3)"		"unprognostic (1.27e-1)"		"unprognostic (3.84e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.71e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.67e-2)"	0.0	0.0	19.0	0.0	17.5	0.0	2.2	7.0	15.8	0.3	3.3	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	33.2	12.2	0.0	0.0	0.0	0.0	18.2	11.8	0.0	0.0	3.6	0.3	0.0	19.0	0.8	0.0	2.0	0.1	0.0	0.0	0.5	0.0	0.0	7.5	1.6	1.7	0.5	38.1	0.2	0.0	0.0	0.0	0.2	0.5	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	17.5	7.0	15.8	33.2	12.2	18.2	11.8	19.0	7.5	38.1	18.5	0.0	0.0	0.0	7.5	0.1	0.0	0.4	0.1	0.0	26.0	2.6	2.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	431.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	536.8	0.0	0.4	0.0	6.6	9.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
HSD11B1L	"HSD1L, SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 19.0"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	9.8	46.6	1.3	46.7	2.6	5.1	32.0	58.2	5.5	34.0	8.4	1.6	5.4	5.1	3.7	6.7	3.0	5.9	46.1	41.8	12.4	5.4	4.4	1.4	38.4	36.5	6.7	7.0	7.3	21.2	1.5	37.2	6.1	1.0	6.3	5.8	4.1	10.9	9.3	3.4	1.6	32.9	3.2	6.3	8.1	42.4	1.6	8.6	3.3	1.0	6.0	4.3	39.1	3.6	3.0	11.3	2.1	5.0	5.7	2.2	2.7	4.4	1.1	4.8	1.3	3.3	0.8	5.9	2.2	0.9	1.7	1.4	1.8	1.0	3.2	3.6	2.3	3.0	2.2	3.6	0.9	7.9	5.5	3.9	1.6	1.6	10.4	1.8	5.1	2.4	2.9	4.6	0.3	2.1	2.1	3.0	14.2	4.1	3.6	0.5	3.1	9.5	0.8	3.2	19.0	0.5	1.6	12.8	3.8	2.6	0.7	3.2	2.7	5.0	4.9	2.2	7.6	2.8	0.9	7.7	1.2	2.4	1.5	1.0	0.5	0.6	2.7	0.6	0.5	1.4	1.6	1.0	1.1	1.8	1.7	1.9	0.7	1.8	2.2	0.4	0.9	46.6	46.7	32.0	58.2	46.1	41.8	38.4	36.5	37.2	32.9	42.4	39.1	8.2	0.0	2.6	13.7	2.6	8.2	8.6	12.9	9.6	11.3	23.7	23.1	2.3	10.0	8.6	23.9	14.6	4.7	3.0	4.5	15.6	12.4	9.5	21.8	6.0	6.1	25.7	1.3	24.7	4.7	6.5	8.1	4.6	5.4	10.2	12.4	8.9	4.1	5.1	8.4	20.4	4.6	12.2	2.8	6.0	13.9	7.2	2.4	5.4	1.9	3.1	30.5	1.0	14.1	4.6	4.8	4.3	12.8	0.9	8.4	4.1	33.3	31.2	12.9	0.0	8.1	9.5	10.8	12.7	4.8	10.2	2.9	3.1	16.6	3.7	9.7
HSPE1	"CPN10, EPF, GroES, HSP10"	ENSG00000115541	"Heat shock protein family E (Hsp10) member 1"	P61604	2	197500140-197503449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1077.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1907.6;Proximal tubular cells: 1978.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 4135.5"	"Low region specificity"	"Detected in all"							"CAB017366, HPA038755, HPA048272"	Supported					NA	Yes		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB017366: AB_10998950, HPA038755: AB_2676190, HPA048272: AB_2680336"	"unprognostic (2.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.83e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.08e-3)"	152.1	709.5	383.2	143.9	387.5	116.8	212.7	410.3	1077.6	122.3	402.1	257.2	164.9	84.3	213.0	132.9	131.4	97.4	208.0	383.7	400.8	410.7	662.7	111.0	154.5	400.9	394.7	130.1	112.6	173.0	125.5	164.0	399.9	137.9	246.3	85.8	121.9	114.8	181.4	80.5	168.2	116.8	403.6	86.5	130.5	58.7	391.2	144.8	104.5	213.1	207.9	216.6	85.5	440.8	593.1	926.1	675.1	521.5	560.5	314.0	905.5	586.2	307.9	620.8	577.3	2796.6	504.6	1079.2	782.2	333.8	1542.1	510.4	1895.0	681.2	782.0	512.3	874.7	1099.8	1789.0	4135.5	239.0	1503.6	497.2	382.4	532.1	577.8	297.6	392.7	631.0	720.9	1588.2	338.0	481.1	1027.2	1107.2	1706.9	1077.5	985.2	1513.4	747.6	568.2	1388.5	967.4	1028.3	581.5	375.1	546.4	713.9	545.5	1588.2	287.1	881.7	355.7	466.1	643.3	501.0	1019.4	427.8	1016.0	1758.3	515.6	726.7	640.6	33.2	95.5	24.4	166.3	174.5	216.3	287.1	223.6	210.1	156.6	221.8	251.7	264.1	12.6	200.3	143.1	263.4	198.7	176.0	383.2	387.5	410.3	1077.6	383.7	400.8	400.9	394.7	399.9	403.6	391.2	440.8	341.6	195.5	160.2	0.0	380.6	435.1	1907.6	690.4	301.7	90.7	393.6	511.2	355.6	381.8	363.3	195.0	250.2	839.3	334.4	553.8	911.7	354.0	22.3	520.7	291.3	296.3	440.3	233.1	0.0	231.2	634.0	370.0	274.2	493.3	324.6	215.7	94.6	1092.0	517.2	63.9	0.0	605.0	427.2	150.6	616.4	36.1	216.6	534.4	409.1	0.0	214.2	204.2	133.9	0.0	0.0	285.3	466.2	141.8	323.4	830.7	562.1	1978.2	475.8	160.2	131.5	283.6	642.5	140.0	241.9	381.2	371.8	976.7	685.9	791.7	775.5	1111.7
HTR1A	"5-HT1A, ADRB2RL1, ADRBRL1"	ENSG00000178394	"5-hydroxytryptamine receptor 1A"	P08908	5	63957874-63962507	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 24.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NTERA-2: 1.2;SCLC-21H: 1.1"	"Low region specificity"	"Detected in many"							HPA018073	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018073: AB_1856704"					"unprognostic (1.81e-1)"													0.0	0.0	0.7	0.0	6.2	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.0	3.4	24.3	3.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.2	0.0	9.1	11.4	0.0	3.4	24.3	7.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR2A	"5-HT2A, HTR2"	ENSG00000102468	"5-hydroxytryptamine receptor 2A"	P28223	13	46831546-46897076	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Behavior, Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.2;choroid plexus: 5.6"	"Cell type enriched"	"Detected in some"	8	"Excitatory neurons: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;ASC TERT1: 4.6;BEWO: 1.4;HEL: 1.5;U-138 MG: 2.3;U-2 OS: 1.4;U-87 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014011	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014011: AB_1856709"	"unprognostic (8.01e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.94e-5)"	"unprognostic (4.78e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.28e-2)"	0.9	0.3	6.7	0.8	9.7	0.1	0.5	0.0	15.2	0.6	5.6	0.5	0.4	0.5	0.0	0.5	0.3	1.6	0.7	11.8	8.7	0.1	0.1	0.3	0.0	0.5	1.4	0.3	0.0	0.0	0.2	0.0	2.9	0.2	0.6	0.8	0.0	0.6	0.3	0.1	0.4	2.6	0.1	0.0	0.2	0.6	1.6	0.7	0.1	0.6	0.2	0.8	0.5	5.8	0.0	0.0	0.0	0.0	1.8	4.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	6.7	9.7	0.0	15.2	11.8	8.7	0.5	1.4	2.9	0.1	1.6	5.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.2	8.6	0.1	0.0	0.0	81.7	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	10.1	0.0	0.0	0.3	0.0	2.2	0.9	1.9	0.0	3.7	0.0	4.6	0.0	2.5	3.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.4"	"Cell type enriched"	"Detected in single"	17	"Granulosa cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 40: Granulosa cells - Unknown function"			"HPA047557: AB_2680087"																		0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.2	1.0	0.6	0.5	0.6	0.7	0.5	0.1	1.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384255-21385398	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"brain: 1.6"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 2.5;Granulosa cells: 1.7;Oligodendrocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA	253000		"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA047557: AB_2680087"																		0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.2	0.8	0.5	0.8	0.7	0.7	0.6	0.2	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGSF21	"MGC15730, RP11-121A23.1"	ENSG00000117154	"Immunoglobin superfamily member 21"	Q96ID5	1	18107798-18378483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 177.8;Excitatory neurons: 82.2;Microglial cells: 74.9;Oligodendrocyte precursor cells: 141.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		23000		"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.85e-4)"	"unprognostic (3.76e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	2.2	4.8	29.6	0.4	35.8	0.4	3.0	41.4	51.7	1.7	9.2	1.0	0.0	1.0	0.4	0.9	1.0	0.8	1.0	37.4	17.6	1.1	0.4	1.5	0.2	26.9	23.4	0.6	1.9	10.4	1.6	1.4	27.0	3.8	0.3	9.4	1.1	1.1	0.3	0.8	0.4	0.3	21.6	13.0	0.6	0.8	24.5	0.8	0.6	0.4	0.7	3.9	1.1	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	35.8	41.4	51.7	37.4	17.6	26.9	23.4	27.0	21.6	24.5	33.5	0.1	0.0	0.0	3.6	0.6	0.3	0.2	0.0	0.0	177.8	9.2	2.7	0.6	1.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.9	0.0	0.0	1.8	3.0	0.0	82.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	28.9	0.1	0.0	23.6	4.0	12.8	0.6	12.8	0.0	74.9	0.0	6.3	0.0	141.3	2.4	0.1	1.3	0.0	0.0	0.9	0.0	0.0	0.0	13.0	6.6	4.5	0.2	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.2
INSYN2A	"C10orf141, FAM196A, FLJ45557, INSYN2"	ENSG00000188916	"Inhibitory synaptic factor 2A"	Q6ZSG2	10	127135426-127196591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.0"	"Cell type enhanced"	"Detected in single"		"Endothelial cells: 1.4"	"Group enriched"	"Detected in some"	13	"breast cancer: 3.4;glioma: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 2.7;U-87 MG: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035898, HPA035899"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA035898: AB_10964352, HPA035899: AB_10961723"	"unprognostic (4.00e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-1)"	0.1	0.0	4.5	0.1	6.2	0.0	0.6	2.8	5.8	0.1	1.2	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.1	3.4	5.3	0.3	0.0	0.2	0.0	4.4	5.4	0.7	0.1	0.0	0.2	0.0	4.2	0.7	0.1	1.6	0.2	0.1	0.0	0.1	0.3	0.1	2.6	0.3	0.2	0.6	8.0	1.1	0.1	0.1	0.1	0.2	0.1	2.3	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.5	6.2	2.8	5.8	3.4	5.3	4.4	5.4	4.2	2.6	8.0	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IQCA1	"DRC11, FLJ22527, IQCA"	ENSG00000132321	"IQ motif containing with AAA domain 1"	Q86XH1	2	236324147-236507535	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.0;choroid plexus: 22.7;thyroid gland: 19.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 180.9;Endometrial ciliated cells: 54.7;Respiratory ciliated cells: 115.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;HBEC3-KT: 3.3;HeLa: 3.8;hTERT-RPE1: 6.9;SuSa: 4.4;U-2 OS: 12.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 7.2"	HPA057320			Uncertain	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA057320: "	"unprognostic (1.73e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.91e-3)"	"unprognostic (5.30e-2)"	2.2	1.2	23.3	0.4	25.3	0.0	1.8	18.1	46.0	1.3	22.7	0.2	0.1	1.7	5.4	0.7	11.0	1.7	0.5	21.2	21.1	4.6	0.1	2.7	0.4	20.8	27.0	2.4	1.3	1.4	10.3	0.2	19.7	1.5	0.1	2.2	1.2	1.3	0.0	0.2	0.3	0.5	13.9	3.1	0.5	4.5	22.2	2.8	19.2	0.0	0.6	1.7	1.0	16.7	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.3	0.1	0.0	0.0	3.2	0.0	1.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	0.2	1.7	0.0	0.0	6.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	12.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.2	0.3	1.3	0.0	0.4	0.0	0.0	0.0	0.0	23.3	25.3	18.1	46.0	21.2	21.1	20.8	27.0	19.7	13.9	22.2	16.7	2.8	16.0	12.6	180.9	0.4	0.5	7.8	26.9	1.8	26.2	1.7	14.1	1.3	11.5	26.7	3.7	16.7	0.5	0.0	0.0	0.0	10.8	24.0	54.7	5.2	10.4	0.0	0.0	26.0	1.5	5.6	3.3	0.5	9.8	1.3	6.7	2.2	0.0	0.3	0.0	11.6	0.0	16.2	0.0	0.0	14.5	2.1	0.4	0.0	9.4	0.0	0.5	1.0	4.5	2.4	1.2	0.0	6.0	0.3	1.7	0.0	11.7	115.7	2.3	0.0	0.8	2.2	31.0	28.3	0.8	0.3	0.3	0.8	1.9	0.0	3.1
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909905-4918256	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.1"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 15.1;Excitatory neurons: 39.6;Inhibitory neurons: 18.6;Oligodendrocyte precursor cells: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074471: "	"unprognostic (6.39e-3)"	"unprognostic (2.64e-1)"			"unprognostic (1.09e-1)"	"unprognostic (8.44e-2)"		"unprognostic (1.33e-1)"		"unprognostic (1.79e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.48e-1)"		"unprognostic (8.77e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-4)"		0.2	0.0	10.6	0.0	22.5	0.0	0.3	27.6	50.1	0.6	3.9	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.0	7.9	0.0	0.0	0.0	0.0	24.9	10.7	0.0	0.0	0.8	0.9	0.0	25.2	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.2	0.1	9.5	0.0	1.2	0.0	24.3	1.2	0.6	0.0	0.0	0.3	0.3	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	22.5	27.6	50.1	21.0	7.9	24.9	10.7	25.2	9.5	24.3	28.2	0.1	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	15.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	16.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009730-30017030	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease variant, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 6.1;brain: 20.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.7;Excitatory neurons: 8.2;Horizontal cells: 13.5;Muller glia cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 62: Horizontal cells - Visual perception"			"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			1.5	6.1	4.7	0.0	20.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	4.7	4.4	0.2	0.0	0.7	0.0	1.6	1.7	0.0	0.0	0.0	1.3	0.2	1.3	0.0	0.0	1.9	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	20.0	0.0	6.5	4.7	4.4	1.6	1.7	1.3	0.1	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.5	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.4	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209839	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 46.9"	"Group enriched"	"Detected in some"	51	"Excitatory neurons: 389.6;Inhibitory neurons: 1425.5"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.0	0.0	9.2	0.0	18.4	0.0	1.7	0.0	46.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.5	17.2	0.0	0.2	0.0	0.0	22.3	15.9	0.0	0.0	0.0	7.0	0.0	24.5	2.6	0.0	8.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	18.4	0.0	46.9	6.5	17.2	22.3	15.9	24.5	0.0	45.5	9.4	0.0	0.0	0.0	17.6	0.0	0.0	2.9	0.0	0.0	15.9	16.7	7.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	0.0	389.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1425.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	2.6	0.0	14.1	14.8	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110210314-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 41.7;Hepatic stellate cells: 50.3;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.5;U-87 MG: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	3.1	4.0	24.9	2.2	9.7	1.1	3.6	2.3	11.3	3.8	0.0	2.1	1.2	2.7	1.2	2.4	3.6	4.2	4.2	20.4	9.0	7.9	0.8	2.8	2.2	21.6	12.3	3.6	5.6	6.8	6.1	2.8	23.7	3.3	1.2	7.5	7.1	3.1	4.9	3.7	2.3	1.6	4.7	4.2	3.4	2.5	11.1	1.9	2.7	5.8	1.6	3.0	3.4	2.2	4.1	2.7	0.4	3.3	1.2	0.3	6.3	13.5	1.4	0.9	0.8	7.2	1.4	5.8	6.1	4.0	3.4	5.5	1.7	1.0	0.5	38.5	4.1	0.5	5.4	0.8	0.4	3.6	1.5	0.2	0.3	2.2	0.2	0.7	5.5	2.8	1.2	1.9	0.1	0.6	3.6	1.1	2.7	1.1	6.8	4.5	0.1	1.0	4.2	0.1	1.0	1.0	0.6	11.9	1.3	3.0	1.5	2.1	2.5	1.5	7.0	1.1	0.5	5.0	3.2	1.0	19.5	3.5	13.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.9	9.7	2.3	11.3	20.4	9.0	21.6	12.3	23.7	4.7	11.1	2.2	11.0	0.0	1.1	8.5	2.6	3.2	15.7	2.5	12.0	4.7	10.6	9.3	8.9	8.6	2.0	3.7	41.7	0.4	1.7	10.0	0.0	6.8	0.5	7.9	2.8	14.0	13.2	0.8	13.4	17.0	0.4	4.3	5.1	19.8	1.3	3.4	50.3	0.4	1.3	3.3	10.0	4.8	0.0	2.2	1.1	0.9	1.5	1.5	1.8	7.5	1.4	3.8	0.0	6.0	1.7	11.8	7.1	4.1	1.2	11.0	2.3	0.6	2.5	41.1	26.3	4.2	8.4	0.7	7.4	4.1	3.0	1.1	2.6	0.4	8.3	9.7
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911934-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 28.9;choroid plexus: 32.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 14.3;MCF7: 5.1;T-47d: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.1	0.0	20.6	0.1	28.9	0.0	0.2	0.0	21.5	0.0	32.1	1.2	0.2	0.6	0.0	0.2	0.1	0.1	0.7	28.8	14.7	0.4	0.0	0.3	0.1	0.0	5.3	0.0	0.9	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.1	0.3	0.0	0.0	0.6	0.0	0.6	0.5	0.3	0.5	12.5	0.3	0.0	0.0	0.0	0.6	0.0	15.8	0.1	14.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	2.1	0.1	1.5	0.0	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.1	6.1	0.7	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.9	0.0	21.5	28.8	14.7	0.0	5.3	0.0	0.6	12.5	15.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	2.0	0.8	1.4	1.4	0.0	0.0	0.0	2.1	0.0	0.1	1.6	0.0	0.0	2.2	0.8	0.3	0.9	1.2	0.0	9.3	0.0	14.4	0.7	0.0	2.0	0.0	0.2	0.0	0.0	0.2	0.0	8.8	0.2	0.0	0.0	0.0	3.4	0.3	0.1	0.0	1.9	0.0	0.3	0.0	18.1	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	7.7	0.0	0.4	0.3	0.1
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148510-19535642	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.0;pituitary gland: 10.7"	"Group enriched"	"Detected in some"	63	"Oligodendrocyte precursor cells: 331.7;Oligodendrocytes: 989.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;OE19: 1.9;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.0	1.8	7.3	0.3	11.9	0.2	0.5	6.5	16.0	0.3	2.8	0.6	0.4	0.1	0.1	0.1	0.2	0.4	0.2	6.4	8.8	0.1	0.1	0.0	0.8	8.4	8.8	0.0	1.5	0.1	10.7	0.0	8.2	0.7	0.5	3.4	1.1	0.2	0.0	0.4	1.1	0.1	5.8	1.1	1.4	1.7	9.7	0.4	0.2	0.0	0.7	0.1	0.3	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.3	11.9	6.5	16.0	6.4	8.8	8.4	8.8	8.2	5.8	9.7	15.4	0.0	0.0	0.0	2.0	9.7	0.5	1.6	0.0	0.0	4.2	1.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	3.2	0.1	0.1	0.1	3.6	0.0	9.3	0.6	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	10.4	1.5	0.0	0.0	0.0	1.9	0.0	0.1	3.6	1.0	0.0	3.4	0.0	331.7	989.4	0.5	0.2	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	0.2	0.5	1.2	3.4	0.0	0.0	0.1	0.3	0.1	0.6	0.4
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium inwardly rectifying channel subfamily J member 6"	P48051	21	37607373-38121345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 24.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 152.6;Horizontal cells: 245.6;Inhibitory neurons: 146.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	6	"cerebral cortex: 10.3;hippocampal formation: 10.6;midbrain: 24.2"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.2;eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	0.0	0.1	2.3	0.1	2.7	0.1	0.0	1.6	10.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.6	1.9	0.0	0.0	0.1	0.2	1.9	24.2	0.0	0.4	0.0	1.7	0.4	2.2	0.2	0.0	1.0	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	1.6	0.0	0.0	0.0	3.5	0.1	29.2	0.1	0.0	0.0	0.3	0.0	2.8	0.0	0.1	1.0	4.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.3	0.1	0.1	0.2	4.3	1.2	0.0	0.0	0.0	0.0	2.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	2.3	2.7	1.6	10.3	10.6	1.9	1.9	24.2	2.2	1.2	1.8	1.5	0.2	0.0	1.1	2.3	0.0	0.1	0.4	0.1	0.0	25.4	0.2	0.3	34.3	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.4	0.1	0.2	1.6	41.4	0.0	152.6	0.0	0.4	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	245.6	146.2	1.8	2.0	0.0	0.0	0.0	0.6	0.0	3.6	16.9	0.0	1.2	0.0	38.2	1.5	0.6	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.6	0.0	0.2	1.1	0.0	1.7	0.0	0.1	0.3	0.1	0.0	0.4	0.4
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium inwardly rectifying channel subfamily J member 9"	Q92806	1	160081538-160090563	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 65.8;choroid plexus: 20.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.9;Excitatory neurons: 23.5;Horizontal cells: 8.4;Inhibitory neurons: 12.6;Oligodendrocytes: 8.3"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070478: AB_2686270"	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	0.0	0.3	55.2	0.0	57.0	0.0	0.0	64.9	65.8	0.0	20.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.8	38.6	0.2	0.0	0.0	0.0	38.1	49.8	0.0	0.0	0.0	2.0	0.0	41.5	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.0	0.0	37.2	0.0	0.1	0.4	58.5	0.0	0.0	0.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	57.0	64.9	65.8	56.8	38.6	38.1	49.8	41.5	37.2	58.5	61.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.9	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.0	8.4	12.6	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.7	0.0	1.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.1	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29926236	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.5;testis: 36.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	6.0	7.5	27.3	7.8	28.7	8.5	5.4	17.6	37.5	5.0	17.4	6.3	7.3	5.1	9.9	5.9	8.3	7.8	4.4	36.9	24.5	3.9	3.5	4.5	9.8	19.5	21.3	7.5	7.5	7.9	3.6	4.5	19.6	6.7	6.5	9.4	6.5	8.0	2.7	12.2	7.0	5.2	20.5	7.6	5.8	36.3	23.0	9.6	5.7	2.4	7.1	6.0	2.7	28.8	9.7	12.4	6.2	15.5	10.0	8.1	12.5	5.8	7.2	5.7	8.9	3.5	12.6	17.4	11.3	8.5	9.6	14.4	6.8	5.5	4.4	26.5	17.0	3.7	7.1	6.0	13.7	9.2	15.9	10.2	15.3	11.6	8.7	6.1	4.7	19.9	9.1	14.8	7.9	28.1	18.7	14.2	3.6	5.0	6.0	13.9	4.5	9.0	7.8	9.1	15.5	15.4	2.4	7.0	31.7	5.8	10.1	7.2	10.0	5.0	5.1	15.3	10.6	12.4	5.3	3.9	12.0	10.4	14.4	7.2	3.3	8.0	2.9	2.6	3.0	3.0	5.4	5.0	3.5	2.4	5.0	4.7	11.1	3.1	4.4	3.8	4.4	1.9	27.3	28.7	17.6	37.5	36.9	24.5	19.5	21.3	19.6	20.5	23.0	28.8	7.1	0.0	9.7	20.9	10.6	6.0	5.7	10.4	12.5	9.9	8.5	8.0	3.4	5.7	5.8	0.0	8.4	5.3	7.9	5.2	3.9	6.9	17.9	9.1	6.8	4.7	7.7	3.0	15.4	4.2	5.1	6.5	4.6	8.7	2.5	10.9	6.4	2.4	7.6	5.0	20.5	7.2	10.2	4.4	5.6	9.0	6.2	6.3	8.8	12.2	5.7	5.0	11.3	17.6	28.9	11.0	7.4	6.4	3.6	8.7	6.5	2.9	6.3	6.5	0.0	5.0	7.8	20.6	26.5	12.4	9.1	6.7	10.6	5.8	6.1	7.0
KCTD17	FLJ12242	ENSG00000100379	"Potassium channel tetramerization domain containing 17"	Q8N5Z5	22	37051736-37063390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Ubl conjugation pathway"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 113.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 90.8"	HPA018459	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA018459: AB_1852169"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.22e-5)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.94e-2)"	8.2	15.6	64.8	9.8	113.7	2.4	6.7	46.0	71.6	14.2	44.4	15.9	3.4	14.9	1.8	7.2	10.7	8.5	26.6	68.0	54.1	5.8	3.5	9.3	10.6	44.8	70.4	13.7	3.7	7.8	43.0	6.5	52.4	11.2	5.2	3.6	3.4	9.0	1.7	21.1	10.4	9.4	43.8	11.1	7.9	46.0	83.8	7.0	7.6	3.0	6.9	16.9	13.0	55.5	15.9	20.5	31.7	23.7	14.9	14.8	1.2	16.2	15.6	25.9	22.3	4.4	4.6	12.2	10.9	20.8	20.3	4.2	10.0	19.0	10.9	23.8	26.8	5.2	5.6	4.9	22.1	0.0	6.1	17.3	9.2	26.6	5.8	17.5	33.6	15.9	1.2	13.2	16.5	12.8	11.0	0.3	20.3	9.4	17.4	19.8	8.4	3.6	6.7	4.1	26.4	32.9	15.0	14.1	7.5	6.6	3.8	4.2	19.6	33.5	31.2	16.0	12.0	17.7	5.5	2.0	29.6	7.3	18.6	0.0	0.8	0.0	0.9	1.0	0.9	1.2	0.6	0.9	0.9	0.4	0.8	0.6	0.0	1.6	0.4	0.2	1.0	0.4	64.8	113.7	46.0	71.6	68.0	54.1	44.8	70.4	52.4	43.8	83.8	55.5	8.8	0.0	0.5	11.1	5.8	1.5	4.6	2.8	1.2	17.3	1.3	1.5	5.0	4.3	0.8	5.5	2.1	0.4	5.0	17.7	0.0	11.9	24.9	0.7	12.7	9.7	13.1	0.8	22.4	6.1	2.8	9.9	4.1	0.9	4.5	12.0	12.8	0.5	9.2	13.5	11.6	5.3	0.0	9.6	17.0	28.1	10.5	9.8	3.6	1.9	13.0	16.4	8.2	4.5	7.1	3.2	16.0	9.1	4.6	1.2	0.5	2.5	1.5	7.8	0.0	7.8	11.7	19.7	7.1	1.3	4.8	7.5	8.5	10.2	7.0	2.4
KCTD4	bA321C24.3	ENSG00000180332	"Potassium channel tetramerization domain containing 4"	Q8WVF5	13	45192853-45194717	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 24.6;choroid plexus: 9.4"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 2.6;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 9.5"	"Group enriched"	"Detected in some"	5	"glioma: 1.2;renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 20.7;hTERT-RPE1: 12.5;RPTEC TERT1: 11.8;U-138 MG: 13.9;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040734	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Centriolar satellite"		"HPA040734: AB_10963227"	"unprognostic (1.36e-1)"		"unprognostic (1.02e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.19e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"			0.1	0.0	20.2	0.0	24.6	0.1	0.5	8.3	17.6	0.1	9.4	1.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	16.6	11.3	0.2	0.0	0.0	0.0	10.9	10.7	0.0	0.2	0.0	1.8	0.2	9.7	0.0	0.2	0.0	0.5	0.1	0.0	3.1	0.5	0.7	12.4	0.0	0.0	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.2	0.0	0.0	0.0	0.5	0.6	20.7	0.0	0.0	2.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.7	12.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.0	3.1	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	24.6	8.3	17.6	16.6	11.3	10.9	10.7	9.7	12.4	13.2	13.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	10.1	9.5	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646191	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.3;pituitary gland: 4.1"	"Group enriched"	"Detected in some"	8	"Astrocytes: 119.5;Early spermatids: 65.6;Excitatory neurons: 129.2;Inhibitory neurons: 72.7;Late spermatids: 96.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;A549: 2.0;GAMG: 2.1;HDLM-2: 2.4;HeLa: 1.9;SCLC-21H: 3.8;U-266/84: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.0	0.4	10.0	0.2	10.3	0.0	0.1	4.3	10.4	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	9.2	5.8	0.0	0.0	0.6	0.0	7.2	7.4	0.0	1.4	0.1	4.1	0.0	7.6	0.4	0.4	1.2	0.2	0.0	0.0	0.7	0.2	0.1	2.7	0.2	0.8	1.1	12.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.0	2.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	0.0	2.1	0.8	0.3	0.0	0.0	2.4	1.0	0.0	1.9	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.1	3.8	0.2	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.4	0.3	3.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	10.0	10.3	4.3	10.4	9.2	5.8	7.2	7.4	7.6	2.7	12.3	4.8	0.1	3.2	0.5	119.5	0.6	0.0	0.0	0.5	0.0	3.6	0.1	0.1	1.4	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	65.6	2.6	0.1	0.0	10.2	0.0	129.2	0.0	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	72.7	0.8	0.0	0.0	0.0	96.8	0.6	0.2	0.0	5.6	0.6	0.3	0.0	5.0	3.1	0.3	0.1	0.7	0.0	0.2	0.0	0.1	10.9	0.9	0.0	0.1	0.0	1.2	1.5	0.0	0.0	0.7	0.1	0.1	0.3	0.3
KIRREL3	"KIAA1867, KIRRE, NEPH2"	ENSG00000149571	"Kirre like nephrin family adhesion molecule 3"	Q8IZU9	11	126423358-127003460	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 21.5"	"Group enriched"	"Detected in some"	16	"Excitatory neurons: 274.4;Inhibitory neurons: 482.6;Oligodendrocytes: 390.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 8.3"	"Cell line enhanced"	"Detected in some"		"BJ: 25.2;BJ hTERT+: 14.7;BJ hTERT+ SV40 Large T+: 9.3;BJ hTERT+ SV40 Large T+ RasG12V: 9.7;fHDF/TERT166: 18.3;U-138 MG: 11.3;U-251 MG: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053324	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053324: "	"unprognostic (1.92e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.23e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.06e-6)"	"unprognostic (9.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.92e-1)"	0.2	1.4	17.3	0.5	21.5	0.3	0.1	4.9	19.9	0.6	0.0	3.8	0.4	0.1	0.0	0.4	0.1	0.2	2.1	15.5	8.5	0.2	0.1	0.0	0.6	12.2	14.6	0.5	0.2	0.0	0.1	0.3	7.6	0.3	0.4	2.5	1.4	1.1	0.0	0.1	0.8	0.5	14.0	2.5	0.6	0.2	16.0	0.0	0.1	0.2	0.4	0.6	0.3	17.8	0.4	3.0	0.2	0.0	0.0	0.1	0.2	25.2	14.7	9.3	9.7	0.0	0.1	0.0	0.1	18.3	0.1	0.1	0.0	0.0	5.7	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.7	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	6.1	0.2	0.4	0.5	0.0	0.0	1.3	0.0	0.1	2.8	0.2	0.1	0.2	0.0	0.0	0.1	0.4	0.0	11.3	7.8	4.5	14.1	0.0	0.0	0.0	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	17.3	21.5	4.9	19.9	15.5	8.5	12.2	14.6	7.6	14.0	16.0	17.8	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.2	0.0	17.3	0.1	0.1	2.2	1.5	0.4	0.0	0.0	0.0	5.4	0.9	0.0	0.1	5.2	0.0	0.1	0.2	0.0	0.0	274.4	0.0	0.0	0.5	0.0	0.1	1.3	0.3	0.4	0.0	0.0	0.0	482.6	0.4	2.0	0.0	0.3	12.9	0.0	0.2	1.8	18.7	0.1	0.5	0.0	23.1	390.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1
KLHL2	MAV	ENSG00000109466	"Kelch like family member 2"	O95198	4	165207561-165323156	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 125.4;Oligodendrocytes: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051637			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA051637: "	"unprognostic (1.14e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.67e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.81e-1)"	11.8	11.8	35.3	12.1	50.9	21.4	13.0	26.7	55.8	5.9	14.3	7.2	5.3	7.7	13.5	19.7	9.9	10.7	5.5	78.4	34.7	15.4	27.1	14.2	11.2	33.2	35.7	4.1	7.8	9.5	16.3	7.7	30.8	8.2	6.7	8.8	20.0	10.0	4.7	6.4	6.5	10.7	33.3	14.6	8.3	6.1	35.5	6.3	12.3	6.8	9.5	15.2	8.8	45.2	16.1	14.7	9.8	10.1	14.1	12.9	10.2	21.3	16.7	10.7	11.7	8.9	11.5	16.3	5.1	10.9	19.2	10.5	16.1	10.4	13.9	27.2	6.0	14.1	12.8	12.9	12.9	14.2	19.3	10.7	30.5	9.8	37.1	18.5	25.9	6.1	6.4	33.0	16.1	6.0	0.4	4.0	6.0	8.9	6.5	5.6	7.0	5.1	18.1	14.9	49.1	8.1	13.5	4.5	13.0	18.1	3.3	15.1	37.0	8.4	17.6	9.6	14.0	21.5	16.3	13.2	10.1	9.7	16.9	1.8	0.9	1.3	0.5	1.0	0.3	0.3	0.3	0.3	0.8	0.8	0.9	1.0	7.2	0.3	1.2	0.4	0.5	0.4	35.3	50.9	26.7	55.8	78.4	34.7	33.2	35.7	30.8	33.3	35.5	45.2	19.0	6.4	17.9	33.3	10.7	6.0	13.1	8.0	4.6	8.9	13.2	10.9	4.7	8.6	9.7	22.0	14.6	4.3	8.3	7.5	27.4	8.7	1.9	8.3	6.6	14.6	15.5	2.1	125.4	12.9	9.4	5.2	8.2	13.5	9.5	4.0	25.7	35.6	8.3	32.0	33.0	6.2	8.2	42.5	13.9	1.7	4.1	22.7	5.4	39.4	13.5	5.8	1.0	43.2	144.5	9.6	7.4	4.5	6.3	11.9	5.4	19.0	10.9	7.3	0.0	11.9	7.2	3.3	7.4	7.7	7.5	3.7	9.2	3.9	3.9	20.1
LACC1	"C13orf31, FAMIN, FLJ38725"	ENSG00000179630	"Laccase domain containing 1"	Q8IV20	13	43879284-43893932	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.0;eosinophil: 3.1;intermediate monocyte: 5.2;myeloid DC: 2.7;non-classical monocyte: 8.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.7;granulocytes: 3.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 37.1;TIME: 118.2"	"Low region specificity"	"Detected in all"							"CAB034228, HPA040150, HPA044211"	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB034228: AB_1564163, HPA040150: AB_10963540, HPA044211: AB_10961258"	"unprognostic (2.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	6.4	6.6	12.7	12.2	22.3	1.9	5.4	10.8	20.6	4.5	6.8	10.3	9.9	3.9	3.2	6.8	3.2	9.8	10.1	11.7	13.6	4.8	7.2	6.4	8.8	13.9	14.5	3.4	3.5	9.9	2.8	6.1	15.2	5.4	13.3	0.8	4.6	4.9	1.4	4.8	13.8	5.8	12.5	7.2	6.8	9.4	17.3	6.5	3.5	1.2	8.3	11.1	2.9	27.4	4.7	2.5	1.3	0.0	2.7	12.3	9.5	10.3	25.7	2.8	3.9	5.3	10.5	9.9	2.3	13.8	6.0	6.7	0.3	2.9	4.5	6.6	1.7	12.3	2.6	1.9	12.5	2.9	37.1	16.3	8.5	10.3	12.6	3.4	5.9	1.1	0.0	7.1	6.4	2.3	0.3	3.7	0.9	2.6	2.2	2.3	0.0	5.2	7.4	5.5	1.6	2.5	3.4	1.2	4.9	6.8	1.5	6.2	118.2	3.5	1.1	18.8	0.1	0.0	0.0	2.4	10.0	3.7	8.0	1.0	3.0	3.1	0.7	5.2	0.8	0.8	0.6	0.6	2.7	1.0	0.2	0.3	0.1	0.4	8.0	0.5	0.8	1.0	12.7	22.3	10.8	20.6	11.7	13.6	13.9	14.5	15.2	12.5	17.3	27.4	4.6	12.8	6.8	1.0	5.9	5.7	8.4	8.1	3.4	0.5	5.1	4.6	24.2	4.3	7.8	11.0	0.0	6.5	1.0	7.6	1.9	5.5	1.3	5.1	3.4	7.4	5.4	1.7	2.1	3.8	4.3	4.5	2.0	8.5	8.2	9.7	5.0	5.1	15.3	0.0	6.2	4.4	6.1	17.6	10.3	3.1	2.1	24.2	1.8	1.9	7.8	2.0	1.0	2.0	39.2	8.0	11.2	1.5	0.5	11.4	10.5	8.2	7.2	0.2	6.6	5.3	6.0	17.1	16.7	8.4	10.2	9.2	4.3	4.6	6.7	10.2
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 99.8;choroid plexus: 48.5;retina: 34.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 68.6;Early spermatids: 43.1;Muller glia cells: 254.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;GAMG: 17.9;HAP1: 23.5;HeLa: 15.5;NTERA-2: 28.5;U-138 MG: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000838		Supported	Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.1	0.1	77.8	0.2	78.1	0.0	0.2	48.5	99.8	0.0	48.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	88.1	51.2	0.3	6.7	0.0	0.3	49.5	52.7	0.2	0.0	0.0	9.8	3.4	50.2	0.0	0.1	34.1	0.1	0.0	0.0	6.1	0.2	0.0	48.3	0.1	0.0	3.0	54.9	0.1	0.0	0.0	0.2	0.1	0.0	73.9	0.0	7.2	0.2	23.2	0.0	0.3	2.6	0.7	0.3	1.8	0.2	7.8	0.0	0.2	3.0	1.4	17.9	0.2	23.5	0.0	0.9	0.0	5.0	0.0	15.5	0.4	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	12.1	0.0	0.2	28.5	0.0	7.0	6.5	0.1	0.0	0.0	0.1	9.2	0.1	5.7	0.0	0.0	0.2	8.0	3.1	0.0	14.6	0.6	4.2	1.1	0.4	5.0	0.0	0.8	3.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.8	78.1	48.5	99.8	88.1	51.2	49.5	52.7	50.2	48.3	54.9	73.9	0.1	0.0	0.0	68.6	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.0	43.1	0.1	0.0	0.3	0.0	0.0	20.6	0.0	8.9	0.1	0.0	0.0	0.0	0.1	3.9	0.0	4.0	8.4	2.5	0.0	0.0	0.0	0.3	21.7	0.0	0.1	0.0	1.9	0.0	254.6	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.4	0.2	4.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.2;salivary gland: 2.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 1.2;Late spermatids: 1.4;Spermatocytes: 3.3;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 6.2;hypothalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 25.6;U-266/70: 8.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 9.7"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	1.3	1.7	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.0	0.0	8.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	6.2	0.0	6.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328880-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 508.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 586.8;T-47d: 373.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	49.0	16.3	102.1	28.6	116.5	21.9	34.7	79.8	173.7	51.7	70.8	44.7	26.7	43.2	39.4	50.9	32.4	45.5	42.2	117.4	82.9	42.7	33.3	38.2	29.5	82.1	78.9	39.6	25.5	22.9	31.6	63.9	80.1	56.4	31.6	34.5	87.4	81.0	47.6	39.7	43.1	30.3	79.4	38.7	90.7	28.0	83.2	23.5	33.8	25.5	87.8	38.8	54.0	100.6	55.1	42.3	32.3	586.8	96.6	113.9	81.8	48.4	38.3	44.9	49.8	104.3	34.0	127.5	60.3	57.2	72.4	44.7	13.1	33.8	44.5	68.6	32.4	116.5	87.2	32.3	92.9	63.6	151.2	60.2	76.4	70.0	39.8	80.9	30.8	48.7	26.8	109.8	24.5	22.3	1.8	41.3	118.1	58.6	39.3	72.8	45.0	28.5	56.1	206.7	26.5	1.7	195.3	28.7	149.6	61.1	373.3	171.8	20.1	208.9	39.0	50.6	161.7	99.7	70.6	28.8	26.1	13.8	30.7	30.5	9.1	19.5	7.8	11.6	9.0	10.1	6.9	8.0	6.9	6.9	1.8	4.4	15.0	22.4	11.5	10.3	2.1	5.1	102.1	116.5	79.8	173.7	117.4	82.9	82.1	78.9	80.1	79.4	83.2	100.6	103.5	44.8	24.1	50.9	88.6	98.4	49.3	105.6	245.3	226.2	170.0	191.5	72.4	153.0	78.1	36.8	73.0	322.8	116.5	50.0	62.6	74.2	2.1	106.5	508.1	65.6	31.1	48.1	204.4	127.6	363.3	149.0	159.6	131.5	307.4	19.5	78.1	85.7	74.0	111.0	37.5	80.6	14.2	138.4	73.2	7.5	95.1	76.1	65.8	22.5	74.6	82.7	83.4	52.8	25.8	107.2	29.9	235.5	174.6	49.3	90.3	56.8	31.0	35.9	32.9	80.6	175.5	4.4	97.9	200.3	92.9	256.0	77.9	61.7	64.9	37.5
LRRC4B	"DKFZp761A179, HSM, LRIG4"	ENSG00000131409	"Leucine rich repeat containing 4B"	Q9NT99	19	50516892-50568435	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.2;cervix: 41.3;pituitary gland: 31.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 34.9;Bipolar cells: 19.6;Excitatory neurons: 32.1;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 48.9"	"Group enriched"	"Detected in many"	9	"glioma: 36.5;testis cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.7;HMC-1: 32.1;REH: 8.7;SH-SY5Y: 27.5;U-2 OS: 25.3;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058986	Uncertain					NA	NA		2700000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA058986: AB_2683871"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.39e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.15e-5)"	"unprognostic (4.29e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.17e-1)"	2.8	5.3	54.4	0.9	35.6	0.0	2.1	20.7	61.2	41.3	0.0	2.8	0.8	16.2	0.1	1.9	10.0	1.2	1.8	49.3	33.2	1.8	1.3	5.8	1.3	50.9	47.6	5.1	0.8	0.2	31.9	4.2	33.3	3.3	0.1	1.6	0.8	1.0	0.7	1.2	3.3	1.3	19.9	0.8	2.9	2.4	38.2	0.0	2.6	0.1	0.5	5.8	13.0	38.1	0.0	0.5	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	4.9	0.0	0.7	0.1	0.1	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.0	0.1	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.5	0.0	1.0	0.1	0.0	8.2	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	5.7	0.2	0.0	0.3	0.0	0.0	25.3	0.0	0.0	0.6	0.1	0.1	0.1	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.4	35.6	20.7	61.2	49.3	33.2	50.9	47.6	33.3	19.9	38.2	38.1	0.7	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.5	0.9	0.0	0.0	32.1	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.7	0.0	0.1	10.1	38.5	0.0	0.0	0.0	0.3	2.2	2.8	0.0	0.0	2.8	0.0	1.6	0.0	29.7	48.9	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	5.8	4.8	8.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304752	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.4;salivary gland: 12.8"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046607, HPA062660"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046607: , HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.5	0.9	6.4	0.3	13.4	0.0	0.1	0.0	10.0	2.2	0.0	3.7	0.6	0.6	0.3	0.3	1.2	0.2	1.3	16.3	5.2	0.3	0.4	0.1	0.0	0.9	9.4	0.3	0.1	0.0	1.9	0.0	2.0	1.0	0.3	0.4	12.8	1.2	0.0	0.1	1.3	0.3	0.2	0.0	0.7	0.2	22.4	0.0	1.6	0.1	0.0	0.6	0.8	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.4	0.0	10.0	16.3	5.2	0.9	9.4	2.0	0.2	22.4	4.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	1.0	4.8	0.3	0.0	0.0	7.2	0.7	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	6.6	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836753	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 11.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.9;Excitatory neurons: 10.2;Horizontal cells: 11.8;Inhibitory neurons: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 4.3;SCLC-21H: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA055094: AB_2682693, HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	2.9	0.0	11.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	0.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.4	0.0	3.8	3.9	3.6	0.6	4.8	0.5	0.2	11.8	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
LY6H	NMLY6	ENSG00000176956	"Lymphocyte antigen 6 family member H"	O94772	8	143157914-143160711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.7;choroid plexus: 35.0;pituitary gland: 55.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.0;Endothelial cells: 18.7;Enteroendocrine cells: 54.9;Excitatory neurons: 24.8;Inhibitory neurons: 47.8;Ionocytes: 22.4;Oligodendrocyte precursor cells: 22.6;Spermatogonia: 22.4"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 2.9;SCLC-21H: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077218	Enhanced				"Intracellular and membrane"	NA	NA		12000		"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA077218: "	"unprognostic (8.76e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.45e-4)"	"unprognostic (3.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.97e-2)"	"unprognostic (2.20e-5)"	"unprognostic (6.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.89e-3)"	2.2	0.4	78.5	0.2	90.6	0.0	0.8	35.7	114.7	1.5	35.0	24.0	2.5	1.6	0.0	1.3	2.0	0.0	0.3	97.9	111.5	0.6	0.1	1.4	0.1	43.4	56.3	1.0	1.0	0.0	55.5	0.0	48.7	0.9	0.0	0.5	0.1	0.0	0.2	0.4	6.6	0.4	46.2	0.2	11.8	5.8	92.6	0.0	0.9	0.0	0.0	0.6	0.4	54.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.5	90.6	35.7	114.7	97.9	111.5	43.4	56.3	48.7	46.2	92.6	54.3	20.0	0.0	0.0	9.1	0.0	0.6	0.2	0.3	0.0	5.8	0.6	0.0	6.2	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	18.7	54.9	0.0	24.8	0.0	0.1	3.7	12.2	0.0	0.0	2.7	0.0	0.0	0.1	0.0	47.8	0.9	22.4	0.0	0.0	2.2	0.0	0.1	0.0	13.1	0.0	2.3	0.0	22.6	5.9	0.1	0.0	0.0	0.0	1.4	0.0	0.0	2.2	3.5	0.0	0.1	0.4	1.9	22.4	0.3	0.0	0.0	0.0	2.5	0.2	0.5
MAGED4	"KIAA1859, MAGE-E1, MAGE1, MGC3210"	ENSG00000154545	"MAGE family member D4"	Q96JG8	X	52184823-52192268	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.0;ASC TERT1: 2.7;Hep G2: 7.7"									HPA003554	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA003554: AB_1853497"					"unprognostic (7.71e-2)"					"unprognostic (8.21e-2)"				"unprognostic (4.07e-4)"	"unprognostic (6.15e-2)"			0.1	0.2	2.0	0.1	1.6	0.0	0.3	0.3	3.8	0.2	0.8	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.1	1.5	3.5	0.1	0.0	0.0	0.0	1.4	1.2	0.2	0.1	0.0	0.3	0.1	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.0	0.5	0.5	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	7.7	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	1.6	0.3	3.8	1.5	3.5	1.4	1.2	1.3	1.0	4.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 325.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	61	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	61	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol		No	No		55000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (1.09e-5)"	"prognostic unfavorable (1.66e-5)"	7.2	6.0	65.3	3.8	78.6	0.9	4.4	39.5	325.5	8.0	0.0	16.5	1.2	8.2	2.4	3.0	7.2	4.2	15.5	92.8	37.5	1.2	0.2	2.2	1.0	201.4	41.4	5.0	1.0	2.0	11.7	2.7	186.0	4.8	3.5	21.7	2.5	7.5	4.5	3.2	4.0	13.1	22.5	0.9	4.3	3.8	85.8	24.0	4.1	5.1	0.9	11.9	4.5	156.7	0.3	2.5	11.1	6.4	60.7	41.5	0.1	36.3	61.8	10.5	10.1	4.4	0.1	0.2	15.3	94.0	3.3	0.5	15.0	0.1	6.1	5.5	1.4	14.2	3.5	0.3	5.8	0.4	5.8	31.3	0.1	58.1	0.3	15.8	8.0	41.3	24.0	0.3	42.8	0.5	26.6	0.8	8.1	0.0	1.0	7.2	32.1	0.1	0.2	0.1	34.8	10.6	1.2	0.1	0.3	14.6	2.3	0.6	1.5	33.7	11.3	11.3	0.5	0.0	1.6	5.0	121.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.1	65.3	78.6	39.5	325.5	92.8	37.5	201.4	41.4	186.0	22.5	85.8	156.7	6.7	3.2	1.1	11.8	2.2	5.5	1.4	1.4	2.8	43.4	1.7	3.6	55.1	0.0	7.9	3.7	25.0	0.3	90.9	1.0	0.0	0.4	13.1	33.2	19.5	5.7	11.4	3.0	34.4	0.0	0.6	46.9	2.6	1.0	7.0	16.7	4.2	0.0	2.4	299.5	45.1	1.7	10.2	0.3	7.4	5.6	51.0	9.4	8.8	12.2	0.7	16.7	0.0	9.5	51.4	0.7	0.0	76.3	1.1	0.5	0.0	0.5	63.6	27.2	32.9	45.7	48.2	10.6	25.6	1.1	4.1	1.1	5.6	3.1	1.4	0.5
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21759657-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 341.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069, CAB079930, CAB079932, CAB079933"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear speckles"	"CAB004229: AB_627547, CAB079930: , CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	31.1	33.1	64.8	35.9	84.4	41.2	29.8	37.3	80.9	31.4	32.9	36.1	25.8	29.6	30.1	43.0	29.0	28.9	42.2	91.3	46.4	42.1	34.2	38.5	36.8	29.1	45.1	29.2	38.1	51.7	12.0	33.1	35.9	32.8	36.2	30.3	28.9	32.7	38.1	45.0	29.5	39.1	43.8	40.5	33.9	43.7	60.1	44.4	46.1	41.9	41.9	35.5	18.9	43.2	78.7	48.0	60.5	37.2	75.9	76.7	25.9	84.7	77.5	73.2	72.0	43.8	40.8	45.8	41.3	112.7	67.5	74.6	73.9	67.9	97.8	180.4	72.1	78.9	43.0	67.7	73.5	113.2	80.5	56.9	60.1	89.4	81.6	58.0	101.7	45.4	341.9	50.5	97.5	36.6	72.0	38.5	24.4	104.5	46.8	79.4	149.6	13.2	55.5	62.9	50.0	28.6	91.5	64.2	57.2	60.4	42.4	47.1	90.1	61.5	79.6	71.9	54.2	47.1	59.4	65.8	60.0	60.0	68.4	1.4	4.9	7.2	15.9	6.0	4.9	2.3	3.6	6.0	4.1	2.6	3.5	6.1	16.5	9.3	6.9	4.0	3.4	4.0	64.8	84.4	37.3	80.9	91.3	46.4	29.1	45.1	35.9	43.8	60.1	43.2	36.8	48.1	35.8	97.6	44.0	60.2	28.4	25.1	28.5	25.5	32.5	24.5	41.5	42.9	31.2	51.5	54.2	21.8	151.7	74.4	19.6	28.5	49.0	33.5	40.3	39.9	59.6	63.8	109.2	39.2	23.2	38.4	52.0	45.0	92.8	28.8	52.1	63.5	53.2	28.6	91.2	42.2	26.4	89.0	77.1	14.7	32.6	74.9	40.9	68.4	75.0	35.8	143.2	82.4	75.1	45.3	35.2	44.4	37.0	43.8	32.8	46.0	32.2	22.4	32.9	44.6	37.3	74.1	53.4	44.9	61.8	19.2	91.4	43.3	38.6	38.8
MAPK8IP2	"IB2, JIP2, PRKM8IPL"	ENSG00000008735	"Mitogen-activated protein kinase 8 interacting protein 2"	Q13387	22	50600793-50613981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.0;pituitary gland: 35.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.8;Enteroendocrine cells: 32.3;Horizontal cells: 99.3;Rod photoreceptor cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 19.3;HEK 293: 11.0;SCLC-21H: 15.7;SH-SY5Y: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034780	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA034780: AB_10670283"	"unprognostic (7.82e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.78e-3)"	"unprognostic (6.33e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.75e-2)"	1.4	9.2	54.7	0.3	50.2	0.0	1.4	27.5	67.8	1.4	0.0	2.1	0.2	2.1	0.3	1.2	1.5	0.0	0.4	53.7	35.1	0.7	0.5	0.5	0.0	78.0	27.0	7.0	1.8	2.0	35.2	0.3	84.0	1.9	0.1	9.6	2.8	0.2	0.3	1.5	1.0	0.2	18.6	0.8	1.5	7.1	39.4	0.2	1.0	0.1	0.0	0.3	1.0	49.2	0.3	1.1	4.7	4.1	0.4	0.0	3.7	0.0	0.0	1.0	0.6	2.4	0.8	0.6	1.0	0.0	19.3	0.0	6.6	0.0	0.0	0.3	11.0	0.0	0.4	1.2	0.5	0.0	0.8	0.3	5.5	0.0	0.1	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	3.4	0.8	1.8	1.1	0.7	0.0	0.0	0.1	15.7	19.8	3.7	4.6	0.2	0.9	0.9	0.0	0.0	0.1	0.1	0.6	0.0	1.1	3.1	0.5	0.5	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.2	27.5	67.8	53.7	35.1	78.0	27.0	84.0	18.6	39.4	49.2	0.6	3.2	2.0	6.5	0.1	0.4	1.6	0.5	0.6	57.8	2.3	3.9	2.3	2.8	2.7	0.0	16.7	0.2	0.0	0.5	0.0	3.0	0.6	0.7	1.7	0.7	32.3	0.0	15.6	2.5	1.1	0.7	0.0	1.5	0.0	0.5	0.0	0.3	0.1	99.3	13.1	0.5	4.1	0.0	0.4	1.8	5.9	0.3	7.2	3.7	0.2	11.2	0.0	6.0	3.2	0.7	0.1	0.7	0.1	1.2	0.3	0.7	0.3	26.7	0.0	1.3	1.0	3.4	2.7	0.6	0.6	1.1	0.3	0.5	0.6	0.5
MARCHF4	"KIAA1399, MARCH-IV, MARCH4, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372483	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"brain: 4.4;pituitary gland: 6.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 69.0;fHDF/TERT166: 43.8;TIME: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014348	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.0	0.7	2.6	0.0	3.9	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	0.0	0.0	3.1	2.2	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.4	0.0	6.2	0.6	1.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.5	2.5	0.0	0.0	0.2	1.6	0.0	69.0	23.2	14.5	5.1	0.1	1.0	0.0	10.5	43.8	24.2	0.1	0.0	26.7	14.1	0.0	0.0	5.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	13.3	19.6	9.3	19.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.4	1.9	0.1	0.0	0.0	2.2	0.0	0.0	32.7	22.7	23.9	0.1	18.6	0.0	0.0	0.0	5.2	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.9	0.0	4.4	3.1	2.2	0.5	4.1	1.1	2.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MDGA2	MAMDC1	ENSG00000139915	"MAM domain containing glycosylphosphatidylinositol anchor 2"	Q7Z553	14	46839629-47675605	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 8.0;retina: 4.4;testis: 3.8"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 1559.3;Inhibitory neurons: 1208.8;Oligodendrocyte precursor cells: 1972.9"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.1;T-47d: 2.5;U-138 MG: 5.6;U-2 OS: 4.0;U-87 MG: 2.1;WM-115: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003084	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA003084: AB_1079302"	"unprognostic (3.27e-1)"			"unprognostic (5.38e-2)"	"unprognostic (9.13e-2)"		"unprognostic (8.92e-3)"		"unprognostic (6.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.49e-3)"	"unprognostic (3.62e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.89e-1)"		0.1	0.2	5.4	0.0	6.3	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	6.4	0.1	0.1	0.0	0.0	7.0	2.7	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	4.4	0.1	0.0	0.0	0.3	0.0	0.0	4.9	0.0	0.2	3.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	2.5	0.0	0.0	5.6	4.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.3	0.1	6.1	6.1	6.4	7.0	2.7	8.0	4.9	3.1	5.1	0.0	0.0	0.0	24.2	0.1	0.4	0.0	0.0	0.0	50.6	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	50.9	0.0	0.0	0.1	0.0	0.0	1559.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1208.8	0.0	0.0	0.0	0.0	7.1	0.3	0.0	5.4	52.5	0.0	0.3	0.0	1972.9	209.4	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.2	4.4	6.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0
MMD2	PAQR10	ENSG00000136297	"Monocyte to macrophage differentiation associated 2"	Q8IY49	7	4905989-4959213	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 27.4;retina: 6.1;testis: 7.1"	"Group enriched"	"Detected in some"	14	"Astrocytes: 253.4;Oligodendrocyte precursor cells: 121.2"	"Cancer enriched"	"Detected in single"	59	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 64: Astrocytes - Nervous system maintenance"								"unprognostic (2.32e-1)"							"unprognostic (1.53e-2)"		"unprognostic (5.03e-2)"	"unprognostic (2.03e-1)"			0.0	0.2	23.8	0.0	25.9	0.0	0.0	8.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	26.6	0.0	0.0	0.0	0.0	25.6	22.3	0.1	0.0	0.0	3.2	0.0	18.2	0.0	0.0	6.1	0.1	0.1	0.0	0.0	0.1	0.0	14.3	0.0	0.0	7.1	27.4	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	25.9	8.5	19.4	22.0	26.6	25.6	22.3	18.2	14.3	27.4	15.9	0.0	0.0	0.0	253.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	13.1	0.0	2.6	0.0	121.2	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRAP2	"bA51G5.2, C6orf117"	ENSG00000135324	"Melanocortin 2 receptor accessory protein 2"	Q96G30	6	84033772-84090881	"Disease related genes, Human disease related genes, Predicted membrane proteins"			Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.5;Inhibitory neurons: 33.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"K-562: 91.7;SCLC-21H: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (3.82e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (8.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (9.85e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.47e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.50e-3)"	"unprognostic (9.12e-2)"	1.0	7.3	10.5	1.3	9.5	0.1	1.6	4.9	20.0	2.6	3.6	5.3	3.7	2.5	1.1	1.4	8.6	1.9	1.1	8.3	11.3	3.4	0.2	0.9	0.5	8.4	8.5	4.6	4.3	0.1	3.6	0.2	8.7	6.1	5.1	2.1	6.9	7.8	1.3	1.9	3.9	1.1	3.8	8.6	7.6	2.8	18.6	0.9	0.6	0.5	1.7	0.8	2.2	13.0	0.0	2.5	0.9	0.0	0.3	1.4	0.1	0.9	0.0	1.5	0.2	1.2	0.1	0.2	0.1	9.6	3.2	0.0	1.7	0.4	0.1	0.8	0.8	3.1	0.2	0.4	0.0	0.7	0.2	0.4	1.3	0.1	0.0	0.1	5.7	0.1	91.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.4	0.1	5.0	0.0	5.3	1.6	30.1	10.2	0.2	0.0	1.5	1.1	0.2	2.6	0.4	0.5	0.4	5.0	1.2	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	9.5	4.9	20.0	8.3	11.3	8.4	8.5	8.7	3.8	18.6	13.0	0.8	0.0	0.5	3.3	0.0	1.8	7.8	1.7	0.6	1.2	0.8	1.0	0.2	1.5	2.1	12.9	0.0	0.1	0.1	6.4	1.9	4.3	2.8	5.1	0.5	2.3	0.0	0.0	56.5	5.3	0.0	1.1	13.7	2.4	0.0	1.8	4.2	0.0	0.0	0.0	33.5	11.3	0.0	0.0	0.4	4.8	4.1	0.2	0.0	2.8	0.0	0.4	0.0	3.5	4.0	0.6	6.4	5.3	0.0	2.8	2.3	0.0	4.5	0.5	0.0	8.1	2.4	0.2	4.7	2.7	1.0	0.0	0.1	1.8	6.8	4.7
MSANTD3-TMEFF1	C9orf30-TMEFF1	ENSG00000251349	"MSANTD3-TMEFF1 readthrough"		9	100442271-100577636	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"brain: 47.4;choroid plexus: 16.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.0;Excitatory neurons: 12.0;Inhibitory neurons: 9.6;Microglial cells: 1.9;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;NTERA-2: 48.9;SCLC-21H: 51.9;SuSa: 70.3"					"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (8.53e-3)"	"unprognostic (1.95e-3)"	"unprognostic (5.92e-2)"		"unprognostic (5.32e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.39e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.46e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	1.5	1.4	24.1	2.3	31.9	0.5	1.3	21.5	47.4	3.5	16.0	3.1	0.5	5.3	1.9	1.4	1.4	2.2	1.7	21.9	35.9	1.2	0.6	1.4	0.6	23.4	28.4	2.3	0.5	1.0	0.9	2.3	24.2	2.1	1.4	4.3	0.6	3.1	1.6	0.5	1.1	4.5	22.3	0.5	1.3	5.5	28.9	2.2	5.7	3.1	1.0	2.1	1.4	29.1	2.8	4.7	99.0	8.3	12.0	6.7	15.7	11.0	7.7	8.0	8.5	0.6	3.2	2.1	5.2	10.0	22.7	1.8	31.4	3.3	18.4	8.0	5.6	0.7	3.2	1.5	6.1	2.1	1.8	2.9	2.7	7.8	9.3	18.1	20.4	19.0	2.1	1.2	16.3	2.0	12.7	1.9	48.9	8.8	4.4	15.1	41.7	0.3	8.0	1.1	51.9	24.0	3.5	2.3	5.5	70.3	1.1	6.4	7.2	8.3	8.5	10.0	10.1	4.4	11.1	9.2	13.0	1.2	8.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.1	31.9	21.5	47.4	21.9	35.9	23.4	28.4	24.2	22.3	28.9	29.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTRNR2L5		ENSG00000249860	"MT-RNR2 like 5"	P0CJ72	10	55599042-55600728	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 2.3"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Not detected"	"Not detected"																"Secreted - unknown location"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"		"Cluster 54: Cardiomyocytes - Muscle contraction"													"unprognostic (2.11e-2)"				"unprognostic (1.20e-1)"				0.0	0.1	1.2	0.1	0.9	0.3	0.0	0.5	1.5	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	1.3	1.7	0.1	0.1	0.0	0.2	1.3	1.4	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.1	0.0	0.6	0.2	0.1	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	1.2	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	1.2	0.2	0.1	0.1	0.0	0.1	1.2	0.9	0.5	1.5	1.3	1.7	1.3	1.4	1.0	0.6	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
MYO16	"KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107"	ENSG00000041515	"Myosin XVI"	Q9Y6X6	13	108596152-109208005	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.4"	"Group enriched"	"Detected in some"	8	"Inhibitory neurons: 460.0;Oligodendrocyte precursor cells: 299.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SH-SY5Y: 4.5;U-2197: 2.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 72.6"	"Low region specificity"	"Detected in all"			"HPA040110, HPA058769, HPA071948"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA040110: AB_10796339, HPA058769: AB_2683814, HPA071948: AB_2686475"	"unprognostic (7.55e-3)"	"unprognostic (7.74e-3)"	"unprognostic (4.52e-4)"	"unprognostic (5.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.01e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.68e-4)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.34e-2)"	1.4	0.7	2.5	0.2	4.9	0.0	0.2	1.2	3.7	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.9	5.4	1.8	0.0	1.9	0.2	0.2	0.6	1.5	0.0	0.1	0.0	1.7	0.1	2.3	0.2	0.1	0.4	0.1	0.7	0.0	0.1	0.0	0.4	2.6	0.0	0.0	1.1	2.6	0.0	0.0	0.2	0.3	0.0	0.2	0.9	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.9	1.2	3.7	5.4	1.8	0.6	1.5	2.3	2.6	2.6	0.9	1.0	0.0	0.6	19.6	0.0	0.3	0.0	0.4	0.0	4.2	0.1	0.3	3.7	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.5	11.3	0.5	1.1	0.1	0.0	3.4	44.6	0.0	0.1	0.8	0.0	0.3	1.3	0.1	0.0	5.9	0.1	0.0	460.0	0.0	0.0	0.0	0.3	11.4	0.9	0.1	1.8	8.4	0.0	2.8	0.0	299.6	4.7	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.1	5.0	7.7	0.0	0.0	0.3	0.3	1.6	0.0	0.0
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		7800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	6.3	7.0	20.3	5.7	21.6	6.2	5.5	17.9	29.6	5.5	17.6	8.8	6.5	6.6	2.6	6.4	4.8	3.4	5.4	23.6	18.3	8.2	9.0	5.7	6.4	19.2	18.0	3.6	6.2	4.8	5.4	4.1	18.5	5.7	3.0	0.6	5.4	3.3	6.1	6.7	9.8	3.4	17.8	11.8	9.4	3.3	19.6	3.5	5.7	2.4	2.8	6.4	5.1	20.9	2.5	9.7	1.6	10.4	4.0	5.0	10.8	7.1	12.7	9.3	11.2	8.0	19.9	1.0	8.8	9.6	15.8	7.3	4.4	7.8	2.6	11.8	13.3	3.6	5.7	53.1	12.7	8.8	14.6	7.7	8.1	6.0	2.7	11.0	14.6	8.8	11.5	14.1	5.5	11.3	4.0	23.6	5.0	6.3	10.2	10.4	3.7	19.3	5.8	3.9	4.0	5.6	5.6	14.2	15.1	1.4	9.7	10.5	11.0	9.9	7.2	24.0	5.3	6.9	6.3	2.3	4.6	13.1	8.3	3.9	39.3	10.4	17.9	35.0	14.2	17.3	17.1	15.4	50.5	14.2	14.0	13.2	1.2	10.6	23.6	12.9	16.3	20.1	20.3	21.6	17.9	29.6	23.6	18.3	19.2	18.0	18.5	17.8	19.6	20.9	8.1	0.0	2.7	7.8	15.0	2.9	4.7	4.5	7.4	14.7	5.2	5.1	3.1	8.6	4.7	5.5	31.3	13.3	10.2	21.8	1.9	11.3	0.4	3.0	3.7	8.4	1.2	9.1	44.5	8.5	14.9	4.6	28.1	4.1	1.3	8.9	9.7	7.7	27.2	16.8	21.5	13.6	2.0	24.9	8.6	1.0	8.1	20.6	3.6	2.8	24.0	4.5	18.6	4.0	6.9	9.5	18.4	6.4	13.2	4.1	28.9	9.0	3.2	13.8	0.0	4.3	4.8	4.4	8.4	8.8	2.4	9.4	12.1	5.8	12.4	3.2
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.5;brain: 99.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.5	0.7	56.1	0.1	46.4	0.0	1.6	42.9	99.0	0.0	0.6	0.2	0.1	0.3	1.3	0.1	0.9	0.1	0.8	45.8	29.0	5.3	0.0	0.0	0.2	52.3	46.4	0.2	2.3	0.9	1.8	0.1	57.5	1.0	0.1	3.7	2.3	1.6	5.7	1.0	0.2	0.2	33.0	0.3	0.4	9.0	88.8	0.2	0.3	2.5	0.0	0.0	0.0	38.9	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	56.1	46.4	42.9	99.0	45.8	29.0	52.3	46.4	57.5	33.0	88.8	38.9	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998409-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.0;brain: 26.0"	"Group enriched"	"Detected in some"	19	"Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.6;glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		120000000		"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	0.7	12.0	14.1	0.9	19.0	0.0	1.6	8.4	17.5	1.6	0.0	2.0	0.2	1.0	0.5	0.5	0.6	1.2	2.0	21.3	22.7	0.2	6.7	2.8	0.1	8.6	14.4	0.3	0.2	0.6	0.8	0.5	8.8	0.9	1.0	1.2	0.7	1.0	0.4	0.8	0.7	1.4	8.8	0.8	0.6	6.3	26.0	0.1	0.3	0.8	0.2	0.6	1.2	21.6	0.0	0.0	0.5	0.0	4.6	4.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.5	1.3	0.0	2.2	0.0	0.1	11.3	0.0	3.5	0.0	0.4	0.0	0.0	11.4	2.4	0.2	15.4	0.2	0.0	0.4	0.0	0.0	1.0	0.0	4.7	0.0	0.0	0.0	5.3	0.0	0.8	0.6	0.1	92.1	7.2	0.0	1.3	0.9	0.1	0.0	0.6	0.0	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.0	8.4	17.5	21.3	22.7	8.6	14.4	8.8	8.8	26.0	21.6	0.4	3.2	1.3	713.0	0.1	0.5	0.3	0.0	0.0	1.0	2.0	1.4	1.8	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	57.6	0.3	6.1	0.4	0.0	0.0	866.5	0.0	0.4	4.8	0.0	0.2	0.0	0.2	2.2	0.0	0.3	0.0	909.2	0.0	0.0	0.0	0.3	24.7	0.9	0.1	1.8	30.9	0.0	1.0	0.0	1729.1	1526.6	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.1	0.0	2.4	1.6	3.7	9.6	0.1	0.1	0.3	0.2	1.9	0.0	0.2
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211958-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"brain: 73.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 195.5"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"	NA	NA		790000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	0.0	0.1	52.8	0.0	53.1	0.0	0.0	15.2	73.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.6	44.2	0.0	0.0	0.0	0.0	33.3	32.3	0.0	0.0	0.0	0.3	0.0	38.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.9	61.5	0.1	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	53.1	15.2	73.6	55.6	44.2	33.3	32.3	38.1	21.5	61.5	49.4	0.0	0.0	0.0	195.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	29.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0
NECAB2	EFCBP2	ENSG00000103154	"N-terminal EF-hand calcium binding protein 2"	Q7Z6G3	16	83968244-84002776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 106.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Hepatocytes: 10.7;Inhibitory neurons: 22.2;Late spermatids: 49.2;Muller glia cells: 17.8;Proximal tubular cells: 27.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	66	"neutrophil: 55.4"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 55.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;MCF7: 6.8;SCLC-21H: 37.6;U-87 MG: 12.2"	"Low region specificity"	"Detected in all"							"HPA013998, HPA014144, CAB068211"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017"	"unprognostic (5.27e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.48e-5)"	"unprognostic (3.45e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (8.89e-3)"	"unprognostic (3.48e-1)"	"unprognostic (8.61e-3)"	"unprognostic (3.75e-2)"	0.9	0.5	67.8	0.6	73.0	0.5	0.7	20.3	106.4	2.0	24.9	1.3	1.2	1.2	0.3	0.1	0.4	0.5	1.2	80.5	62.0	11.1	26.0	0.5	0.2	32.1	50.7	0.5	1.9	6.7	16.2	0.3	80.2	0.3	0.2	3.1	0.1	0.1	0.2	0.2	1.2	0.4	24.9	1.6	1.8	10.5	59.4	0.2	0.5	0.2	0.0	0.3	0.2	31.4	0.2	4.4	10.1	0.0	0.0	1.4	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.0	1.6	0.2	0.8	0.0	1.9	0.0	0.0	0.1	2.9	0.0	0.0	0.5	0.1	0.0	1.7	0.5	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.0	6.8	0.0	0.0	5.0	0.4	0.6	0.1	0.0	0.6	0.0	0.0	37.6	1.5	0.0	0.2	3.1	1.4	5.2	1.4	0.3	0.2	2.8	0.4	0.0	0.1	0.0	0.0	12.2	0.5	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.1	67.8	73.0	20.3	106.4	80.5	62.0	32.1	50.7	80.2	24.9	59.4	31.4	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	16.6	0.0	0.1	0.1	7.2	0.0	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	10.7	3.4	0.0	22.2	0.0	0.0	0.0	0.0	49.2	0.3	0.3	0.0	3.7	0.2	17.8	0.0	4.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	27.8	0.0	0.3	0.0	0.1	0.0	2.1	3.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0
NEUROD2	"bHLHa1, NDRF"	ENSG00000171532	"Neuronal differentiation 2"	Q15784	17	39603536-39609777	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	81	"brain: 94.7;choroid plexus: 37.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.1;Cone photoreceptor cells: 4.2;Enteroendocrine cells: 23.8;Excitatory neurons: 14.9"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.7;glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	139	"SCLC-21H: 29.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 68.0;hippocampal formation: 76.9"							NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (5.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.51e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.21e-6)"	"unprognostic (4.20e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.57e-3)"	0.0	0.0	53.0	0.0	58.9	0.0	0.0	74.5	94.7	0.0	37.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.9	37.2	0.0	0.0	0.0	0.0	56.0	38.1	0.0	0.0	0.0	0.0	0.0	55.8	0.0	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.0	38.5	0.0	0.1	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	53.0	58.9	74.5	94.7	73.9	37.2	56.0	38.1	55.8	38.5	37.2	58.1	0.1	0.0	0.0	1.0	0.2	0.3	1.1	0.0	0.0	10.1	0.2	0.3	1.5	0.0	0.0	0.0	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	23.8	0.0	14.9	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.3	0.0	0.6	0.2	0.0	1.9	0.1	0.6	1.0	0.5	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	1.8	0.0	1.7	0.4	0.6	0.3	0.0	0.0	0.8	0.4	0.0	0.1	1.1
NKAIN3	"FAM77D, FLJ39630, NKAIN3-IT1"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-63014000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"brain: 18.9"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1258.6;Oligodendrocyte precursor cells: 811.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;SCLC-21H: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018833: AB_2669943"	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.2	1.7	18.9	0.3	11.8	0.9	0.3	0.8	9.9	0.6	0.0	0.4	0.3	0.4	0.7	0.2	0.2	0.3	0.3	16.1	10.6	0.4	2.0	0.2	0.3	3.7	11.2	0.4	0.3	0.7	0.0	0.2	2.2	0.3	0.4	1.7	1.2	0.4	0.6	0.7	0.4	0.2	1.4	0.4	0.3	0.4	16.1	0.1	0.2	0.1	0.1	0.2	0.0	4.8	0.4	0.6	2.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.5	0.1	0.1	0.4	0.1	0.9	1.2	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.5	1.3	0.1	0.2	0.3	0.5	0.8	0.4	1.1	1.9	0.3	0.2	0.0	0.6	3.7	0.3	0.3	0.4	0.2	0.6	0.3	0.4	0.4	0.5	0.5	0.4	0.3	0.6	0.5	0.2	0.6	0.4	1.2	0.9	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.1	0.0	18.9	11.8	0.8	9.9	16.1	10.6	3.7	11.2	2.2	1.4	16.1	4.8	0.0	0.0	0.0	1258.6	0.0	0.4	0.1	0.0	0.0	10.4	1.3	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.2	6.3	0.0	0.0	0.0	35.7	0.7	0.1	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	168.5	0.0	0.0	0.0	0.0	4.2	0.3	0.0	1.8	21.5	0.0	0.0	0.0	811.8	3.8	0.6	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.2	0.0	7.6	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2
NPY2R		ENSG00000185149	"Neuropeptide Y receptor Y2"	P49146	4	155208636-155217078	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.3;breast: 1.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.8;Excitatory neurons: 6.7;Leydig cells: 21.1;Oligodendrocytes: 13.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;ASC diff: 2.1;HSkMC: 1.0;SH-SY5Y: 7.5"	"Group enriched"	"Detected in many"	5	"amygdala: 12.9;basal ganglia: 12.3;hippocampal formation: 46.7;hypothalamus: 23.7"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 14.2"							NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (7.14e-2)"				"unprognostic (4.36e-3)"					"unprognostic (7.08e-2)"		"unprognostic (5.50e-2)"			"unprognostic (9.35e-2)"			0.3	0.2	2.0	0.2	1.1	0.0	1.6	0.1	2.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.5	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.5	0.2	0.7	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.1	2.4	5.3	3.5	1.5	0.6	0.6	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NSG2	"CALY3, HMP19"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045706-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 198.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"SCLC-21H: 39.5;SH-SY5Y: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA046531: AB_2732528, HPA056191: AB_2683062"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	0.5	33.3	115.8	2.6	198.5	0.0	0.1	43.8	152.8	0.0	1.7	6.9	2.3	0.0	0.4	0.1	0.0	0.3	1.0	125.2	171.9	0.7	0.4	0.3	0.0	54.5	82.1	0.1	0.9	0.0	7.0	0.0	101.1	0.2	3.9	39.2	0.1	0.1	0.3	0.1	3.8	1.8	52.4	0.2	3.0	14.7	100.3	0.0	0.6	0.0	0.0	0.1	1.2	47.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	64.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.8	198.5	43.8	152.8	125.2	171.9	54.5	82.1	101.1	52.4	100.3	47.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NSMF	NELF	ENSG00000165802	"NMDA receptor synaptonuclear signaling and neuronal migration factor"	Q6X4W1	9	137447570-137459334	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 361.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Peritubular cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 3.5;intermediate monocyte: 13.8;myeloid DC: 6.3;non-classical monocyte: 12.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.3;granulocytes: 3.5;monocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044316	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044316: AB_10964877"	"unprognostic (1.48e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.34e-3)"	"prognostic favorable (1.85e-6)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-2)"	23.1	14.5	167.1	12.6	154.3	12.2	20.3	66.6	361.3	24.2	73.4	22.7	29.9	32.8	10.7	16.3	28.7	9.7	16.1	360.8	115.1	30.8	23.5	19.8	13.0	99.7	153.1	22.5	31.6	17.9	70.6	7.1	75.1	31.2	10.4	12.1	20.2	13.8	8.9	20.6	24.9	13.9	109.9	17.0	23.5	18.9	210.5	8.4	23.9	3.9	10.3	22.2	17.5	105.4	24.4	19.3	33.7	50.4	77.1	36.4	28.9	23.0	30.2	21.5	16.5	51.7	14.3	30.2	30.3	34.0	48.1	72.7	50.0	30.9	12.9	39.7	53.8	23.5	46.7	69.5	41.7	16.2	51.5	41.7	57.9	25.1	58.3	48.5	23.1	0.8	55.0	4.9	29.2	56.4	0.7	69.8	42.9	97.6	51.4	14.6	53.3	68.0	14.9	12.1	135.7	112.8	55.0	30.3	35.7	13.9	21.5	33.0	58.6	37.9	30.9	92.9	39.6	10.3	17.0	45.8	21.6	21.2	35.6	1.6	2.1	3.5	1.5	13.8	0.3	0.2	0.5	0.9	6.3	0.1	0.5	0.7	0.3	0.0	12.1	0.2	0.8	1.8	167.1	154.3	66.6	361.3	360.8	115.1	99.7	153.1	75.1	109.9	210.5	105.4	9.9	0.0	3.9	71.5	5.9	13.6	9.4	3.6	7.4	9.6	14.3	12.4	6.1	11.5	2.3	11.0	8.4	0.4	17.7	40.7	5.9	8.2	7.1	7.6	18.3	9.5	19.2	1.7	24.2	21.4	1.3	11.0	10.2	11.1	2.5	12.0	9.7	26.3	6.7	28.6	14.9	21.3	8.2	8.6	21.2	15.3	23.9	10.5	16.0	15.9	9.8	10.3	6.2	16.1	5.3	21.4	34.3	71.5	8.5	32.6	43.4	29.7	2.9	12.9	13.1	8.3	10.9	3.0	5.9	6.3	14.6	1.5	8.0	11.0	20.5	16.7
NTM	"CEPU-1, HNT, IGLON2, NTRI"	ENSG00000182667	Neurotrimin	Q9P121	11	131370478-132336822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 321.8;choroid plexus: 89.2;retina: 74.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 608.9;Astrocytes: 2164.2;Cone photoreceptor cells: 950.8;Excitatory neurons: 651.0;Inhibitory neurons: 1056.6;Oligodendrocyte precursor cells: 1930.7;Oligodendrocytes: 1257.6;Rod photoreceptor cells: 1415.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	175	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	175	"dendritic cells: 17.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 122.4;U-138 MG: 47.7;U-2 OS: 81.8;WM-115: 166.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB024875	Enhanced				"Intracellular and membrane"	NA	NA		58000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB024875: "	"unprognostic (1.52e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.99e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (4.60e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.31e-3)"	17.9	4.7	137.2	2.3	138.8	0.0	2.9	165.1	321.8	1.6	89.2	12.0	2.5	1.3	0.6	9.4	0.9	9.6	30.5	136.9	131.5	2.3	0.3	25.8	0.4	144.0	135.4	0.3	0.9	22.1	0.9	0.7	143.6	1.9	3.8	74.8	2.7	2.8	0.9	6.1	4.6	4.5	135.0	0.5	2.0	0.6	154.2	0.5	1.1	5.0	0.4	3.5	1.8	158.4	0.1	0.0	7.5	0.1	0.9	22.2	0.0	36.7	19.5	11.7	6.8	0.1	0.0	0.0	0.0	20.3	0.0	0.3	0.0	43.6	12.6	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.2	2.0	0.0	38.0	45.0	29.0	7.5	0.0	0.0	0.3	122.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	3.9	20.8	0.0	2.4	3.8	0.0	0.0	0.2	1.3	0.0	0.1	8.1	47.7	81.8	2.2	31.6	0.0	0.0	0.2	0.1	0.0	166.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	137.2	138.8	165.1	321.8	136.9	131.5	144.0	135.4	143.6	135.0	154.2	158.4	1.2	608.9	27.6	2164.2	0.0	1.8	0.0	1.5	2.2	225.3	0.9	4.4	13.7	0.0	29.7	20.2	950.8	0.0	5.4	0.4	0.0	0.6	10.9	0.0	0.5	2.9	0.0	2.7	651.0	0.0	0.0	22.2	0.5	0.0	53.0	0.1	0.7	0.0	0.1	40.4	1056.6	0.1	0.0	0.0	3.8	2.2	0.3	0.7	3.6	139.6	0.0	30.5	0.0	1930.7	1257.6	0.1	0.2	0.4	0.1	0.1	0.0	0.1	1.5	1415.0	0.0	20.6	7.5	0.4	0.9	0.5	4.8	0.0	0.8	0.0	0.8	0.1
OCM	OCM1	ENSG00000122543	Oncomodulin	P0CE72	7	5879827-5886363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 2.3;Excitatory neurons: 8.6;Inhibitory neurons: 7.0;Late spermatids: 2.4;Microglial cells: 4.7;Oligodendrocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "	"unprognostic (1.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.90e-4)"	0.2	0.2	2.9	0.3	2.1	0.7	0.5	2.3	3.2	0.4	1.6	0.2	0.0	0.1	0.9	0.2	0.3	0.2	0.1	2.1	2.4	0.3	0.3	0.2	2.1	1.9	2.0	0.3	0.2	0.0	0.3	0.0	2.0	0.3	0.2	0.6	0.3	0.3	0.1	0.7	0.7	0.1	1.8	1.2	0.2	2.1	2.4	0.8	0.3	0.0	0.8	0.1	0.3	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.8	0.4	0.2	0.1	0.4	1.1	0.3	0.0	1.4	1.5	0.4	0.6	0.0	0.2	0.0	2.7	0.4	2.9	2.1	2.3	3.2	2.1	2.4	1.9	2.0	2.0	1.8	2.4	2.2	0.1	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	7.0	0.0	0.0	0.6	0.0	2.4	0.0	0.1	0.0	4.7	0.3	0.5	1.0	1.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121180	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 555.7;choroid plexus: 246.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 193.1;Hepatic stellate cells: 78.1;Inhibitory neurons: 70.0"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.8;myeloid DC: 2.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 2.6;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 96.0;MCF7: 84.1;NTERA-2: 104.9;OE19: 78.9;SCLC-21H: 155.6;SiHa: 131.8;T-47d: 200.2;U-2197: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		200000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	36.7	25.4	410.4	13.0	427.0	0.2	36.8	309.6	555.7	29.9	246.9	24.0	5.0	29.0	70.4	12.1	30.3	8.6	20.7	474.7	309.0	20.3	4.8	15.0	14.5	296.6	301.7	19.4	12.3	4.9	82.8	1.0	293.9	19.3	13.8	47.3	14.0	18.1	17.5	15.3	16.5	17.9	279.9	35.1	15.4	6.8	317.0	11.5	17.5	23.0	19.1	25.0	26.7	372.3	0.0	6.1	12.1	0.2	1.7	1.4	0.5	3.6	0.0	0.0	0.0	0.1	2.7	0.1	0.8	5.2	49.2	2.3	2.6	0.0	0.0	14.4	0.9	0.2	96.0	0.0	0.5	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.3	84.1	0.5	0.3	104.9	78.9	0.0	0.1	0.3	48.3	0.0	0.1	155.6	20.5	131.8	0.4	8.6	7.9	200.2	0.0	0.1	7.7	16.6	87.1	0.2	0.2	0.1	0.3	0.7	0.1	4.3	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	410.4	427.0	309.6	555.7	474.7	309.0	296.6	301.7	293.9	279.9	317.0	372.3	44.2	0.0	7.9	43.8	0.1	9.7	3.3	0.0	3.4	21.6	3.1	3.0	5.9	11.5	1.8	0.0	43.8	0.0	0.1	2.4	0.0	9.7	5.8	0.5	20.4	50.0	2.4	0.0	193.1	2.7	0.0	17.3	0.0	0.7	2.5	14.4	78.1	1.1	0.4	38.7	70.0	2.5	0.0	3.2	7.3	11.9	44.4	2.8	21.4	32.8	2.7	38.6	0.0	48.7	17.3	2.5	2.5	29.3	0.4	5.1	0.0	0.1	0.0	15.7	0.0	13.3	8.8	0.6	3.7	1.3	6.3	0.0	0.7	12.9	4.2	1.4
OPALIN	"HTMP10, TMEM10, TMP10"	ENSG00000197430	"Oligodendrocytic myelin paranodal and inner loop protein"	Q96PE5	10	96343221-96359365	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	654	"brain: 166.5;choroid plexus: 47.8"	"Cell type enriched"	"Detected in some"	304	"Oligodendrocytes: 304.5"	"Cancer enriched"	"Detected in single"	36	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Region enhanced"	"Detected in all"		"white matter: 240.1"	"Low region specificity"	"Detected in all"			HPA014372	Supported					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA014372: AB_2158172"					"unprognostic (1.18e-1)"													0.0	0.0	112.6	0.0	135.3	0.0	0.0	58.9	166.5	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.9	86.6	0.0	0.0	0.0	0.0	101.3	106.0	0.0	0.0	0.0	0.1	0.0	83.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	149.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.6	135.3	58.9	166.5	104.9	86.6	101.3	106.0	83.4	72.4	94.9	149.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	304.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRD1		ENSG00000116329	"Opioid receptor delta 1"	P41143	1	28812142-28871267	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Excitatory neurons: 11.8;Inhibitory neurons: 15.7;Skeletal myocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 16.4;SCLC-21H: 6.4;SH-SY5Y: 6.5;WM-115: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070831	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070831: AB_2732167"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-3)"	"unprognostic (6.28e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.95e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-7)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-3)"	0.1	0.5	1.4	0.1	1.6	0.4	0.0	0.0	3.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.1	4.4	0.1	0.1	0.3	0.0	0.1	0.1	4.7	0.1	0.1	0.5	0.2	0.0	1.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	16.4	0.1	0.0	0.1	6.4	6.5	0.0	0.1	1.1	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.4	22.0	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.0	0.2	0.0	0.0	1.4	1.6	0.0	3.2	1.9	0.0	4.4	0.1	4.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	3.7	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	11.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	2.6	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	1.2
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.5"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.1	0.1	7.3	0.0	14.5	0.0	0.0	1.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	5.4	0.0	0.0	0.1	0.0	5.8	1.7	0.0	0.0	0.0	0.0	0.2	5.1	1.6	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	6.9	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.5	1.3	8.3	3.9	5.4	5.8	1.7	5.1	0.3	6.9	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	4.5	0.6	0.1	0.0	0.0	6.7	0.0	8.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
OTOF	"DFNB6, DFNB9, FER1L2"	ENSG00000115155	Otoferlin	Q9HC10	2	26457203-26558756	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"bone marrow: 6.4;brain: 23.1"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 4.0;Skeletal myocytes: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HDLM-2: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012410	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA012410: AB_1854836"	"unprognostic (4.01e-3)"	"unprognostic (7.85e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.20e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.85e-14)"	"unprognostic (1.33e-2)"	"unprognostic (5.19e-1)"	"unprognostic (9.65e-2)"	"unprognostic (8.96e-5)"	0.2	0.5	23.1	0.3	16.3	6.4	0.2	0.2	13.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.3	0.1	4.1	3.3	0.0	0.0	0.2	0.1	5.2	2.8	0.0	0.1	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.1	4.2	0.5	0.2	1.1	3.0	0.9	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.1	16.3	0.2	13.1	4.1	3.3	5.2	2.8	4.0	4.2	3.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.8	0.3	0.0	0.0	0.1	0.5	0.4	0.0	0.0
PABPC1L2A	RBM32A	ENSG00000186288	"Poly(A) binding protein cytoplasmic 1 like 2A"	Q5JQF8	X	73077276-73079512	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;prostate: 2.5"	"Group enriched"	"Detected in some"	10	"Early spermatids: 14.3;Late spermatids: 48.5"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.5"									HPA041573	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA041573: AB_2677556"					"unprognostic (4.30e-2)"							"unprognostic (2.19e-1)"			"unprognostic (3.22e-1)"			0.0	1.0	4.6	0.0	3.9	0.0	0.0	2.3	6.3	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.7	6.1	0.0	0.0	0.0	0.0	2.6	2.7	0.0	0.0	0.1	2.0	0.0	2.5	2.5	0.0	1.1	1.8	0.2	0.0	0.0	0.1	0.0	0.8	0.2	0.0	1.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.9	2.3	6.3	3.7	6.1	2.6	2.7	2.5	0.8	4.3	3.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	48.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	3.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149294-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.4;placenta: 25.9;prostate: 10.6;seminal vesicle: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA		88000		"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	0.5	5.1	20.5	0.2	35.4	0.0	0.1	0.9	23.9	1.5	0.0	0.5	0.1	1.6	0.5	0.3	1.2	0.5	1.2	19.6	15.2	2.1	0.1	0.7	0.0	7.7	24.9	2.3	0.2	0.0	1.4	25.9	11.3	10.6	0.2	3.0	0.5	17.3	0.0	0.0	0.4	0.7	3.7	0.0	0.4	1.4	16.8	0.1	0.5	0.0	0.0	1.8	2.8	19.1	0.0	0.7	8.7	0.0	0.3	0.0	0.0	8.6	4.6	0.7	0.4	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.9	0.0	4.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	11.5	27.4	0.0	0.3	0.0	4.2	0.0	24.1	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.3	55.4	14.5	0.0	0.1	12.9	0.0	0.0	0.0	1.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	35.4	0.9	23.9	19.6	15.2	7.7	24.9	11.3	3.7	16.8	19.1	1.4	0.0	0.6	58.1	0.0	0.1	0.5	0.1	1.2	15.0	1.2	2.7	2.3	0.0	0.7	0.0	0.0	0.8	0.0	0.9	1.9	0.0	5.6	26.5	4.6	4.0	0.0	0.0	64.9	0.0	0.9	15.5	0.0	29.1	0.0	5.0	0.0	0.0	1.8	0.0	57.7	0.2	0.0	0.0	0.0	1.7	0.0	0.5	0.0	6.5	0.0	8.6	0.0	46.8	59.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.1	2.7	0.0	4.3	11.5	17.4	0.9	0.0	0.3	2.9	0.2	3.9	0.1	0.4
PCDH11X	"PCDH-X, PCDH11, PCDHX, PPP1R119"	ENSG00000102290	"Protocadherin 11 X-linked"	Q9BZA7	X	91779261-92623230	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 10.7;ovary: 7.4"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 120.4;Inhibitory neurons: 349.7;Oligodendrocyte precursor cells: 173.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.5;AN3-CA: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077495	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA077495: "	"unprognostic (4.22e-3)"	"unprognostic (1.16e-1)"		"unprognostic (1.39e-4)"	"unprognostic (1.18e-1)"			"unprognostic (8.20e-3)"		"unprognostic (6.32e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.19e-2)"		"unprognostic (4.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.86e-1)"	0.0	0.2	10.7	0.2	7.7	0.0	0.2	0.0	3.7	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.2	0.0	0.0	0.0	0.2	1.6	4.8	7.4	0.0	1.0	0.2	0.8	2.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	7.8	0.0	0.1	0.2	0.2	0.0	0.0	1.2	0.0	0.0	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	7.7	0.0	3.7	2.4	6.2	1.6	4.8	2.0	0.0	7.8	1.2	0.5	9.6	7.4	2.3	0.2	1.5	0.5	0.2	1.2	4.2	1.0	1.8	0.7	0.0	3.2	0.0	0.0	20.8	0.1	0.1	0.0	0.0	0.6	0.2	0.1	2.1	0.0	0.0	120.4	0.0	0.3	1.0	0.0	0.2	1.3	0.1	4.6	0.3	1.0	33.7	349.7	0.0	0.0	0.0	2.0	0.6	9.6	1.0	10.6	12.2	0.0	0.2	0.0	173.9	5.3	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.8	1.4	6.6	0.6	0.8	0.3	1.0	0.1	0.9	15.7	0.6	0.1	0.1	0.4
PCDH11Y	"PCDH22, PCDHY"	ENSG00000099715	"Protocadherin 11 Y-linked"	Q9BZA8	Y	5000226-5742224	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 4.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 29.1;Excitatory neurons: 52.9;Horizontal cells: 47.1;Inhibitory neurons: 88.1;Oligodendrocyte precursor cells: 54.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"								"unprognostic (9.26e-2)"							"unprognostic (1.84e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.55e-2)"			0.0	0.0	3.8	0.1	4.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	3.4	0.1	0.0	0.0	0.0	2.1	2.3	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.2	0.8	0.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.8	4.7	0.0	4.6	2.3	3.4	2.1	2.3	1.7	0.7	0.4	0.9	0.3	6.4	29.1	1.6	0.5	1.8	1.0	0.0	0.6	3.0	0.3	0.0	0.6	0.0	13.6	14.7	0.0	5.2	0.0	0.1	0.0	0.0	0.3	0.5	0.2	3.9	0.0	0.0	52.9	0.0	0.3	2.7	0.0	0.5	18.9	0.1	3.6	0.0	0.3	47.1	88.1	0.2	2.0	0.0	4.8	0.1	0.3	2.7	0.0	21.5	0.0	0.3	0.0	54.8	4.4	0.1	0.0	0.0	0.4	0.9	0.0	0.7	9.5	3.6	0.0	1.2	0.4	0.3	2.0	0.2	1.6	2.2	2.5	0.0	0.0	1.5
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 21.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Excitatory neurons: 24.5;Inhibitory neurons: 51.8;Oligodendrocyte precursor cells: 40.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6;ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol		NA	NA		83000		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	1.8	0.1	6.8	0.2	7.6	0.0	1.7	0.0	10.7	1.6	0.0	1.3	0.2	1.1	0.2	0.8	0.6	0.4	0.3	10.7	12.0	0.2	0.0	0.1	0.2	0.6	1.3	1.0	0.1	0.1	0.7	0.1	4.1	0.2	1.7	1.8	0.6	0.3	0.4	0.9	0.4	0.9	0.0	0.0	0.5	0.6	21.5	0.8	0.2	0.9	0.0	0.8	0.6	0.0	0.0	0.0	18.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	3.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.6	0.0	10.7	10.7	12.0	0.6	1.3	4.1	0.0	21.5	0.0	29.9	0.0	0.5	13.4	0.0	3.1	0.1	0.9	4.6	12.9	0.5	0.8	1.8	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.4	6.2	11.3	1.8	0.0	24.5	0.0	0.1	2.9	0.0	1.4	0.0	2.5	1.1	0.0	0.1	0.0	51.8	0.1	0.0	0.3	3.4	2.2	3.4	0.1	0.0	7.5	0.0	1.9	0.0	40.7	2.2	0.1	0.1	0.4	0.0	0.4	0.0	0.2	1.3	1.9	0.0	5.9	7.8	0.1	1.5	1.0	1.6	0.0	0.2	0.7	0.0	0.1
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1717.4;Late spermatids: 4366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm		NA	NA		830000	"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	25.6	21.8	79.4	7.6	62.2	12.9	18.4	23.9	87.0	14.3	17.5	17.1	14.1	12.3	10.2	19.7	14.0	7.0	15.5	62.5	51.7	50.4	21.5	20.9	7.0	48.8	59.7	19.1	21.3	17.8	37.3	7.8	54.7	17.2	9.4	10.0	22.7	10.6	6.7	13.9	19.7	6.9	34.4	12.5	16.6	23.9	70.5	10.2	19.1	5.4	9.3	10.9	12.6	57.6	43.4	51.9	8.1	15.5	19.4	27.3	9.9	15.2	23.8	14.5	12.1	42.5	65.7	14.4	15.7	21.9	20.0	31.9	15.8	43.4	9.5	16.2	13.4	14.7	60.9	31.7	38.1	14.0	20.6	38.9	40.7	15.3	16.9	23.6	6.9	6.3	26.2	31.9	13.8	29.1	2.0	24.9	22.3	41.9	19.7	16.7	4.8	40.4	62.9	51.9	7.8	9.3	63.3	57.7	23.2	3.3	19.0	19.4	12.5	10.5	20.3	14.2	14.4	19.3	9.8	8.4	43.2	39.9	10.3	0.6	2.4	0.1	0.8	2.2	1.5	0.6	0.8	0.9	1.3	1.7	0.8	0.6	0.6	0.9	4.3	0.6	0.7	1.4	79.4	62.2	23.9	87.0	62.5	51.7	48.8	59.7	54.7	34.4	70.5	57.6	15.8	80.1	66.6	44.1	37.7	28.4	142.4	72.2	27.3	46.3	74.8	53.5	48.0	34.3	73.2	101.2	22.9	42.9	23.6	97.6	180.0	146.4	1717.4	66.9	28.3	36.1	30.1	15.8	49.3	196.6	86.3	39.4	63.2	73.2	31.8	23.8	17.2	54.2	207.6	52.2	48.7	55.4	12.2	58.2	101.0	4366.5	50.1	118.7	42.7	61.8	38.4	14.9	20.6	16.6	13.5	223.4	36.4	54.2	146.4	184.7	108.4	95.7	71.1	43.3	6.6	17.0	35.0	678.1	30.4	60.7	28.4	124.1	27.3	22.1	57.5	239.8
PDXP	"CIN, dJ37E16.5, FLJ32703"	ENSG00000241360	"Pyridoxal phosphatase"	Q96GD0	22	37658723-37666932	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 209.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.4;Inhibitory neurons: 25.0;Microglial cells: 7.5;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 5.8;Plasma cells: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"plasmacytoid DC: 11.6"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000531	Approved					NA	NA		94000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000531: AB_2666018"	"unprognostic (6.29e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	5.8	23.7	144.7	0.8	158.7	5.8	5.3	106.1	209.2	6.7	83.0	20.6	26.5	8.5	5.6	3.8	8.0	3.9	26.3	165.0	129.2	15.9	74.5	5.7	7.5	117.5	130.0	8.5	13.5	9.5	39.6	1.1	119.8	7.3	11.6	29.6	12.0	6.0	15.8	3.4	32.2	7.2	109.2	14.3	11.9	27.0	137.8	13.5	5.9	14.1	9.5	7.8	3.8	148.0	8.6	19.6	39.4	34.4	12.0	3.7	5.3	18.9	9.7	34.0	26.7	9.9	1.2	54.0	18.8	9.8	28.5	4.4	52.8	0.6	28.5	16.9	105.2	11.0	26.6	41.2	8.3	39.2	47.0	1.8	4.7	17.6	23.7	14.0	15.6	61.1	33.3	31.1	29.9	12.3	74.3	61.3	20.6	15.2	46.4	58.5	28.5	39.7	14.6	1.1	89.5	57.8	17.8	15.4	36.1	17.2	5.0	31.8	9.8	28.7	36.6	30.2	37.6	33.0	44.1	57.4	27.2	14.3	38.5	0.0	0.3	0.5	0.9	0.5	0.1	1.3	0.4	0.5	0.6	1.2	0.3	0.1	0.3	0.9	0.4	11.6	0.5	0.2	144.7	158.7	106.1	209.2	165.0	129.2	117.5	130.0	119.8	109.2	137.8	148.0	0.1	0.0	0.6	3.3	2.8	0.0	0.0	0.0	2.8	1.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.0	2.1	19.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	25.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.5	0.1	0.2	0.0	8.0	5.8	0.1	0.1	0.0	9.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.9	0.2	0.4	0.1
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 47.0"	"Group enriched"	"Detected in some"	83	"Early spermatids: 47.8;Late spermatids: 119.0"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 152.2;hypothalamus: 60.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 132.2"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.0	0.0	43.2	0.1	31.1	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	17.6	0.0	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.0	0.0	8.3	9.2	0.2	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	31.1	0.0	43.1	47.0	17.6	1.8	4.1	0.2	21.0	9.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	119.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	16.8	0.2	14.1	9.8	2.2	0.0	21.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	11.1	0.1	0.1	14.2	11.5	0.0	0.0	2.3	0.1	4.1	8.2	0.3	0.0	0.2	0.4	0.0	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	2.3	0.2	0.1	3.2	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	14.1	0.0	21.1	14.2	11.5	4.1	8.2	1.5	2.3	13.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;retina: 1.6;testis: 2.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 11.9;SH-SY5Y: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.0	0.4	5.2	0.0	5.8	0.0	0.0	0.1	6.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.5	0.0	0.0	0.0	0.0	1.3	3.9	0.0	0.4	0.0	0.2	0.0	2.8	0.0	0.1	1.6	0.0	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.9	0.0	0.0	0.0	0.5	0.1	0.4	21.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	0.1	6.6	6.1	4.5	1.3	3.9	2.8	2.0	7.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PNMA2	"MA2, RGAG2"	ENSG00000240694	"PNMA family member 2"	Q9UL42	8	26504701-26514092	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;retina: 24.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.2;Horizontal cells: 30.3;Inhibitory neurons: 92.0;Muller glia cells: 26.9"	"Cancer enhanced"	"Detected in many"		"glioma: 28.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 63.0;hTERT-RPE1: 78.4;JURKAT: 43.3;SH-SY5Y: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001936	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA001936: AB_1079647"	"unprognostic (1.25e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.43e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.58e-5)"	"unprognostic (9.00e-3)"	2.6	10.8	52.2	1.2	55.1	0.4	1.9	1.3	73.4	3.5	0.0	1.4	0.8	0.8	1.0	0.5	2.5	3.9	4.9	55.1	88.4	3.2	0.9	6.8	0.4	29.0	25.7	0.8	3.9	2.7	15.4	0.5	28.7	0.8	0.9	24.5	0.3	0.9	0.5	0.6	1.1	1.9	16.5	0.5	2.8	1.7	67.0	0.2	2.7	0.2	0.3	2.2	0.8	29.2	0.0	11.7	63.0	0.6	12.2	2.6	0.1	3.2	17.2	7.8	2.6	0.5	8.4	0.0	2.3	1.2	19.3	0.2	39.5	0.0	6.0	0.0	7.0	0.0	8.7	0.1	0.9	0.0	0.4	4.2	0.0	33.4	0.2	78.4	37.7	43.3	0.0	0.1	4.9	0.3	19.3	0.1	34.7	0.7	0.1	0.1	12.8	0.0	18.7	4.3	30.7	44.9	0.0	0.1	2.1	4.5	0.2	1.2	18.6	0.8	12.7	16.1	2.6	5.9	4.6	0.1	36.1	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	52.2	55.1	1.3	73.4	55.1	88.4	29.0	25.7	28.7	16.5	67.0	29.2	0.4	3.2	13.0	20.5	0.6	0.0	0.1	0.2	0.0	6.5	0.9	1.1	0.5	0.0	3.7	0.0	2.1	0.0	0.0	0.1	0.0	0.3	5.4	1.0	4.5	1.0	10.8	0.0	71.2	0.0	0.1	3.6	0.0	1.5	1.3	0.0	0.4	0.1	0.1	30.3	92.0	0.5	0.0	1.6	0.8	1.5	11.1	0.1	1.8	12.2	0.0	26.9	0.0	19.1	11.5	2.7	0.0	12.0	0.0	0.0	0.0	5.4	2.9	6.2	0.0	0.2	4.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.2
PNMA5	KIAA1934	ENSG00000198883	"PNMA family member 5"	Q96PV4	X	152988824-152994116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 22.8;testis: 8.7"	"Group enriched"	"Detected in some"	14	"Spermatocytes: 20.3;Spermatogonia: 71.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	578	"HMC-1: 356.2;U-266/70: 560.6;U-266/84: 355.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044690, HPA073946"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA044690: AB_2679049, HPA073946: "	"unprognostic (5.25e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.55e-2)"	"prognostic favorable (3.16e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.76e-9)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.41e-2)"	0.0	0.0	8.8	0.1	11.2	0.0	0.0	0.3	9.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	22.8	0.0	0.0	0.0	0.1	3.0	5.2	0.0	0.0	0.0	0.9	0.1	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	2.0	0.5	0.1	8.7	20.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	356.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	560.6	355.8	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	11.2	0.3	9.4	8.9	22.8	3.0	5.2	3.5	2.0	20.1	2.4	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	1.7	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	2.6	0.4	1.3	0.3	1.2	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	71.9	0.0	0.0	0.3	0.9	0.1	0.0	0.0
PNMA6A	"MGC15827, PNMA6C"	ENSG00000235961	"PNMA family member 6A"	P0CW24	X	153072454-153075019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 27.0;Distal tubular cells: 11.7;Horizontal cells: 23.5;Muller glia cells: 21.1;Proximal tubular cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.5;HMC-1: 6.7;SK-MEL-30: 6.9;U-2 OS: 14.7;U-698: 8.5"									"HPA045007, HPA052115"	Uncertain		Uncertain	Nucleoli,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria	Nucleoli	"HPA045007: AB_2679181, HPA052115: AB_2681734"	"unprognostic (2.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.76e-4)"	"unprognostic (5.75e-3)"	"prognostic favorable (1.93e-5)"	"unprognostic (4.61e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.22e-2)"	1.9	1.8	17.3	0.2	16.8	0.4	1.1	8.8	26.5	3.1	3.4	1.7	0.6	2.4	5.9	0.4	3.0	1.0	2.1	16.5	16.7	8.2	10.2	0.6	0.4	16.4	13.1	5.1	0.9	2.2	11.9	0.2	16.1	0.5	0.2	3.5	1.0	0.6	0.5	1.1	0.9	0.7	8.9	0.9	1.2	1.7	17.3	0.2	3.1	0.7	0.3	0.4	0.7	16.7	0.0	5.3	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.5	0.0	1.8	0.4	0.9	0.0	2.8	0.0	0.0	0.0	0.6	0.0	0.3	0.2	7.5	3.3	6.7	1.1	0.0	0.1	0.0	0.2	0.2	5.6	1.4	0.0	0.1	0.4	1.1	0.0	3.3	5.9	0.0	0.0	0.0	0.0	0.3	0.0	3.2	1.9	0.4	0.0	6.9	0.3	0.0	4.2	0.0	0.0	14.7	0.0	0.0	5.7	4.6	8.5	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	16.8	8.8	26.5	16.5	16.7	16.4	13.1	16.1	8.9	17.3	16.7	0.2	0.0	0.0	4.6	0.5	0.0	0.3	0.0	0.0	27.0	0.3	0.5	2.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	11.7	1.5	0.0	0.4	3.4	0.4	0.0	0.0	8.1	0.2	0.0	2.4	0.0	0.8	0.0	6.5	0.7	2.9	4.0	23.5	9.6	0.0	0.0	0.8	0.4	0.7	2.8	0.8	0.0	1.9	0.0	21.1	0.0	4.5	1.4	0.3	0.0	3.0	0.7	0.1	0.0	27.0	0.0	8.7	0.0	0.8	1.9	1.0	2.8	0.0	0.0	0.0	0.7	0.9	0.0	0.1
PNMA8B	"KIAA1183, PNMAL2"	ENSG00000204851	"PNMA family member 8B"	Q9ULN7	19	46486906-46495879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 14.7;brain: 41.6"	"Group enriched"	"Detected in some"	4	"Adipocytes: 8.3;Granulosa cells: 5.3;Theca cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;AN3-CA: 1.8;SH-SY5Y: 1.4"	"Low region specificity"	"Detected in all"							HPA054810	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA054810: AB_2682609"	"unprognostic (1.31e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (4.26e-4)"	"unprognostic (7.30e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.32e-2)"	2.7	14.7	32.8	0.3	31.1	0.0	2.4	0.0	41.6	1.9	0.0	1.5	0.3	1.7	0.5	0.5	1.6	1.0	1.9	20.1	25.3	0.7	0.4	0.7	0.4	22.5	15.0	3.9	0.9	0.2	7.3	0.3	27.3	1.6	0.1	2.1	1.5	1.0	0.5	2.3	0.9	0.6	2.1	1.9	0.9	0.8	18.5	3.5	0.8	0.4	0.1	1.1	1.6	19.0	0.0	0.0	1.4	1.8	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	31.1	0.0	41.6	20.1	25.3	22.5	15.0	27.3	2.1	18.5	19.0	8.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.3	0.0	0.5	0.9	0.8	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.1	0.0	5.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0
PNMA8C		ENSG00000277531	"PNMA family member 8C"	A0A1B0GUJ8	19	46424697-46428951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.9;pituitary gland: 8.6"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 1.3;Endometrial ciliated cells: 1.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 1.1;HMC-1: 2.4;SH-SY5Y: 3.7"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (3.25e-2)"			"unprognostic (2.38e-1)"	"unprognostic (3.89e-2)"			"unprognostic (4.91e-3)"		"unprognostic (2.58e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.92e-2)"		0.0	1.1	12.3	0.1	13.0	0.1	0.2	1.6	11.4	0.0	1.5	0.2	0.0	0.1	2.0	0.0	1.2	0.2	0.1	11.0	15.1	0.0	0.0	0.1	0.0	5.9	10.2	0.1	0.0	0.1	8.6	0.0	7.1	0.3	0.0	2.0	0.0	0.4	0.7	0.1	0.1	0.1	5.9	0.0	0.0	0.6	15.9	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	12.3	13.0	1.6	11.4	11.0	15.1	5.9	10.2	7.1	5.9	15.9	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"		X	83508290-83512127	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	7	"brain: 11.9"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 11.0"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	99	"AF22: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA062295: AB_2732681"					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.0	0.0	2.3	0.0	11.9	0.0	0.0	2.6	4.5	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	2.5	1.6	0.0	0.0	0.0	2.9	5.5	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	11.9	2.6	4.5	1.5	2.5	2.9	5.5	2.5	2.6	3.4	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU6F2	RPF-1	ENSG00000106536	"POU class 6 homeobox 2"	P78424	7	38977909-39493095	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 129.3;Excitatory neurons: 471.3;Oligodendrocyte precursor cells: 286.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.2;Karpas-707: 1.3;NTERA-2: 2.6;SK-BR-3: 1.1;SuSa: 1.5;T-47d: 2.9;U-266/70: 2.2;U-266/84: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.00e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.5	0.0	0.4	0.0	0.0	0.2	0.6	0.1	0.8	0.0	0.1	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	1.5	2.9	0.0	0.0	0.0	0.2	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	1.4	0.9	0.5	0.2	0.6	0.3	0.1	0.3	2.0	0.0	0.0	1.7	129.3	0.0	0.0	0.3	0.0	0.0	4.9	0.0	0.0	2.1	8.6	0.0	0.0	8.4	0.3	0.0	0.2	0.0	1.5	4.1	0.0	0.0	0.4	0.0	0.0	471.3	0.0	0.3	0.7	0.0	0.0	1.3	0.0	0.0	3.5	0.1	0.0	50.3	0.1	0.0	0.0	0.2	4.1	0.0	0.0	0.0	26.2	0.0	0.1	0.0	286.5	5.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.3	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0
PRDM12	PFM9	ENSG00000130711	"PR/SET domain 12"	Q9H4Q4	9	130664594-130682986	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 2.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Excitatory neurons: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"RH-30: 19.1"	"Region enriched"	"Detected in some"	7	"basal ganglia: 10.9"	"Group enriched"	"Detected in some"	26	"basal ganglia: 3.8;hypothalamus: 1.3"	HPA043143	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA043143: AB_10806379"	"unprognostic (3.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.81e-4)"	"unprognostic (7.90e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.01e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.30e-4)"	"unprognostic (1.40e-1)"	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.7	0.0	0.1	0.1	0.0	19.1	0.4	0.0	0.0	0.8	0.2	0.3	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.2	0.4	0.2	1.9	0.2	0.2	0.2	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		660000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	141.7	128.0	198.0	137.2	210.0	150.2	171.2	217.0	454.6	168.2	185.5	169.9	151.7	172.9	159.0	161.3	217.6	114.9	122.8	195.5	215.6	180.5	218.6	133.9	157.2	214.9	213.0	250.0	121.9	133.7	111.7	164.9	218.5	141.6	172.8	118.0	124.0	147.6	208.6	123.5	155.4	138.8	213.0	125.0	117.1	135.0	204.3	167.2	162.3	158.5	185.0	158.7	145.8	278.0	616.6	528.8	416.5	249.8	300.2	270.3	634.3	392.8	298.5	494.5	366.9	452.5	629.6	676.0	588.5	338.3	331.7	385.4	790.0	514.2	621.8	509.8	529.8	529.7	309.5	524.4	219.4	637.9	367.2	197.0	367.3	375.1	450.3	468.5	518.1	425.7	866.0	628.2	490.4	385.3	636.5	602.1	714.7	538.3	609.3	549.2	392.3	914.4	436.8	473.2	538.4	313.8	401.7	570.1	355.8	546.5	658.3	526.9	314.0	294.7	341.8	358.3	552.8	262.8	777.5	540.4	321.1	516.7	543.8	141.1	166.1	107.1	130.9	261.6	172.3	172.3	170.6	156.7	160.2	127.0	167.3	147.7	64.7	132.2	346.2	135.3	191.6	316.1	198.0	210.0	217.0	454.6	195.5	215.6	214.9	213.0	218.5	213.0	204.3	278.0	265.8	179.5	137.1	39.5	251.0	386.6	826.7	248.5	272.6	128.3	208.5	197.1	166.0	178.7	161.4	189.4	77.2	457.2	245.6	246.5	373.7	310.4	42.5	493.7	221.5	242.1	261.3	452.0	43.4	214.8	676.3	268.7	143.2	291.3	234.2	224.5	188.8	187.0	349.9	112.7	41.3	295.9	201.4	209.5	363.6	107.9	238.9	261.7	282.8	47.8	283.3	244.1	178.2	38.7	71.4	220.8	207.1	213.3	299.8	657.6	218.9	343.8	345.5	128.0	144.7	185.1	337.7	558.4	348.4	350.4	377.6	566.0	359.3	219.0	358.9	556.3
RAB3C		ENSG00000152932	"RAB3C, member RAS oncogene family"	Q96E17	5	58582221-58859394	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 62.5"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 140.6;Inhibitory neurons: 509.9;Oligodendrocyte precursor cells: 131.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0;pancreatic cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HEL: 2.5;NB-4: 1.6;SCLC-21H: 10.2;SH-SY5Y: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, HPA048156"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA003160: AB_1079731, HPA048156: AB_2680291"	"unprognostic (1.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.52e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.70e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.61e-3)"	1.1	9.0	19.1	1.2	20.6	0.0	0.7	0.9	32.7	0.1	0.0	0.6	1.6	0.7	0.0	0.2	0.2	0.7	0.1	10.2	62.5	0.0	0.1	0.1	0.2	7.4	12.3	0.3	1.7	0.1	6.8	0.1	31.6	0.0	0.8	6.0	0.1	0.0	0.1	0.0	1.8	0.7	3.9	0.0	0.9	0.1	19.2	0.1	0.1	0.0	0.2	0.6	0.2	3.8	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	20.6	0.9	32.7	10.2	62.5	7.4	12.3	31.6	3.9	19.2	3.8	8.6	0.0	0.6	10.1	0.4	0.1	0.0	0.0	0.0	28.3	0.3	0.3	0.7	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.9	0.1	20.0	0.0	0.1	12.1	57.6	1.3	140.6	9.6	0.8	0.2	0.0	0.0	2.5	0.0	5.7	1.2	0.1	3.3	509.9	5.5	0.0	0.9	1.1	11.8	0.9	0.1	1.8	6.5	0.0	1.6	0.0	131.2	8.4	3.9	1.2	0.7	0.0	0.0	0.3	0.1	0.0	6.7	13.1	0.5	0.2	2.4	4.1	0.0	0.1	0.0	1.3	0.1	0.3	0.0
RAB6B		ENSG00000154917	"RAB6B, member RAS oncogene family"	Q9NRW1	3	133824235-133895882	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 138.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1"	"Cancer enhanced"	"Detected in all"		"glioma: 18.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	47	"T-cells: 7.3"	"Cell line enriched"	"Detected in many"	4	"HEL: 226.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017713, HPA059131"	Uncertain		Approved	"Golgi apparatus"		NA	NA		2200000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"		"CAB017713: , HPA059131: AB_2683916"	"unprognostic (2.87e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (3.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.80e-2)"	"prognostic favorable (3.97e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.05e-3)"	6.8	11.1	45.7	2.8	72.6	12.0	4.4	0.4	138.0	2.9	0.0	6.8	2.4	3.0	2.1	4.2	16.2	3.2	20.8	71.8	31.3	7.1	0.9	3.1	3.3	74.6	43.1	2.1	4.4	24.9	12.0	1.7	55.7	2.7	2.1	29.4	10.1	5.9	2.7	1.5	2.9	8.4	3.7	5.9	5.5	4.0	21.5	1.4	5.2	2.8	2.0	1.6	2.2	63.1	0.1	3.0	5.8	14.9	10.1	10.3	0.5	3.0	6.3	7.2	0.8	1.6	1.5	0.2	6.3	2.4	21.2	0.4	13.8	0.4	3.6	0.2	8.6	226.6	3.5	0.5	1.2	1.4	8.5	3.1	2.9	1.1	0.2	0.1	2.9	8.3	53.4	0.6	1.1	5.5	0.7	21.3	18.0	10.8	2.2	0.2	0.4	2.3	4.0	1.3	47.2	10.1	4.4	4.2	26.7	22.5	16.8	9.7	3.7	6.5	15.5	3.2	5.4	5.6	1.5	0.5	0.7	0.5	5.6	0.0	0.0	0.0	0.6	0.0	7.3	0.1	0.1	1.7	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.8	45.7	72.6	0.4	138.0	71.8	31.3	74.6	43.1	55.7	3.7	21.5	63.1	2.0	0.0	0.0	25.8	0.2	1.3	2.2	0.5	0.6	10.5	2.0	2.3	30.8	1.5	2.8	1.8	2.1	0.3	0.6	2.2	3.9	3.6	0.1	2.3	0.9	3.5	0.0	79.2	60.5	1.3	0.7	3.7	2.0	1.3	0.0	12.4	7.9	0.1	0.2	67.3	54.1	0.2	0.0	0.6	1.1	0.2	1.8	0.4	1.8	16.9	0.1	10.2	0.0	17.1	9.6	2.5	1.1	6.8	0.1	2.0	0.0	1.5	9.3	21.3	0.0	4.1	13.8	0.9	12.7	0.8	1.4	0.3	1.1	2.2	0.0	0.6
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36246913-36302114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;kidney: 24.6"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 355.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	3.8	1.7	25.2	0.3	27.0	0.0	7.6	4.6	29.9	1.2	5.4	0.8	0.2	0.7	1.8	0.5	1.2	1.8	1.5	25.1	12.2	24.6	9.9	2.0	0.2	9.9	18.9	2.1	0.4	0.2	2.9	5.0	7.4	13.5	0.4	5.3	0.6	2.9	0.4	0.4	0.4	0.6	12.6	0.2	1.8	4.7	18.6	0.1	2.2	2.9	0.6	6.9	0.8	15.2	0.0	0.0	0.1	0.2	12.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	27.0	4.6	29.9	25.1	12.2	9.9	18.9	7.4	12.6	18.6	15.2	0.3	0.0	0.0	355.9	0.0	0.0	0.1	0.0	0.6	0.4	4.1	2.3	0.3	0.0	0.0	9.2	0.0	0.0	1.3	0.0	46.9	0.0	0.1	0.1	0.7	0.4	0.0	0.0	5.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	1.3	1.9	0.0	4.5	0.0	0.0	0.0	0.3	0.8	2.1	0.2	1.8	23.4	0.0	16.1	0.0	5.5	2.8	0.0	0.0	2.2	0.0	1.3	0.0	0.2	0.0	0.6	13.1	0.6	8.3	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.1
RAP2A	"K-REV, RAP2"	ENSG00000125249	"RAP2A, member of RAS oncogene family"	P10114	13	97434169-97469128	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018552	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB018552: AB_2177305"	"unprognostic (2.40e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.53e-1)"	14.9	8.2	26.3	10.7	32.4	4.1	11.7	21.9	39.5	11.7	13.2	10.2	7.9	8.7	4.5	15.9	6.7	12.7	11.3	32.5	23.7	14.4	8.6	13.8	18.0	23.8	25.3	6.7	4.8	7.8	7.9	25.4	24.6	6.4	11.2	7.5	5.4	7.2	10.5	7.2	8.1	12.3	27.0	15.1	6.5	4.5	31.2	13.3	6.6	15.3	12.9	11.5	7.7	30.6	18.5	5.2	19.3	13.9	31.2	18.5	7.6	13.4	8.8	12.9	14.4	9.8	10.6	14.1	8.4	22.1	12.6	14.1	16.6	13.4	16.9	26.3	8.6	15.4	19.8	14.5	22.5	13.6	9.5	28.5	17.1	12.8	17.6	19.5	28.2	15.8	5.2	26.2	17.3	6.7	9.4	21.1	11.1	16.0	7.8	12.1	20.7	9.3	12.7	6.0	21.9	37.4	9.5	22.5	19.8	26.1	18.1	6.8	21.2	12.6	12.5	12.5	13.1	18.7	15.8	7.7	35.0	16.1	20.8	0.0	0.3	0.4	1.9	1.4	0.8	0.5	0.7	1.4	1.0	0.2	0.4	1.5	0.1	0.4	2.0	1.6	1.3	0.4	26.3	32.4	21.9	39.5	32.5	23.7	23.8	25.3	24.6	27.0	31.2	30.6	34.0	12.8	6.4	17.3	6.7	22.7	4.5	8.2	8.6	10.7	19.1	15.6	15.8	14.3	6.3	1.8	8.4	2.0	31.1	17.0	9.8	5.3	2.5	7.1	19.6	23.7	16.8	9.9	83.8	6.2	11.5	20.0	7.7	9.8	5.1	12.0	29.6	18.1	32.9	28.6	33.3	13.4	10.2	49.1	66.4	1.9	7.2	33.7	16.0	49.6	22.0	17.6	4.1	54.3	44.1	11.1	16.9	6.0	12.3	8.4	6.5	21.9	4.6	5.9	26.3	11.6	36.0	6.5	8.0	22.3	21.9	3.7	12.7	11.1	12.9	4.5
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 142.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 441.1;Inhibitory neurons: 416.6;Microglial cells: 142.4;Oligodendrocyte precursor cells: 303.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.5;SCLC-21H: 8.3;U-266/70: 11.0;U-266/84: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	5.3	45.6	105.0	1.8	113.1	0.2	6.8	69.8	141.6	6.1	49.1	2.1	2.4	5.6	3.1	2.6	3.4	4.7	7.5	142.3	77.7	5.3	34.6	11.4	2.0	61.2	75.0	13.1	4.5	4.0	6.2	2.6	60.8	4.1	1.6	18.8	2.4	3.3	1.5	14.9	2.3	5.4	55.7	0.6	7.7	4.7	128.3	2.2	5.5	1.7	2.0	5.3	3.2	121.9	0.1	0.2	3.2	0.5	0.1	0.3	0.1	1.1	0.7	0.1	0.3	0.0	3.7	0.0	0.2	0.0	0.2	0.7	2.8	0.7	0.3	0.2	5.9	0.6	2.8	0.0	0.0	3.2	0.9	0.1	0.9	0.0	0.0	3.2	3.5	1.6	0.0	21.5	0.1	0.1	0.2	0.2	0.4	1.8	0.4	0.1	0.7	0.0	0.0	6.6	8.3	3.0	0.1	0.1	1.1	1.6	0.1	0.1	1.0	0.1	0.3	0.0	0.3	11.0	23.0	0.0	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.0	113.1	69.8	141.6	142.3	77.7	61.2	75.0	60.8	55.7	128.3	121.9	14.7	3.2	2.8	23.2	1.9	6.1	1.1	0.1	2.8	3.5	5.5	3.9	6.9	0.0	0.0	0.0	45.9	0.1	0.1	0.0	0.0	1.7	2.5	1.2	0.2	32.4	7.8	0.0	441.1	2.7	0.1	4.8	3.1	0.9	0.0	3.3	23.9	11.8	0.1	1.7	416.6	0.5	0.0	1.2	2.1	1.4	4.4	0.2	3.6	142.4	0.0	1.3	0.0	303.1	28.4	1.5	0.1	1.5	1.6	0.5	0.0	0.0	0.0	9.2	0.0	0.4	1.2	0.7	4.1	1.6	3.8	0.1	0.6	4.2	0.1	0.7
RBMX2	"CGI-79, Snu17"	ENSG00000134597	"RNA binding motif protein X-linked 2"	Q9Y388	X	130401987-130413656	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026609	Approved		Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nuclear membrane"	Nucleoli	"HPA026609: AB_1846601"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.04e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.44e-9)"	"unprognostic (1.06e-1)"	"unprognostic (4.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.63e-3)"	15.6	12.2	26.3	10.1	26.1	11.8	14.6	26.1	48.8	21.7	23.6	17.3	10.4	16.8	16.4	13.8	16.3	9.9	13.9	26.3	27.4	14.4	13.0	11.6	14.1	25.8	26.3	18.0	16.5	10.5	11.9	10.5	26.1	15.0	11.6	11.2	11.9	12.3	12.4	17.4	12.8	13.2	25.3	15.1	14.5	7.0	26.2	17.2	12.6	10.0	16.6	16.6	15.6	27.9	22.7	23.3	23.4	24.3	23.1	41.3	23.2	21.0	21.1	23.2	25.4	17.5	27.6	21.8	48.9	16.1	31.1	24.4	37.2	19.2	33.4	20.2	32.5	19.8	22.6	18.6	20.2	30.6	22.8	30.2	27.1	25.9	36.1	33.8	26.1	27.2	17.2	18.8	26.4	39.2	36.4	37.9	17.4	40.0	37.2	27.4	22.7	29.5	23.7	18.0	26.8	32.0	13.2	28.0	39.1	18.8	18.2	22.2	17.5	19.0	15.5	44.8	43.6	24.6	27.9	30.5	22.9	49.5	23.9	9.3	6.8	8.6	7.7	7.7	8.2	10.9	10.0	10.7	5.9	9.0	10.6	9.7	6.0	7.3	7.2	7.7	16.5	4.1	26.3	26.1	26.1	48.8	26.3	27.4	25.8	26.3	26.1	25.3	26.2	27.9	30.5	19.2	19.0	5.5	32.9	32.1	29.0	42.8	22.8	22.0	27.5	33.0	22.6	22.8	40.1	11.0	10.4	33.1	28.4	14.1	15.6	34.2	3.8	21.0	43.5	31.9	40.7	19.4	7.4	35.6	40.8	27.3	13.7	18.3	35.5	27.8	45.0	24.5	34.5	16.8	8.2	23.6	36.7	47.6	24.4	5.8	32.3	27.6	28.4	2.8	41.5	23.3	41.2	7.1	9.4	29.8	18.1	44.0	17.9	26.4	17.9	39.5	27.9	12.5	32.9	30.8	29.8	30.2	53.3	22.4	29.7	25.9	32.0	31.9	29.2	22.9
RESP18		ENSG00000182698	"Regulated endocrine specific protein 18"	Q5W5W9	2	219327407-219333177	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"brain: 14.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 9.4;Late spermatids: 32.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 25: Spermatids - Spermatogenesis"								"unprognostic (2.57e-2)"										"unprognostic (2.12e-1)"			0.0	0.0	2.9	0.0	14.8	0.0	0.0	1.5	7.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.4	0.0	0.0	0.0	0.0	3.8	5.2	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	14.8	1.5	7.4	5.0	5.4	3.8	5.2	4.1	1.9	5.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIMS3	"NIM3, RIM3"	ENSG00000117016	"Regulating synaptic membrane exocytosis 3"	Q9UJD0	1	40620680-40665682	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 105.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 12.6;Excitatory neurons: 37.7;Inhibitory neurons: 21.1;Late spermatids: 34.4;Muller glia cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 77.4;JURKAT: 26.7;SH-SY5Y: 35.2;U-87 MG: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055285			Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA055285: AB_2682771"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-4)"	"unprognostic (3.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.19e-2)"	1.0	6.2	33.4	1.9	63.8	3.6	2.5	0.0	80.2	1.6	0.0	4.4	0.6	3.5	1.6	2.3	2.7	0.9	2.1	27.0	29.3	1.4	0.4	3.5	1.7	0.7	38.1	1.8	0.7	2.9	1.0	3.2	0.4	2.5	3.1	6.5	1.6	3.3	0.3	2.2	2.2	4.1	2.8	1.2	3.4	3.7	105.9	4.3	2.2	0.5	2.3	2.5	1.5	30.2	4.1	1.6	5.8	6.2	0.3	0.0	0.9	0.1	0.1	1.0	1.2	0.7	1.2	77.4	0.1	0.1	2.8	0.7	3.8	0.7	0.6	13.5	1.9	4.4	0.5	2.1	0.2	0.7	3.5	0.1	3.1	0.2	0.2	0.2	0.3	26.7	3.8	2.9	0.0	7.0	11.7	0.4	3.8	0.7	0.4	5.3	5.3	14.3	1.1	1.0	19.9	35.2	0.8	3.7	2.6	7.7	0.9	21.4	0.1	0.6	5.9	0.1	1.1	0.7	5.9	16.8	32.2	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	33.4	63.8	0.0	80.2	27.0	29.3	0.7	38.1	0.4	2.8	105.9	30.2	0.0	6.4	0.0	2.6	0.4	0.5	0.2	0.1	0.6	6.1	1.5	2.5	1.8	0.0	0.1	1.8	0.0	0.1	7.3	6.0	0.0	0.9	12.6	0.0	0.0	0.5	0.0	1.3	37.7	1.5	0.1	0.5	0.0	0.1	1.3	10.7	0.0	0.0	2.7	5.0	21.1	4.2	0.0	2.6	1.4	34.4	0.0	1.5	0.0	3.7	0.9	13.4	0.0	4.0	4.5	2.3	1.4	0.7	0.2	0.4	0.0	0.7	0.0	0.7	0.0	1.5	2.5	2.7	2.0	0.1	0.1	0.3	0.9	0.7	1.6	0.2
RNF112	"BFP, ZNF179"	ENSG00000128482	"Ring finger protein 112"	Q9ULX5	17	19411125-19417276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.1;Bipolar cells: 6.6;Excitatory neurons: 19.6;Inhibitory neurons: 11.6;Muller glia cells: 7.6;Oligodendrocyte precursor cells: 13.6;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in some"	8	"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;fHDF/TERT166: 6.2;SCLC-21H: 6.0;SH-SY5Y: 10.6;U-87 MG: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015970	Enhanced		Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA015970: AB_1859103"	"unprognostic (1.16e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.43e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-9)"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.24e-1)"	2.2	5.4	20.2	1.5	21.9	0.1	1.9	33.8	25.0	3.2	7.2	9.4	1.8	3.0	4.5	1.7	3.2	2.8	3.6	24.7	16.8	3.9	1.0	2.8	0.7	12.7	14.2	2.4	1.3	0.0	5.5	0.5	14.0	12.3	2.8	1.5	1.2	2.0	1.3	1.9	6.9	2.2	12.9	3.0	2.5	2.3	16.6	0.2	2.2	1.3	0.2	8.4	3.2	23.2	0.0	0.0	0.1	0.4	1.4	5.2	0.2	0.3	1.2	0.1	0.0	0.2	0.0	0.0	0.1	6.2	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	4.2	0.0	0.1	2.1	0.2	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.4	0.1	0.2	0.2	0.0	0.0	6.0	10.6	0.1	0.0	0.0	1.4	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.1	0.0	0.0	34.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	21.9	33.8	25.0	24.7	16.8	12.7	14.2	14.0	12.9	16.6	23.2	1.1	0.0	0.0	8.1	0.0	1.0	0.0	0.2	0.0	6.6	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.2	0.3	0.5	0.0	0.0	19.6	0.0	0.0	3.3	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	11.6	0.2	0.0	0.6	0.4	0.2	0.0	0.3	0.0	4.7	0.1	7.6	1.0	13.6	3.3	0.0	1.4	3.8	0.0	0.2	0.5	0.0	0.1	0.7	6.6	1.4	1.5	1.7	0.7	0.3	1.0	0.3	0.2	0.0	0.1	0.1
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710160-153760024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;choroid plexus: 10.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 72.8;Excitatory neurons: 91.4;Inhibitory neurons: 95.7;Oligodendrocyte precursor cells: 38.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HSkMC: 5.8;REH: 6.7;SH-SY5Y: 7.6;THP-1: 17.5;U-87 MG: 4.5"									HPA035837	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	1.5	2.5	18.8	2.9	19.2	6.1	0.8	15.0	27.6	3.0	10.8	0.6	0.1	0.2	0.9	0.6	0.5	1.0	4.0	18.3	21.8	0.2	0.4	1.4	1.2	17.7	15.3	0.1	0.3	0.0	4.0	0.1	17.6	2.4	0.1	3.5	1.4	3.4	0.1	0.7	0.5	0.1	14.1	2.5	0.3	1.6	18.0	0.1	0.2	0.5	0.6	0.5	1.5	17.5	0.2	0.0	8.8	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	6.7	0.0	0.3	0.0	0.1	0.0	7.6	0.0	0.0	0.2	0.1	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	2.4	0.0	2.1	0.0	0.6	0.6	18.8	19.2	15.0	27.6	18.3	21.8	17.7	15.3	17.6	14.1	18.0	17.5	0.1	0.0	0.5	6.8	0.0	0.4	0.1	0.6	0.6	0.7	0.1	0.6	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.2	0.0	0.4	91.4	0.0	0.0	2.9	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	95.7	0.0	0.0	5.9	2.9	14.6	0.0	1.5	1.8	2.8	0.7	0.8	0.0	38.7	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	1.6	0.0	0.0	0.3	1.5	1.3	0.0	0.3	0.0	0.6	0.0	0.0	0.2
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;pituitary gland: 5.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 49.3;Excitatory neurons: 22.7;Inhibitory neurons: 28.7;Late spermatids: 56.4;Oligodendrocyte precursor cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064161: AB_2685202"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	0.4	1.0	9.8	0.5	9.8	1.0	0.2	5.7	13.8	0.2	2.9	0.3	0.5	0.2	0.8	0.4	0.3	0.4	0.4	10.6	8.4	0.7	0.1	0.3	1.1	11.8	7.6	0.4	0.2	0.4	5.1	1.0	11.9	0.2	0.3	4.9	0.6	0.2	0.6	0.6	0.5	0.2	4.2	0.8	0.3	3.7	7.9	1.4	0.5	0.1	1.2	0.2	0.1	9.3	1.3	7.3	2.9	9.8	0.1	0.1	6.8	0.5	0.5	1.6	1.2	3.3	1.2	6.5	1.9	0.1	2.2	1.3	7.8	0.6	0.9	7.0	4.6	1.1	5.5	2.4	1.1	0.5	4.9	0.2	0.1	3.6	0.8	0.9	0.3	4.4	8.0	2.1	0.1	4.0	7.6	1.1	4.5	1.9	1.3	4.1	1.5	3.4	2.0	1.2	5.0	4.8	1.8	0.8	1.9	2.6	5.0	1.7	0.4	1.0	4.5	2.2	2.5	3.6	14.9	8.5	4.0	0.5	0.6	1.1	0.2	0.2	0.3	0.1	0.1	0.7	0.3	0.3	0.1	0.8	0.6	0.7	0.7	0.5	0.3	0.7	0.2	0.2	9.8	9.8	5.7	13.8	10.6	8.4	11.8	7.6	11.9	4.2	7.9	9.3	0.9	0.0	0.5	11.8	2.2	0.0	0.3	0.2	0.0	17.9	0.7	0.3	1.2	1.5	0.2	7.3	16.7	3.1	0.3	0.5	0.0	0.9	49.3	0.7	0.3	1.9	4.2	0.4	22.7	0.2	3.0	0.6	1.1	0.6	0.0	3.8	0.4	0.2	2.2	10.1	28.7	0.8	2.0	1.9	0.8	56.4	0.6	0.7	1.8	3.7	1.0	5.5	0.0	18.6	7.0	0.6	0.1	1.5	2.0	0.2	0.6	1.0	1.4	10.3	0.0	0.7	0.9	3.8	5.2	0.2	0.0	1.6	0.5	1.1	0.8	0.2
RSPO2	MGC35555	ENSG00000147655	"R-spondin 2"	Q6UXX9	8	107899316-108083642	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	"Developmental protein, Heparin-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;intestine: 13.9;placenta: 17.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 75.3;Inhibitory neurons: 86.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;U-266/70: 4.2"	"Group enriched"	"Detected in many"	7	"amygdala: 7.9;cerebral cortex: 17.9;hippocampal formation: 21.3;white matter: 13.2"	"Group enriched"	"Detected in many"	4	"amygdala: 8.3;cerebral cortex: 7.7;hippocampal formation: 8.5;midbrain: 12.9;spinal cord: 7.7"	"HPA024764, CAB025900, HPA053068"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031"	"unprognostic (1.10e-2)"		"unprognostic (2.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.33e-3)"		"unprognostic (1.82e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (1.40e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	0.2	0.0	2.8	0.7	4.4	0.1	0.0	1.3	16.2	3.4	2.6	13.9	3.4	0.0	1.7	5.9	0.0	3.2	0.2	6.6	13.2	0.0	0.4	7.1	0.0	2.6	23.0	0.3	0.0	0.0	2.9	17.3	2.0	8.7	7.8	0.3	0.0	2.3	0.0	0.0	4.6	0.3	2.1	0.0	7.6	0.7	3.5	0.0	0.0	0.0	0.0	1.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.4	1.3	16.2	6.6	13.2	2.6	23.0	2.0	2.1	3.5	6.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.3	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	86.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	4.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	1.7	0.0	0.0	1.0	0.0	0.2	0.0	0.0
RTN3	"ASYIP, HAP, NSPL2, NSPLII, RTN3-A1"	ENSG00000133318	"Reticulon 3"	O95197	11	63681446-63759891	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 514.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1074.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 1074.7;monocytes: 400.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015649, HPA015650"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		130000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA015649: AB_1856498, HPA015650: AB_1856499"	"unprognostic (8.11e-3)"	"unprognostic (8.51e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (5.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-2)"	207.5	81.8	361.4	54.1	412.2	108.5	93.3	338.4	514.5	87.6	190.7	88.1	54.0	62.5	81.2	55.7	88.5	56.3	57.4	428.4	378.9	92.8	87.5	77.8	36.0	404.5	309.1	48.1	91.1	109.9	81.0	62.2	417.2	53.3	79.9	194.4	138.8	76.1	70.2	103.7	65.2	80.1	329.2	51.7	57.0	46.6	334.0	53.7	175.5	43.7	48.5	55.7	54.2	384.0	157.5	113.8	134.0	128.4	242.3	170.9	53.4	139.3	147.5	120.5	128.4	99.6	338.1	184.2	231.7	210.0	115.7	157.2	194.0	68.7	157.5	149.5	103.5	236.5	151.3	70.4	201.1	212.8	182.4	113.5	199.2	146.7	162.3	200.7	165.2	158.9	136.2	290.1	107.4	129.2	113.4	235.2	156.7	127.3	127.3	148.4	93.8	342.9	239.7	87.5	282.7	164.0	226.2	245.3	271.5	95.4	271.1	172.7	155.2	71.3	95.6	251.1	108.4	183.4	169.9	145.6	274.7	173.8	77.2	441.0	400.1	487.7	41.4	187.6	44.8	28.6	41.6	41.3	130.8	19.4	30.1	32.7	1074.7	41.7	240.4	79.0	68.6	323.0	361.4	412.2	338.4	514.5	428.4	378.9	404.5	309.1	417.2	329.2	334.0	384.0	62.8	134.6	67.5	110.7	35.9	144.5	103.5	63.0	101.3	157.7	125.2	59.9	36.1	81.5	91.9	244.6	70.9	68.6	55.6	118.2	29.4	154.4	35.8	96.4	74.3	68.1	99.8	85.8	398.8	117.1	105.6	96.7	60.1	129.2	77.3	71.4	85.6	81.3	143.7	82.4	372.7	83.5	122.1	178.3	110.8	71.2	79.2	151.4	113.8	100.2	178.0	150.3	42.2	200.6	294.8	103.3	82.0	89.9	94.8	79.4	94.5	55.9	156.0	97.6	78.9	53.1	78.6	194.7	133.5	85.9	146.2	86.5	48.8	51.7	96.5	99.8
RTN4RL2	"NgR2, NGRH1"	ENSG00000186907	"Reticulon 4 receptor like 2"	Q86UN3	11	57460528-57477534	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 39.1;liver: 40.7;thyroid gland: 30.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.9;Cholangiocytes: 12.8;Excitatory neurons: 16.7;Hepatocytes: 14.0;Oligodendrocyte precursor cells: 9.5;Spermatocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.1;Karpas-707: 67.5;REH: 42.3;RPMI-8226: 134.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"amygdala: 13.5;cerebral cortex: 23.8;hippocampal formation: 21.0"						"Intracellular and membrane"	NA	NA		27000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (6.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.40e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (3.05e-7)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.18e-2)"	4.1	0.7	19.0	0.3	39.1	0.8	3.5	0.0	27.3	2.1	0.0	1.0	1.1	2.0	0.2	1.6	1.7	3.0	3.3	25.2	0.0	2.8	40.7	2.6	0.4	0.0	0.0	1.1	2.4	3.7	3.6	1.9	0.0	1.6	0.1	1.0	3.4	0.3	1.7	4.3	1.1	0.7	0.0	1.0	1.5	1.8	0.0	1.9	30.5	0.4	0.3	1.2	1.6	8.2	7.4	10.1	7.6	13.1	3.1	4.4	1.0	0.1	2.9	0.3	2.7	1.3	1.4	0.2	0.2	0.4	4.3	0.2	11.9	0.2	0.1	1.7	4.7	2.3	1.1	7.2	4.4	1.7	44.1	11.9	1.3	1.1	1.1	1.3	0.1	12.9	1.6	67.5	0.1	1.4	0.2	5.3	13.3	0.5	7.6	42.3	5.4	134.0	0.1	0.2	14.0	1.2	1.1	0.6	7.7	0.6	8.5	2.0	0.1	0.5	22.7	3.1	2.4	4.1	9.2	1.4	16.7	7.3	5.8	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.0	39.1	0.0	27.3	25.2	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.7	0.0	0.0	2.0	0.4	5.7	0.4	0.3	2.8	19.9	2.1	1.5	0.4	12.8	0.1	0.0	0.0	0.0	0.9	0.2	3.9	1.3	2.6	0.6	0.9	2.1	1.8	0.8	16.7	0.6	5.5	1.6	0.5	2.1	0.0	0.0	1.1	14.0	0.4	0.0	1.1	0.6	0.0	0.0	2.1	1.3	0.3	0.6	1.8	3.7	0.5	0.8	2.1	9.5	1.2	0.8	0.1	1.2	0.0	1.0	0.0	1.1	0.0	1.4	6.6	1.0	5.4	10.2	1.7	1.1	2.8	0.0	0.9	0.1	0.2	0.2
RTP1	"MGC35450, Z3CXXC1"	ENSG00000175077	"Receptor transporter protein 1"	P59025	3	187197486-187201462	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 2.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.3;Late spermatids: 1.9;Spermatocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"SuSa: 4.0;T-47d: 2.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"							"unprognostic (2.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.29e-1)"		"unprognostic (1.91e-1)"				"unprognostic (2.63e-1)"			"unprognostic (2.89e-1)"			0.0	0.0	1.2	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	2.7	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.1	1.1	0.9	2.7	0.4	0.9	0.4	0.5	2.8	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTP5	"C2orf85, CXXC11, FLJ33590, Z3CXXC5"	ENSG00000188011	"Receptor transporter protein 5 (putative)"	Q14D33	2	241869600-241873823	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.8;Inhibitory neurons: 4.1;Late spermatids: 2.8;Oligodendrocyte precursor cells: 17.6"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"MOLT-4: 1.3;SCLC-21H: 2.6"					"Low region specificity"	"Detected in all"			HPA050902	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA050902: AB_2681268"	"unprognostic (3.26e-2)"	"unprognostic (5.38e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.40e-4)"	"unprognostic (8.68e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.34e-4)"	"unprognostic (3.30e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.91e-1)"	"unprognostic (9.08e-8)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.72e-2)"	0.3	0.0	25.8	0.1	10.0	0.3	0.1	0.0	18.9	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	29.7	32.9	0.1	0.1	0.5	0.5	5.1	17.3	0.0	0.0	0.0	0.1	0.0	16.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	6.2	1.4	0.3	0.4	25.4	0.3	0.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	10.0	0.0	18.9	29.7	32.9	5.1	17.3	16.3	6.2	25.4	1.3	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	1.0	0.0	0.0	0.0	17.6	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 208.4;pituitary gland: 98.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.4;Early spermatids: 24.4;Enteroendocrine cells: 39.0;Excitatory neurons: 46.1;Horizontal cells: 32.0;Inhibitory neurons: 30.4;Late spermatids: 83.4"	"Group enriched"	"Detected in many"	5	"glioma: 8.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 62.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Enhanced	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	0.3	14.3	149.2	0.4	159.5	2.3	0.3	93.0	208.4	0.2	45.6	3.4	1.2	0.5	0.2	0.8	0.2	0.3	1.8	169.4	105.3	1.8	0.2	0.4	0.2	108.0	106.4	0.8	3.8	3.1	98.3	1.5	108.5	0.8	0.6	31.2	0.3	0.3	0.1	7.9	1.3	0.5	79.2	1.6	2.3	15.2	109.4	0.4	1.4	0.3	0.1	0.2	0.7	135.7	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	4.3	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.9	0.2	0.0	0.5	0.3	0.3	0.1	0.1	1.1	0.3	0.1	62.5	40.3	0.3	0.0	0.3	0.1	0.5	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.2	159.5	93.0	208.4	169.4	105.3	108.0	106.4	108.5	79.2	109.4	135.7	0.1	0.0	0.6	17.3	0.0	0.3	0.3	0.0	0.0	55.4	0.2	0.3	1.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	1.3	24.4	0.2	0.3	0.2	39.0	18.7	46.1	3.1	0.0	1.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	32.0	30.4	0.5	4.1	0.3	0.5	83.4	1.5	0.3	0.0	4.7	0.1	6.5	1.0	16.1	12.5	1.0	1.2	3.4	0.0	0.4	0.0	0.8	0.0	16.8	0.0	0.8	0.5	1.4	1.3	0.0	0.4	0.1	0.1	3.0	0.1	0.3
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50130160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4"	"Cell type enriched"	"Detected in many"	4	"Bipolar cells: 56.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HEL: 8.6;HMC-1: 28.0;SH-SY5Y: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	0.9	1.4	14.9	0.8	14.0	0.3	0.5	19.4	15.4	1.6	0.0	1.0	0.2	3.1	0.8	0.5	0.5	0.3	1.2	15.3	11.0	3.1	0.8	6.0	0.3	9.4	8.8	1.3	0.2	0.7	3.4	0.7	8.5	3.0	0.1	1.3	0.1	0.7	1.4	0.3	0.9	0.4	6.0	1.7	1.1	2.1	11.2	0.1	0.9	0.5	0.5	1.8	1.1	10.1	0.0	0.2	4.2	0.0	1.1	0.3	0.0	3.0	1.1	0.1	0.0	0.6	0.0	0.1	4.1	1.3	0.0	0.1	0.3	0.0	0.1	12.7	0.1	8.6	0.3	0.0	0.7	0.0	28.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	12.9	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.6	1.6	0.3	0.1	0.2	0.0	0.1	2.2	0.1	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	14.0	19.4	15.4	15.3	11.0	9.4	8.8	8.5	6.0	11.2	10.1	0.6	0.0	0.5	6.2	0.0	0.4	0.1	0.2	0.6	56.1	0.2	0.3	1.1	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	3.1	0.0	1.4	6.1	12.7	2.7	8.3	0.4	0.2	2.3	0.5	0.1	2.5	0.1	8.2	0.3	0.1	11.8	7.2	0.3	0.0	0.6	1.0	2.2	1.5	5.7	0.0	1.0	2.0	2.2	0.0	2.5	0.4	0.2	0.1	3.4	0.2	0.0	0.3	1.1	0.0	4.6	0.0	0.1	2.8	1.5	1.1	0.2	0.1	0.4	0.2	0.7	0.1	0.1
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087526-165204050	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 16.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 78.4;Excitatory neurons: 227.3;Inhibitory neurons: 169.4;Oligodendrocyte precursor cells: 358.4"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 13.2;naive B-cell: 15.3"	"Lineage enriched"	"Detected in single"	32	"B-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 5.9;Karpas-707: 10.3;MOLT-4: 30.3;RPTEC TERT1: 14.9;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035396: AB_2674607"	"unprognostic (1.80e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.96e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-4)"	"unprognostic (4.55e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.93e-2)"	1.0	1.5	10.9	0.5	10.9	0.2	1.0	7.2	12.1	0.6	0.0	0.6	0.3	0.4	0.1	0.4	0.4	0.5	0.6	10.1	16.9	0.5	0.2	0.2	0.8	6.0	8.8	0.6	0.5	0.4	0.1	0.1	9.2	0.2	0.7	1.0	0.1	0.4	0.9	0.0	0.5	0.5	3.0	0.5	0.9	0.5	13.4	3.1	0.2	0.6	1.2	0.5	0.0	6.5	0.0	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.3	0.6	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	4.9	0.0	5.9	0.0	10.3	0.1	0.0	30.3	0.0	0.0	0.1	2.4	0.1	1.3	0.0	14.9	0.0	3.8	6.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.2	0.1	0.8	0.0	1.4	0.6	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	15.3	0.1	0.0	0.0	0.2	0.0	0.4	0.1	0.1	10.9	10.9	7.2	12.1	10.1	16.9	6.0	8.8	9.2	3.0	13.4	6.5	0.9	0.0	0.5	8.5	6.5	0.0	0.2	0.0	0.6	4.4	0.1	0.4	6.5	0.0	0.0	1.8	12.5	0.0	0.0	0.0	0.0	0.2	78.4	0.0	0.0	2.9	8.9	0.0	227.3	0.0	0.0	0.5	1.1	0.0	0.0	0.3	0.0	0.2	0.1	5.0	169.4	1.2	0.0	0.0	0.3	11.5	0.3	0.2	1.8	19.7	0.0	0.3	0.0	358.4	9.2	0.1	0.0	0.7	5.3	0.0	0.0	0.0	0.0	0.8	13.1	0.3	31.8	0.7	2.4	0.0	0.1	0.0	0.1	0.3	0.1	0.1
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 109.6;tongue: 56.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 134.6"	HPA017293	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	23.5	5.4	2.6	1.2	86.6	0.0	9.2	41.3	109.6	2.1	0.0	2.6	2.4	3.1	1.6	5.3	5.4	3.2	11.8	2.1	14.0	2.1	0.4	8.9	2.1	53.3	15.4	0.5	5.1	6.8	2.7	1.8	45.9	2.2	2.1	0.9	2.5	2.3	30.4	3.9	4.7	7.1	15.2	0.0	2.9	0.7	23.1	8.6	14.5	56.8	0.7	3.0	1.4	28.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	86.6	41.3	109.6	2.1	14.0	53.3	15.4	45.9	15.2	23.1	28.5	12.3	0.0	0.0	2.9	0.0	1.3	0.6	2.0	2.8	1.7	0.5	5.7	4.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	3.0	0.0	0.0	18.2	0.0	0.1	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	2.0	1.2	1.4	8.7	2.1	1.1	0.0	1.9	0.0	0.5	0.0	1.5	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.1	5.8	0.8	46.0	0.6	38.8	0.1	0.6	0.5	1.1	0.0	0.1	0.0	0.0	0.2
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 64.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 41.2;Early spermatids: 55.6;Excitatory neurons: 10.6;Horizontal cells: 35.3;Inhibitory neurons: 14.2;Late spermatids: 11.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.0	0.5	3.4	0.0	4.8	0.0	0.0	12.5	64.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	19.4	0.0	0.0	0.0	0.0	22.9	8.5	0.0	0.3	0.0	3.4	0.0	18.1	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.8	12.5	64.2	1.6	19.4	22.9	8.5	18.1	0.1	26.2	23.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.1	1.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	55.6	0.0	0.0	0.3	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	14.2	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SERPINI1	PI12	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825569	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 301.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 219.4;Excitatory neurons: 176.9;Inhibitory neurons: 228.8;Oligodendrocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.2;Karpas-707: 29.1;U-266/84: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Uncertain	Cytosol	"Secreted in brain"	NA	NA		750000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA001565: AB_1079924, HPA056092: AB_2683036"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	13.1	15.8	138.8	4.1	157.7	2.3	11.7	115.9	301.4	8.4	82.1	5.1	2.2	8.6	8.2	5.5	7.9	6.3	14.0	162.0	129.1	32.1	4.1	6.4	4.6	122.8	153.6	6.9	39.5	6.9	42.8	6.7	123.9	11.8	4.4	84.4	23.0	7.4	3.2	3.1	4.4	6.1	134.6	8.7	10.8	15.8	134.5	4.4	11.2	8.1	8.2	4.9	6.0	164.8	0.8	3.5	5.5	0.4	10.3	2.2	0.3	1.9	2.7	1.3	2.2	1.5	5.9	29.2	9.5	1.3	4.5	1.3	3.9	3.8	1.5	7.7	6.5	8.9	22.5	10.7	0.7	1.4	1.1	3.8	1.4	0.8	1.3	2.9	0.4	10.5	18.9	29.1	1.2	2.7	0.8	1.9	3.3	4.2	4.5	2.7	0.4	3.2	11.2	1.0	2.2	13.4	3.6	6.8	8.3	12.4	10.6	4.4	1.0	5.5	0.5	0.5	10.3	23.0	28.4	18.8	4.2	7.7	3.2	1.5	0.3	0.8	9.3	0.7	6.9	22.1	9.7	10.2	0.5	25.2	6.9	8.1	0.9	9.5	0.5	7.2	27.2	5.2	138.8	157.7	115.9	301.4	162.0	129.1	122.8	153.6	123.9	134.6	134.5	164.8	49.8	6.4	1.5	43.1	10.7	3.7	13.2	6.4	14.2	219.4	3.6	14.1	8.2	1.5	6.7	5.5	14.6	6.1	6.2	0.7	7.9	1.8	0.4	2.0	1.0	16.0	4.8	7.4	176.9	18.0	6.0	8.9	2.6	1.7	2.5	2.3	3.9	0.6	2.3	5.0	228.8	0.3	73.2	0.6	3.2	2.4	4.1	0.9	7.2	25.3	1.2	78.0	2.1	31.2	174.7	3.0	0.0	2.6	14.6	6.7	0.0	39.9	13.6	35.4	26.3	5.2	54.7	3.0	27.4	0.5	1.7	5.1	6.2	1.1	0.3	2.3
SEZ6L		ENSG00000100095	"Seizure related 6 homolog like"	Q9BYH1	22	26169462-26383597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 222.1;Inhibitory neurons: 137.7;Oligodendrocyte precursor cells: 586.1"	"Group enriched"	"Detected in some"	6	"glioma: 14.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 5.9;myeloid DC: 5.7;non-classical monocyte: 5.3"	"Group enriched"	"Detected in many"	58	"dendritic cells: 5.7;monocytes: 5.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 39.9;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045135			Approved	Vesicles		NA	NA		6700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA045135: AB_2732518"	"unprognostic (1.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-6)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.18e-1)"	0.1	10.0	25.0	0.5	37.5	0.2	0.0	8.9	50.6	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	1.3	60.8	52.0	0.0	0.0	0.2	0.0	24.5	23.6	0.0	1.5	0.0	5.8	0.0	19.0	0.2	0.2	4.5	0.2	0.1	0.1	0.3	0.4	0.3	4.0	0.2	1.4	0.3	49.0	0.9	0.1	0.0	0.0	0.1	0.1	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	10.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.9	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.5	25.0	37.5	8.9	50.6	60.8	52.0	24.5	23.6	19.0	4.0	49.0	24.9	0.0	0.0	0.0	21.9	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.1	0.2	0.0	0.4	222.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.9	137.7	0.0	0.0	0.0	2.1	2.0	0.6	1.5	0.0	10.3	3.5	0.7	0.0	586.1	5.5	0.6	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 405.2;Early spermatids: 96.4;Late spermatids: 168.4"	"Cancer enhanced"	"Detected in all"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	3.2	11.7	52.1	4.6	45.5	13.7	2.5	40.0	63.6	3.2	21.9	6.1	6.9	3.1	16.6	3.1	4.2	4.0	3.5	48.0	45.2	11.4	29.4	3.6	3.9	51.5	49.2	2.6	2.4	2.0	3.5	3.7	41.4	4.2	5.7	6.2	2.2	4.5	7.7	4.5	6.5	3.9	42.6	5.6	4.6	2.4	57.0	4.9	3.7	4.6	3.0	3.8	2.3	37.4	4.2	9.1	13.7	11.5	3.0	5.0	5.4	8.4	5.4	13.3	6.9	13.7	10.7	2.3	8.8	8.9	9.2	3.7	10.8	11.1	6.0	10.2	6.7	10.7	11.0	18.7	4.4	5.9	11.1	5.8	3.5	9.0	1.1	4.9	7.4	3.2	9.5	2.9	4.3	8.7	1.5	9.5	17.1	8.1	6.6	10.6	12.2	3.1	8.1	10.5	9.0	2.7	8.6	4.3	3.5	7.7	2.2	5.3	6.8	4.1	13.5	6.1	10.2	4.0	4.1	3.1	15.0	10.3	5.3	4.7	6.0	3.5	0.6	2.6	0.9	1.6	0.3	0.7	2.7	2.4	0.4	0.5	4.6	4.3	3.2	1.9	0.7	1.7	52.1	45.5	40.0	63.6	48.0	45.2	51.5	49.2	41.4	42.6	57.0	37.4	7.1	0.0	4.4	405.2	4.8	4.7	4.3	7.6	4.6	26.8	6.9	5.5	5.8	7.2	4.8	36.8	33.3	12.4	6.8	18.4	3.9	5.1	96.4	5.1	13.1	7.6	13.8	13.7	84.4	9.1	2.4	8.9	9.2	11.2	0.0	42.8	9.3	61.3	12.4	20.2	57.4	8.6	2.0	8.7	9.6	168.4	10.5	9.6	8.8	43.1	19.7	65.8	10.3	40.2	29.9	8.0	6.5	11.3	7.1	3.6	17.5	22.2	3.2	42.3	13.1	12.2	8.8	11.2	15.7	7.3	9.2	4.2	6.3	15.9	8.8	2.3
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	22.2	30.2	84.3	20.2	83.0	28.4	31.0	52.5	102.7	32.1	53.8	37.0	15.5	26.3	51.7	36.0	27.4	21.2	27.1	83.0	81.3	36.5	19.3	28.2	24.3	64.0	67.5	28.9	27.9	27.4	80.7	15.8	62.6	53.7	10.1	15.7	41.9	21.6	21.6	33.3	32.6	17.9	58.4	37.6	33.6	30.0	76.9	17.5	41.4	13.9	14.1	31.8	28.7	68.4	20.7	31.1	27.9	39.0	15.5	18.6	41.4	17.4	20.4	23.6	23.9	31.2	38.6	9.9	18.5	25.3	8.7	28.4	17.2	20.6	8.2	14.5	35.3	17.2	55.6	33.8	13.3	10.4	25.0	20.1	13.4	24.1	13.7	34.1	24.9	26.4	10.5	14.4	14.3	43.5	22.4	14.0	13.7	14.7	13.5	48.5	14.2	8.0	30.5	42.5	13.5	31.9	21.7	16.2	13.4	17.1	41.9	12.3	29.3	18.9	21.5	28.1	23.4	11.8	1.9	9.5	16.4	13.6	17.0	7.0	0.3	1.3	0.9	0.1	0.8	0.1	0.3	0.5	0.4	0.3	1.1	0.6	0.1	0.9	0.0	0.5	0.6	0.4	84.3	83.0	52.5	102.7	83.0	81.3	64.0	67.5	62.6	58.4	76.9	68.4	9.4	6.4	24.7	52.9	5.4	6.8	8.3	13.8	5.7	59.6	31.9	24.0	15.6	11.5	23.5	12.9	135.5	13.8	9.3	7.1	0.0	6.7	18.2	9.9	11.0	11.8	13.8	5.7	39.7	4.5	8.8	10.0	14.3	14.7	20.3	18.1	14.3	8.3	7.8	30.3	38.2	9.9	16.2	7.6	9.9	38.1	8.1	9.2	5.4	16.9	6.3	11.9	7.2	22.6	10.3	6.4	4.5	12.0	4.6	15.0	7.0	4.0	16.5	51.2	19.7	9.6	11.0	4.1	6.7	11.9	7.7	14.1	11.6	15.2	8.2	13.5
SHISA9		ENSG00000237515	"Shisa family member 9"	B4DS77	16	12901598-13240416	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 48.5;LHCN-M2: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072399			Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"HPA072399: AB_2686517"	"unprognostic (1.88e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.69e-5)"	"unprognostic (2.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.90e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	0.5	2.8	12.5	0.8	12.7	1.3	0.6	0.0	14.8	0.3	0.0	3.2	0.8	0.4	1.1	0.5	0.2	0.4	0.6	10.9	6.3	1.9	0.6	0.2	0.4	6.9	5.9	0.4	0.6	0.1	0.9	0.4	6.2	4.2	0.9	3.7	0.9	0.7	1.5	0.9	0.9	0.6	1.7	0.4	0.5	0.7	11.0	0.1	2.1	0.0	0.3	0.2	0.2	4.2	0.8	0.4	0.6	0.5	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.5	0.5	48.5	0.1	0.7	0.6	0.1	0.2	0.1	0.6	0.2	0.6	0.9	0.3	0.1	0.6	0.6	1.5	0.1	0.1	3.3	0.4	0.1	0.6	0.4	1.0	40.5	5.5	0.4	0.7	10.2	0.7	0.5	0.6	0.4	0.3	10.9	1.5	10.1	0.5	0.4	1.4	0.4	4.4	0.9	0.4	0.4	0.6	5.8	0.6	0.4	0.9	1.0	0.5	0.4	0.3	1.0	0.8	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	12.5	12.7	0.0	14.8	10.9	6.3	6.9	5.9	6.2	1.7	11.0	4.2	0.0	25.6	20.1	5.2	0.1	0.1	0.5	0.2	0.0	0.8	1.7	0.8	1.3	1.5	7.0	1.8	0.0	0.1	0.0	0.3	1.9	1.4	4.8	0.1	0.5	1.1	0.0	0.0	265.0	0.0	0.0	2.0	0.0	0.3	11.4	0.0	0.0	0.0	0.0	0.0	427.9	0.3	0.0	0.0	0.4	3.4	0.3	1.0	0.0	5.6	0.0	0.5	0.0	636.3	4.9	0.1	2.3	0.0	0.0	1.8	0.0	1.3	11.8	0.3	0.0	6.6	0.2	0.5	2.0	0.0	0.1	0.1	1.3	0.0	0.8	0.6
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532555-113629575	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 33.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035862	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favorable (4.09e-5)"	1.2	2.8	5.2	5.2	5.6	3.4	5.4	4.7	6.4	3.1	0.0	6.2	2.0	0.7	0.2	1.4	1.9	3.7	0.4	6.4	3.6	0.8	0.6	1.8	8.8	2.8	3.5	0.2	0.7	0.5	5.4	1.0	2.1	5.1	10.2	0.4	10.8	1.5	0.3	0.5	5.4	0.7	5.7	7.1	3.5	0.9	4.9	5.2	0.4	0.4	8.8	4.5	0.9	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	1.5	0.0	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	4.2	0.0	15.4	4.2	0.2	0.0	16.2	21.0	6.2	0.0	0.5	0.0	14.9	0.2	0.1	0.0	4.2	0.2	0.0	13.8	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	7.0	0.1	7.1	7.5	4.7	5.8	1.5	6.6	5.9	5.1	0.3	9.1	0.0	33.7	3.9	3.4	5.2	5.6	4.7	6.4	6.4	3.6	2.8	3.5	2.1	5.7	4.9	3.3	1.6	6.4	3.3	7.2	47.4	0.4	1.4	1.9	0.0	1.4	9.7	4.7	1.1	4.3	4.2	1.8	0.0	0.0	34.5	17.2	0.0	0.4	5.0	3.1	0.7	1.0	10.2	0.8	117.8	1.1	0.2	0.4	8.2	6.3	3.8	0.0	0.4	0.5	11.2	0.0	86.8	23.3	2.0	3.5	1.8	1.5	0.0	10.1	5.4	23.4	2.6	0.1	21.6	4.5	4.0	0.8	3.9	0.0	14.5	3.9	2.2	0.1	9.3	0.2	0.0	0.7	0.7	0.2	0.1	0.9	0.3	0.1	16.4	0.3	7.0	1.9
SIPA1L1	"E6TP1, KIAA0440, SPAR1"	ENSG00000197555	"Signal induced proliferation associated 1 like 1"	O43166	14	71320449-71741229	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 575.1;Inhibitory neurons: 447.6;Oligodendrocyte precursor cells: 221.2;Oligodendrocytes: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 101.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002875, HPA077689"	Approved		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Actin filaments"	"HPA002875: AB_1079974, HPA077689: "	"unprognostic (1.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.64e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (6.80e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.03e-2)"	6.2	14.5	29.7	11.6	33.4	11.7	9.0	6.1	27.8	9.4	31.3	12.1	10.3	7.1	11.0	14.4	13.8	15.5	3.3	30.9	4.5	14.9	12.3	11.5	11.0	2.7	0.5	4.7	12.7	19.2	16.0	5.1	1.4	7.9	11.7	13.3	10.7	8.5	3.0	8.7	11.1	10.5	0.6	25.3	18.1	19.8	10.1	12.5	14.3	2.8	15.8	12.7	6.1	11.3	27.0	8.3	18.9	14.2	5.6	16.0	34.2	35.9	42.4	14.3	18.1	48.1	14.8	12.6	9.1	59.1	12.9	26.1	13.9	32.3	27.1	11.4	6.5	26.5	55.3	11.3	46.3	3.2	9.8	11.7	26.7	22.1	52.0	16.3	15.5	17.5	11.8	30.7	19.8	40.5	10.8	3.0	10.8	24.6	22.4	15.7	20.4	13.4	10.2	41.1	23.2	61.9	36.8	28.6	2.6	12.1	17.0	1.4	43.3	101.4	37.2	11.6	20.8	25.0	30.3	18.3	17.3	8.6	34.6	6.9	5.2	1.1	1.7	5.8	3.8	3.2	1.5	2.4	1.3	7.4	1.0	1.1	22.9	2.2	7.1	0.4	1.6	2.3	29.7	33.4	6.1	27.8	30.9	4.5	2.7	0.5	1.4	0.6	10.1	11.3	14.4	67.3	30.5	163.9	53.8	11.9	15.2	20.2	30.7	19.6	13.0	21.2	5.3	21.5	23.6	14.7	18.8	7.8	23.9	19.3	13.7	24.6	74.4	28.8	18.8	12.9	32.4	1.3	575.1	19.9	8.5	11.3	46.9	35.3	13.9	26.4	5.0	17.5	5.1	58.9	447.6	16.8	10.2	21.4	67.2	31.2	7.8	49.2	5.4	120.9	34.6	58.2	9.2	221.2	251.3	23.0	15.5	35.3	24.9	16.2	18.3	28.4	34.4	15.9	0.0	5.4	18.2	22.4	36.8	17.3	8.4	9.4	24.3	102.0	22.5	27.2
SIRPA	"BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2"	ENSG00000198053	"Signal regulatory protein alpha"	P78324	20	1894167-1940592	"CD markers, Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 157.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 138.1;Excitatory neurons: 87.4;Hofbauer cells: 100.8;Macrophages: 82.5;monocytes: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 24.1;eosinophil: 48.7;myeloid DC: 13.9;neutrophil: 50.8"	"Group enriched"	"Detected in many"	150	"dendritic cells: 13.9;granulocytes: 50.8;monocytes: 24.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 142.7;RPTEC TERT1: 100.3;SK-MEL-30: 120.2"									"CAB002776, CAB015122, HPA054437, HPA058511"	Enhanced					NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"			"CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738"	"unprognostic (9.78e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.19e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.84e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.24e-2)"	49.7	40.4	145.5	49.2	146.6	44.1	41.2	98.9	157.3	27.2	56.0	16.6	27.0	15.0	19.9	13.1	23.3	27.3	30.3	155.1	105.0	27.3	53.4	42.3	22.5	101.0	123.4	19.5	12.6	4.8	15.9	26.3	94.9	15.6	14.8	39.8	29.9	15.3	17.4	29.8	22.3	21.6	99.9	28.1	11.8	6.9	135.2	7.1	12.2	9.0	16.9	35.4	21.9	126.6	11.8	25.2	12.5	23.2	29.4	27.5	1.8	60.5	51.1	16.2	4.9	16.2	0.3	0.0	14.3	142.7	43.6	11.6	10.0	70.6	6.7	0.1	7.1	0.0	2.8	9.0	35.4	24.4	28.5	24.9	32.5	13.8	16.6	46.1	50.8	0.2	1.4	15.4	22.0	0.7	0.0	33.9	13.9	0.0	11.2	0.1	22.2	16.1	100.3	0.0	1.7	3.7	8.2	0.0	120.2	4.5	4.0	76.9	76.6	71.1	36.7	46.4	30.5	0.1	0.1	0.2	22.2	77.3	8.2	0.3	24.1	48.7	0.0	6.0	0.0	0.1	0.0	0.0	13.9	0.0	0.0	0.0	50.8	0.0	2.2	0.9	0.1	10.0	145.5	146.6	98.9	157.3	155.1	105.0	101.0	123.4	94.9	99.9	135.2	126.6	60.6	3.2	6.5	138.1	4.3	14.3	12.8	28.3	6.2	13.2	18.8	27.7	12.7	34.3	10.1	9.2	14.6	20.2	0.6	2.8	1.9	26.8	0.5	1.5	2.2	13.7	9.6	4.4	87.4	2.1	2.1	23.7	1.1	4.8	17.7	1.6	20.3	29.3	100.8	15.2	44.2	3.5	2.0	57.2	54.3	1.2	5.0	82.5	23.2	33.7	85.0	23.7	0.0	40.7	51.1	25.1	9.9	1.9	1.6	9.7	17.7	16.1	5.1	26.8	6.6	3.4	7.8	0.2	8.3	2.8	6.7	36.5	2.1	0.0	2.6	7.7
SKOR2	"CORL2, Fussel-18, FUSSEL18"	ENSG00000215474	"SKI family transcriptional corepressor 2"	Q2VWA4	18	47206169-47251660	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 1.8;Spermatocytes: 2.5;Spermatogonia: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"NTERA-2: 3.9"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.4"	"Not detected"	"Not detected"			HPA046206	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA046206: AB_2679588"					"unprognostic (1.53e-1)"					"unprognostic (1.93e-1)"				"unprognostic (1.92e-1)"	"unprognostic (6.31e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.8	0.6	1.8	0.2	1.1	2.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 9.1"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075017	Approved		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	0.5	0.3	1.1	0.0	3.3	0.2	0.6	0.2	6.0	0.7	0.0	0.3	0.1	0.4	0.0	0.3	0.9	0.1	0.6	0.8	1.1	0.4	0.2	0.3	0.0	4.0	1.4	0.3	0.4	0.0	1.6	0.0	3.6	1.7	0.0	0.1	1.2	0.0	0.5	0.7	0.2	0.0	0.3	0.3	0.4	0.8	2.8	0.0	0.7	0.0	0.0	0.4	0.7	9.1	0.3	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.4	0.1	2.1	0.0	0.2	0.1	1.3	0.0	0.0	0.0	1.2	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	0.2	6.0	0.8	1.1	4.0	1.4	3.6	0.3	2.8	9.1	0.6	0.0	0.0	0.7	0.0	1.3	0.5	0.6	0.6	0.1	0.6	0.8	0.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.3	0.1	0.9	0.2	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.0	1.7	0.7	0.1	1.0	0.0	0.4	0.2	0.0	0.8	1.4	2.5	4.4	0.7	5.4	0.0	0.0	1.4	0.0	0.5	4.0	0.3	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	1.5	2.4	2.1	7.7	0.5	0.9	0.0	0.3	0.6	0.1	0.7
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 782.3;choroid plexus: 202.7"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 4607.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	0.6	4.6	546.9	0.6	731.2	0.4	3.8	388.1	782.3	1.2	202.7	0.2	0.5	1.0	0.3	0.2	0.3	0.2	0.9	631.1	432.5	0.2	34.9	0.6	1.9	450.6	533.6	0.1	9.5	0.1	2.6	1.1	384.2	0.3	0.1	60.1	4.6	0.1	0.3	1.3	0.2	0.3	409.7	0.5	2.1	1.7	498.7	0.2	0.3	0.5	1.6	0.3	0.6	453.4	0.0	0.1	0.5	0.0	0.2	2.1	0.0	0.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	1.1	0.0	0.1	0.5	0.0	0.3	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.1	0.1	0.1	546.9	731.2	388.1	782.3	631.1	432.5	450.6	533.6	384.2	409.7	498.7	453.4	0.4	3.2	4.8	4607.2	0.4	2.9	0.0	0.0	0.0	109.9	8.1	2.4	3.1	0.0	0.0	0.0	148.0	25.6	0.3	0.1	0.0	0.1	96.6	1.8	11.7	1.6	0.0	0.0	83.7	3.4	1.0	3.1	1.1	1.5	0.0	0.7	0.0	6.7	3.3	6.7	81.5	0.0	0.0	0.0	3.0	97.9	0.0	0.6	1.8	194.9	31.6	10.1	0.0	634.9	12.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.8	161.2	0.0	0.3	1.8	0.5	1.3	0.0	1.1	269.4	0.2	0.0	0.0	0.1
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 238.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.2;Proximal enterocytes: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA009675: AB_2668252, HPA050883: AB_2681260"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	28.8	38.0	144.8	12.0	238.7	0.8	18.0	77.5	200.1	32.1	72.0	94.4	39.3	41.8	24.0	64.7	36.6	21.4	79.0	206.5	95.1	45.0	38.5	24.0	9.2	108.8	98.2	33.6	24.2	58.8	22.2	4.7	109.5	35.0	49.1	41.2	68.9	40.0	90.8	33.5	40.5	65.5	82.7	11.9	41.3	9.5	101.4	7.2	60.7	78.2	31.2	55.8	31.1	115.8	58.2	22.9	32.2	101.9	42.3	18.6	14.9	17.0	26.4	31.0	37.2	58.2	37.1	32.2	40.0	41.3	34.1	48.0	66.3	39.0	24.3	0.1	58.6	23.2	46.7	46.2	39.2	1.6	52.5	53.3	33.4	27.6	12.0	62.9	32.8	34.7	68.8	39.4	6.2	41.6	20.7	32.8	23.6	61.0	71.1	10.0	8.8	49.4	83.3	10.2	2.4	31.9	11.7	70.8	30.0	34.8	37.1	50.1	11.7	9.8	41.8	2.6	11.2	7.3	10.7	28.3	4.5	54.2	15.6	0.5	0.0	0.0	2.0	0.0	0.4	1.0	1.1	0.9	0.2	0.4	1.5	1.4	0.0	0.3	0.0	0.4	1.3	0.4	144.8	238.7	77.5	200.1	206.5	95.1	108.8	98.2	109.5	82.7	101.4	115.8	6.2	9.6	20.9	11.8	7.0	10.5	8.8	11.5	12.0	13.1	18.9	15.6	39.5	47.1	10.0	46.0	8.4	1.4	4.5	164.2	19.6	54.7	15.9	8.2	6.4	8.0	13.8	1.3	24.7	28.5	1.8	10.2	12.8	17.5	7.0	17.9	16.1	38.0	2.7	8.4	17.9	34.5	10.2	3.0	2.6	71.2	19.0	1.4	17.8	12.2	1.0	28.7	4.1	17.1	12.6	55.5	57.9	29.3	17.6	13.6	106.8	28.7	6.4	22.0	13.1	12.1	12.7	0.5	4.6	34.1	23.3	0.8	5.2	39.5	34.2	30.3
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724486-38729372	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.7;Horizontal cells: 58.9;Inhibitory neurons: 20.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			0.0	0.0	12.4	0.0	39.8	0.2	0.0	3.4	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	36.5	0.3	0.0	0.0	0.0	14.2	6.8	0.0	0.0	0.0	7.6	0.0	8.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	39.8	3.4	22.0	2.4	36.5	14.2	6.8	8.7	6.3	5.1	1.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	14.7	0.0	0.0	0.4	0.0	0.1	0.0	4.2	0.0	1.3	0.0	0.0	0.0	2.5	0.2	0.0	0.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.9	20.7	0.0	0.0	0.0	0.4	0.6	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.1	0.0	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.3"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 3.4;cerebral cortex: 1.5;hypothalamus: 5.2;midbrain: 2.1;thalamus: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.4	0.0	3.4	0.2	0.0	0.0	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.4	0.0	0.3	2.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	0.0	1.5	0.0	5.2	0.3	2.1	0.2	0.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042795	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 16.1"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.0	0.1	3.7	0.0	3.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	1.0	0.8	0.0	0.1	0.0	0.0	1.1	1.6	0.0	0.2	0.1	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.4	3.0	0.5	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.9	0.0	1.3	1.0	0.8	1.1	1.6	0.9	0.6	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	16.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599251-46759118	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	0.5	5.0	9.1	2.4	41.6	3.6	5.8	6.3	14.6	1.2	0.5	0.6	1.2	0.8	2.6	1.9	1.7	1.6	1.1	8.6	17.0	2.6	3.1	1.3	6.3	13.9	7.5	4.3	3.4	8.9	9.2	1.1	14.2	4.6	0.9	4.9	6.0	2.0	5.7	2.1	2.2	0.7	6.7	3.7	6.3	0.8	14.5	3.2	4.3	2.5	6.3	1.8	1.3	5.1	10.4	7.7	1.1	3.3	1.2	7.4	4.3	9.6	12.0	5.7	4.5	7.9	10.9	22.7	2.9	15.6	11.0	4.6	7.4	10.9	10.3	11.9	3.9	2.3	3.1	3.3	4.6	1.0	17.9	4.6	1.4	16.1	10.6	26.8	8.2	7.7	0.2	0.3	7.9	15.7	2.6	1.2	5.3	5.0	9.2	10.0	0.4	0.2	4.4	11.4	8.2	1.0	4.9	7.3	2.1	9.2	9.7	0.4	0.4	12.0	4.0	1.8	5.7	2.3	0.5	11.2	17.1	0.1	4.0	0.5	0.2	0.1	0.1	0.2	0.1	1.7	0.2	0.1	1.1	1.7	0.1	0.1	0.8	0.5	0.2	2.8	0.3	0.2	9.1	41.6	6.3	14.6	8.6	17.0	13.9	7.5	14.2	6.7	14.5	5.1	0.5	3.2	8.2	11.4	21.0	0.6	10.1	0.9	1.2	13.0	16.9	8.6	5.7	1.5	2.6	16.5	4.2	7.9	24.4	0.3	0.0	17.6	0.0	1.8	2.0	1.5	2.4	5.5	43.3	14.2	0.7	2.7	13.3	1.7	0.0	4.5	0.7	6.5	6.4	13.5	66.8	2.0	0.0	6.3	8.4	0.6	0.9	9.2	1.8	3.7	8.0	6.1	1.0	69.9	1.6	16.4	0.1	0.4	2.8	21.0	0.1	2.1	0.1	3.5	6.6	12.1	1.9	0.0	1.6	4.2	1.0	7.3	2.9	1.3	0.9	11.5
SMIM10L2B	"LINC00087, NCRNA00087, RP11-85L21.2"	ENSG00000196972	"Small integral membrane protein 10 like 2B"	P0DMW5	X	135094985-135098712	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.1;Cardiomyocytes: 4.8;Horizontal cells: 11.8;Muller glia cells: 5.0;Peritubular cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;GAMG: 2.1;HHSteC: 1.8;HSkMC: 2.9;NTERA-2: 1.6"															NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (2.60e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.18e-3)"	"unprognostic (7.25e-3)"	"unprognostic (9.55e-2)"	"unprognostic (5.90e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.03e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.98e-2)"	1.2	3.3	17.7	0.4	19.3	0.0	1.3	6.2	24.2	3.1	0.5	1.4	0.4	2.7	2.1	2.0	3.1	0.8	11.1	19.2	23.4	3.7	1.3	1.4	0.4	20.3	20.9	4.5	1.0	5.8	3.7	0.4	29.5	3.5	0.4	2.2	3.0	2.1	0.8	1.6	0.8	1.4	7.7	1.0	1.6	5.6	16.9	0.1	2.2	0.8	0.3	1.2	2.2	14.4	0.0	0.0	1.3	1.2	1.8	0.2	0.6	0.4	0.2	0.2	0.3	0.5	0.0	0.0	0.2	0.2	2.1	0.1	0.4	0.4	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.2	0.0	0.1	0.3	0.1	0.6	0.0	0.0	0.1	0.0	0.4	0.0	1.6	0.3	0.1	0.0	0.3	0.0	0.7	0.2	0.6	0.2	0.2	0.1	0.0	1.3	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	19.3	6.2	24.2	19.2	23.4	20.3	20.9	29.5	7.7	16.9	14.4	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.1	1.0	1.8	4.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.3	0.1	0.1	1.2	0.7	1.2	0.0	0.0	0.7	0.1	1.1	0.0	0.2	0.0	1.3	0.7	1.7	0.0	11.8	0.0	0.3	0.0	0.3	0.0	0.8	3.1	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.4	0.1	1.7	0.0	1.5	0.0	0.6	2.3	1.0	0.5	0.8	0.0	0.3	0.0	0.9	0.1	0.4
SMIM17		ENSG00000268182	"Small integral membrane protein 17"	P0DL12	19	56643159-56657247	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 18.0;Inhibitory neurons: 32.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.0;HEK 293: 1.8;SCLC-21H: 1.7"					"Low region specificity"	"Detected in all"			"HPA071857, HPA071861"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA071857: AB_2686461, HPA071861: AB_2686462"	"unprognostic (1.32e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (9.02e-3)"	"unprognostic (3.46e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.71e-3)"	"unprognostic (7.51e-3)"	0.4	0.3	6.0	0.2	4.9	0.2	0.6	3.7	8.9	0.4	0.0	0.7	0.3	0.6	1.3	0.3	0.5	0.2	0.4	6.4	8.9	0.3	0.2	0.3	0.2	6.9	6.7	0.5	0.3	0.1	1.6	0.2	8.2	0.4	0.3	2.7	0.4	1.0	0.5	0.7	0.2	0.4	3.3	0.3	0.3	0.4	7.5	0.3	0.3	0.2	0.2	0.4	0.3	2.8	0.1	0.0	2.0	0.5	0.3	0.2	0.5	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.3	0.2	0.2	0.1	0.3	0.3	0.2	0.1	1.8	1.1	0.4	0.4	0.3	1.0	0.3	0.3	0.3	0.1	0.3	0.3	0.2	1.1	0.1	0.0	0.5	0.0	1.3	0.3	0.1	0.0	0.3	0.7	1.2	0.1	0.1	0.0	1.7	0.3	0.6	0.1	0.3	0.3	0.0	0.4	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	4.9	3.7	8.9	6.4	8.9	6.9	6.7	8.2	3.3	7.5	2.8	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.5	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM39		ENSG00000284479	"Small integral membrane protein 39"	A0A1B0GW54	2	131035092-131035262	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.1"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;HEK 293: 1.5"	"Not detected"	"Not detected"													NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"																						1.2	0.1	2.2	0.0	3.4	0.0	0.1	0.0	4.2	0.3	0.5	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.1	5.0	4.2	0.1	0.0	0.1	0.0	4.2	1.6	0.2	0.1	0.0	0.1	0.0	5.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	1.1	0.0	0.1	0.1	3.2	0.0	0.2	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	0.0	4.2	5.0	4.2	4.2	1.6	5.1	1.1	3.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNX32	"FLJ30934, SNX6B"	ENSG00000172803	"Sorting nexin 32"	Q86XE0	11	65833834-65856896	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 37.8;choroid plexus: 15.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Early spermatids: 11.3;Excitatory neurons: 48.4;Inhibitory neurons: 34.2;Late spermatids: 12.3;Oligodendrocyte precursor cells: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 4.5;HSkMC: 5.8;REH: 1.9;SH-SY5Y: 2.3;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041775	Uncertain		Uncertain	"Cell Junctions,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Focal adhesion sites"		"HPA041775: AB_10797268"	"unprognostic (6.74e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.00e-1)"	"unprognostic (9.28e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.36e-2)"	0.3	0.1	22.8	0.1	24.0	0.3	0.3	17.1	37.8	0.6	15.0	1.0	1.0	0.7	0.2	0.1	0.7	0.8	0.2	23.7	17.8	0.2	0.0	0.1	0.1	18.1	18.2	0.7	0.1	0.2	0.4	0.0	18.3	0.2	0.4	1.1	0.0	0.1	0.0	0.4	0.5	0.5	16.9	0.2	0.2	2.1	18.7	0.4	0.1	0.2	0.2	0.4	0.2	23.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.5	5.8	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.2	0.1	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	7.0	1.2	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.3	0.2	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	22.8	24.0	17.1	37.8	23.7	17.8	18.1	18.2	18.3	16.9	18.7	23.1	0.3	0.0	0.6	25.5	0.6	0.4	0.3	0.0	1.2	2.4	0.7	1.0	0.8	0.0	0.6	0.0	0.0	0.1	0.1	0.6	0.0	0.1	11.3	0.3	3.6	0.6	0.0	0.8	48.4	0.0	0.4	0.9	1.1	0.5	3.8	2.8	0.4	0.0	0.3	0.0	34.2	0.8	0.0	0.3	0.3	12.3	0.3	0.2	1.8	3.7	0.0	0.9	1.0	12.1	10.2	0.2	0.5	1.2	0.5	0.2	3.9	0.4	0.7	0.6	0.0	1.0	0.8	6.1	1.7	0.5	0.4	0.0	0.7	1.3	1.7	0.1
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.3	0.9	2.3	0.6	2.5	0.0	0.1	2.4	6.6	0.4	0.0	0.3	0.1	0.7	0.0	0.8	0.3	0.7	0.2	2.6	1.7	0.2	0.1	1.0	0.2	3.8	1.2	1.2	0.6	0.0	2.0	0.4	1.9	0.4	0.2	1.2	0.4	0.1	0.1	0.3	0.6	0.1	0.7	0.4	1.3	0.7	3.8	0.0	0.6	0.1	0.0	0.4	0.3	4.4	0.3	4.2	9.3	1.5	0.0	0.8	0.4	0.9	1.1	1.2	2.9	0.3	0.4	0.6	0.3	0.2	7.3	0.0	1.0	0.0	0.7	1.1	0.1	0.8	0.0	0.1	0.0	0.4	0.2	1.5	0.0	4.4	0.0	1.0	0.0	1.5	0.4	0.2	0.7	0.7	6.5	0.0	4.3	0.0	1.0	0.6	2.2	0.0	0.2	0.0	28.9	16.9	0.0	0.0	0.2	1.1	0.0	0.4	0.2	6.8	1.5	0.5	2.2	0.3	0.1	0.1	5.4	1.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	2.5	2.4	6.6	2.6	1.7	3.8	1.2	1.9	0.7	3.8	4.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	57.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	44.2	32.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135704498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.9;choroid plexus: 13.1;testis: 16.9"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 78.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 2.3;endometrial cancer: 0.6;head and neck cancer: 2.3;lung cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 20.9;U-266/84: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA059439			Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.1	0.0	15.5	0.0	17.0	0.0	0.0	13.9	28.9	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.3	13.7	0.0	0.0	0.0	0.0	17.8	13.7	0.1	0.0	0.1	3.2	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.5	0.1	0.1	16.9	13.5	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	17.0	13.9	28.9	16.3	13.7	17.8	13.7	17.8	13.5	13.5	19.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	15.9	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	78.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SORCS3	"KIAA1059, SORCS"	ENSG00000156395	"Sortilin related VPS10 domain containing receptor 3"	Q9UPU3	10	104641290-105265242	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 11.7"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 270.4;Inhibitory neurons: 193.7;Oligodendrocyte precursor cells: 462.9"	"Group enriched"	"Detected in some"	13	"glioma: 1.8;renal cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.39e-2)"			"unprognostic (8.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-1)"		"unprognostic (1.98e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (2.63e-2)"	"unprognostic (1.97e-1)"			0.2	2.0	6.5	0.1	7.7	0.0	0.1	1.8	7.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	7.0	11.7	0.2	0.0	0.0	0.0	3.6	4.1	0.8	0.0	0.0	0.2	0.0	2.2	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.2	1.7	0.0	0.1	1.0	10.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	7.7	1.8	7.5	7.0	11.7	3.6	4.1	2.2	1.7	10.3	4.8	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.1	0.1	0.0	0.0	270.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	462.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20008865-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA		9800	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	12.5	9.6	30.8	7.3	35.1	23.6	9.2	24.1	43.7	6.1	22.3	15.1	9.8	12.8	4.7	9.2	8.3	14.8	5.0	41.4	21.4	4.7	1.2	5.7	5.3	32.8	25.8	16.6	4.8	3.3	6.4	3.6	24.5	6.1	10.0	6.1	6.2	5.0	5.1	3.6	10.5	9.5	21.0	13.5	10.3	22.8	41.1	3.0	5.2	2.8	5.2	4.6	4.3	47.3	26.2	37.3	15.7	7.2	14.7	6.9	29.1	10.0	12.4	12.4	21.4	67.6	17.1	1.5	45.3	11.4	24.3	21.1	10.7	33.4	3.7	12.8	18.5	14.5	34.4	10.5	4.9	1.3	5.6	10.6	36.9	10.2	24.9	46.8	0.0	4.4	1.0	15.1	10.4	24.0	0.3	5.3	14.5	17.0	6.3	11.8	49.5	23.6	32.2	11.4	7.1	6.9	75.7	35.6	13.9	62.2	26.3	9.1	0.3	0.5	21.1	0.9	30.8	5.4	11.7	0.9	19.1	12.6	6.5	42.1	15.8	33.0	2.2	8.4	3.2	1.8	1.5	3.4	26.6	1.4	1.0	1.4	11.1	13.0	7.9	4.6	0.6	5.5	30.8	35.1	24.1	43.7	41.4	21.4	32.8	25.8	24.5	21.0	41.1	47.3	28.7	22.4	14.7	170.4	5.7	5.5	12.5	22.0	10.8	7.4	5.8	4.7	10.3	7.2	21.1	18.4	68.8	5.5	10.2	56.8	9.8	30.9	100.0	40.1	44.1	13.1	7.7	82.5	217.1	36.3	11.5	18.6	34.1	64.1	116.4	29.5	3.9	0.2	22.0	0.0	220.8	54.8	12.2	12.4	15.9	54.5	5.0	29.0	21.4	187.4	84.7	13.6	11.3	125.2	317.8	67.7	24.7	44.8	7.0	19.7	25.2	3.6	18.1	31.4	59.2	7.3	81.3	73.8	68.9	5.9	2.6	2.2	10.0	87.8	27.4	21.5
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;intestine: 1.0;liver: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"OE19: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"				"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	2.3	0.0	1.3	0.0	0.8	0.5	3.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.6	0.0	1.1	0.1	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.2	2.5	0.1	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.3	0.5	3.3	0.9	0.6	1.6	1.0	2.5	1.0	1.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 291.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	23.4	49.7	188.4	21.3	197.6	11.4	20.0	112.5	291.7	29.2	16.6	26.5	5.5	30.0	5.0	11.6	27.9	10.9	17.1	215.0	162.0	24.8	3.7	23.6	25.8	259.6	158.1	50.5	16.4	17.5	102.2	10.0	266.1	24.3	5.2	38.8	11.7	12.7	4.3	20.2	24.8	14.7	100.8	48.2	15.1	9.0	159.3	43.5	63.9	3.7	12.4	21.9	19.0	179.9	10.4	11.6	74.4	125.1	1.9	7.3	5.1	12.0	0.4	35.8	16.8	73.6	13.7	0.5	36.3	4.6	2.0	68.6	52.2	1.3	11.1	5.2	14.0	5.1	17.0	27.6	9.9	3.9	42.0	15.3	0.3	11.5	2.9	1.5	1.3	34.4	98.8	2.2	9.6	11.7	142.0	17.7	76.5	2.4	81.7	143.8	12.1	58.0	60.9	2.0	192.5	146.6	5.7	3.4	14.9	5.9	2.1	25.9	1.9	0.8	20.4	0.8	2.6	4.9	10.4	3.6	2.1	14.3	48.8	1.1	0.0	1.1	2.5	0.1	2.7	0.2	5.2	4.5	0.1	0.6	6.2	5.3	0.1	0.0	0.1	1.1	0.9	2.0	188.4	197.6	112.5	291.7	215.0	162.0	259.6	158.1	266.1	100.8	159.3	179.9	5.8	6.4	2.5	16.3	17.1	8.2	6.9	11.9	8.6	108.5	4.7	14.7	2.3	4.3	3.2	3.7	52.1	11.7	13.4	1.1	13.7	4.0	10.0	1.6	17.9	7.8	37.2	4.6	56.9	2.5	4.0	25.4	2.0	2.7	4.5	254.2	6.8	0.0	2.3	109.4	67.1	0.6	4.1	2.2	7.6	18.8	30.1	3.5	7.2	7.5	4.6	37.2	16.5	21.1	11.3	2.2	0.1	35.7	5.3	4.5	0.1	5.0	0.8	44.5	13.1	3.0	20.9	3.3	6.7	1.6	4.3	8.8	28.6	51.0	0.6	2.7
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 333.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 45.6;Horizontal cells: 92.5;Oligodendrocyte precursor cells: 27.6;Oligodendrocytes: 217.4"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	0.3	10.2	128.0	0.2	147.2	0.1	0.2	154.9	333.3	0.5	66.3	4.3	0.6	0.4	0.9	0.1	0.3	0.2	0.1	148.1	150.9	0.1	0.1	0.1	0.0	185.1	152.3	0.2	0.1	0.0	1.1	0.0	184.4	0.5	1.4	21.4	0.1	0.2	0.2	0.4	1.6	0.6	151.1	0.0	0.9	0.6	150.9	0.0	0.1	0.0	0.0	0.6	0.6	265.7	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	86.8	3.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.0	147.2	154.9	333.3	148.1	150.9	185.1	152.3	184.4	151.1	150.9	265.7	0.1	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	45.6	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	92.5	18.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.6	0.0	9.7	0.0	27.6	217.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.8	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5
STOML1	"FLJ36370, hUNC-24, SLP-1, STORP"	ENSG00000067221	"Stomatin like 1"	Q9UBI4	15	73978926-73994622	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042353	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 65: Brain - Ion transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA042353: AB_10797387"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.67e-2)"	11.4	17.3	33.0	6.5	33.7	4.5	10.4	22.0	38.5	9.8	17.1	11.0	5.9	9.1	5.6	9.4	7.3	6.3	23.6	36.8	32.4	8.6	13.2	10.2	5.6	34.6	30.5	8.5	10.1	7.8	16.6	7.5	36.8	9.9	3.6	3.1	8.3	8.8	18.6	9.4	7.9	7.7	26.5	7.9	9.5	13.1	32.6	8.1	13.6	8.9	3.8	11.8	9.2	28.4	5.8	10.8	6.4	8.8	12.7	8.0	5.4	18.3	7.1	9.8	8.3	3.2	31.4	5.8	28.3	14.9	7.3	18.9	6.1	12.9	3.1	19.4	6.6	6.1	10.0	3.6	12.5	4.0	4.6	14.3	9.9	15.4	14.5	8.1	9.3	13.1	14.6	10.9	14.3	8.8	7.6	2.9	3.1	8.9	8.6	4.5	6.5	8.9	20.7	6.3	12.1	7.9	8.4	10.9	11.9	4.0	9.1	4.4	14.3	22.4	7.2	25.8	24.9	10.6	5.8	3.0	20.6	12.1	11.6	1.0	4.1	2.5	5.3	7.7	4.4	4.5	4.3	7.0	6.5	5.6	8.7	9.2	2.1	8.0	18.2	11.5	8.1	5.5	33.0	33.7	22.0	38.5	36.8	32.4	34.6	30.5	36.8	26.5	32.6	28.4	15.2	0.0	4.1	7.2	5.3	3.2	3.7	7.2	1.8	13.1	7.0	4.8	10.8	2.8	5.8	7.3	6.2	13.0	3.5	8.9	1.9	25.1	1.0	2.8	6.2	7.7	10.2	4.2	6.9	19.0	8.6	11.4	12.8	5.4	4.5	8.5	5.0	5.1	10.8	16.8	8.1	7.3	4.1	3.3	2.2	2.6	9.0	3.3	3.6	2.8	2.5	11.9	2.1	7.5	4.1	20.8	4.9	11.7	3.4	6.8	12.6	4.8	2.7	14.0	6.6	7.5	9.7	20.8	7.8	4.7	2.0	5.6	4.1	13.7	5.6	3.3
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 79.8"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	3.4	0.8	65.6	1.2	64.8	5.5	9.6	31.2	44.7	4.6	14.1	4.4	4.0	1.2	5.1	14.3	10.7	5.9	3.0	60.1	79.8	14.3	3.0	5.0	1.0	36.5	68.3	2.8	0.9	0.3	10.0	2.5	39.5	2.1	5.0	10.2	5.6	2.7	13.2	8.0	4.3	1.7	27.0	16.3	5.7	3.3	60.9	2.5	10.8	17.4	2.9	6.3	9.5	53.7	4.7	3.1	12.1	0.2	0.0	0.1	13.4	0.0	0.1	0.0	0.3	10.0	4.2	0.0	5.5	0.0	3.4	30.6	16.5	39.8	0.0	0.8	5.5	113.4	19.9	4.2	0.0	0.0	60.9	1.7	33.5	0.0	11.0	0.0	0.0	6.1	40.2	58.3	1.2	6.8	5.4	0.0	11.9	11.5	2.4	0.1	17.6	3.4	8.4	46.0	28.1	1.7	13.7	0.6	0.0	9.9	1.7	0.3	0.3	2.4	8.8	9.7	2.6	6.0	11.9	0.1	8.4	0.4	2.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.1	65.6	64.8	31.2	44.7	60.1	79.8	36.5	68.3	39.5	27.0	60.9	53.7	6.3	3.2	0.5	253.4	0.1	13.6	13.2	20.5	30.7	0.6	11.8	8.1	1.1	2.8	6.8	18.4	12.5	1.4	0.1	4.8	7.9	0.6	0.4	56.0	1.2	5.0	0.0	12.2	0.9	0.5	0.4	8.3	7.1	16.1	0.0	12.5	4.2	0.9	3.4	3.3	4.4	3.2	14.2	18.0	6.1	1.6	10.2	13.5	1.8	23.4	2.3	23.9	0.0	12.1	15.2	3.2	2.7	8.6	1.0	6.8	4.6	20.6	5.8	6.1	0.0	36.1	3.2	1.0	5.9	24.3	8.8	15.5	0.9	6.3	2.7	33.2
SYNDIG1L	"capucin, DSPC1, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405894-74426210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	42	"brain: 468.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.7;Bipolar cells: 10.9;Inhibitory neurons: 4.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Region enriched"	"Detected in all"	5	"basal ganglia: 468.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 280.7"	"Region enriched"	"Detected in many"	7	"basal ganglia: 125.1"	"HPA042594, HPA048487"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 56: Bipolar cells - Visual perception"			"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.5	0.1	42.9	0.0	468.2	0.0	0.3	1.2	65.4	0.3	0.5	0.4	0.0	0.3	11.0	0.1	0.2	0.2	0.2	3.4	30.8	0.3	0.1	1.4	0.1	16.7	50.9	0.2	0.2	0.0	0.7	0.0	12.9	0.3	0.2	4.6	0.2	0.2	0.2	0.4	0.5	0.3	19.6	0.2	0.2	0.2	100.2	0.0	0.3	0.0	0.0	0.2	0.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	468.2	1.2	65.4	3.4	30.8	16.7	50.9	12.9	19.6	100.2	7.5	0.1	0.0	2.7	1.0	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0
SYNGR3		ENSG00000127561	"Synaptogyrin 3"	O43761	16	1989660-1994275	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 122.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.2;Inhibitory neurons: 33.7;Spermatogonia: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.9;NK-cells: 2.0;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.9;HMC-1: 30.3;Karpas-707: 25.8;SK-BR-3: 32.1;U-266/70: 40.2"									"CAB034278, HPA042842"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB034278: AB_2200905, HPA042842: AB_2678198"	"unprognostic (8.89e-3)"	"prognostic favorable (6.92e-4)"	"unprognostic (6.07e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.92e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.12e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.78e-2)"	0.3	9.4	83.0	2.9	86.4	0.9	0.3	35.7	106.5	0.5	10.6	5.3	1.3	0.2	0.0	0.5	0.4	0.4	0.9	74.7	110.7	3.8	0.3	1.0	3.2	88.2	95.3	0.6	0.8	7.3	12.3	1.6	122.6	0.8	1.1	9.5	1.1	0.1	0.1	0.6	5.9	0.7	34.3	2.5	2.3	5.6	121.3	0.5	0.4	0.0	3.7	0.4	1.3	70.5	0.9	4.0	3.7	0.5	0.4	0.4	4.5	1.9	3.1	1.5	1.2	6.3	2.9	6.2	1.4	1.4	4.1	3.5	4.1	0.5	0.4	49.9	2.9	0.1	5.9	3.1	2.1	0.0	30.3	0.9	0.2	0.1	1.0	7.2	0.4	1.9	17.9	25.8	0.7	4.7	0.3	0.3	19.0	0.7	1.8	0.0	0.5	4.9	2.4	0.1	8.6	10.7	4.4	32.1	0.4	2.0	4.5	0.4	0.7	0.9	14.5	0.1	0.7	40.2	5.0	7.2	0.6	5.5	0.6	0.0	0.3	0.0	0.3	0.1	0.8	1.2	0.6	1.1	0.3	1.9	0.7	0.3	0.0	2.0	0.3	0.0	0.6	0.4	83.0	86.4	35.7	106.5	74.7	110.7	88.2	95.3	122.6	34.3	121.3	70.5	0.1	0.0	0.6	3.3	5.0	0.3	0.8	0.6	1.2	5.0	0.2	0.3	5.4	0.0	0.6	0.0	2.1	0.5	2.1	0.9	1.9	2.0	0.8	0.0	0.1	0.5	0.0	0.0	24.2	0.5	0.8	1.2	0.5	0.1	1.3	1.4	0.0	0.0	0.3	6.7	33.7	0.5	0.0	0.6	0.4	0.5	0.0	0.5	0.0	1.9	2.7	1.1	2.1	2.5	3.5	1.2	0.0	0.0	2.3	5.5	0.1	0.1	0.9	2.1	0.0	0.1	0.3	3.0	8.6	0.4	0.3	3.1	2.9	0.4	0.3	1.7
SYT5		ENSG00000129990	"Synaptotagmin 5"	O00445	19	55171196-55180289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 72.6;pituitary gland: 59.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 57.6;Excitatory neurons: 20.3;Late spermatids: 41.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 27.1;HMC-1: 60.2;K-562: 22.7;OE19: 95.7;SCLC-21H: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078390	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA078390: AB_2732382"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.76e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.15e-3)"	"unprognostic (3.71e-7)"	"unprognostic (7.09e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-1)"	0.2	9.7	40.1	1.9	46.0	0.5	0.1	0.0	72.6	0.8	0.0	2.0	1.3	0.1	0.0	0.2	0.2	0.2	0.2	53.4	58.5	0.1	0.1	0.2	0.2	12.2	20.3	0.0	2.5	0.7	59.3	0.0	22.1	0.1	0.7	4.4	0.0	0.0	0.1	0.8	1.1	0.5	13.3	0.1	1.9	5.4	32.4	0.2	0.1	0.0	0.3	0.1	0.3	39.9	0.2	0.2	0.4	0.4	0.9	0.0	0.3	0.6	0.0	0.0	0.9	0.0	1.1	1.7	27.1	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.1	1.1	0.1	60.2	0.7	0.2	0.0	0.1	0.0	0.5	0.5	22.7	3.8	0.0	0.6	0.5	0.0	0.1	95.7	3.8	0.1	0.4	0.3	0.0	0.1	15.9	7.1	0.0	1.1	0.9	0.0	0.5	0.1	0.1	1.4	1.3	1.7	0.1	0.2	1.4	0.9	0.5	0.1	0.3	1.4	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.5	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.1	40.1	46.0	0.0	72.6	53.4	58.5	12.2	20.3	22.1	13.3	32.4	39.9	0.2	0.0	0.0	3.3	1.0	0.6	0.1	1.4	0.0	2.8	0.1	0.6	1.1	0.0	0.4	0.0	4.2	0.0	1.0	0.8	0.0	0.3	15.4	9.1	0.3	0.1	57.6	2.7	20.3	0.4	0.1	0.3	5.6	0.2	0.0	0.7	0.4	0.0	0.2	6.7	11.9	0.8	4.1	0.6	0.0	41.4	0.3	0.1	0.0	3.7	0.1	0.4	0.0	1.5	2.5	0.9	0.1	0.4	0.1	0.1	2.1	0.0	4.0	0.4	0.0	0.0	0.7	8.2	7.6	0.0	0.1	0.0	1.0	0.2	0.6	0.4
TAFA1	"FAM19A1, TAFA-1"	ENSG00000183662	"TAFA chemokine like family member 1"	Q7Z5A9	3	68004247-68545621	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 15.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	6	"T-cells: 20.7"	"Cell line enriched"	"Detected in single"	10	"REH: 1.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 12.5;cerebral cortex: 35.6;hippocampal formation: 33.0"	HPA013407	Approved				"Secreted in brain"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA013407: AB_1848386"	"unprognostic (5.19e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.95e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-4)"	"unprognostic (5.77e-2)"	0.2	1.1	4.1	0.3	7.3	0.0	0.0	0.0	13.9	0.0	1.6	0.2	1.3	0.2	1.1	0.1	0.0	0.7	0.1	13.9	9.1	0.3	0.3	0.1	0.6	12.4	1.0	0.0	0.0	0.0	0.4	0.0	15.4	1.4	0.1	0.3	0.1	3.8	0.1	0.0	0.2	0.3	0.4	0.4	0.1	0.2	8.6	0.0	0.1	0.2	0.2	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	20.7	0.0	15.9	0.0	16.6	11.1	0.0	0.0	11.9	15.9	0.4	3.7	0.0	0.1	8.4	3.3	4.1	7.3	0.0	13.9	13.9	9.1	12.4	1.0	15.4	0.4	8.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998739-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7"	"Cancer enriched"	"Detected in many"	4	"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced					NA	NA		9000000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062620: AB_2684810"	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	0.3	33.5	291.3	1.5	313.2	0.0	0.1	250.3	442.4	0.0	172.3	11.4	0.6	0.0	0.0	0.2	0.0	0.2	0.6	318.0	310.2	4.5	0.3	0.5	0.2	300.5	235.8	0.3	5.6	0.0	100.9	0.0	292.8	0.5	2.3	74.3	0.2	0.2	0.2	0.6	2.4	1.1	212.3	0.1	3.3	0.3	254.2	1.3	0.4	0.0	0.2	0.2	1.1	309.3	0.0	0.0	104.1	0.2	0.0	0.0	0.1	2.6	1.9	0.1	0.1	0.4	0.2	0.0	3.8	0.0	0.1	0.7	0.1	7.2	1.4	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.8	0.4	0.0	0.1	0.0	4.0	0.0	9.0	15.1	2.8	0.0	41.6	0.0	55.5	94.5	0.0	0.1	0.0	2.1	0.1	0.3	0.0	0.3	0.3	0.0	0.3	0.1	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	291.3	313.2	250.3	442.4	318.0	310.2	300.5	235.8	292.8	212.3	254.2	309.3	0.1	0.0	0.0	16.6	0.0	0.8	1.2	1.0	0.0	104.3	0.2	0.3	0.7	0.0	1.8	5.5	8.4	0.0	0.1	0.0	0.0	0.1	2.6	0.2	0.0	1.1	5.3	0.0	78.1	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	297.8	49.3	0.0	30.5	0.0	0.0	0.9	0.0	0.4	0.0	15.0	0.0	16.3	0.0	32.2	18.8	2.3	0.0	0.0	0.0	1.1	0.0	31.9	12.8	50.7	0.0	0.4	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.9
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357629-150400308	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	13.0	10.8	44.2	14.5	43.8	13.9	13.5	43.4	104.8	15.4	40.1	20.4	7.3	16.7	7.4	16.6	14.8	6.5	14.9	43.3	42.2	14.8	9.5	12.5	18.3	44.3	43.6	15.7	14.8	9.9	11.0	10.3	44.5	15.7	8.7	9.6	12.1	10.8	21.4	16.6	15.3	11.7	40.9	18.8	14.3	14.5	45.0	20.5	12.6	9.7	16.2	19.7	14.1	48.9	78.3	85.0	42.7	80.3	16.2	21.4	115.1	59.4	24.5	81.1	80.9	211.5	59.3	113.1	53.2	21.9	92.6	88.2	93.0	107.4	57.4	59.9	100.8	54.9	55.6	80.8	17.4	91.5	40.7	18.0	24.8	94.1	71.4	20.1	36.1	59.2	80.2	32.8	27.7	70.7	100.4	67.4	128.8	35.3	80.4	91.4	67.4	64.8	19.5	54.3	58.0	59.7	68.5	111.0	55.2	66.8	49.7	36.1	35.0	59.3	73.5	71.8	113.4	40.6	55.6	123.4	46.6	78.2	54.1	1.6	2.2	1.1	3.8	2.0	4.8	4.6	3.6	3.8	2.1	4.2	3.1	3.4	1.4	8.3	2.1	2.2	2.4	3.2	44.2	43.8	43.4	104.8	43.3	42.2	44.3	43.6	44.5	40.9	45.0	48.9	18.5	9.6	22.4	7.8	41.7	40.0	21.1	14.5	15.9	25.4	13.6	12.7	17.9	11.5	10.4	11.0	41.7	21.7	29.7	24.0	5.9	19.6	8.4	13.2	17.3	24.4	18.7	23.3	7.4	23.4	41.0	20.1	18.3	17.6	23.5	29.1	12.8	10.0	28.8	21.9	6.4	18.8	16.2	27.9	53.3	6.8	19.0	40.0	12.4	2.8	27.8	9.7	33.0	3.0	8.9	15.2	8.4	15.8	26.1	37.8	15.1	6.3	10.1	25.6	26.3	20.3	17.7	27.6	34.1	22.7	39.1	8.9	26.3	20.1	32.0	19.3
TFPT	"amida, FB1, INO80F"	ENSG00000105619	"TCF3 fusion partner"	P0C1Z6	19	54107020-54115657	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034958, HPA058534"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA034958: AB_10603036, HPA058534: AB_2683745"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (6.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.66e-2)"	12.1	15.8	27.4	8.9	25.2	10.4	12.8	23.1	41.3	11.7	18.6	15.7	9.7	11.7	4.3	10.0	9.9	7.2	16.1	26.5	24.7	12.0	10.5	12.3	10.7	24.1	25.0	9.5	8.7	9.2	10.9	8.4	24.3	22.2	4.1	5.0	13.1	5.4	19.4	13.2	12.2	6.1	20.9	19.1	14.1	9.1	24.0	13.5	11.2	10.6	6.4	12.3	9.4	28.0	23.5	28.5	18.2	12.9	6.7	9.5	11.8	25.1	15.5	23.9	24.5	17.8	23.6	20.5	20.2	12.8	12.5	11.2	10.8	19.6	7.8	43.5	52.2	30.7	27.5	20.8	39.6	16.1	34.7	11.2	9.5	18.8	15.7	11.5	18.7	30.8	19.3	45.8	9.2	30.2	34.3	47.2	11.0	34.1	19.8	30.6	10.0	15.4	10.0	35.9	19.2	17.4	9.2	38.4	45.1	5.6	14.0	48.9	37.8	52.4	19.3	7.5	36.9	33.8	48.2	18.5	20.7	40.4	34.4	10.5	9.2	6.4	15.4	10.7	14.6	9.4	19.4	20.1	19.0	9.3	16.2	17.2	6.5	21.4	3.9	43.3	26.0	11.2	27.4	25.2	23.1	41.3	26.5	24.7	24.1	25.0	24.3	20.9	24.0	28.0	25.3	16.0	7.2	5.2	12.2	17.0	9.8	25.5	12.0	10.9	31.4	32.3	2.5	12.8	28.6	22.0	2.1	22.4	30.3	22.5	15.6	21.0	9.6	27.1	8.2	29.5	15.6	7.8	5.0	27.6	29.1	11.3	11.2	13.3	15.2	20.8	37.9	9.6	135.7	0.0	4.1	35.7	32.6	28.1	41.0	5.5	12.2	43.5	39.2	1.0	49.7	17.8	25.7	2.5	3.6	55.9	18.4	17.0	13.1	31.9	23.0	24.8	46.4	12.4	6.6	7.8	16.5	11.0	16.0	5.8	17.3	26.1	22.8	41.1	16.1	13.0
TMEFF2	"CT120.2, HPP1, TENB2, TPEF, TR"	ENSG00000144339	"Transmembrane protein with EGF like and two follistatin like domains 2"	Q9UIK5	2	191949043-192194933	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.3;prostate: 36.6;seminal vesicle: 13.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 416.1;Inhibitory neurons: 382.0;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 1337.5"	"Cancer enriched"	"Detected in some"	21	"prostate cancer: 57.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 36.9;LHCN-M2: 107.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015587	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA015587: AB_1858069"	"unprognostic (2.12e-3)"	"unprognostic (5.37e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.89e-7)"	"unprognostic (4.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.79e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-1)"	0.3	2.3	30.2	0.1	25.8	0.0	0.3	16.0	26.6	0.1	5.8	0.9	0.6	0.0	8.1	1.2	0.1	1.7	1.8	28.5	26.9	0.0	0.0	0.1	0.0	21.5	23.5	0.2	0.0	0.0	0.3	0.0	22.4	36.6	1.5	3.3	0.1	13.3	0.3	0.2	0.6	0.1	16.6	0.0	0.9	0.7	26.3	0.0	0.2	0.6	0.1	0.8	0.5	33.3	0.0	0.9	36.9	0.0	5.6	5.8	0.1	0.1	0.7	1.8	2.2	0.0	0.0	0.0	0.0	10.3	4.5	0.0	2.3	0.0	7.1	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.0	15.6	0.0	2.0	10.8	9.0	0.1	0.0	0.0	0.0	107.1	0.0	0.0	0.1	2.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.2	2.8	0.0	0.0	0.0	7.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	25.8	16.0	26.6	28.5	26.9	21.5	23.5	22.4	16.6	26.3	33.3	0.1	0.0	0.0	11.8	0.0	0.1	0.1	0.0	0.0	16.6	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.0	0.0	416.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.6	382.0	0.5	0.0	0.0	0.7	2.3	26.4	0.0	0.0	11.2	0.0	0.6	0.0	210.6	1337.5	0.0	0.0	8.6	0.0	5.7	0.1	0.0	0.0	1.6	6.6	24.6	0.6	1.2	2.6	0.3	0.3	0.0	0.4	0.0	0.0	0.1
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 10.3;Breast glandular cells: 8.8;Endometrial stromal cells: 8.9;Glandular and luminal cells: 8.8;Granulosa cells: 9.6;Hofbauer cells: 8.9;monocytes: 19.1;Syncytiotrophoblasts: 8.8;Theca cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	7.3	7.7	11.0	6.9	12.7	3.6	7.5	2.9	16.6	6.5	6.4	6.9	3.4	6.8	6.3	4.3	4.7	3.7	3.3	14.4	6.1	3.3	5.3	5.2	9.5	4.4	5.3	8.5	4.7	14.1	4.1	4.8	5.3	12.2	5.4	4.5	8.9	6.5	4.6	4.2	6.3	6.8	5.3	13.3	7.2	3.9	6.5	8.6	6.2	4.3	9.4	6.3	5.1	11.3	4.7	7.1	3.8	8.2	10.1	7.6	2.9	4.3	7.9	6.0	6.1	5.1	2.0	19.5	3.5	4.8	17.0	8.1	7.4	3.7	5.2	9.9	4.6	6.5	5.8	4.0	17.9	13.6	3.0	6.7	6.5	7.8	8.4	7.7	4.1	24.9	12.3	51.5	4.4	13.6	15.4	4.5	9.8	6.0	7.8	17.4	4.5	17.7	3.5	3.4	12.5	8.4	14.4	18.8	41.3	2.4	25.2	12.2	2.5	6.0	6.8	2.3	8.3	27.8	27.5	20.7	3.1	11.4	11.0	0.3	1.3	0.2	0.6	1.0	0.2	1.3	0.7	0.4	0.7	2.2	0.9	0.8	1.0	0.8	1.0	4.7	0.1	0.5	11.0	12.7	2.9	16.6	14.4	6.1	4.4	5.3	5.3	5.3	6.5	11.3	1.7	0.0	10.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	8.8	5.2	0.0	0.0	1.3	0.0	0.0	4.7	3.0	0.0	0.0	1.4	0.0	5.0	8.9	0.5	0.0	0.0	0.0	4.6	1.2	1.3	0.0	8.8	0.0	9.6	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	19.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.0	1.9	4.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.8	1.1	9.7	0.0	0.0
TMEM275		ENSG00000282881	"Transmembrane protein 275"	A0A0U1RQS6	1	46532166-46543969	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 2.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 1.2;basal ganglia: 1.6;hypothalamus: 1.2"											NA	NA				"Cluster 65: Brain - Ion transport"																							0.0	0.0	1.3	0.0	1.1	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	1.7	1.2	2.0	0.7	0.7	1.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 282.6;pituitary gland: 82.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.9;Bipolar cells: 92.2;Excitatory neurons: 110.7;Horizontal cells: 50.5;Inhibitory neurons: 88.0;Muller glia cells: 67.9;Oligodendrocyte precursor cells: 42.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.0;ASC diff: 42.6;EFO-21: 25.3;Hep G2: 27.3;hTERT-RPE1: 23.3;SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	1.9	16.8	205.4	1.3	228.2	0.0	1.6	90.2	282.6	2.7	29.6	8.4	0.5	2.6	0.4	2.3	1.4	1.9	10.4	238.3	265.6	3.1	0.5	1.3	0.2	133.0	121.9	0.6	3.2	3.9	82.1	0.9	119.1	1.8	0.8	21.2	1.2	1.3	2.9	0.7	3.5	2.2	100.3	0.5	2.6	2.4	177.3	0.1	5.8	0.2	0.1	0.7	2.3	166.3	0.0	1.0	0.3	36.0	42.6	2.0	0.0	3.9	0.7	1.4	0.8	0.1	1.8	0.1	25.3	2.3	3.6	0.5	10.7	0.1	1.2	0.2	1.7	0.0	0.5	27.3	6.5	0.0	0.5	15.8	0.0	0.5	1.2	23.3	0.0	1.5	0.0	0.3	1.0	1.6	0.2	0.0	3.3	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.6	21.0	2.5	0.0	0.0	0.3	0.3	0.0	0.4	0.8	8.4	0.3	2.4	5.3	2.1	0.3	1.4	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	205.4	228.2	90.2	282.6	238.3	265.6	133.0	121.9	119.1	100.3	177.3	166.3	0.2	0.0	0.0	35.9	0.0	0.0	0.2	1.9	0.0	92.2	0.1	2.5	0.5	0.0	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.5	1.7	0.4	11.7	0.4	0.0	0.0	110.7	0.0	0.1	4.1	0.0	0.3	0.0	0.3	0.0	0.0	0.2	50.5	88.0	0.0	0.0	0.0	0.3	1.6	0.3	0.1	0.0	18.7	0.6	67.9	0.0	42.3	18.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	27.5	0.0	1.2	4.1	3.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693352	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 185.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Excitatory neurons: 45.2;Horizontal cells: 42.1;Inhibitory neurons: 32.6;Oligodendrocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.4;AN3-CA: 5.4;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favorable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.8	6.6	100.8	0.7	136.7	0.2	2.5	55.3	120.4	1.8	0.0	12.8	5.2	3.3	0.5	11.0	10.4	1.7	9.8	112.3	69.9	4.4	2.7	10.2	0.3	110.3	102.3	1.8	6.0	2.1	19.5	2.2	107.7	2.3	1.8	6.3	5.7	3.6	10.5	8.2	9.5	3.6	47.5	2.6	4.9	2.2	124.6	0.4	6.9	5.3	1.4	6.8	2.7	185.2	0.2	7.4	0.3	5.4	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.5	0.0	1.9	2.9	2.9	0.0	0.0	1.5	2.5	0.2	3.6	0.2	0.8	0.2	0.3	0.0	0.7	0.0	0.1	0.2	0.0	0.1	0.1	2.7	0.0	0.2	0.2	0.5	0.2	0.8	0.7	0.3	0.1	1.0	0.2	1.0	13.2	1.6	0.8	0.3	3.6	0.3	0.7	0.2	0.1	0.2	2.7	0.0	0.2	1.0	0.2	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	100.8	136.7	55.3	120.4	112.3	69.9	110.3	102.3	107.7	47.5	124.6	185.2	1.6	38.5	10.0	6.8	0.7	4.1	1.4	0.6	9.6	21.3	3.1	2.4	18.4	2.8	5.3	1.8	0.0	0.0	1.1	5.7	1.9	2.4	9.1	26.6	0.9	2.0	10.2	0.0	45.2	0.7	0.3	3.3	3.1	5.8	4.5	0.1	2.2	4.3	3.3	42.1	32.6	6.5	0.0	0.0	2.2	7.2	0.3	1.2	1.8	4.7	0.1	0.9	0.0	6.6	104.7	0.7	5.2	0.4	3.3	0.8	10.3	1.1	13.5	2.4	0.0	1.5	4.2	2.2	0.8	6.7	3.1	0.0	4.8	0.1	4.8	4.1
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086585-109121565	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055162	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055162: AB_2732592"										"unprognostic (1.92e-2)"				"unprognostic (8.58e-2)"		"unprognostic (1.17e-1)"		0.0	0.0	3.2	0.0	0.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	0.0	5.2	3.4	1.4	0.9	1.2	1.2	1.7	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM46	"FLJ23229, TRIFIC"	ENSG00000163462	"Tripartite motif containing 46"	Q7Z4K8	1	155173787-155184971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Early spermatids: 6.5;Excitatory neurons: 13.1;Inhibitory neurons: 9.7;Late spermatids: 7.5;Oligodendrocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055583	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA055583: AB_2732599"	"unprognostic (1.06e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (2.61e-7)"	"unprognostic (1.75e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.65e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-12)"	"unprognostic (8.58e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-2)"	0.6	0.4	8.3	0.5	9.2	0.3	0.5	8.4	10.1	1.1	4.0	0.8	0.3	3.1	3.3	0.4	2.3	0.4	0.3	9.4	7.6	0.6	0.1	0.5	0.5	7.3	6.3	0.3	0.5	0.1	4.9	0.1	7.5	1.1	0.1	1.1	0.4	0.8	0.1	0.3	0.7	0.9	6.2	1.0	1.0	1.9	7.9	1.1	0.3	0.0	0.2	0.5	0.9	8.8	1.7	2.2	1.5	0.1	0.3	1.3	0.1	1.6	1.7	1.9	2.2	0.0	0.8	0.7	1.1	2.0	0.4	1.8	0.0	0.7	0.6	3.9	0.7	1.3	2.6	0.1	0.8	0.4	4.1	1.4	0.4	2.0	0.7	4.5	2.5	4.1	0.0	3.2	1.0	1.1	2.4	0.2	5.7	0.2	2.3	4.1	0.1	0.8	0.3	0.0	3.9	9.3	0.7	0.5	1.2	0.6	2.8	3.4	3.7	3.8	1.2	0.2	0.8	3.2	1.2	0.7	4.0	0.6	1.1	0.4	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.1	8.3	9.2	8.4	10.1	9.4	7.6	7.3	6.3	7.5	6.2	7.9	8.8	0.2	0.0	0.0	1.0	0.3	0.4	0.8	0.2	0.0	6.9	2.9	1.8	1.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.7	6.5	2.9	0.4	0.7	1.8	0.8	13.1	0.2	0.0	0.8	1.5	3.9	0.0	0.1	0.4	0.0	0.8	0.0	9.7	0.0	0.0	0.0	1.0	7.5	0.3	0.2	0.0	0.0	2.6	0.6	2.1	3.0	9.8	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.6	0.0	1.4	0.9	1.3	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.8
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"brain: 110.8;choroid plexus: 32.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.1;Excitatory neurons: 39.3;Horizontal cells: 18.5;Inhibitory neurons: 19.7;Oligodendrocyte precursor cells: 27.2"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria	"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	0.0	0.6	73.9	0.3	74.7	0.0	0.0	49.7	110.8	0.0	32.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	84.2	60.6	0.2	0.0	0.0	0.0	45.1	46.3	0.0	0.0	0.0	0.9	0.0	46.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.1	43.0	0.0	0.2	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.1	69.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	26.8	1.4	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	73.9	74.7	49.7	110.8	84.2	60.6	45.1	46.3	46.4	43.0	60.4	69.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	39.1	0.2	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.8	0.2	0.2	1.8	0.0	39.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	18.5	19.7	0.1	0.0	0.0	0.0	1.0	0.3	0.0	0.0	4.7	0.0	1.7	0.0	27.2	5.0	0.1	1.2	0.7	0.0	0.1	0.0	0.0	1.2	8.4	0.0	0.0	0.1	7.0	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"TUB like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 32.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Oligodendrocytes: 544.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.4	2.5	27.1	2.1	32.7	1.1	3.1	15.0	16.1	2.8	0.0	2.5	4.0	3.0	2.8	3.5	2.1	2.2	2.6	15.2	13.1	3.1	2.3	2.7	3.1	16.1	23.9	2.5	2.7	5.0	4.6	2.6	10.8	2.4	2.0	7.0	3.1	2.4	6.3	6.0	4.3	2.4	14.8	2.9	3.0	4.0	19.3	3.2	4.6	3.6	3.0	2.4	3.0	27.1	2.7	5.7	4.1	9.1	7.2	4.5	8.6	2.6	3.7	2.4	2.9	8.4	1.7	7.4	2.5	5.3	7.0	4.7	4.9	6.4	4.4	4.8	2.7	3.7	4.2	8.7	5.2	3.4	3.9	3.5	7.3	4.0	8.3	8.7	6.2	7.0	5.8	11.3	6.8	4.1	3.5	3.9	2.8	3.2	2.6	7.4	9.8	4.7	4.0	4.3	7.9	9.8	7.5	11.1	8.0	3.9	6.5	4.5	10.0	6.2	7.4	9.2	10.1	7.7	10.1	6.2	5.9	2.6	7.8	0.3	1.4	0.0	1.8	1.5	2.4	1.8	2.1	2.4	0.9	1.9	1.5	1.7	0.1	1.3	2.1	3.2	2.9	1.6	27.1	32.7	15.0	16.1	15.2	13.1	16.1	23.9	10.8	14.8	19.3	27.1	27.0	3.2	25.4	62.7	25.8	21.4	16.4	12.3	16.5	51.2	31.3	22.5	52.8	12.8	20.6	25.8	171.0	29.4	25.9	16.5	15.6	18.0	5.3	46.5	51.2	25.7	20.4	7.8	157.3	15.7	8.9	20.0	13.7	51.6	5.1	17.7	16.8	15.2	12.9	158.2	153.4	13.3	8.2	17.9	10.7	8.4	28.3	15.4	16.0	76.8	13.0	16.1	14.4	137.2	544.9	22.5	15.3	41.8	24.7	20.8	53.2	26.0	18.8	79.8	13.1	33.9	26.8	21.8	33.5	19.6	39.2	18.9	21.1	52.4	17.3	23.6
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17 like family member 11"	C9JVI0	4	9215405-9216997	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"brain: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	3.2	0.0	1.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	2.4	1.4	3.4	2.4	1.0	3.6	0.2	2.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L15		ENSG00000223569	"Ubiquitin specific peptidase 17 like family member 15"	C9J2P7	4	9234385-9236046	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	87	"brain: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	7.1	0.0	3.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	3.8	0.0	0.0	0.0	0.0	10.4	0.9	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	3.5	0.0	7.6	6.8	3.8	10.4	0.9	12.3	0.9	12.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L22		ENSG00000248933	"Ubiquitin specific peptidase 17 like family member 22"	D6RA61	4	9267619-9269211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"brain: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	1.4	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	1.2	0.8	0.6	1.3	0.1	1.8	0.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 8.4"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 7.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 3.1;WM-115: 2.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5"	"Low region specificity"	"Detected in some"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.0	0.0	1.6	0.0	4.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.4	0.0	2.8	0.2	8.4	0.1	0.2	0.0	0.0	2.3	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VSTM2B		ENSG00000187135	"V-set and transmembrane domain containing 2B"	A6NLU5	19	29526499-29564479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 46.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.6;Excitatory neurons: 55.9;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 97.5;Oligodendrocytes: 228.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"								"unprognostic (1.74e-1)"				"unprognostic (1.87e-3)"	"unprognostic (6.64e-2)"				"unprognostic (1.08e-2)"	"unprognostic (5.35e-2)"			0.0	0.1	32.2	0.0	41.0	0.0	0.0	14.7	46.8	2.9	0.2	0.4	0.0	0.1	0.4	0.0	0.1	0.0	0.0	35.6	23.1	0.0	0.0	0.0	0.0	26.4	20.6	0.0	0.0	0.0	0.2	0.0	24.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.2	17.2	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	1.7	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.2	41.0	14.7	46.8	35.6	23.1	26.4	20.6	24.1	17.2	27.5	40.9	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	55.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.1	0.0	97.5	228.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VWC2L		ENSG00000174453	"Von Willebrand factor C domain containing 2 like"	B2RUY7	2	214411054-214578976	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 2.7;retina: 1.4"	"Group enriched"	"Detected in some"	21	"Excitatory neurons: 67.4;Inhibitory neurons: 132.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044815, HPA059414"	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044815: AB_10962359, HPA059414: AB_2684007"	"unprognostic (8.77e-2)"				"unprognostic (2.83e-3)"			"unprognostic (2.05e-2)"		"unprognostic (8.49e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.05e-1)"		"unprognostic (3.89e-1)"		0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.2	0.0	0.0	0.0	0.0	0.8	1.8	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.7	0.1	2.1	2.7	2.2	0.8	1.8	1.8	0.2	2.3	1.8	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	67.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	132.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	4.5	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
VXN	"C8orf46, MGC33510"	ENSG00000169085	Vexin	Q8TAG6	8	66493520-66518524	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 123.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.1;Proximal tubular cells: 3.4;Syncytiotrophoblasts: 1.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.5;GAMG: 5.4;HBF TERT88: 3.9;LHCN-M2: 4.4;T-47d: 5.8;WM-115: 4.5"	"Group enriched"	"Detected in all"	8	"amygdala: 159.7;basal ganglia: 78.9;cerebral cortex: 298.2;hippocampal formation: 219.3;white matter: 199.5"	"Low region specificity"	"Detected in all"			HPA075134			Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA075134: AB_2686736"	"unprognostic (6.87e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-4)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.53e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.91e-2)"	0.3	0.5	61.0	0.3	72.1	0.0	0.5	52.0	87.2	0.9	21.7	1.8	0.0	0.7	1.3	0.0	0.5	0.2	0.3	123.8	47.4	0.6	1.4	0.3	0.0	53.1	56.2	0.3	0.6	0.4	0.4	0.0	56.0	1.5	0.3	0.2	0.1	5.4	0.5	0.2	0.5	1.1	53.4	0.1	1.2	0.3	53.7	0.0	0.2	0.0	0.3	0.3	0.4	84.5	2.7	0.1	1.0	1.3	0.1	0.1	0.0	0.2	0.4	1.2	1.3	0.1	4.5	0.0	0.1	2.9	5.4	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.1	4.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.9	0.1	0.2	0.0	0.1	0.1	3.0	0.1	5.8	0.0	0.0	0.4	0.9	0.0	1.9	2.0	1.1	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	72.1	52.0	87.2	123.8	47.4	53.1	56.2	56.0	53.4	53.7	84.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	0.0	0.0
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710355-784729	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	6	"brain: 29.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 23.0;Excitatory neurons: 47.2;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 70.1;Respiratory ciliated cells: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;SCLC-21H: 2.4;THP-1: 3.4"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.7	1.2	15.1	0.2	19.6	0.0	0.8	5.9	19.9	0.5	0.0	2.0	2.7	0.4	0.1	1.5	2.0	0.3	4.5	14.6	9.0	0.7	1.2	2.4	0.0	14.2	8.6	0.6	1.8	0.4	4.5	0.2	14.9	0.5	2.3	4.3	1.7	0.5	3.6	2.2	2.4	0.4	3.3	1.2	2.3	0.7	15.5	0.0	1.1	1.6	0.3	1.0	0.6	29.5	0.0	0.8	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	2.1	0.1	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.4	0.4	0.0	0.0	0.7	0.3	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.8	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	19.6	5.9	19.9	14.6	9.0	14.2	8.6	14.9	3.3	15.5	29.5	0.2	19.2	23.0	17.0	0.0	2.7	1.0	0.1	2.2	7.0	1.1	0.9	8.9	1.5	5.7	3.7	0.0	0.0	0.4	2.0	0.0	0.8	2.5	11.9	0.7	2.8	3.0	0.0	47.2	0.8	0.1	4.7	4.1	3.6	1.3	0.0	0.7	2.3	1.7	10.1	38.3	6.7	0.0	0.6	1.1	0.4	0.9	0.8	0.0	1.9	0.0	0.6	0.0	26.7	70.1	0.1	1.4	0.0	1.7	0.3	7.7	0.5	21.8	0.3	6.6	1.4	2.4	5.0	2.5	2.3	3.1	0.0	1.5	0.5	2.4	2.6
ZMAT3	"FLJ12296, MGC10613, PAG608, WIG-1, WIG1"	ENSG00000172667	"Zinc finger matrin-type 3"	Q9HA38	3	178960121-179072215	"Predicted intracellular proteins"	"Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HSkMC: 76.0;LHCN-M2: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027569, HPA028671, HPA054356"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460"	"unprognostic (3.53e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.46e-2)"	5.2	7.9	9.9	5.2	10.9	3.4	5.9	4.4	14.5	5.8	3.4	6.3	3.4	5.2	6.2	6.8	5.8	8.9	6.1	12.1	11.0	6.3	12.6	5.9	7.4	10.5	12.1	4.4	4.1	8.8	4.9	5.6	11.9	5.9	8.5	6.1	4.3	7.7	3.1	6.1	3.4	11.2	9.9	6.9	5.1	4.1	12.5	10.2	7.5	4.4	6.4	6.1	3.7	11.7	5.9	4.0	12.8	8.4	57.4	64.2	28.3	23.1	33.9	3.3	4.3	5.1	3.5	24.2	11.1	36.2	5.1	5.4	4.6	24.6	7.6	20.7	7.0	10.7	7.8	16.2	45.7	11.7	16.0	76.0	45.2	8.1	16.7	51.2	48.5	6.8	5.7	3.3	87.7	5.8	9.3	2.1	5.7	8.3	3.3	10.7	11.1	5.2	19.2	11.3	3.0	12.7	7.1	6.4	7.7	23.8	8.0	4.9	53.2	49.9	19.2	8.3	11.0	3.2	2.9	10.2	29.6	1.7	34.9	2.1	0.7	1.7	1.8	0.6	1.0	0.9	1.3	1.4	0.7	1.8	2.2	1.5	0.8	1.6	1.4	0.8	1.0	0.6	9.9	10.9	4.4	14.5	12.1	11.0	10.5	12.1	11.9	9.9	12.5	11.7	11.2	54.5	105.8	38.2	24.6	39.6	10.6	26.1	34.1	19.5	22.2	22.9	21.0	24.3	53.8	35.0	25.0	10.7	25.1	14.0	7.9	16.1	1.1	12.0	15.7	14.6	20.9	14.5	40.7	20.7	2.9	28.2	19.9	12.2	39.8	19.8	17.2	32.1	18.2	62.2	36.7	9.5	30.5	40.2	16.6	2.2	20.2	24.4	51.6	41.2	49.7	15.5	32.0	87.4	18.9	28.6	11.9	29.0	11.1	17.3	14.0	20.2	45.1	11.1	39.5	25.0	23.8	9.5	13.1	25.2	36.7	4.4	29.8	42.8	10.4	11.1